################################################################################
#                                                                              #
#                          GUIDELINE EXTRACTION REPORT                         #
#                      ISO 11135 Parameters & Requirements                     #
#                                                                              #
################################################################################

Generated: 2025-12-03 09:28:17
Total Parameters Extracted: 849


CATEGORY: HUMIDITY

┌─ PARAMETER 01 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: moisture
│  Relevance Score: 5.0/5.0
│
│  Context:
│    oisture content. At low levels of humidity, below 30 %, microbial
│    resistance may increase with decreased humidity for some products.
│    For this reason it is common practice to control and monitor the
│    humidity of the atmosphere to which the product is exposed in order
│    to attempt to equilibrate the moisture content of the microorganisms
│    with the local conditions. Consideration should be given to the
│    packaged product to ensure that excessive relative humidity will not
│    impact the product functionality and package integrity. One of the
│    ways to assist in addressing the humidity in the product is to pre
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 02 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: moisture
│  Relevance Score: 3.5/5.0
│
│  Context:
│    necessary to correctly operate the sterilizing equipment and to
│    achieve effective sterilization of medical devices. D.6.1 General No
│    guidance offered. D.6.2 Process characterization D.6.2.1 No guidance
│    offered. D.6.2.2 The resistance of microorganisms to deactivation by
│    EO is affected by their moisture content. At low levels of humidity,
│    below 30 %, microbial resistance may increase with decreased humidity
│    for some products. For this reason it is common practice to control
│    and monitor the humidity of the atmosphere to which the product is
│    exposed in order to attempt to equilibrate the moistur
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 03 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: relative humidity
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ason it is common practice to control and monitor the humidity of the
│    atmosphere to which the product is exposed in order to attempt to
│    equilibrate the moisture content of the microorganisms with the local
│    conditions. Consideration should be given to the packaged product to
│    ensure that excessive relative humidity will not impact the product
│    functionality and package integrity. One of the ways to assist in
│    addressing the humidity in the product is to precondition product at
│    a defined temperature and humidity. Such preconditioning can reduce
│    the duration of the sterilization cycle. For health care faciliti
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 04 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: relative humidity
│  Relevance Score: 3.0/5.0
│
│  Context:
│    cally calculated by measuring the partial pressure of water vapour
│    injected into the chamber. The relative humidity value is then
│    determined using the steam tables by a ratio of the partial pressure
│    to the saturated vapour pressure for the actual cycle process
│    temperature. This will indicate the relative humidity value in the
│    head space of the chamber and will be accurate until load or other
│    reactions impact the actual water vapour content in the head space.
│    Consideration should be given to the amount of moisture introduced
│    into the chamber with the load from preconditioning. f) No guidance
│    offered. g)
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 05 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: moisture
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ed vapour pressure for the actual cycle process temperature. This
│    will indicate the relative humidity value in the head space of the
│    chamber and will be accurate until load or other reactions impact the
│    actual water vapour content in the head space. Consideration should
│    be given to the amount of moisture introduced into the chamber with
│    the load from preconditioning. f) No guidance offered. g) Forced gas
│    circulation is particularly important when gas mixtures are used in
│    order to ensure uniform conditions are maintained and to avoid
│    stratification of gases that might have an impact on microbia
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 06 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: relative humidity
│  Relevance Score: 2.5/5.0
│
│  Context:
│    performs in accordance with predetermined criteria and thereby yields
│    product meeting its specification [SOURCE: ISO/TS 11139:2006,
│    definition 2.30] 3.27 preconditioning treatment of product, prior to
│    the sterilization cycle, in a room or chamber to attain specified
│    conditions for temperature and relative humidity 3.28 process
│    challenge device PCD item designed to constitute a defined resistance
│    to a sterilization process and used to assess performance of the
│    process [SOURCE: ISO/TS 11139:2006, definition 2.33] Note 1 to entry:
│    For the purpose of this International Standard, a PCD can be product,
│    simulated
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 07 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: relative humidity
│  Relevance Score: 2.5/5.0
│
│  Context:
│    od and/or hold time; 2) pressure change; c) inert gas addition (if
│    used); 1) pressure (∆P or terminal pressure) and rate (∆P/time) of
│    attainment of pressure on admission of the inert gas. d) conditioning
│    (if used); 1) during the conditioning phase, pressure rise (∆P or
│    terminal pressure) or % relative humidity and rate (∆P/time) of
│    attainment of pressure on injection of steam; 2) number of steam
│    pulse/vacuum stages, if applicable; e) EO injection: 1) pressure,
│    pressure rise (∆P) and rate (∆P/time) of attainment of specified
│    pressure on admission of EO and correlation of methods used to
│    monitor EO co
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 08 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: relative humidity
│  Relevance Score: 2.5/5.0
│
│  Context:
│    Temperature and humidity sensors should be located within the sterile
│    barrier system or amongst the unit packages in the sterilization
│    load. When preconditioning is used, the product should be
│    preconditioned within the specified time range. When preconditioning
│    is not used, the temperature and relative humidity within the load
│    should be within defined limits prior to the end of the conditioning
│    phase of the cycle. The temperature and humidity profile within the
│    sterilization load should be evaluated during the time that is needed
│    for the sterilization load to attain the minimum predetermined
│    temperature
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 09 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: relative humidity
│  Relevance Score: 2.5/5.0
│
│  Context:
│    g, or extend preconditioning time to allow the internal temperature
│    and humidity to be within acceptable ranges. NOTE The minimum
│    temperature of products entering preconditioning or the storage
│    conditions are defined during PQ. b) The reference position for
│    routine monitoring of temperature and relative humidity during
│    preconditioning should be correlated to the location at which it is
│    most difficult to achieve the desired conditions. Monitoring data for
│    the operation of the preconditioning area should be reviewed in
│    conjunction with other data for the release of product. c) No
│    guidance offered. d) No
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 10 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: relative humidity
│  Relevance Score: 2.5/5.0
│
│  Context:
│    s a method of releasing product from sterilization as sterile without
│    the use of BIs, relying instead on a demonstration of conformity of
│    the physical processing parameters to all specifications. Therefore,
│    data are gathered for additional processing parameters such as direct
│    analysis of chamber relative humidity and EO concentration, in order
│    to ensure that the sterilization process has met specification. a)
│    Temperature measurement. The requirement to measure temperature
│    within the sterilizer from a minimum of two locations is established
│    in order to ensure that an undetected fault in a temperature sens
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 11 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: relative humidity
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ence should be defined within the processing specification. If either
│    the controlling or the monitoring sensor do not meet specification
│    and an investigation cannot determine the accuracy of the chamber
│    readings, the load is rejected b) Humidity measurement. Direct
│    analysis of the head space for relative humidity can be performed
│    using electronic sensors, Gas Chromotography (GC), Infrared (IR) or
│    other spectroscopic methods currently available to ﻿ © ISO 2014 – All
│    rights reserved 57 BS EN ISO 11135:2014+A1:2019 --- PAGE 80 --- ﻿
│    ISO 11135:2014+A1:2018 indicate water vapour concentration and
│    calculation
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 12 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: relative humidity
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ensure that the results from the original OQ are still valid (see
│    Figure D.1). In order to do so, it is common practice to perform
│    periodic requalification of equipment and should include: a) review
│    of IQ status of equipment; b) assessment of trends in equipment
│    performance; c) temperature and relative humidity profiles of the
│    preconditioning areas (if used); d) chamber temperature profile; e)
│    temperature profile of the aeration areas (if used). These
│    requalification exercises should indicate no significant changes in
│    the performance of preconditioning (if used), chamber or aeration
│    areas since the pre
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 13 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: relative humidity
│  Relevance Score: 2.5/5.0
│
│  Context:
│    rameters other than exposure time is made, the overall effect to the
│    cycle should be evaluated since the adjustment might not achieve the
│    desired result because the parameters are interrelated. For example,
│    the result of decreasing temperature would actually increase the EO
│    concentration and the relative humidity if no change is made to the
│    pressure parameters. The data obtained from process lethality studies
│    are used to establish the minimum EO gas exposure time required for
│    the sterilization process. If these studies are performed in a
│    developmental chamber, caution should be taken in directly applying
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 14 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: relative humidity
│  Relevance Score: 2.5/5.0
│
│  Context:
│    nt of parameters other than exposure time is made, the overall effect
│    to the cycle should be evaluated since the adjustment might not
│    achieve the desired result because the parameters are interrelated.
│    For example, the result of decreasing temperature would actually
│    increase EO concentration and relative humidity if no change is made
│    to the steam injection pressure and the EO injection pressure rise.
│    D.14.2.5 [B.2.5] SLRs can be calculated using the results of
│    fractional cycles. If there are no surviving internal PCDs, a
│    worst-case estimate of the SLR can be obtained by running the
│    calculation with one
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 15 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: RH
│  Relevance Score: 2.5/5.0
│
│  Context:
│    the sterilization process by extrapolation to a known predicted
│    probability of a surviving microorganism, taking account of the
│    required SAL. ﻿ 28 © ISO 2014 – All rights reserved BS EN ISO
│    11135:2014+A1:2019 --- PAGE 51 --- ﻿ ISO 11135:2014+A1:2018 Annex C
│    (informative) Temperature sensors, RH sensors and biological
│    indicator numbers C.1 Temperature sensors It is recommended to use
│    one sensor per 2,5 m3 during OQ to establish a thermal map of the
│    room or chamber that captures potential hot or cold locations.
│    Therefore, monitoring should include more than one plane and
│    locations near
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 16 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: RH
│  Relevance Score: 2.5/5.0
│
│  Context:
│    eters are in conformance with the specifications established during
│    the validation for the specific product(s) in a defined load.
│    Parametric release is based upon a documented review of processing
│    records rather than the testing of biological indicators or PCDs. The
│    values and tolerances for both RH and EO concentration might need to
│    be generated after review of a predefined number of routine cycles.
│    During this evaluation period, BI’s might be used as part of the
│    routine monitoring and control of loads processed. The rationale for
│    the number of runs selected should be justified and recorde
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 17 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: moisture
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ct the product functionality and package integrity. One of the ways
│    to assist in addressing the humidity in the product is to
│    precondition product at a defined temperature and humidity. Such
│    preconditioning can reduce the duration of the sterilization cycle.
│    For health care facilities, excessive moisture content can also be
│    caused by inadequate drying after cleaning. Product heating and
│    humidification are used to establish reproducible product temperature
│    and moisture content prior to EO exposure. Studies establishing
│    minimum residence time in preconditioning cells/rooms ensure that the
│    required
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 18 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: moisture
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ature and humidity. Such preconditioning can reduce the duration of
│    the sterilization cycle. For health care facilities, excessive
│    moisture content can also be caused by inadequate drying after
│    cleaning. Product heating and humidification are used to establish
│    reproducible product temperature and moisture content prior to EO
│    exposure. Studies establishing minimum residence time in
│    preconditioning cells/rooms ensure that the required conditions are
│    attained in the sterilization load. Precautions should be taken to
│    prevent excessive water condensation on the sterilization load.
│    Although it is common
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 19 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: relative humidity
│  Relevance Score: 2.0/5.0
│
│  Context:
│    with inert gas/steam; 2) depth (∆P or terminal pressure) and rate
│    (∆P/time) of attainment of vacuum; 3) number of times of repetition
│    and any variations in successive repetitions; e) conditioning and/or
│    humidity dwell phases (if used): 1) pressure levels and/or rate of
│    attainment of vacuum or relative humidity levels (whichever is being
│    controlled and monitored); 2) number of steam pulses/vacuum (if
│    used); 3) time; 4) chamber temperature; ﻿ 20 © ISO 2014 – All rights
│    reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 43 --- ﻿ ISO
│    11135:2014+A1:2018 5) temperature and humidity of the sterilization
│    load
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 20 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: RH
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ed); d) vacuum and pressure levels and rates of pressure changes in
│    the sterilization chamber; e) if used, confirmation that chamber
│    recirculation operational during sterilant dwell; f) temperature set
│    point and range within the sterilization chamber; g) humidity control
│    set point (pressure or %RH) and range within the sterilization
│    chamber environment; h) EO and diluent gas (if used) injection
│    pressure set point and range; this will include EO concentration if
│    EO analysis equipment is installed on the sterilization chamber; ﻿
│    44 © ISO 2014 – All rights reserved BS EN ISO 11135:2014+A1:2
│
└───────────────────────────────────────────────────────────────────────────────


CATEGORY: TEMPERATURE

┌─ PARAMETER 01 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 5.0/5.0
│
│  Context:
│    rature sensors should be distributed evenly throughout the usable
│    chamber volume. NOTE See Table C.1 for the recommended number of
│    sensors. ﻿ 50 © ISO 2014 – All rights reserved BS EN ISO
│    11135:2014+A1:2019 --- PAGE 73 --- ﻿ ISO 11135:2014+A1:2018 3) In
│    empty chamber OQ exercises, the recorded temperature range, within
│    the usable chamber volume during EO or inert gas exposure, of ± 3 °C
│    of the average recorded chamber temperature at each time point should
│    be obtained after an equilibration period. When the OQ exercise is
│    carried out using a loaded chamber, then the ± 3 °C tolerance might
│    not be a
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 02 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 5.0/5.0
│
│  Context:
│    r of sensors. ﻿ 50 © ISO 2014 – All rights reserved BS EN ISO
│    11135:2014+A1:2019 --- PAGE 73 --- ﻿ ISO 11135:2014+A1:2018 3) In
│    empty chamber OQ exercises, the recorded temperature range, within
│    the usable chamber volume during EO or inert gas exposure, of ± 3 °C
│    of the average recorded chamber temperature at each time point should
│    be obtained after an equilibration period. When the OQ exercise is
│    carried out using a loaded chamber, then the ± 3 °C tolerance might
│    not be achievable. 4) chamber leak rate (performed either under
│    vacuum for subatmospheric cycles or under vacuum and at pressure for
│    s
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 03 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 5.0/5.0
│
│  Context:
│    out using a loaded chamber, then the ± 3 °C tolerance might not be
│    achievable. 4) chamber leak rate (performed either under vacuum for
│    subatmospheric cycles or under vacuum and at pressure for
│    superatmospheric cycles); 5) pressure rise on injection of steam
│    during the conditioning phase; 6) the temperature of the injected
│    EO-gas should be within the volatizer specification or above the
│    boiling point of EO (10,7°C at atmospheric pressure); 7) pressure
│    rise and rate of attainment on admission of EO and correlation of
│    factors with which it is intended to monitor EO concentration; 8)
│    depth and rate o
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 04 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: °C
│  Relevance Score: 5.0/5.0
│
│  Context:
│    under vacuum for subatmospheric cycles or under vacuum and at
│    pressure for superatmospheric cycles); 5) pressure rise on injection
│    of steam during the conditioning phase; 6) the temperature of the
│    injected EO-gas should be within the volatizer specification or above
│    the boiling point of EO (10,7°C at atmospheric pressure); 7) pressure
│    rise and rate of attainment on admission of EO and correlation of
│    factors with which it is intended to monitor EO concentration; 8)
│    depth and rate of attainment of vacuum used to remove EO; 9) pressure
│    rise and rate of attainment of pressure on admission of
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 05 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 3.0/5.0
│
│  Context:
│    tent of treatment for the sterilization process by extrapolation to a
│    known predicted probability of a surviving microorganism, taking
│    account of the required SAL. ﻿ 28 © ISO 2014 – All rights reserved
│    BS EN ISO 11135:2014+A1:2019 --- PAGE 51 --- ﻿ ISO 11135:2014+A1:2018
│    Annex C (informative) Temperature sensors, RH sensors and biological
│    indicator numbers C.1 Temperature sensors It is recommended to use
│    one sensor per 2,5 m3 during OQ to establish a thermal map of the
│    room or chamber that captures potential hot or cold locations.
│    Therefore, monitoring should include more than one plane and loc
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 06 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 3.0/5.0
│
│  Context:
│    known predicted probability of a surviving microorganism, taking
│    account of the required SAL. ﻿ 28 © ISO 2014 – All rights reserved
│    BS EN ISO 11135:2014+A1:2019 --- PAGE 51 --- ﻿ ISO 11135:2014+A1:2018
│    Annex C (informative) Temperature sensors, RH sensors and biological
│    indicator numbers C.1 Temperature sensors It is recommended to use
│    one sensor per 2,5 m3 during OQ to establish a thermal map of the
│    room or chamber that captures potential hot or cold locations.
│    Therefore, monitoring should include more than one plane and
│    locations near doors. For PQ, one temperature sensor is required per
│    cubic
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 07 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ical indicator numbers C.1 Temperature sensors It is recommended to
│    use one sensor per 2,5 m3 during OQ to establish a thermal map of the
│    room or chamber that captures potential hot or cold locations.
│    Therefore, monitoring should include more than one plane and
│    locations near doors. For PQ, one temperature sensor is required per
│    cubic metre of product volume. The minimum number of temperature
│    sensors is three. For PQ, humidity sensors should be placed within
│    the packaging (where possible) within the load. This can be achieved
│    by placing the sensor within the sterile barrier system or amongst
│    the u
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 08 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 3.0/5.0
│
│  Context:
│    2,5 m3 during OQ to establish a thermal map of the room or chamber
│    that captures potential hot or cold locations. Therefore, monitoring
│    should include more than one plane and locations near doors. For PQ,
│    one temperature sensor is required per cubic metre of product volume.
│    The minimum number of temperature sensors is three. For PQ, humidity
│    sensors should be placed within the packaging (where possible) within
│    the load. This can be achieved by placing the sensor within the
│    sterile barrier system or amongst the unit packages. The result of
│    the calculation should be rounded to the next higher number.
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 09 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 3.0/5.0
│
│  Context:
│    with the local conditions. Consideration should be given to the
│    packaged product to ensure that excessive relative humidity will not
│    impact the product functionality and package integrity. One of the
│    ways to assist in addressing the humidity in the product is to
│    precondition product at a defined temperature and humidity. Such
│    preconditioning can reduce the duration of the sterilization cycle.
│    For health care facilities, excessive moisture content can also be
│    caused by inadequate drying after cleaning. Product heating and
│    humidification are used to establish reproducible product temperature
│    and moist
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 10 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 3.0/5.0
│
│  Context:
│    a defined temperature and humidity. Such preconditioning can reduce
│    the duration of the sterilization cycle. For health care facilities,
│    excessive moisture content can also be caused by inadequate drying
│    after cleaning. Product heating and humidification are used to
│    establish reproducible product temperature and moisture content prior
│    to EO exposure. Studies establishing minimum residence time in
│    preconditioning cells/rooms ensure that the required conditions are
│    attained in the sterilization load. Precautions should be taken to
│    prevent excessive water condensation on the sterilization load.
│    Althoug
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 11 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 3.0/5.0
│
│  Context:
│    sideration should be given to the possibility of excessive
│    condensation in product and packaging. b) Residues of EO and its
│    reaction products can be hazardous. It is essential for the
│    manufacturer of the product to be sterilized to be aware of the
│    possible occurrence of residues in the product. Temperature, dwell
│    time, forced heated air circulation, load characteristics, product
│    and packaging ﻿ © ISO 2014 – All rights reserved 35 BS EN ISO
│    11135:2014+A1:2019 --- PAGE 58 --- ﻿ ISO 11135:2014+A1:2018 materials
│    all affect the efficiency of aeration, and the set points and
│    tolerances should be taken
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 12 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 3.0/5.0
│
│  Context:
│    rsion of unheated water as an aerosol (e.g. spinning disc humidifiers
│    and nebulizers) can be a potential source of microbial contamination.
│    The preconditioning area (if used) should have the following
│    performance and monitoring capabilities: — adequate air circulation
│    to ensure the uniformity of temperature and humidity in the usable
│    space, and to ensure that uniformity is maintained in a loaded room
│    or chamber; — airflow detection equipment, alarm systems or
│    indicators monitoring the circulation system to ensure conformance to
│    predetermined tolerances; — means of recording time of load entry
│    into
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 13 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 3.0/5.0
│
│  Context:
│    area over a period long enough to demonstrate that values are
│    maintained within the desired ranges. The temperature and humidity in
│    a number of locations distributed throughout the preconditioning area
│    should be determined. NOTE See Table C.1 and Table C.2 for
│    recommendations on the number of temperature and humidity sensors. b)
│    Sterilization Phase 1) If inert gases are used instead of EO, account
│    should be taken of the differences in the relative heat capacity when
│    assessing the results. 2) Temperature/humidity distribution:
│    Temperature/humidity sensors should be located in those locations t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 14 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 3.0/5.0
│
│  Context:
│    uld be determined. NOTE See Table C.1 and Table C.2 for
│    recommendations on the number of temperature and humidity sensors. b)
│    Sterilization Phase 1) If inert gases are used instead of EO, account
│    should be taken of the differences in the relative heat capacity when
│    assessing the results. 2) Temperature/humidity distribution:
│    Temperature/humidity sensors should be located in those locations
│    that are likely to represent the maximum temperature differential,
│    such as locations near unheated portions of the chamber or door and
│    locations near steam or gas entry ports. The remaining temperature
│    senso
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 15 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 3.0/5.0
│
│  Context:
│    C.1 and Table C.2 for recommendations on the number of temperature
│    and humidity sensors. b) Sterilization Phase 1) If inert gases are
│    used instead of EO, account should be taken of the differences in the
│    relative heat capacity when assessing the results. 2)
│    Temperature/humidity distribution: Temperature/humidity sensors
│    should be located in those locations that are likely to represent the
│    maximum temperature differential, such as locations near unheated
│    portions of the chamber or door and locations near steam or gas entry
│    ports. The remaining temperature sensors should be distributed evenly
│    thr
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 16 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 3.0/5.0
│
│  Context:
│    n Phase 1) If inert gases are used instead of EO, account should be
│    taken of the differences in the relative heat capacity when assessing
│    the results. 2) Temperature/humidity distribution:
│    Temperature/humidity sensors should be located in those locations
│    that are likely to represent the maximum temperature differential,
│    such as locations near unheated portions of the chamber or door and
│    locations near steam or gas entry ports. The remaining temperature
│    sensors should be distributed evenly throughout the usable chamber
│    volume. NOTE See Table C.1 for the recommended number of sensors. ﻿
│    50 © ISO 2
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 17 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 3.0/5.0
│
│  Context:
│    . 2) Temperature/humidity distribution: Temperature/humidity sensors
│    should be located in those locations that are likely to represent the
│    maximum temperature differential, such as locations near unheated
│    portions of the chamber or door and locations near steam or gas entry
│    ports. The remaining temperature sensors should be distributed evenly
│    throughout the usable chamber volume. NOTE See Table C.1 for the
│    recommended number of sensors. ﻿ 50 © ISO 2014 – All rights reserved
│    BS EN ISO 11135:2014+A1:2019 --- PAGE 73 --- ﻿ ISO 11135:2014+A1:2018
│    3) In empty chamber OQ exercises, the recorded temper
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 18 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ases); 10) number of times these last two stages are repeated and any
│    variations in successive repetitions; 11) the reliability of the
│    supply of filtered air, inert gasses, water and steam; 12) replicate
│    cycles should be carried out to demonstrate the repeatability of
│    control; 13) a chamber wall temperature study should be completed to
│    verify adequate temperature uniformity provided by the jacket heating
│    system. The study should characterize the temperature profile for
│    comparison on a periodic basis to ensure the system continues to
│    operate effectively. c) Aeration Phase 1) When performing aerati
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 19 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 3.0/5.0
│
│  Context:
│    eated and any variations in successive repetitions; 11) the
│    reliability of the supply of filtered air, inert gasses, water and
│    steam; 12) replicate cycles should be carried out to demonstrate the
│    repeatability of control; 13) a chamber wall temperature study should
│    be completed to verify adequate temperature uniformity provided by
│    the jacket heating system. The study should characterize the
│    temperature profile for comparison on a periodic basis to ensure the
│    system continues to operate effectively. c) Aeration Phase 1) When
│    performing aeration, the temperature profile of the aeration area
│    should b
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 20 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 3.0/5.0
│
│  Context:
│    air, inert gasses, water and steam; 12) replicate cycles should be
│    carried out to demonstrate the repeatability of control; 13) a
│    chamber wall temperature study should be completed to verify adequate
│    temperature uniformity provided by the jacket heating system. The
│    study should characterize the temperature profile for comparison on a
│    periodic basis to ensure the system continues to operate effectively.
│    c) Aeration Phase 1) When performing aeration, the temperature
│    profile of the aeration area should be determined in the same manner
│    as recommended for preconditioning areas. The air flow rates and
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 21 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 3.0/5.0
│
│  Context:
│    hould be completed to verify adequate temperature uniformity provided
│    by the jacket heating system. The study should characterize the
│    temperature profile for comparison on a periodic basis to ensure the
│    system continues to operate effectively. c) Aeration Phase 1) When
│    performing aeration, the temperature profile of the aeration area
│    should be determined in the same manner as recommended for
│    preconditioning areas. The air flow rates and air flow patterns
│    through the area should also be determined. D.9.4 Performance
│    qualification D.9.4.1 General PQ consists of rigorous microbiological
│    and physical
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 22 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: thermal
│  Relevance Score: 3.0/5.0
│
│  Context:
│    L. ﻿ 28 © ISO 2014 – All rights reserved BS EN ISO
│    11135:2014+A1:2019 --- PAGE 51 --- ﻿ ISO 11135:2014+A1:2018 Annex C
│    (informative) Temperature sensors, RH sensors and biological
│    indicator numbers C.1 Temperature sensors It is recommended to use
│    one sensor per 2,5 m3 during OQ to establish a thermal map of the
│    room or chamber that captures potential hot or cold locations.
│    Therefore, monitoring should include more than one plane and
│    locations near doors. For PQ, one temperature sensor is required per
│    cubic metre of product volume. The minimum number of temperature
│    sensors is three. For PQ, h
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 23 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: heat
│  Relevance Score: 3.0/5.0
│
│  Context:
│    buted throughout the preconditioning area should be determined. NOTE
│    See Table C.1 and Table C.2 for recommendations on the number of
│    temperature and humidity sensors. b) Sterilization Phase 1) If inert
│    gases are used instead of EO, account should be taken of the
│    differences in the relative heat capacity when assessing the results.
│    2) Temperature/humidity distribution: Temperature/humidity sensors
│    should be located in those locations that are likely to represent the
│    maximum temperature differential, such as locations near unheated
│    portions of the chamber or door and locations near steam
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 24 [MED ] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    2.11] Note 1 to entry: For the purposes of this International
│    Standard, the D value is the exposure time required to achieve 90 %
│    inactivation of the population of the test organism. 3.9 development
│    act of elaborating a specification [SOURCE: ISO/TS 11139:2006,
│    definition 2.13] 3.10 dew point The temperature at which the
│    saturation water vapour pressure is equal to the partial pressure of
│    the water vapour in the atmosphere Note 1 to entry: Any cooling of
│    the atmosphere below the dew point would produce water condensation.
│    3.11 establish determine by theoretical evaluation and confirm by
│    experimentatio
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 25 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    s, consistently performs in accordance with predetermined criteria
│    and thereby yields product meeting its specification [SOURCE: ISO/TS
│    11139:2006, definition 2.30] 3.27 preconditioning treatment of
│    product, prior to the sterilization cycle, in a room or chamber to
│    attain specified conditions for temperature and relative humidity
│    3.28 process challenge device PCD item designed to constitute a
│    defined resistance to a sterilization process and used to assess
│    performance of the process [SOURCE: ISO/TS 11139:2006, definition
│    2.33] Note 1 to entry: For the purpose of this International
│    Standard, a PCD can
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 26 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    s include: ﻿ 12 © ISO 2014 – All rights reserved BS EN ISO
│    11135:2014+A1:2019 --- PAGE 35 --- ﻿ ISO 11135:2014+A1:2018 a)
│    preconditioning (if used); b) the sterilization cycle; c) aeration
│    (if used). 6.2.3 The process variables for preconditioning (if used)
│    include at a minimum: a) time; b) temperature; c) humidity; d)
│    transfer time. 6.2.4 The process variables for the sterilization
│    cycle include: a) exposure time; b) temperature; c) humidity; d) EO
│    concentration; e) pressure. 6.2.5 The process variables for aeration
│    (if used) include at a minimum: a) time; b) temperature. NOTE In aer
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 27 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    oning (if used); b) the sterilization cycle; c) aeration (if used).
│    6.2.3 The process variables for preconditioning (if used) include at
│    a minimum: a) time; b) temperature; c) humidity; d) transfer time.
│    6.2.4 The process variables for the sterilization cycle include: a)
│    exposure time; b) temperature; c) humidity; d) EO concentration; e)
│    pressure. 6.2.5 The process variables for aeration (if used) include
│    at a minimum: a) time; b) temperature. NOTE In aeration these
│    parameters are considered process variables only if aeration is
│    considered to contribute to ensuring the microbicidal effe
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 28 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    a) time; b) temperature; c) humidity; d) transfer time. 6.2.4 The
│    process variables for the sterilization cycle include: a) exposure
│    time; b) temperature; c) humidity; d) EO concentration; e) pressure.
│    6.2.5 The process variables for aeration (if used) include at a
│    minimum: a) time; b) temperature. NOTE In aeration these parameters
│    are considered process variables only if aeration is considered to
│    contribute to ensuring the microbicidal effectiveness of the
│    sterilization process (See AAMI TIR16:2009, clause 5.1.3.3) 6.3
│    Equipment characterization 6.3.1 The specification for the equipme
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 29 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    of the process without requiring three further consecutive successful
│    runs. Examples of this type of failure may include, but are not
│    limited to, power failures, other loss of services, or failure of
│    external monitoring equipment. 9.4.3.2 PPQ shall confirm the process
│    such that: a) the minimum temperature of product to enter the
│    sterilization process and/or the defined conditions required to
│    achieve it shall be established; b) at the end of the defined
│    preconditioning time (if used), the sterilization load temperature
│    and humidity have been established; c) the specified maximum elapsed
│    time betw
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 30 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ing equipment. 9.4.3.2 PPQ shall confirm the process such that: a)
│    the minimum temperature of product to enter the sterilization process
│    and/or the defined conditions required to achieve it shall be
│    established; b) at the end of the defined preconditioning time (if
│    used), the sterilization load temperature and humidity have been
│    established; c) the specified maximum elapsed time between the
│    completion of preconditioning (if used) and the commencement of the
│    sterilization cycle is appropriate; d) at the end of the defined
│    conditioning time, if used, the sterilization load temperature and
│    humidity
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 31 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    lization load temperature and humidity have been established; c) the
│    specified maximum elapsed time between the completion of
│    preconditioning (if used) and the commencement of the sterilization
│    cycle is appropriate; d) at the end of the defined conditioning time,
│    if used, the sterilization load temperature and humidity have been
│    established; e) the chamber humidity was recorded if parametric
│    release was to be used; f) gaseous EO has been admitted to the
│    sterilizer chamber; g) pressure rise and the quantity of EO used or
│    concentration of EO in the sterilizer chamber have been established
│    [see 9.5
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 32 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    r reference specific qualified product, defined load configurations
│    and the documented specification for the EO sterilization process and
│    shall address: NOTE For practical purposes, rates can be determined
│    as the time taken (with tolerances) to attain a specified pressure
│    change. a) the minimum temperature of product to enter the
│    sterilization process and/or the defined conditions required to
│    achieve the minimum required temperature; b) preconditioning (if
│    used): 1) time in chamber/area, temperature and humidity of
│    chamber/area; 2) temperature and humidity of the sterilization load;
│    3) maximum e
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 33 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    cess and shall address: NOTE For practical purposes, rates can be
│    determined as the time taken (with tolerances) to attain a specified
│    pressure change. a) the minimum temperature of product to enter the
│    sterilization process and/or the defined conditions required to
│    achieve the minimum required temperature; b) preconditioning (if
│    used): 1) time in chamber/area, temperature and humidity of
│    chamber/area; 2) temperature and humidity of the sterilization load;
│    3) maximum elapsed time between removal of the load from
│    preconditioning and commencement of the sterilization cycle; c)
│    vacuum levels and r
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 34 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ermined as the time taken (with tolerances) to attain a specified
│    pressure change. a) the minimum temperature of product to enter the
│    sterilization process and/or the defined conditions required to
│    achieve the minimum required temperature; b) preconditioning (if
│    used): 1) time in chamber/area, temperature and humidity of
│    chamber/area; 2) temperature and humidity of the sterilization load;
│    3) maximum elapsed time between removal of the load from
│    preconditioning and commencement of the sterilization cycle; c)
│    vacuum levels and rate of evacuation (if used): 1) holding time under
│    vacuum (if used);
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 35 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    attain a specified pressure change. a) the minimum temperature of
│    product to enter the sterilization process and/or the defined
│    conditions required to achieve the minimum required temperature; b)
│    preconditioning (if used): 1) time in chamber/area, temperature and
│    humidity of chamber/area; 2) temperature and humidity of the
│    sterilization load; 3) maximum elapsed time between removal of the
│    load from preconditioning and commencement of the sterilization
│    cycle; c) vacuum levels and rate of evacuation (if used): 1) holding
│    time under vacuum (if used); NOTE The rate of evacuation is commonly
│    speci
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 36 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    rminal pressure) and rate (∆P/time) of attainment of vacuum; 2)
│    pressure (∆P or terminal pressure) and rate (∆P/time) of attainment
│    of pressure associated with inert gas/air/steam; 3) number of times
│    of repetition and any variations in successive repetitions; h)
│    aeration (if used): 1) time and temperature within the chamber and/or
│    room; 2) pressure changes (if any) within the chamber and/or room; 3)
│    rate of change of air or other gas; 4) temperature of the
│    sterilization load. 9.5.5 If parametric release is to be used, the
│    validation report shall also specify: a) the value and tolerances for
│    cha
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 37 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    iated with inert gas/air/steam; 3) number of times of repetition and
│    any variations in successive repetitions; h) aeration (if used): 1)
│    time and temperature within the chamber and/or room; 2) pressure
│    changes (if any) within the chamber and/or room; 3) rate of change of
│    air or other gas; 4) temperature of the sterilization load. 9.5.5 If
│    parametric release is to be used, the validation report shall also
│    specify: a) the value and tolerances for chamber humidity by direct
│    measurement during conditioning; b) the value and tolerances for the
│    EO concentration determined from direct analysis of cham
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 38 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ces for the EO concentration determined from direct analysis of
│    chamber atmosphere using analytical methods to establish the process
│    specification for routine processing. The sampling shall be conducted
│    at defined intervals sufficient to verify the required conditions
│    throughout EO exposure. c) temperature of the chamber; recorded from
│    two separate monitoring locations. 9.5.6 A process specification
│    including the process parameters and their tolerances shall be
│    established for routine processing based upon the documentation
│    generated during the validation. This process specification shall
│    also inc
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 39 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    for each sterilization cycle to demonstrate that the sterilization
│    process specification has been met. These data shall include at least
│    the following: NOTE For practical purposes, rates can be determined
│    as the time taken (with tolerances) to attain a specified pressure
│    change. a) the minimum temperature of product entering the
│    sterilization process and/or the defined conditions used to acclimate
│    the load; b) temperature and humidity within the preconditioning area
│    (if used), monitored and recorded from a specified position; c) time
│    of commencement of preconditioning and of removal of load from
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 40 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    include at least the following: NOTE For practical purposes, rates
│    can be determined as the time taken (with tolerances) to attain a
│    specified pressure change. a) the minimum temperature of product
│    entering the sterilization process and/or the defined conditions used
│    to acclimate the load; b) temperature and humidity within the
│    preconditioning area (if used), monitored and recorded from a
│    specified position; c) time of commencement of preconditioning and of
│    removal of load from preconditioning (if used) of each sterilization
│    load; d) elapsed time between removal of the sterilization load from
│    p
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 41 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    .10.2 i); 2) the direct measurement of the concentration of EO in the
│    sterilizer chamber; 3) volume of EO used; j) EO-injection time k)
│    inert gas injection, if used; l) exposure time; m) time taken to
│    evacuate the chamber; n) time and pressure changes during post
│    exposure flushing; o) time, temperature, pressure changes (if any)
│    during aeration. 10.3 If biological indicators are used in routine
│    monitoring, they shall comply with 8.6 and 8.7. If the PCD that is
│    used for routine release is different from that used in the MPQ, it
│    should be at least as resistant to the process as is the PCD used in
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 42 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ne monitoring, they shall comply with 8.8. Chemical indicators shall
│    not replace biological indicators for product release or be used to
│    support a rationale to release a load parametrically. 10.5 If
│    parametric release is performed, the following additional data shall
│    be recorded and retained: a) temperature in the chamber from a
│    minimum of two locations throughout the sterilization cycle; b)
│    chamber humidity during conditioning as determined by direct
│    measurement; c) the EO concentration, determined from direct analysis
│    of chamber atmosphere using analytical methods at defined intervals
│    sufficient
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 43 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    rilization equipment that delivers the same process parameters,
│    having undergone IQ and OQ, shall be qualified either a) in the same
│    manner as the original chamber, or b) using a reduced MPQ that
│    demonstrates the delivery of the required level of microbiological
│    lethality and PPQ to demonstrate temperature and humidity uniformity
│    of the load and control by the production chamber. The rationale for
│    this reduced qualification shall be recorded and documented. The
│    influence of different geographical locations on the product or load
│    properties shall be determined. 12.5.2 Product A product may be added
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 44 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ed within the packaging (where possible) within the load. This can be
│    achieved by placing the sensor within the sterile barrier system or
│    amongst the unit packages. The result of the calculation should be
│    rounded to the next higher number. Table C.1 provides guidance for
│    determining the number of temperature sensors. Table C.1 — Minimum
│    recommended number of temperature sensors Volume m3 Number for OQ
│    (usable chamber/room volume) Number for PQ (product load volume)
│    Preconditioning Conditioning/ sterilization Aeration Preconditioning
│    Conditioning/ sterilization Aeration ≤ 1 3 3 10 4 10 15 6 15 20 8 20
│    2
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 45 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    can be achieved by placing the sensor within the sterile barrier
│    system or amongst the unit packages. The result of the calculation
│    should be rounded to the next higher number. Table C.1 provides
│    guidance for determining the number of temperature sensors. Table C.1
│    — Minimum recommended number of temperature sensors Volume m3 Number
│    for OQ (usable chamber/room volume) Number for PQ (product load
│    volume) Preconditioning Conditioning/ sterilization Aeration
│    Preconditioning Conditioning/ sterilization Aeration ≤ 1 3 3 10 4 10
│    15 6 15 20 8 20 25 10 25 30 12 30 35 14 35 40 16 40 50 20 50 100 40
│    100 EXAMPLE
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 46 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ditions are attained in the sterilization load. Precautions should be
│    taken to prevent excessive water condensation on the sterilization
│    load. Although it is common practice to perform preconditioning in a
│    separate chamber, room or cell, sterilization cycles can be designed
│    to attain the required temperature and humidity ranges within the
│    load during a conditioning phase in the sterilization chamber. To
│    minimize the risk of excessive condensation, it is recommended that
│    the load temperature should be maintained above the process
│    environmental dewpoint temperature during the preconditioning and
│    condi
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 47 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    econditioning in a separate chamber, room or cell, sterilization
│    cycles can be designed to attain the required temperature and
│    humidity ranges within the load during a conditioning phase in the
│    sterilization chamber. To minimize the risk of excessive
│    condensation, it is recommended that the load temperature should be
│    maintained above the process environmental dewpoint temperature
│    during the preconditioning and conditioning phases of the
│    sterilization process. The actual temperature and humidity ranges
│    within the sterilization load at the end of preconditioning should be
│    demonstrated during PQ. Wher
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 48 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    n be designed to attain the required temperature and humidity ranges
│    within the load during a conditioning phase in the sterilization
│    chamber. To minimize the risk of excessive condensation, it is
│    recommended that the load temperature should be maintained above the
│    process environmental dewpoint temperature during the preconditioning
│    and conditioning phases of the sterilization process. The actual
│    temperature and humidity ranges within the sterilization load at the
│    end of preconditioning should be demonstrated during PQ. Where
│    applicable, a maximum time between removal of the load from
│    preconditioni
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 49 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ng phase in the sterilization chamber. To minimize the risk of
│    excessive condensation, it is recommended that the load temperature
│    should be maintained above the process environmental dewpoint
│    temperature during the preconditioning and conditioning phases of the
│    sterilization process. The actual temperature and humidity ranges
│    within the sterilization load at the end of preconditioning should be
│    demonstrated during PQ. Where applicable, a maximum time between
│    removal of the load from preconditioning and the start of the
│    sterilization cycle needs to be established. A transfer time of 60
│    min or less i
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 50 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    tration; 2) pressure, pressure rise (∆P) and rate (∆P/time) of
│    attainment of specified pressure on admission of any inert gasses (if
│    used); f) maintenance of specified conditions for the exposure time:
│    1) pressure differential used to apply sterilant or inert gas
│    make-ups (if used); 2) chamber temperature; g) EO removal: 1) depth
│    (ΔP or terminal pressure) and rate (ΔP/time) of attainment of vacuum
│    to remove EO; h) flushing (if used): 1) pressure rise and rate of
│    attainment of pressure; 2) depth (ΔP or terminal pressure) and rate
│    (ΔP/time) of attainment of vacuum to remove EO; ﻿ 36 © ISO 2014 –
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 51 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ed in a loaded room or chamber; — airflow detection equipment, alarm
│    systems or indicators monitoring the circulation system to ensure
│    conformance to predetermined tolerances; — means of recording time of
│    load entry into and removal from the preconditioning area; — means of
│    monitoring cell/room temperature and humidity; — means of controlling
│    cell/room temperature and humidity. b) Sterilizer characterization.
│    The sterilization chamber should have the following performance and
│    monitoring capabilities: — means of monitoring time, chamber
│    pressure, temperature and humidity (if humidity additions are
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 52 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    nt, alarm systems or indicators monitoring the circulation system to
│    ensure conformance to predetermined tolerances; — means of recording
│    time of load entry into and removal from the preconditioning area; —
│    means of monitoring cell/room temperature and humidity; — means of
│    controlling cell/room temperature and humidity. b) Sterilizer
│    characterization. The sterilization chamber should have the following
│    performance and monitoring capabilities: — means of monitoring time,
│    chamber pressure, temperature and humidity (if humidity additions are
│    controlled by sensor readings); — means of controlling tim
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 53 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    g area; — means of monitoring cell/room temperature and humidity; —
│    means of controlling cell/room temperature and humidity. b)
│    Sterilizer characterization. The sterilization chamber should have
│    the following performance and monitoring capabilities: — means of
│    monitoring time, chamber pressure, temperature and humidity (if
│    humidity additions are controlled by sensor readings); — means of
│    controlling time, chamber pressure, temperature and humidity, if
│    humidity additions are controlled by sensor readings (when sensors
│    are fixed on the equipment, ensure that a correlation is made during
│    IQ or OQ to
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 54 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    erilizer characterization. The sterilization chamber should have the
│    following performance and monitoring capabilities: — means of
│    monitoring time, chamber pressure, temperature and humidity (if
│    humidity additions are controlled by sensor readings); — means of
│    controlling time, chamber pressure, temperature and humidity, if
│    humidity additions are controlled by sensor readings (when sensors
│    are fixed on the equipment, ensure that a correlation is made during
│    IQ or OQ to the pressure rise); — if humidity is not controlled by
│    sensor readings, means to monitor and control steam additions; — if
│    paramet
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 55 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    at remedial action can be taken in a timely fashion. ﻿ © ISO 2014 –
│    All rights reserved 37 BS EN ISO 11135:2014+A1:2019 --- PAGE 60 ---
│    ﻿ ISO 11135:2014+A1:2018 c) Aeration area characterization. An
│    aeration area (chamber, cell or room) can be used to remove EO
│    residuals from product/packaging. Temperature uniformity, fresh air
│    make-up and air re-circulation throughout the area are important to
│    ensure consistent and reproducible results. The aeration area should
│    have the following performance and monitoring capabilities: — airflow
│    detection equipment, alarm systems or indicators monitoring the air
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 56 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    itoring capabilities: — airflow detection equipment, alarm systems or
│    indicators monitoring the air handling system to ensure that it
│    operates within predetermined tolerances and maintains adequate
│    airflow in a loaded room or chamber; — equipment to re-circulate air;
│    — means of monitoring room temperature; — means of controlling room
│    temperature. D.6.3.2 The equipment specification should be reviewed
│    to ensure that regulatory and safety requirements are met, technical
│    specifications are appropriate, and services and infrastructure
│    necessary to operate the equipment are available. The following i
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 57 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    equipment, alarm systems or indicators monitoring the air handling
│    system to ensure that it operates within predetermined tolerances and
│    maintains adequate airflow in a loaded room or chamber; — equipment
│    to re-circulate air; — means of monitoring room temperature; — means
│    of controlling room temperature. D.6.3.2 The equipment specification
│    should be reviewed to ensure that regulatory and safety requirements
│    are met, technical specifications are appropriate, and services and
│    infrastructure necessary to operate the equipment are available. The
│    following items should be considered when preparing t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 58 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    means of emptying the tank of EO and a provision for cleaning in the
│    event of contamination or excessive accumulation of polymers. b) The
│    system for admission of EO to the sterilizer should be equipped with
│    a vaporizer to prevent liquid EO from being admitted to the
│    sterilizer chamber. c) The temperature of the EO gas flowing from the
│    vaporizer to the sterilizer chamber should be measured to demonstrate
│    that gaseous EO has been produced. d) Steam is utilized to humidify
│    the load and is not intended to be a sterilant. The consistency of
│    steam supply can be determined by the periodic analysis of t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 59 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ured to demonstrate that gaseous EO has been produced. d) Steam is
│    utilized to humidify the load and is not intended to be a sterilant.
│    The consistency of steam supply can be determined by the periodic
│    analysis of the boiler feed water or condensate. e) A minimum of two
│    probes to measure chamber temperature should be used. Large volume
│    chambers can be fitted with more than two probes so as to ensure that
│    the monitoring/control system captures data that reflects the
│    temperature throughout the chamber during use. NOTE The purpose of
│    two separate probes is to prevent the failure of one sensor from cau
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 60 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    e determined by the periodic analysis of the boiler feed water or
│    condensate. e) A minimum of two probes to measure chamber temperature
│    should be used. Large volume chambers can be fitted with more than
│    two probes so as to ensure that the monitoring/control system
│    captures data that reflects the temperature throughout the chamber
│    during use. NOTE The purpose of two separate probes is to prevent the
│    failure of one sensor from causing an out-of- specification process
│    from being erroneously accepted. Comparing two separate temperature
│    sensors will detect that one of the sensors has failed. A dual eleme
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 61 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    roughout the chamber during use. NOTE The purpose of two separate
│    probes is to prevent the failure of one sensor from causing an
│    out-of- specification process from being erroneously accepted.
│    Comparing two separate temperature sensors will detect that one of
│    the sensors has failed. A dual element temperature probe can be used
│    to meet this need. f) It is important to maintain uniform conditions
│    within the sterilizer chamber during processing. This can be achieved
│    by forced gas circulation. If used, a gas circulation system should
│    be equipped with a monitoring device to indicate when circulation is
│    in
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 62 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    g device to indicate when circulation is ineffective as devices that
│    solely monitor “power on” to the fan or pump are not sufficient. g)
│    Areas used for storage of cylinders, tanks or cartridges of EO or EO
│    gas mixtures should be secured and ventilated. h) Where ambient
│    conditions are subject to temperature variation greater than the
│    range recommended by the supplier, storage areas for the containers
│    of EO should include provision for temperature control. It might not
│    be possible to calibrate controlling and monitoring instruments under
│    actual processing conditions, e.g. humidity sensors. Calibrati
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 63 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    used for storage of cylinders, tanks or cartridges of EO or EO gas
│    mixtures should be secured and ventilated. h) Where ambient
│    conditions are subject to temperature variation greater than the
│    range recommended by the supplier, storage areas for the containers
│    of EO should include provision for temperature control. It might not
│    be possible to calibrate controlling and monitoring instruments under
│    actual processing conditions, e.g. humidity sensors. Calibration
│    results for these instruments should be correlated against
│    qualification studies. Processing conditions can have a detrimental
│    effect on som
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 64 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    can withstand the sterilization process without losing its ability to
│    protect the product. Validation of the SBS should consider the
│    potential stresses that the SBS can be exposed to during an EO
│    sterilization process. Considerations would include vacuum/pressure
│    levels, rate of pressure change, temperature, etc. It is common
│    practice to demonstrate suitability of the SBS by exposure of the SBS
│    to multiple sterilization processes (see D.7.2.1 and D.7.2.2).
│    Packaging considerations are addressed in more detail in the ISO
│    11607‑1 and ISO 11607‑2. D.7.1.5 The load configuration in the
│    chamber can infl
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 65 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    imulate the specified process and can range from a simple visual
│    inspection to a battery of specialized tests. Elements that could
│    affect safety, quality or performance include: a) cycle pressure
│    changes that could affect the sterile barrier system seal integrity;
│    b) effects of EO exposure time, temperature, humidity and, if
│    applicable, any diluent gases present in the intended sterilization
│    mixture; c) inclusion of new materials known to retain higher EO
│    residuals; d) packaging characteristics; e) the presence of
│    lubricants, especially within mated surface areas; f) whether the
│    medical device re
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 66 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    production chamber. D.8.4 When establishing process definition it is
│    important to consider the impact of the selected processing
│    parameters and their tolerances on the safety and functionality of
│    the product and its packaging. As there are a number of parameters
│    within a sterilization process, (temperature, humidity, pressure
│    changes/rates, EO concentration and time), it is impractical to
│    assess the tolerances of all combinations of all variables. A
│    determination should be made as to which variables will have the
│    greatest impact, and those should be assessed. Data supporting this
│    activity can be c
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 67 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    control and abatement systems; i) other critical systems that could
│    affect process conditions, such as process automation, safety
│    systems, etc.; j) the calibration of instruments (e.g. sensors,
│    recorders, gauges and test instruments) that monitor, control,
│    indicate or record parameters such as temperature, humidity, pressure
│    and EO concentration. ﻿ 48 © ISO 2014 – All rights reserved BS EN
│    ISO 11135:2014+A1:2019 --- PAGE 71 --- ﻿ ISO 11135:2014+A1:2018 k)
│    the documented procedures for IQ should specify how each element of
│    this qualification is planned, performed and reviewed. D.9.2.1.2
│    Guidanc
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 68 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    e of parameters and operating limits should include the initial
│    sterilization process that has been defined in process definition
│    (see Clause 8). OQ should also determine the performance of
│    associated ancillary systems. For example, the capability of the EO
│    vaporizer to achieve a minimum EO input temperature. The system
│    software (e.g. computerized measurement and control systems) should
│    be tested in all fault conditions during OQ. The user is responsible
│    for assuring the software is validated. OQ can include the following
│    when using a predefined cycle: a) Preconditioning Phase 1) The
│    pattern of air
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 69 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    using a predefined cycle: a) Preconditioning Phase 1) The pattern of
│    air circulation throughout the area to be occupied by the
│    sterilization load(s) should be determined. This can be performed by
│    smoke tests in combination with calculation of air change rates and
│    anemometric determinations. 2) Temperature and humidity should be
│    monitored throughout the preconditioning area over a period long
│    enough to demonstrate that values are maintained within the desired
│    ranges. The temperature and humidity in a number of locations
│    distributed throughout the preconditioning area should be determined.
│    NOTE Se
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 70 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    be performed by smoke tests in combination with calculation of air
│    change rates and anemometric determinations. 2) Temperature and
│    humidity should be monitored throughout the preconditioning area over
│    a period long enough to demonstrate that values are maintained within
│    the desired ranges. The temperature and humidity in a number of
│    locations distributed throughout the preconditioning area should be
│    determined. NOTE See Table C.1 and Table C.2 for recommendations on
│    the number of temperature and humidity sensors. b) Sterilization
│    Phase 1) If inert gases are used instead of EO, account should
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 71 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    IQ and OQ should be used to set the parameters for MPQ. Exposure time
│    is the key parameter that is varied during microbiological
│    qualification. Other parameters can be adjusted as necessary to
│    provide assurance that the MPQ delivers less lethality than the
│    normal production process. For example, temperature, humidity, and/or
│    EO concentrations could be run at set points that are at the lower
│    extreme of the normal process range. This would provide assurance
│    that any observed values within the specified range will produce
│    acceptable lethality. MPQ should be conducted using product that is
│    at or below
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 72 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    and/or EO concentrations could be run at set points that are at the
│    lower extreme of the normal process range. This would provide
│    assurance that any observed values within the specified range will
│    produce acceptable lethality. MPQ should be conducted using product
│    that is at or below the minimum temperature specified for product to
│    enter the preconditioning area. If it is anticipated that initial
│    product temperature could vary, for example because of transport for
│    sterilization at a remote facility, the design of the qualification
│    testing should reflect this possibility. For fractional cycles (sub-
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 73 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    This would provide assurance that any observed values within the
│    specified range will produce acceptable lethality. MPQ should be
│    conducted using product that is at or below the minimum temperature
│    specified for product to enter the preconditioning area. If it is
│    anticipated that initial product temperature could vary, for example
│    because of transport for sterilization at a remote facility, the
│    design of the qualification testing should reflect this possibility.
│    For fractional cycles (sub-lethal or half cycle), it might also be
│    necessary to shorten the post-exposure phases of the cycle or to
│    remove
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 74 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    to represent EO product families. PCDs should be placed within the
│    product case and evenly distributed in the sterilization load, but
│    distribution should include those locations where sterilization
│    conditions are the most difficult to achieve. The locations used
│    should include those selected for temperature monitoring. For loads
│    that are palletized, these locations should also include the top and
│    bottom of the pallets to ensure that all potential stratification
│    within the chamber is assessed. For guidance on sample numbers, see
│    Table C.3. D.9.4.2.3 No guidance offered D.9.4.2.4 If a developmental
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 75 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ding states. The guidance on PPQ of preconditioning also applies to
│    the performance qualification of conditioning (i.e. during
│    sterilization). See Table C.1 and Table C.2 for the recommended
│    minimum number of sensors. a) No guidance offered. b) It is important
│    to establish and report the product temperature and humidity ranges
│    of the sterilization load after exposure to the specified
│    preconditioning time (if used). c) During the product transfer from
│    preconditioning (if used) to the sterilization chamber, conditions of
│    product temperature and humidity might be impacted. It is important
│    to ensure th
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 76 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    red. b) It is important to establish and report the product
│    temperature and humidity ranges of the sterilization load after
│    exposure to the specified preconditioning time (if used). c) During
│    the product transfer from preconditioning (if used) to the
│    sterilization chamber, conditions of product temperature and humidity
│    might be impacted. It is important to ensure that this effect is
│    considered during PQ and is commonly addressed during PQ by ensuring
│    that the time of transfer specified in the PQ reflects the maximum
│    time specification to be used for product transfer during routine
│    sterilization. d
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 77 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    d humidity might be impacted. It is important to ensure that this
│    effect is considered during PQ and is commonly addressed during PQ by
│    ensuring that the time of transfer specified in the PQ reflects the
│    maximum time specification to be used for product transfer during
│    routine sterilization. d) Temperature and humidity sensors should be
│    located within the sterile barrier system or amongst the unit
│    packages in the sterilization load. When preconditioning is used, the
│    product should be preconditioned within the specified time range.
│    When preconditioning is not used, the temperature and relative humi
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 78 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    sterilization. d) Temperature and humidity sensors should be located
│    within the sterile barrier system or amongst the unit packages in the
│    sterilization load. When preconditioning is used, the product should
│    be preconditioned within the specified time range. When
│    preconditioning is not used, the temperature and relative humidity
│    within the load should be within defined limits prior to the end of
│    the conditioning phase of the cycle. The temperature and humidity
│    profile within the sterilization load should be evaluated during the
│    time that is needed for the sterilization load to attain the minimum
│    pr
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 79 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ilization load. When preconditioning is used, the product should be
│    preconditioned within the specified time range. When preconditioning
│    is not used, the temperature and relative humidity within the load
│    should be within defined limits prior to the end of the conditioning
│    phase of the cycle. The temperature and humidity profile within the
│    sterilization load should be evaluated during the time that is needed
│    for the sterilization load to attain the minimum predetermined
│    temperature and humidity. For product, consideration should be given
│    to locating humidity sensors in areas of the load that are mos
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 80 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ve humidity within the load should be within defined limits prior to
│    the end of the conditioning phase of the cycle. The temperature and
│    humidity profile within the sterilization load should be evaluated
│    during the time that is needed for the sterilization load to attain
│    the minimum predetermined temperature and humidity. For product,
│    consideration should be given to locating humidity sensors in areas
│    of the load that are most likely to experience variation in humidity,
│    e.g. pallet centers, pallet edges and surfaces. For PQ, humidity
│    sensors should be placed within the packaging (where possible) wit
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 81 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    r system or amongst the unit packages. e) No guidance offered. f) If
│    parametric release is used, the EO concentration profile for the
│    entire gas dwell phase should be assessed to determine how the gas
│    concentration changes over the phase. g) No guidance offered. h) No
│    guidance offered. i) The temperature sensors within the sterilization
│    load should be placed in the locations that are most likely to
│    experience the greatest temperature variation. These locations should
│    take into account hot or cold spots located during OQ. The locations
│    of hot and cold spots within a load can be significantly diff
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 82 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    he entire gas dwell phase should be assessed to determine how the gas
│    concentration changes over the phase. g) No guidance offered. h) No
│    guidance offered. i) The temperature sensors within the sterilization
│    load should be placed in the locations that are most likely to
│    experience the greatest temperature variation. These locations should
│    take into account hot or cold spots located during OQ. The locations
│    of hot and cold spots within a load can be significantly different
│    than the locations in an empty chamber. During PQ, it is important to
│    take into account the relationship between the load tempe
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 83 [MED ] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ature variation. These locations should take into account hot or cold
│    spots located during OQ. The locations of hot and cold spots within a
│    load can be significantly different than the locations in an empty
│    chamber. During PQ, it is important to take into account the
│    relationship between the load temperature and the chamber temperature
│    in order to ensure adequate load temperature in the routine process.
│    If sensors are used in the sterilization chamber and 100 % EO or
│    potentially flammable sterilant mixtures are used, the temperature
│    and humidity sensors should be intrinsically safe, or should ﻿ 54
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 84 [MED ] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ons should take into account hot or cold spots located during OQ. The
│    locations of hot and cold spots within a load can be significantly
│    different than the locations in an empty chamber. During PQ, it is
│    important to take into account the relationship between the load
│    temperature and the chamber temperature in order to ensure adequate
│    load temperature in the routine process. If sensors are used in the
│    sterilization chamber and 100 % EO or potentially flammable sterilant
│    mixtures are used, the temperature and humidity sensors should be
│    intrinsically safe, or should ﻿ 54 © ISO 2014 – All rights rese
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 85 [MED ] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ts located during OQ. The locations of hot and cold spots within a
│    load can be significantly different than the locations in an empty
│    chamber. During PQ, it is important to take into account the
│    relationship between the load temperature and the chamber temperature
│    in order to ensure adequate load temperature in the routine process.
│    If sensors are used in the sterilization chamber and 100 % EO or
│    potentially flammable sterilant mixtures are used, the temperature
│    and humidity sensors should be intrinsically safe, or should ﻿ 54 ©
│    ISO 2014 – All rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE
│    7
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 86 [MED ] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    is important to take into account the relationship between the load
│    temperature and the chamber temperature in order to ensure adequate
│    load temperature in the routine process. If sensors are used in the
│    sterilization chamber and 100 % EO or potentially flammable sterilant
│    mixtures are used, the temperature and humidity sensors should be
│    intrinsically safe, or should ﻿ 54 © ISO 2014 – All rights reserved
│    BS EN ISO 11135:2014+A1:2019 --- PAGE 77 --- ﻿ ISO 11135:2014+A1:2018
│    be of an explosion proof design. These sensors should also be
│    functionally compatible with EO and with any diluent gases. j)
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 87 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    humidity sensors should be intrinsically safe, or should ﻿ 54 © ISO
│    2014 – All rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 77
│    --- ﻿ ISO 11135:2014+A1:2018 be of an explosion proof design. These
│    sensors should also be functionally compatible with EO and with any
│    diluent gases. j) The temperature within the sterilization load
│    during the aeration process should be measured over the period of
│    time required for the sterilization load to attain acceptable
│    residual levels or measured over the period of time required for the
│    sterilization load temperature to stabilize. NOTE This can be establi
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 88 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    EO and with any diluent gases. j) The temperature within the
│    sterilization load during the aeration process should be measured
│    over the period of time required for the sterilization load to attain
│    acceptable residual levels or measured over the period of time
│    required for the sterilization load temperature to stabilize. NOTE
│    This can be established during additional studies after completion of
│    MPQ/PPQ. D.9.4.4 Review and approval of validation D.9.5.1 No
│    guidance offered. D.9.5.2 Any discrepancies observed during the
│    validation process should be documented, and their effect on the
│    results of the
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 89 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    rametric release of product. D.9.5.6 No guidance offered. ﻿ © ISO
│    2014 – All rights reserved 55 BS EN ISO 11135:2014+A1:2019 --- PAGE
│    78 --- ﻿ ISO 11135:2014+A1:2018 D.10 Routine monitoring and control
│    D.10.1 No guidance offered. D.10.2 Guidance on the bulleted items of
│    10.2 follows: a) The temperature of products entering the
│    preconditioning area should be at or above the minimum temperature
│    specified or the defined conditions of storage should be met. If the
│    product has been exposed to extreme temperatures, for example during
│    transport, it might be necessary to store the product prior to pre
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 90 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    d 55 BS EN ISO 11135:2014+A1:2019 --- PAGE 78 --- ﻿ ISO
│    11135:2014+A1:2018 D.10 Routine monitoring and control D.10.1 No
│    guidance offered. D.10.2 Guidance on the bulleted items of 10.2
│    follows: a) The temperature of products entering the preconditioning
│    area should be at or above the minimum temperature specified or the
│    defined conditions of storage should be met. If the product has been
│    exposed to extreme temperatures, for example during transport, it
│    might be necessary to store the product prior to preconditioning, or
│    extend preconditioning time to allow the internal temperature and
│    humidity
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 91 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    e the minimum temperature specified or the defined conditions of
│    storage should be met. If the product has been exposed to extreme
│    temperatures, for example during transport, it might be necessary to
│    store the product prior to preconditioning, or extend preconditioning
│    time to allow the internal temperature and humidity to be within
│    acceptable ranges. NOTE The minimum temperature of products entering
│    preconditioning or the storage conditions are defined during PQ. b)
│    The reference position for routine monitoring of temperature and
│    relative humidity during preconditioning should be correlated to t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 92 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ould be met. If the product has been exposed to extreme temperatures,
│    for example during transport, it might be necessary to store the
│    product prior to preconditioning, or extend preconditioning time to
│    allow the internal temperature and humidity to be within acceptable
│    ranges. NOTE The minimum temperature of products entering
│    preconditioning or the storage conditions are defined during PQ. b)
│    The reference position for routine monitoring of temperature and
│    relative humidity during preconditioning should be correlated to the
│    location at which it is most difficult to achieve the desired
│    conditions
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 93 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    o preconditioning, or extend preconditioning time to allow the
│    internal temperature and humidity to be within acceptable ranges.
│    NOTE The minimum temperature of products entering preconditioning or
│    the storage conditions are defined during PQ. b) The reference
│    position for routine monitoring of temperature and relative humidity
│    during preconditioning should be correlated to the location at which
│    it is most difficult to achieve the desired conditions. Monitoring
│    data for the operation of the preconditioning area should be reviewed
│    in conjunction with other data for the release of product. c) No gu
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 94 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    The humidity in the chamber is typically calculated by measuring the
│    partial pressure of water vapour injected into the chamber. The
│    relative humidity value is then determined using the steam tables by
│    a ratio of the partial pressure to the saturated vapour pressure for
│    the actual cycle process temperature. This will indicate the relative
│    humidity value in the head space of the chamber and will be accurate
│    until load or other reactions impact the actual water vapour content
│    in the head space. Consideration should be given to the amount of
│    moisture introduced into the chamber with the load from pre
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 95 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ion of conformity of the physical processing parameters to all
│    specifications. Therefore, data are gathered for additional
│    processing parameters such as direct analysis of chamber relative
│    humidity and EO concentration, in order to ensure that the
│    sterilization process has met specification. a) Temperature
│    measurement. The requirement to measure temperature within the
│    sterilizer from a minimum of two locations is established in order to
│    ensure that an undetected fault in a temperature sensor does not lead
│    to the inadvertent release of an improperly processed load. If there
│    is a difference in the tw
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 96 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ers to all specifications. Therefore, data are gathered for
│    additional processing parameters such as direct analysis of chamber
│    relative humidity and EO concentration, in order to ensure that the
│    sterilization process has met specification. a) Temperature
│    measurement. The requirement to measure temperature within the
│    sterilizer from a minimum of two locations is established in order to
│    ensure that an undetected fault in a temperature sensor does not lead
│    to the inadvertent release of an improperly processed load. If there
│    is a difference in the two temperature data points, the acceptable
│    temperatu
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 97 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    elative humidity and EO concentration, in order to ensure that the
│    sterilization process has met specification. a) Temperature
│    measurement. The requirement to measure temperature within the
│    sterilizer from a minimum of two locations is established in order to
│    ensure that an undetected fault in a temperature sensor does not lead
│    to the inadvertent release of an improperly processed load. If there
│    is a difference in the two temperature data points, the acceptable
│    temperature difference should be defined within the processing
│    specification. If either the controlling or the monitoring sensor do
│    not mee
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 98 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    easurement. The requirement to measure temperature within the
│    sterilizer from a minimum of two locations is established in order to
│    ensure that an undetected fault in a temperature sensor does not lead
│    to the inadvertent release of an improperly processed load. If there
│    is a difference in the two temperature data points, the acceptable
│    temperature difference should be defined within the processing
│    specification. If either the controlling or the monitoring sensor do
│    not meet specification and an investigation cannot determine the
│    accuracy of the chamber readings, the load is rejected b) Humidity
│    mea
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 99 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    mperature within the sterilizer from a minimum of two locations is
│    established in order to ensure that an undetected fault in a
│    temperature sensor does not lead to the inadvertent release of an
│    improperly processed load. If there is a difference in the two
│    temperature data points, the acceptable temperature difference should
│    be defined within the processing specification. If either the
│    controlling or the monitoring sensor do not meet specification and an
│    investigation cannot determine the accuracy of the chamber readings,
│    the load is rejected b) Humidity measurement. Direct analysis of the
│    head spa
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 100 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ing the year to ensure that the results from the original OQ are
│    still valid (see Figure D.1). In order to do so, it is common
│    practice to perform periodic requalification of equipment and should
│    include: a) review of IQ status of equipment; b) assessment of trends
│    in equipment performance; c) temperature and relative humidity
│    profiles of the preconditioning areas (if used); d) chamber
│    temperature profile; e) temperature profile of the aeration areas (if
│    used). These requalification exercises should indicate no significant
│    changes in the performance of preconditioning (if used), chamber or
│    aerati
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 101 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    In order to do so, it is common practice to perform periodic
│    requalification of equipment and should include: a) review of IQ
│    status of equipment; b) assessment of trends in equipment
│    performance; c) temperature and relative humidity profiles of the
│    preconditioning areas (if used); d) chamber temperature profile; e)
│    temperature profile of the aeration areas (if used). These
│    requalification exercises should indicate no significant changes in
│    the performance of preconditioning (if used), chamber or aeration
│    areas since the previous (re)qualification. If equipment changes are
│    necessary as a result
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 102 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    common practice to perform periodic requalification of equipment and
│    should include: a) review of IQ status of equipment; b) assessment of
│    trends in equipment performance; c) temperature and relative humidity
│    profiles of the preconditioning areas (if used); d) chamber
│    temperature profile; e) temperature profile of the aeration areas (if
│    used). These requalification exercises should indicate no significant
│    changes in the performance of preconditioning (if used), chamber or
│    aeration areas since the previous (re)qualification. If equipment
│    changes are necessary as a result of these exercises, requa
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 103 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    PCD in the product load to the resistance of the product bioburden,
│    or, after a defined interval, to provide evidence that there has been
│    no inadvertent change since the previous requalification study. This
│    would typically include, minimally, one fractional or half cycle
│    exposure including load temperature and humidity measurements.
│    Fractional cycles in a developmental chamber can also be used to
│    support a requalification program, but requalification of the
│    production chamber should be performed in the production chamber. It
│    is recommended that a MPQ cycle and load temperature and humidity
│    measurem
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 104 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    posure including load temperature and humidity measurements.
│    Fractional cycles in a developmental chamber can also be used to
│    support a requalification program, but requalification of the
│    production chamber should be performed in the production chamber. It
│    is recommended that a MPQ cycle and load temperature and humidity
│    measurements (MPQ/PPQ) be performed at least every two years to
│    verify that the documented paperwork review has captured any changes
│    in the product or sterilization process. Requalification can also
│    include verification that if the sterilization process specification
│    is changed, the
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 105 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    monstrate process equivalence. D.12.5.5 Evaluation of preconditioning
│    or aeration areas The criteria for establishing process equivalence
│    are the same for preconditioning or aeration areas, with the
│    exception that humidity usually does not apply to aeration. An
│    evaluation that compares the load temperature and humidity profiles
│    within each environment should be performed. At a minimum,
│    temperature and humidity uniformity within the load and the
│    relationship of this uniformity with the corresponding set points and
│    recorded control variables for the areas should be evaluated. If the
│    pieces of equipm
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 106 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    criteria for establishing process equivalence are the same for
│    preconditioning or aeration areas, with the exception that humidity
│    usually does not apply to aeration. An evaluation that compares the
│    load temperature and humidity profiles within each environment should
│    be performed. At a minimum, temperature and humidity uniformity
│    within the load and the relationship of this uniformity with the
│    corresponding set points and recorded control variables for the areas
│    should be evaluated. If the pieces of equipment use different set
│    points or have different control limits, it might not be possible to
│    de
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 107 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    et points or have different control limits, it might not be possible
│    to declare that they are equivalent. Process equivalence for the
│    preconditioning or aeration processes can be established if analysis
│    of performance data concludes that conditions within the load meet
│    the parameter limits (e.g. temperature distribution, residual levels,
│    etc.) at the end of preconditioning or the end of aeration. Product
│    EO sterilization residuals levels should be verified in the candidate
│    aeration room/chamber/cell. D.12.5.6 Evaluation of sterilization
│    chamber performance An evaluation that compares the delivery o
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 108 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ct with higher or more resistant bioburden levels than previously
│    qualified, even if the product does not support microbiological
│    growth. Another issue to be evaluated when shipping product between
│    sites is the difference in shipping conditions, such as time in
│    transit and seasonal effects (e.g. temperature, humidity, etc.).
│    Holding of product under defined conditions to simulate
│    shipping/transport conditions should be performed if required.
│    D.12.5.8 Results evaluation The results of the evaluation will
│    determine whether the different pieces or sets of equipment perform
│    equivalently. If the differe
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 109 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    duct. See D.7.1.6 for information on the development of PCDs and
│    D.8.6 for information on determining the appropriateness of the
│    internal PCD, placed within the sterile barrier system of the
│    product. The parameters that primarily affect lethality are exposure
│    time, EO concentration, humidity and temperature. If an adjustment of
│    parameters other than exposure time is made, the overall effect to
│    the cycle should be evaluated since the adjustment might not achieve
│    the desired result because the parameters are interrelated. For
│    example, the result of decreasing temperature would actually increase
│    the E
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 110 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    O concentration, humidity and temperature. If an adjustment of
│    parameters other than exposure time is made, the overall effect to
│    the cycle should be evaluated since the adjustment might not achieve
│    the desired result because the parameters are interrelated. For
│    example, the result of decreasing temperature would actually increase
│    the EO concentration and the relative humidity if no change is made
│    to the pressure parameters. The data obtained from process lethality
│    studies are used to establish the minimum EO gas exposure time
│    required for the sterilization process. If these studies are
│    performed in
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 111 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    the exposure time while holding all other parameters either constant
│    at ﻿ 72 © ISO 2014 – All rights reserved BS EN ISO
│    11135:2014+A1:2019 --- PAGE 95 --- ﻿ ISO 11135:2014+A1:2018 nominal
│    conditions, or at selected minimum acceptable processing conditions.
│    Utilizing the allowed minimum process temperature for the enumeration
│    study ensures the required lethality is obtained when operating
│    within the specified temperature range. The parameters that primarily
│    affect lethality are exposure time, EO concentration, humidity, and
│    temperature. If an adjustment of parameters other than exposure time
│    is mad
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 112 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ISO 11135:2014+A1:2019 --- PAGE 95 --- ﻿ ISO 11135:2014+A1:2018
│    nominal conditions, or at selected minimum acceptable processing
│    conditions. Utilizing the allowed minimum process temperature for the
│    enumeration study ensures the required lethality is obtained when
│    operating within the specified temperature range. The parameters that
│    primarily affect lethality are exposure time, EO concentration,
│    humidity, and temperature. If an adjustment of parameters other than
│    exposure time is made, the overall effect to the cycle should be
│    evaluated since the adjustment might not achieve the desired result
│    beca
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 113 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    e processing conditions. Utilizing the allowed minimum process
│    temperature for the enumeration study ensures the required lethality
│    is obtained when operating within the specified temperature range.
│    The parameters that primarily affect lethality are exposure time, EO
│    concentration, humidity, and temperature. If an adjustment of
│    parameters other than exposure time is made, the overall effect to
│    the cycle should be evaluated since the adjustment might not achieve
│    the desired result because the parameters are interrelated. For
│    example, the result of decreasing temperature would actually increase
│    EO co
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 114 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    concentration, humidity, and temperature. If an adjustment of
│    parameters other than exposure time is made, the overall effect to
│    the cycle should be evaluated since the adjustment might not achieve
│    the desired result because the parameters are interrelated. For
│    example, the result of decreasing temperature would actually increase
│    EO concentration and relative humidity if no change is made to the
│    steam injection pressure and the EO injection pressure rise. D.14.2.5
│    [B.2.5] SLRs can be calculated using the results of fractional
│    cycles. If there are no surviving internal PCDs, a worst-case
│    estimate
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 115 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    load to ambient conditions. The aeration period shall be sufficient
│    to allow EO residues to dissipate to a level that will not adversely
│    affect new PCDs in the full exposure sterilization cycle (see
│    9.4.1.8). E.2.11 Distribute new internal PCDs (that are the same type
│    as used in the half cycle), temperature sensors, and humidity sensors
│    throughout the sterilization load, including locations where
│    sterilizing conditions are most difficult to achieve. It is
│    recommended to use the number of internal PCDs, temperature sensors,
│    and humidity sensors as detailed in Table C.1, Table C.2, for PQ and
│    Table C
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 116 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    2.11 Distribute new internal PCDs (that are the same type as used in
│    the half cycle), temperature sensors, and humidity sensors throughout
│    the sterilization load, including locations where sterilizing
│    conditions are most difficult to achieve. It is recommended to use
│    the number of internal PCDs, temperature sensors, and humidity
│    sensors as detailed in Table C.1, Table C.2, for PQ and Table C.3 for
│    MPQ. E.2.12 Process the same load by exposing it to the defined
│    sterilization process where the specified exposure time is at least
│    double that of the half cycle in E.2.7 (i.e. a full sterilization
│    cycle)
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 117 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.5/5.0
│
│  Context:
│    A1:2019 --- PAGE 98 --- ﻿ ISO 11135:2014+A1:2018 f) confirmation of
│    no growth of the test microorganism from internal PCDs and external
│    PCDs (if used) exposed to the full sterilization cycle; g)
│    confirmation that the sterilization load humidity at the end of
│    conditioning and sterilization load temperature during EO exposure
│    are equivalent or greater than the minimum values achieved in the
│    half cycle, acceptance criteria for equivalence should be documented
│    in the protocol; h) confirmation that product functionality,
│    stability, biocompatibility, and package integrity comply with the
│    specified requ
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 118 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: thermal
│  Relevance Score: 2.5/5.0
│
│  Context:
│    vides guidance on designing a life cycle assessment study. ﻿ 34 ©
│    ISO 2014 – All rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE
│    57 --- ﻿ ISO 11135:2014+A1:2018 D.5.5.3 Effluent gas should be
│    discharged through an EO gas treatment system, such as a catalytic
│    oxidizer, wet acid scrubber or thermal oxidizer in compliance with
│    local permit requirements or emission control legislation. When
│    choosing a diluent, the ozone depleting potential of the diluent as
│    well as the disposal of any by- products should be taken into
│    consideration. D.6 Process and equipment characterization In health
│    care fa
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 119 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: thermal
│  Relevance Score: 2.5/5.0
│
│  Context:
│    Concepts and Exploring the Applications. Pharm. Tech. 2002, 26 (10)
│    pp. 114–134 [37] Pflug I.J. Microbiology and Engineering of
│    Sterilization Processes, Minneapolis. Environmental Sterilization
│    Services, Minneapolis, Eleventh Edition, 2003 [38] Pflug I.J.,
│    Holcomb R.G., Gomez M.M. Thermal Destruction of Miroorganisms. In:
│    Disinfection, Sterilization, and Preservation, (Block S. ed.).
│    Lippincott, Williams & Wilkins, Philadelphia, 2001, pp. 79–129. [39]
│    Rodriguez A.C., Young B., Caulk K., Zelewski J., Dwasnica S., Aguirre
│    S. Calculating Accumulated Lethality and Survivor
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 120 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: thermal
│  Relevance Score: 2.5/5.0
│
│  Context:
│    +A1:2018 [41] Shintani Comparison of D10-value accuracy by the
│    limited Spearman-Karber procedure (LSKP), the Stumbo-Murphy-Cochran
│    procedure (SMCP), and the survival-curve method (EN). Biomed.
│    Instrum. Technol. 1995, 29 (2) pp. 113–124 [42] Stumbo C.R., Murphy
│    J.R., Cochran J. Nature of Thermal Death Time Curves for P.A. 3679
│    and Clostridium Botulinum. Food Technol. 1950, 4 pp. 321–326 [43] USP
│    Monograph on Biological Indicator for Ethylene Oxide Sterilization,
│    Paper Carrier, USP36– NF31 (2013), page 2659 ﻿ © ISO 2014 – All
│    rights reserved 79 BS EN ISO 11135:2014+A1:2019 --- PAGE 10
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 121 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: heat
│  Relevance Score: 2.5/5.0
│
│  Context:
│    process) to a previously validated product, package or loading
│    configuration shall be considered to meet the requirement to perform
│    product definition. Any demonstration of equivalence shall be
│    documented. 7.1.3 Product shall be designed to allow removal of air,
│    if applicable, and penetration of heat, humidity and EO during the
│    sterilization process, and removal of EO at the end of the process.
│    7.1.4 Packaging shall be designed to allow removal of air and
│    penetration of heat, humidity and EO during the sterilization
│    process, and removal of EO at the end of the process. 7.1.5 The load
│    config
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 122 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: heat
│  Relevance Score: 2.5/5.0
│
│  Context:
│    lence shall be documented. 7.1.3 Product shall be designed to allow
│    removal of air, if applicable, and penetration of heat, humidity and
│    EO during the sterilization process, and removal of EO at the end of
│    the process. 7.1.4 Packaging shall be designed to allow removal of
│    air and penetration of heat, humidity and EO during the sterilization
│    process, and removal of EO at the end of the process. 7.1.5 The load
│    configuration shall be designed to allow removal of air and
│    penetration of heat, humidity and EO during the sterilization
│    process, and removal of EO at the end of the process. 7.1.6 It
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 123 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: heat
│  Relevance Score: 2.5/5.0
│
│  Context:
│    O at the end of the process. 7.1.4 Packaging shall be designed to
│    allow removal of air and penetration of heat, humidity and EO during
│    the sterilization process, and removal of EO at the end of the
│    process. 7.1.5 The load configuration shall be designed to allow
│    removal of air and penetration of heat, humidity and EO during the
│    sterilization process, and removal of EO at the end of the process.
│    7.1.6 It shall be demonstrated that the specified sterilization
│    process is effective in sterilizing the most difficult-to-sterilize
│    location within the product. This can be achieved by performing proc
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 124 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: heat
│  Relevance Score: 2.5/5.0
│
│  Context:
│    med to compare the new or modified product to the validated product
│    and/or PCD that was used to validate the existing EO process. The
│    construction and configuration of the new or modified product should
│    be carefully examined for any features that could present obstacles
│    to the penetration of EO, heat or humidity. For medical device
│    manufacturers, this comparison should also involve an examination of
│    factors that could affect the initial bioburden on the product,
│    including the location of the manufacturing facilities, the types of
│    raw material used, the sources of these materials and producti
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 125 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: heat
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ter challenge to the sterilization cycle than the product/PCD
│    previously validated. If the product configuration, density or load
│    configuration of the candidate product and its packaging could
│    present a greater challenge to the sterilization process than the
│    previously validated product, then EO, heat and humidity penetration
│    studies and/or cycle lethality studies should be conducted. As part
│    of the technical review the following questions should be considered.
│    If the answer to any of the following questions is “yes”, then
│    further evaluation of the new or modified product might be necessary
│    to
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 126 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: heat
│  Relevance Score: 2.5/5.0
│
│  Context:
│    characteristics routinely sterilized, when developing a
│    representative or most challenging load for validation. Products or
│    surrogate product materials utilized in validation loads should
│    represent those that typically present the most challenging condition
│    for lethality (i.e. for penetration of heat, humidity, and EO gas
│    diffusion; density). Consideration should be given to include load
│    material with substantially varying characteristics such as:
│    absorbent materials, barriers to diffusion such as rigid materials,
│    sealed liquids, containers, etc. D.9.4.1.7 No guidance offered
│    D.9.4.1.8 If
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 127 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: heat
│  Relevance Score: 2.5/5.0
│
│  Context:
│    on in accordance with ISO 11140‑1. Internal chemical indicators in
│    health care facilities: a) An internal chemical indicator can be used
│    within each package to be sterilized. If used, the chemical indicator
│    should be placed in that area of the package considered to be the
│    least accessible to EO, heat, and humidity penetration; this might or
│    might not be the centre of the pack. While internal chemical
│    indicators do not verify sterility, they allow detection of
│    procedural errors and equipment malfunctions. The use of chemical
│    indicators that respond to all the parameters of the EO process is b
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 128 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: heat
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ed for the impact on product release. ISO 10993‑7 should be used as
│    guidance for making this evaluation. D.12.5.11.3 Determination of
│    product design effects The design of the candidate product should be
│    carefully reviewed for any changes or differences that could present
│    greater obstacles to EO, heat, or humidity penetration than the
│    existing product or PCD. Examples of possible changes include longer
│    lumens, the addition of closures, or a larger number of mated
│    surfaces or product density. Review the product design against the
│    original product functionality testing to ensure that the changes
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 129 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: heat
│  Relevance Score: 2.5/5.0
│
│  Context:
│    the product will not retain higher EO residual levels or levels that
│    will exceed the regulated limits. D.12.5.11.5 Determination of
│    sterile barrier system effects The sterile barrier system of the
│    candidate product should be carefully examined for any factors that
│    could present obstacles to EO, heat, or humidity penetration. These
│    factors can include a decrease in porosity of the venting material, a
│    smaller venting surface area, the occlusion of the venting area, or
│    any other feature that would make the candidate product a greater
│    challenge to the sterilization process than the existing pro
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 130 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: heat
│  Relevance Score: 2.5/5.0
│
│  Context:
│    of the medical device allows diffusion of EO; b) absorbency of the
│    different parts of both the product and material; c) weights and
│    densities of items; d) load configuration, especially for a mixed
│    product load. Health care considerations: To demonstrate adequate
│    penetration of EO, humidity and heat into product, a PCD should be
│    chosen for routine monitoring and validation of the EO sterilization
│    process. The resistance of the PCD to EO should be shown to be equal
│    to or greater than the resistance of the bioburden of product to be
│    sterilized at the most difficult to sterilize location on th
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 131 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ging considerations are addressed in more detail in the ISO 11607‑1
│    and ISO 11607‑2. D.7.1.5 The load configuration in the chamber can
│    influence product heat, humidity, EO gas penetration and EO gas
│    removal. The load configuration is to be defined during the
│    validation to ensure adequate product temperature, humidity and EO
│    penetration and EO removal during processing. D.7.1.6 A PCD is a
│    device into which a microbiological challenge is located. Examples of
│    ways to develop PCDs for use in the demonstration of equivalence
│    include, but are not limited to a) placement of a microbiological
│    challenge bet
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 132 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: temperature
│  Relevance Score: 2.0/5.0
│
│  Context:
│    g equipment (i.e. environmental and/or chamber); d) door safety
│    interlocks; e) safety pressure relief valves or rupture discs; f)
│    filters (for periodic replacement); g) volatizers/vaporizers; h)
│    chamber jacket re-circulation system; i) chamber jacket system; j)
│    audible and visual alarms; k) temperature and humidity sensor
│    equipment; l) boiler system for steam and heat supply; m) evacuation
│    equipment (vacuum pumps); n) weighing scales; o) valves; p) pressure
│    transducers; q) timers; r) recorders; s) air/gas circulation systems.
│    D.12.2.2 Sterilization equipment that is not calibrated or is
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 133 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: heat
│  Relevance Score: 2.0/5.0
│
│  Context:
│    common practice to demonstrate suitability of the SBS by exposure of
│    the SBS to multiple sterilization processes (see D.7.2.1 and
│    D.7.2.2). Packaging considerations are addressed in more detail in
│    the ISO 11607‑1 and ISO 11607‑2. D.7.1.5 The load configuration in
│    the chamber can influence product heat, humidity, EO gas penetration
│    and EO gas removal. The load configuration is to be defined during
│    the validation to ensure adequate product temperature, humidity and
│    EO penetration and EO removal during processing. D.7.1.6 A PCD is a
│    device into which a microbiological challenge is located. Examp
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 134 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: heat
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ; e) safety pressure relief valves or rupture discs; f) filters (for
│    periodic replacement); g) volatizers/vaporizers; h) chamber jacket
│    re-circulation system; i) chamber jacket system; j) audible and
│    visual alarms; k) temperature and humidity sensor equipment; l)
│    boiler system for steam and heat supply; m) evacuation equipment
│    (vacuum pumps); n) weighing scales; o) valves; p) pressure
│    transducers; q) timers; r) recorders; s) air/gas circulation systems.
│    D.12.2.2 Sterilization equipment that is not calibrated or is not
│    properly maintained can generate an inaccurate record of the pr
│
└───────────────────────────────────────────────────────────────────────────────


CATEGORY: VALIDATION

┌─ PARAMETER 01 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 5.0/5.0
│
│  Context:
│    ocess, they shall comply with ISO 11737‑2. 9 Validation 9.1 General
│    9.1.1 The purpose of validation is to demonstrate that the
│    sterilization process established in the process definition (see
│    Clause 8) can be delivered effectively and reproducibly to the
│    product within the sterilization load. Validation consists of a
│    number of identified stages: installation qualification (IQ),
│    operational qualification (OQ) and performance qualification (PQ).
│    Testing shall not commence until the procedures and/or protocols have
│    been approved. 9.1.2 IQ is undertaken to demonstrate that the
│    sterilization equipme
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 02 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 5.0/5.0
│
│  Context:
│    ral 9.1.1 The purpose of validation is to demonstrate that the
│    sterilization process established in the process definition (see
│    Clause 8) can be delivered effectively and reproducibly to the
│    product within the sterilization load. Validation consists of a
│    number of identified stages: installation qualification (IQ),
│    operational qualification (OQ) and performance qualification (PQ).
│    Testing shall not commence until the procedures and/or protocols have
│    been approved. 9.1.2 IQ is undertaken to demonstrate that the
│    sterilization equipment and any ancillary items have been supplied
│    and installed in accord
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 03 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 5.0/5.0
│
│  Context:
│    ion is to demonstrate that the sterilization process established in
│    the process definition (see Clause 8) can be delivered effectively
│    and reproducibly to the product within the sterilization load.
│    Validation consists of a number of identified stages: installation
│    qualification (IQ), operational qualification (OQ) and performance
│    qualification (PQ). Testing shall not commence until the procedures
│    and/or protocols have been approved. 9.1.2 IQ is undertaken to
│    demonstrate that the sterilization equipment and any ancillary items
│    have been supplied and installed in accordance with their
│    specification. 9.
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 04 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 5.0/5.0
│
│  Context:
│    ilization process established in the process definition (see Clause
│    8) can be delivered effectively and reproducibly to the product
│    within the sterilization load. Validation consists of a number of
│    identified stages: installation qualification (IQ), operational
│    qualification (OQ) and performance qualification (PQ). Testing shall
│    not commence until the procedures and/or protocols have been
│    approved. 9.1.2 IQ is undertaken to demonstrate that the
│    sterilization equipment and any ancillary items have been supplied
│    and installed in accordance with their specification. 9.1.3 OQ is
│    undertaken to demonstrat
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 05 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 5.0/5.0
│
│  Context:
│    purpose of validation is to demonstrate that the sterilization
│    process established in the process definition (see Clause 8) can be
│    delivered effectively and reproducibly to the product within the
│    sterilization load. Validation consists of a number of identified
│    stages: installation qualification (IQ), operational qualification
│    (OQ) and performance qualification (PQ). Testing shall not commence
│    until the procedures and/or protocols have been approved. 9.1.2 IQ is
│    undertaken to demonstrate that the sterilization equipment and any
│    ancillary items have been supplied and installed in accordance
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 06 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 5.0/5.0
│
│  Context:
│    ibly to the product within the sterilization load. Validation
│    consists of a number of identified stages: installation qualification
│    (IQ), operational qualification (OQ) and performance qualification
│    (PQ). Testing shall not commence until the procedures and/or
│    protocols have been approved. 9.1.2 IQ is undertaken to demonstrate
│    that the sterilization equipment and any ancillary items have been
│    supplied and installed in accordance with their specification. 9.1.3
│    OQ is undertaken to demonstrate the ability of the equipment to meet
│    the performance requirements of its design specification. 9.1.
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 07 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 5.0/5.0
│
│  Context:
│    strate that the sterilization process established in the process
│    definition (see Clause 8) can be delivered effectively and
│    reproducibly to the product within the sterilization load. Validation
│    consists of a number of identified stages: installation qualification
│    (IQ), operational qualification (OQ) and performance qualification
│    (PQ). Testing shall not commence until the procedures and/or
│    protocols have been approved. 9.1.2 IQ is undertaken to demonstrate
│    that the sterilization equipment and any ancillary items have been
│    supplied and installed in accordance with their specification. 9.1.3
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 08 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 5.0/5.0
│
│  Context:
│    and performance qualification (PQ). Testing shall not commence until
│    the procedures and/or protocols have been approved. 9.1.2 IQ is
│    undertaken to demonstrate that the sterilization equipment and any
│    ancillary items have been supplied and installed in accordance with
│    their specification. 9.1.3 OQ is undertaken to demonstrate the
│    ability of the equipment to meet the performance requirements of its
│    design specification. 9.1.4 PQ is the stage of validation that uses
│    product to demonstrate that the equipment consistently operates in
│    accordance with predetermined acceptance criteria and the p
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 09 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 5.0/5.0
│
│  Context:
│    ss established in the process definition (see Clause 8) can be
│    delivered effectively and reproducibly to the product within the
│    sterilization load. Validation consists of a number of identified
│    stages: installation qualification (IQ), operational qualification
│    (OQ) and performance qualification (PQ). Testing shall not commence
│    until the procedures and/or protocols have been approved. 9.1.2 IQ is
│    undertaken to demonstrate that the sterilization equipment and any
│    ancillary items have been supplied and installed in accordance with
│    their specification. 9.1.3 OQ is undertaken to demonstrate th
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 10 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: performance qualification
│  Relevance Score: 5.0/5.0
│
│  Context:
│    hat the sterilization process established in the process definition
│    (see Clause 8) can be delivered effectively and reproducibly to the
│    product within the sterilization load. Validation consists of a
│    number of identified stages: installation qualification (IQ),
│    operational qualification (OQ) and performance qualification (PQ).
│    Testing shall not commence until the procedures and/or protocols have
│    been approved. 9.1.2 IQ is undertaken to demonstrate that the
│    sterilization equipment and any ancillary items have been supplied
│    and installed in accordance with their specification. 9.1.3 OQ is
│    undertaken to demonstrat
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 11 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 4.5/5.0
│
│  Context:
│    erate effectively. c) Aeration Phase 1) When performing aeration, the
│    temperature profile of the aeration area should be determined in the
│    same manner as recommended for preconditioning areas. The air flow
│    rates and air flow patterns through the area should also be
│    determined. D.9.4 Performance qualification D.9.4.1 General PQ
│    consists of rigorous microbiological and physical testing, beyond
│    routine monitoring, to demonstrate the efficacy and reproducibility
│    of the sterilization process. PQ is normally not started until after
│    completion and approval of the IQ and OQ testing. Acceptance criteria
│    shou
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 12 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 4.5/5.0
│
│  Context:
│    ature results in condensate formation in the load and product that
│    results in a low and erratic kill rate. D.9.4.1.9 No guidance offered
│    D.9.4.1.10 No guidance offered ﻿ 52 © ISO 2014 – All rights reserved
│    BS EN ISO 11135:2014+A1:2019 --- PAGE 75 --- ﻿ ISO 11135:2014+A1:2018
│    D.9.4.2 Performance qualification — Microbiological D.9.4.2.1 Results
│    obtained during process definition and, where applicable, IQ and OQ
│    should be used to set the parameters for MPQ. Exposure time is the
│    key parameter that is varied during microbiological qualification.
│    Other parameters can be adjusted as necessary to provide a
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 13 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 4.5/5.0
│
│  Context:
│    -- PAGE 75 --- ﻿ ISO 11135:2014+A1:2018 D.9.4.2 Performance
│    qualification — Microbiological D.9.4.2.1 Results obtained during
│    process definition and, where applicable, IQ and OQ should be used to
│    set the parameters for MPQ. Exposure time is the key parameter that
│    is varied during microbiological qualification. Other parameters can
│    be adjusted as necessary to provide assurance that the MPQ delivers
│    less lethality than the normal production process. For example,
│    temperature, humidity, and/or EO concentrations could be run at set
│    points that are at the lower extreme of the normal process range.
│    This wou
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 14 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 4.5/5.0
│
│  Context:
│    determined. D.9.4 Performance qualification D.9.4.1 General PQ
│    consists of rigorous microbiological and physical testing, beyond
│    routine monitoring, to demonstrate the efficacy and reproducibility
│    of the sterilization process. PQ is normally not started until after
│    completion and approval of the IQ and OQ testing. Acceptance criteria
│    should include conformance with the specifications for the
│    sterilization process parameters and microbiological challenge. PQ
│    activities should be clearly defined in a written document (e.g.
│    protocol). Where elements of the PQ are carried out by separate parti
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 15 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 4.5/5.0
│
│  Context:
│    .9.4.1.9 No guidance offered D.9.4.1.10 No guidance offered ﻿ 52 ©
│    ISO 2014 – All rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE
│    75 --- ﻿ ISO 11135:2014+A1:2018 D.9.4.2 Performance qualification —
│    Microbiological D.9.4.2.1 Results obtained during process definition
│    and, where applicable, IQ and OQ should be used to set the parameters
│    for MPQ. Exposure time is the key parameter that is varied during
│    microbiological qualification. Other parameters can be adjusted as
│    necessary to provide assurance that the MPQ delivers less lethality
│    than the normal production process. For example, te
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 16 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 4.5/5.0
│
│  Context:
│    ted. D.9.5.3 Typically the validation report is approved by the
│    designated responsible person(s) as defined in the validation
│    protocol. D.9.5.4 The validation report(s) should also include or
│    reference the following: — The specifications for the sterilizer and
│    the sterilization process; a) the IQ/OQ data; b) the records,
│    physical and microbiological, of all PQ runs; c) an indication that
│    all gauges, recorders, etc. were calibrated and within their
│    specifications; d) provision for future review and requalification;
│    e) the validation protocol(s)/procedure(s); f) the documented
│    procedures
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 17 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 4.5/5.0
│
│  Context:
│    ned. D.9.4 Performance qualification D.9.4.1 General PQ consists of
│    rigorous microbiological and physical testing, beyond routine
│    monitoring, to demonstrate the efficacy and reproducibility of the
│    sterilization process. PQ is normally not started until after
│    completion and approval of the IQ and OQ testing. Acceptance criteria
│    should include conformance with the specifications for the
│    sterilization process parameters and microbiological challenge. PQ
│    activities should be clearly defined in a written document (e.g.
│    protocol). Where elements of the PQ are carried out by separate
│    parties, tho
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 18 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 4.5/5.0
│
│  Context:
│    9 No guidance offered D.9.4.1.10 No guidance offered ﻿ 52 © ISO 2014
│    – All rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 75 --- ﻿
│    ISO 11135:2014+A1:2018 D.9.4.2 Performance qualification —
│    Microbiological D.9.4.2.1 Results obtained during process definition
│    and, where applicable, IQ and OQ should be used to set the parameters
│    for MPQ. Exposure time is the key parameter that is varied during
│    microbiological qualification. Other parameters can be adjusted as
│    necessary to provide assurance that the MPQ delivers less lethality
│    than the normal production process. For example, temperatu
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 19 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 4.5/5.0
│
│  Context:
│    . D.9.5.3 Typically the validation report is approved by the
│    designated responsible person(s) as defined in the validation
│    protocol. D.9.5.4 The validation report(s) should also include or
│    reference the following: — The specifications for the sterilizer and
│    the sterilization process; a) the IQ/OQ data; b) the records,
│    physical and microbiological, of all PQ runs; c) an indication that
│    all gauges, recorders, etc. were calibrated and within their
│    specifications; d) provision for future review and requalification;
│    e) the validation protocol(s)/procedure(s); f) the documented
│    procedures us
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 20 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 4.5/5.0
│
│  Context:
│    Phase 1) When performing aeration, the temperature profile of the
│    aeration area should be determined in the same manner as recommended
│    for preconditioning areas. The air flow rates and air flow patterns
│    through the area should also be determined. D.9.4 Performance
│    qualification D.9.4.1 General PQ consists of rigorous microbiological
│    and physical testing, beyond routine monitoring, to demonstrate the
│    efficacy and reproducibility of the sterilization process. PQ is
│    normally not started until after completion and approval of the IQ
│    and OQ testing. Acceptance criteria should include conforman
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 21 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 4.5/5.0
│
│  Context:
│    air flow rates and air flow patterns through the area should also be
│    determined. D.9.4 Performance qualification D.9.4.1 General PQ
│    consists of rigorous microbiological and physical testing, beyond
│    routine monitoring, to demonstrate the efficacy and reproducibility
│    of the sterilization process. PQ is normally not started until after
│    completion and approval of the IQ and OQ testing. Acceptance criteria
│    should include conformance with the specifications for the
│    sterilization process parameters and microbiological challenge. PQ
│    activities should be clearly defined in a written document (e.g.
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 22 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 4.5/5.0
│
│  Context:
│    esignated responsible person(s) as defined in the validation
│    protocol. D.9.5.4 The validation report(s) should also include or
│    reference the following: — The specifications for the sterilizer and
│    the sterilization process; a) the IQ/OQ data; b) the records,
│    physical and microbiological, of all PQ runs; c) an indication that
│    all gauges, recorders, etc. were calibrated and within their
│    specifications; d) provision for future review and requalification;
│    e) the validation protocol(s)/procedure(s); f) the documented
│    procedures used; g) documented operating procedures including process
│    contr
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 23 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: performance qualification
│  Relevance Score: 4.5/5.0
│
│  Context:
│    inues to operate effectively. c) Aeration Phase 1) When performing
│    aeration, the temperature profile of the aeration area should be
│    determined in the same manner as recommended for preconditioning
│    areas. The air flow rates and air flow patterns through the area
│    should also be determined. D.9.4 Performance qualification D.9.4.1
│    General PQ consists of rigorous microbiological and physical testing,
│    beyond routine monitoring, to demonstrate the efficacy and
│    reproducibility of the sterilization process. PQ is normally not
│    started until after completion and approval of the IQ and OQ testing.
│    Acceptance criteria shou
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 24 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: performance qualification
│  Relevance Score: 4.5/5.0
│
│  Context:
│    load temperature results in condensate formation in the load and
│    product that results in a low and erratic kill rate. D.9.4.1.9 No
│    guidance offered D.9.4.1.10 No guidance offered ﻿ 52 © ISO 2014 –
│    All rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 75 --- ﻿
│    ISO 11135:2014+A1:2018 D.9.4.2 Performance qualification —
│    Microbiological D.9.4.2.1 Results obtained during process definition
│    and, where applicable, IQ and OQ should be used to set the parameters
│    for MPQ. Exposure time is the key parameter that is varied during
│    microbiological qualification. Other parameters can be adjusted as
│    necessary to provide a
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 25 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 4.0/5.0
│
│  Context:
│    nstrate that the sterilization equipment and any ancillary items have
│    been supplied and installed in accordance with their specification.
│    9.1.3 OQ is undertaken to demonstrate the ability of the equipment to
│    meet the performance requirements of its design specification. 9.1.4
│    PQ is the stage of validation that uses product to demonstrate that
│    the equipment consistently operates in accordance with predetermined
│    acceptance criteria and the process yields product that is sterile
│    and meets the specified requirements. IQ and OQ may be a one-time
│    exercise for the specific equipment being employed for a
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 26 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 4.0/5.0
│
│  Context:
│    1135:2014+A1:2018 j) during aeration (if used), the temperature of
│    the sterilization load has been established. 9.5 Review and approval
│    of validation 9.5.1 The purpose of this activity is to undertake and
│    document a review of the validation data to confirm the acceptability
│    against the approved validation procedures/protocol for the
│    sterilization process and to approve the process specification. 9.5.2
│    Information gathered or produced during product definition, process
│    definition, IQ, OQ and PQ, including results from incubation of
│    biological indicators, shall be recorded and reviewed for accepta
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 27 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 4.0/5.0
│
│  Context:
│    ove the process specification. 9.5.2 Information gathered or produced
│    during product definition, process definition, IQ, OQ and PQ,
│    including results from incubation of biological indicators, shall be
│    recorded and reviewed for acceptability. The results of this review
│    shall be recorded. 9.5.3 A validation report shall be prepared. The
│    report shall be reviewed and approved by the designated responsible
│    person(s). 9.5.4 The validation report shall describe or reference
│    specific qualified product, defined load configurations and the
│    documented specification for the EO sterilization process and shall
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 28 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 4.0/5.0
│
│  Context:
│    Validation of the sterilization process should be performed according
│    to an approved written document (e.g. protocol) that defines the
│    testing procedures and the acceptance criteria, prior to initiation
│    of testing. This document should be reviewed by a sterilization
│    specialist(s). The elements of validation, as defined in this clause,
│    are a) IQ, b) OQ, and c) PQ. ﻿ © ISO 2014 – All rights reserved 47
│    BS EN ISO 11135:2014+A1:2019 --- PAGE 70 --- ﻿ ISO 11135:2014+A1:2018
│    In a health care facility, IQ and OQ are typically performed by the
│    sterilizer manufacturer, although they can be performed by a
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 29 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 4.0/5.0
│
│  Context:
│    fter completion of MPQ/PPQ. D.9.4.4 Review and approval of validation
│    D.9.5.1 No guidance offered. D.9.5.2 Any discrepancies observed
│    during the validation process should be documented, and their effect
│    on the results of the validation should be determined and documented.
│    D.9.5.3 Typically the validation report is approved by the designated
│    responsible person(s) as defined in the validation protocol. D.9.5.4
│    The validation report(s) should also include or reference the
│    following: — The specifications for the sterilizer and the
│    sterilization process; a) the IQ/OQ data; b) the records, physical
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 30 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 4.0/5.0
│
│  Context:
│    ce offered. D.9.5.2 Any discrepancies observed during the validation
│    process should be documented, and their effect on the results of the
│    validation should be determined and documented. D.9.5.3 Typically the
│    validation report is approved by the designated responsible person(s)
│    as defined in the validation protocol. D.9.5.4 The validation
│    report(s) should also include or reference the following: — The
│    specifications for the sterilizer and the sterilization process; a)
│    the IQ/OQ data; b) the records, physical and microbiological, of all
│    PQ runs; c) an indication that all gauges, recorders, etc. w
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 31 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 4.0/5.0
│
│  Context:
│    cies observed during the validation process should be documented, and
│    their effect on the results of the validation should be determined
│    and documented. D.9.5.3 Typically the validation report is approved
│    by the designated responsible person(s) as defined in the validation
│    protocol. D.9.5.4 The validation report(s) should also include or
│    reference the following: — The specifications for the sterilizer and
│    the sterilization process; a) the IQ/OQ data; b) the records,
│    physical and microbiological, of all PQ runs; c) an indication that
│    all gauges, recorders, etc. were calibrated and within their sp
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 32 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 4.0/5.0
│
│  Context:
│    ing of the sterilization process shall be confirmed (see 4.3.3).
│    9.3.2 OQ shall demonstrate that the installed equipment is capable of
│    meeting its operating specification. ﻿ © ISO 2014 – All rights
│    reserved 17 BS EN ISO 11135:2014+A1:2019 --- PAGE 40 --- ﻿ ISO
│    11135:2014+A1:2018 9.4 Performance qualification, PQ 9.4.1 General
│    9.4.1.1 PQ consists of both microbiological and physical performance
│    qualification and is performed in the equipment used to sterilize the
│    product. 9.4.1.2 PQ shall be performed on the introduction of new or
│    modified products, packaging, load configuration, equipment or proce
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 33 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 4.0/5.0
│
│  Context:
│    uration to provide a relationship of the dynamics of the products
│    within the case against the PCD during process development. D.9.4.2.5
│    See AAMI TIR16:2009[25], 4.3.2. ﻿ © ISO 2014 – All rights reserved
│    53 BS EN ISO 11135:2014+A1:2019 --- PAGE 76 --- ﻿ ISO
│    11135:2014+A1:2018 D.9.4.3 Performance qualification — Physical NOTE
│    Results obtained from OQ can be used to identify features needing
│    evaluation during PPQ. D.9.4.3.1 If, in any of these runs, sterility
│    or product functionality requirements are not met, an investigation
│    should be conducted to determine if additional qualification runs are
│    necessa
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 34 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 4.0/5.0
│
│  Context:
│    .4.3 Performance qualification — Physical NOTE Results obtained from
│    OQ can be used to identify features needing evaluation during PPQ.
│    D.9.4.3.1 If, in any of these runs, sterility or product
│    functionality requirements are not met, an investigation should be
│    conducted to determine if additional qualification runs are
│    necessary. If process parameters cannot be maintained within the
│    defined limits, an investigation should be conducted. If
│    modifications are made, additional runs might be necessary. D.9.4.3.2
│    PPQ should be carried out with the loading patterns and pallet
│    separations specified in the do
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 35 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 4.0/5.0
│
│  Context:
│    to qualify the process. The sterilization process should be validated
│    in one chamber. The ﻿ © ISO 2014 – All rights reserved 63 BS EN ISO
│    11135:2014+A1:2019 --- PAGE 86 --- ﻿ ISO 11135:2014+A1:2018 remaining
│    equipment can undergo reduced PQ if the remaining equipment has
│    undergone installation qualification (IQ) and operational
│    qualification (OQ) (see 9.2 and 9.3). Equivalence can also be used to
│    reduce requalification of several pieces of equipment. The equipment
│    used to deliver a sterilization process commonly consists of a
│    chamber or room and ancillary control systems. Sterilization process
│    equi
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 36 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 4.0/5.0
│
│  Context:
│    ization process should be validated in one chamber. The ﻿ © ISO 2014
│    – All rights reserved 63 BS EN ISO 11135:2014+A1:2019 --- PAGE 86
│    --- ﻿ ISO 11135:2014+A1:2018 remaining equipment can undergo reduced
│    PQ if the remaining equipment has undergone installation
│    qualification (IQ) and operational qualification (OQ) (see 9.2 and
│    9.3). Equivalence can also be used to reduce requalification of
│    several pieces of equipment. The equipment used to deliver a
│    sterilization process commonly consists of a chamber or room and
│    ancillary control systems. Sterilization process equipment might be
│    located within a giv
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 37 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    mance requirements of its design specification. 9.1.4 PQ is the stage
│    of validation that uses product to demonstrate that the equipment
│    consistently operates in accordance with predetermined acceptance
│    criteria and the process yields product that is sterile and meets the
│    specified requirements. IQ and OQ may be a one-time exercise for the
│    specific equipment being employed for a sterilization process. PQ
│    should be carried out for each new process and/or product to be
│    validated to demonstrate that the process complies with identified
│    acceptance criteria and is capable of delivering the requi
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 38 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    to undertake and document a review of the validation data to confirm
│    the acceptability against the approved validation procedures/protocol
│    for the sterilization process and to approve the process
│    specification. 9.5.2 Information gathered or produced during product
│    definition, process definition, IQ, OQ and PQ, including results from
│    incubation of biological indicators, shall be recorded and reviewed
│    for acceptability. The results of this review shall be recorded.
│    9.5.3 A validation report shall be prepared. The report shall be
│    reviewed and approved by the designated responsible person(s).
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 39 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    and recorded. 12.2.3 Records of maintenance shall be retained (see
│    4.1.2). 12.2.4 The maintenance scheme, maintenance procedures and
│    maintenance records shall be reviewed at specified intervals by a
│    designated person and the results of the review shall be documented.
│    12.3 Requalification 12.3.1 IQ, OQ, PQ and subsequent
│    requalification(s) shall be reviewed annually to determine the extent
│    of requalification that is necessary. This shall include an
│    assessment of the need to reconfirm the product SAL through
│    microbiological studies. The outcome of this review, including the
│    rationale for dec
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 40 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    be performed according to an approved written document (e.g.
│    protocol) that defines the testing procedures and the acceptance
│    criteria, prior to initiation of testing. This document should be
│    reviewed by a sterilization specialist(s). The elements of
│    validation, as defined in this clause, are a) IQ, b) OQ, and c) PQ. ﻿
│    © ISO 2014 – All rights reserved 47 BS EN ISO 11135:2014+A1:2019 ---
│    PAGE 70 --- ﻿ ISO 11135:2014+A1:2018 In a health care facility, IQ
│    and OQ are typically performed by the sterilizer manufacturer,
│    although they can be performed by any qualified personnel. MPQ data
│    might
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 41 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    testing. This document should be reviewed by a sterilization
│    specialist(s). The elements of validation, as defined in this clause,
│    are a) IQ, b) OQ, and c) PQ. ﻿ © ISO 2014 – All rights reserved 47
│    BS EN ISO 11135:2014+A1:2019 --- PAGE 70 --- ﻿ ISO 11135:2014+A1:2018
│    In a health care facility, IQ and OQ are typically performed by the
│    sterilizer manufacturer, although they can be performed by any
│    qualified personnel. MPQ data might be available from the sterilizer
│    manufacturer for general loads. For health care facilities, this
│    means describing and documenting the following: a) the valida
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 42 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    ficant changes in equipment. The rationale for reduced
│    requalification is documented. D.12.3.3 Review of PQ should include
│    assessment that the sterilization process remains valid for the
│    designated product(s). Factors to be considered include, but are not
│    limited to, the following: a) review of IQ status of the equipment;
│    b) review of OQ status of the equipment; c) confirmation that there
│    have been no significant changes to the product design, manufacturing
│    and packaging materials, PCDs, suppliers, manufacturing area or
│    facility, load configuration, or manufacturing process that could af
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 43 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    process. The sterilization process should be validated in one
│    chamber. The ﻿ © ISO 2014 – All rights reserved 63 BS EN ISO
│    11135:2014+A1:2019 --- PAGE 86 --- ﻿ ISO 11135:2014+A1:2018 remaining
│    equipment can undergo reduced PQ if the remaining equipment has
│    undergone installation qualification (IQ) and operational
│    qualification (OQ) (see 9.2 and 9.3). Equivalence can also be used to
│    reduce requalification of several pieces of equipment. The equipment
│    used to deliver a sterilization process commonly consists of a
│    chamber or room and ancillary control systems. Sterilization process
│    equipmen
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 44 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    requirements of its design specification. 9.1.4 PQ is the stage of
│    validation that uses product to demonstrate that the equipment
│    consistently operates in accordance with predetermined acceptance
│    criteria and the process yields product that is sterile and meets the
│    specified requirements. IQ and OQ may be a one-time exercise for the
│    specific equipment being employed for a sterilization process. PQ
│    should be carried out for each new process and/or product to be
│    validated to demonstrate that the process complies with identified
│    acceptance criteria and is capable of delivering the required SA
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 45 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    ion and documented in the design history file. 9.3 Operational
│    qualification, OQ 9.3.1 Prior to OQ, the calibration of all
│    instrumentation (including any test instruments) used for monitoring,
│    controlling, indicating or recording of the sterilization process
│    shall be confirmed (see 4.3.3). 9.3.2 OQ shall demonstrate that the
│    installed equipment is capable of meeting its operating
│    specification. ﻿ © ISO 2014 – All rights reserved 17 BS EN ISO
│    11135:2014+A1:2019 --- PAGE 40 --- ﻿ ISO 11135:2014+A1:2018 9.4
│    Performance qualification, PQ 9.4.1 General 9.4.1.1 PQ consists of
│    both microbiologi
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 46 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    ndertake and document a review of the validation data to confirm the
│    acceptability against the approved validation procedures/protocol for
│    the sterilization process and to approve the process specification.
│    9.5.2 Information gathered or produced during product definition,
│    process definition, IQ, OQ and PQ, including results from incubation
│    of biological indicators, shall be recorded and reviewed for
│    acceptability. The results of this review shall be recorded. 9.5.3 A
│    validation report shall be prepared. The report shall be reviewed and
│    approved by the designated responsible person(s). 9.5
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 47 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    recorded. 12.2.3 Records of maintenance shall be retained (see
│    4.1.2). 12.2.4 The maintenance scheme, maintenance procedures and
│    maintenance records shall be reviewed at specified intervals by a
│    designated person and the results of the review shall be documented.
│    12.3 Requalification 12.3.1 IQ, OQ, PQ and subsequent
│    requalification(s) shall be reviewed annually to determine the extent
│    of requalification that is necessary. This shall include an
│    assessment of the need to reconfirm the product SAL through
│    microbiological studies. The outcome of this review, including the
│    rationale for decisio
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 48 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    rmed according to an approved written document (e.g. protocol) that
│    defines the testing procedures and the acceptance criteria, prior to
│    initiation of testing. This document should be reviewed by a
│    sterilization specialist(s). The elements of validation, as defined
│    in this clause, are a) IQ, b) OQ, and c) PQ. ﻿ © ISO 2014 – All
│    rights reserved 47 BS EN ISO 11135:2014+A1:2019 --- PAGE 70 --- ﻿
│    ISO 11135:2014+A1:2018 In a health care facility, IQ and OQ are
│    typically performed by the sterilizer manufacturer, although they can
│    be performed by any qualified personnel. MPQ data might be avail
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 49 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    . This document should be reviewed by a sterilization specialist(s).
│    The elements of validation, as defined in this clause, are a) IQ, b)
│    OQ, and c) PQ. ﻿ © ISO 2014 – All rights reserved 47 BS EN ISO
│    11135:2014+A1:2019 --- PAGE 70 --- ﻿ ISO 11135:2014+A1:2018 In a
│    health care facility, IQ and OQ are typically performed by the
│    sterilizer manufacturer, although they can be performed by any
│    qualified personnel. MPQ data might be available from the sterilizer
│    manufacturer for general loads. For health care facilities, this
│    means describing and documenting the following: a) the validation st
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 50 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    the products within the case against the PCD during process
│    development. D.9.4.2.5 See AAMI TIR16:2009[25], 4.3.2. ﻿ © ISO 2014 –
│    All rights reserved 53 BS EN ISO 11135:2014+A1:2019 --- PAGE 76 ---
│    ﻿ ISO 11135:2014+A1:2018 D.9.4.3 Performance qualification — Physical
│    NOTE Results obtained from OQ can be used to identify features
│    needing evaluation during PPQ. D.9.4.3.1 If, in any of these runs,
│    sterility or product functionality requirements are not met, an
│    investigation should be conducted to determine if additional
│    qualification runs are necessary. If process parameters cannot be
│    maint
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 51 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    for reduced requalification is documented. D.12.3.3 Review of PQ
│    should include assessment that the sterilization process remains
│    valid for the designated product(s). Factors to be considered
│    include, but are not limited to, the following: a) review of IQ
│    status of the equipment; b) review of OQ status of the equipment; c)
│    confirmation that there have been no significant changes to the
│    product design, manufacturing and packaging materials, PCDs,
│    suppliers, manufacturing area or facility, load configuration, or
│    manufacturing process that could affect product sterility; d)
│    confirmation t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 52 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    should be validated in one chamber. The ﻿ © ISO 2014 – All rights
│    reserved 63 BS EN ISO 11135:2014+A1:2019 --- PAGE 86 --- ﻿ ISO
│    11135:2014+A1:2018 remaining equipment can undergo reduced PQ if the
│    remaining equipment has undergone installation qualification (IQ) and
│    operational qualification (OQ) (see 9.2 and 9.3). Equivalence can
│    also be used to reduce requalification of several pieces of
│    equipment. The equipment used to deliver a sterilization process
│    commonly consists of a chamber or room and ancillary control systems.
│    Sterilization process equipment might be located within a given p
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 53 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    undertaken to demonstrate that the sterilization equipment and any
│    ancillary items have been supplied and installed in accordance with
│    their specification. 9.1.3 OQ is undertaken to demonstrate the
│    ability of the equipment to meet the performance requirements of its
│    design specification. 9.1.4 PQ is the stage of validation that uses
│    product to demonstrate that the equipment consistently operates in
│    accordance with predetermined acceptance criteria and the process
│    yields product that is sterile and meets the specified requirements.
│    IQ and OQ may be a one-time exercise for the specific equi
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 54 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    ilization process shall be confirmed (see 4.3.3). 9.3.2 OQ shall
│    demonstrate that the installed equipment is capable of meeting its
│    operating specification. ﻿ © ISO 2014 – All rights reserved 17 BS EN
│    ISO 11135:2014+A1:2019 --- PAGE 40 --- ﻿ ISO 11135:2014+A1:2018 9.4
│    Performance qualification, PQ 9.4.1 General 9.4.1.1 PQ consists of
│    both microbiological and physical performance qualification and is
│    performed in the equipment used to sterilize the product. 9.4.1.2 PQ
│    shall be performed on the introduction of new or modified products,
│    packaging, load configuration, equipment or process p
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 55 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    confirmed (see 4.3.3). 9.3.2 OQ shall demonstrate that the installed
│    equipment is capable of meeting its operating specification. ﻿ © ISO
│    2014 – All rights reserved 17 BS EN ISO 11135:2014+A1:2019 --- PAGE
│    40 --- ﻿ ISO 11135:2014+A1:2018 9.4 Performance qualification, PQ
│    9.4.1 General 9.4.1.1 PQ consists of both microbiological and
│    physical performance qualification and is performed in the equipment
│    used to sterilize the product. 9.4.1.2 PQ shall be performed on the
│    introduction of new or modified products, packaging, load
│    configuration, equipment or process parameters, unless equivalen
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 56 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    loads are reused for the validation cycles, they shall be aerated
│    between exposures to meet the regulations for worker safety and to
│    ensure that EO residues in the load do not affect the biological
│    challenge in the next microbiological PQ study. 9.4.1.9 If chemical
│    indicators are used as part of PQ, these shall comply with ISO
│    11140‑1, and shall be used in conjunction with microbiological and
│    physical monitoring. 9.4.1.10 Biological indicators used in PQ shall
│    comply with the applicable clauses of ISO 11138‑1:2006 and ISO
│    11138‑2:2009, Clause 5 and 9.5. 9.4.2 Performance qualification — M
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 57 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    and document a review of the validation data to confirm the
│    acceptability against the approved validation procedures/protocol for
│    the sterilization process and to approve the process specification.
│    9.5.2 Information gathered or produced during product definition,
│    process definition, IQ, OQ and PQ, including results from incubation
│    of biological indicators, shall be recorded and reviewed for
│    acceptability. The results of this review shall be recorded. 9.5.3 A
│    validation report shall be prepared. The report shall be reviewed and
│    approved by the designated responsible person(s). 9.5.4 The
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 58 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    rded. 12.2.3 Records of maintenance shall be retained (see 4.1.2).
│    12.2.4 The maintenance scheme, maintenance procedures and maintenance
│    records shall be reviewed at specified intervals by a designated
│    person and the results of the review shall be documented. 12.3
│    Requalification 12.3.1 IQ, OQ, PQ and subsequent requalification(s)
│    shall be reviewed annually to determine the extent of requalification
│    that is necessary. This shall include an assessment of the need to
│    reconfirm the product SAL through microbiological studies. The
│    outcome of this review, including the rationale for decisions
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 59 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    ng to an approved written document (e.g. protocol) that defines the
│    testing procedures and the acceptance criteria, prior to initiation
│    of testing. This document should be reviewed by a sterilization
│    specialist(s). The elements of validation, as defined in this clause,
│    are a) IQ, b) OQ, and c) PQ. ﻿ © ISO 2014 – All rights reserved 47
│    BS EN ISO 11135:2014+A1:2019 --- PAGE 70 --- ﻿ ISO 11135:2014+A1:2018
│    In a health care facility, IQ and OQ are typically performed by the
│    sterilizer manufacturer, although they can be performed by any
│    qualified personnel. MPQ data might be available from th
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 60 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    Q might need to be repeated. NOTE For large preconditioning or
│    aeration rooms containing multiple sterilization loads, the extent of
│    requalification can be reduced if there have been no significant
│    changes in equipment. The rationale for reduced requalification is
│    documented. D.12.3.3 Review of PQ should include assessment that the
│    sterilization process remains valid for the designated product(s).
│    Factors to be considered include, but are not limited to, the
│    following: a) review of IQ status of the equipment; b) review of OQ
│    status of the equipment; c) confirmation that there have been n
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 61 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 4.0/5.0
│
│  Context:
│    nt is intended to minimize the amount of testing required to qualify
│    the process. The sterilization process should be validated in one
│    chamber. The ﻿ © ISO 2014 – All rights reserved 63 BS EN ISO
│    11135:2014+A1:2019 --- PAGE 86 --- ﻿ ISO 11135:2014+A1:2018 remaining
│    equipment can undergo reduced PQ if the remaining equipment has
│    undergone installation qualification (IQ) and operational
│    qualification (OQ) (see 9.2 and 9.3). Equivalence can also be used to
│    reduce requalification of several pieces of equipment. The equipment
│    used to deliver a sterilization process commonly consists of a chamb
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 62 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: performance qualification
│  Relevance Score: 4.0/5.0
│
│  Context:
│    ng or recording of the sterilization process shall be confirmed (see
│    4.3.3). 9.3.2 OQ shall demonstrate that the installed equipment is
│    capable of meeting its operating specification. ﻿ © ISO 2014 – All
│    rights reserved 17 BS EN ISO 11135:2014+A1:2019 --- PAGE 40 --- ﻿
│    ISO 11135:2014+A1:2018 9.4 Performance qualification, PQ 9.4.1
│    General 9.4.1.1 PQ consists of both microbiological and physical
│    performance qualification and is performed in the equipment used to
│    sterilize the product. 9.4.1.2 PQ shall be performed on the
│    introduction of new or modified products, packaging, load
│    configuration, equipment or proce
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 63 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: performance qualification
│  Relevance Score: 4.0/5.0
│
│  Context:
│    utine configuration to provide a relationship of the dynamics of the
│    products within the case against the PCD during process development.
│    D.9.4.2.5 See AAMI TIR16:2009[25], 4.3.2. ﻿ © ISO 2014 – All rights
│    reserved 53 BS EN ISO 11135:2014+A1:2019 --- PAGE 76 --- ﻿ ISO
│    11135:2014+A1:2018 D.9.4.3 Performance qualification — Physical NOTE
│    Results obtained from OQ can be used to identify features needing
│    evaluation during PPQ. D.9.4.3.1 If, in any of these runs, sterility
│    or product functionality requirements are not met, an investigation
│    should be conducted to determine if additional qualification runs are
│    necessa
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 64 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.5/5.0
│
│  Context:
│    health care facilities. The guidance, in Annex D, is intended for
│    people who have a basic knowledge of the principles of EO
│    sterilization. Methods other than those given in the guidance can be
│    used if they are effective in achieving compliance with the
│    requirements of ISO 11135. The development, validation and routine
│    control of a sterilization process comprises a number of discrete but
│    interrelated activities; e.g. calibration, maintenance, product
│    definition, process definition, installation qualification,
│    operational qualification and performance qualification. While the
│    activities required by
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 65 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.5/5.0
│
│  Context:
│    f establishing the sterilization process and shall not be used as an
│    indicator that the required SAL has been achieved. 8.9 If tests of
│    sterility are performed during the definition of the sterilization
│    process, they shall comply with ISO 11737‑2. 9 Validation 9.1 General
│    9.1.1 The purpose of validation is to demonstrate that the
│    sterilization process established in the process definition (see
│    Clause 8) can be delivered effectively and reproducibly to the
│    product within the sterilization load. Validation consists of a
│    number of identified stages: installation qualification (IQ),
│    operational qua
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 66 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.5/5.0
│
│  Context:
│    sponsible individuals, departments and/or outside contractors; c) the
│    criteria for successful validation. For health care facilities, there
│    is an option of contracting with an outside service to perform this
│    validation; however, the health care facility is still responsible
│    for ensuring that the validation complies with the requirements of
│    this International Standard. D.9.1.2 No guidance offered. D.9.1.3 No
│    guidance offered. D.9.1.4 No guidance offered. D.9.2 Installation
│    qualification D.9.2.1 Equipment D.9.2.1.1 The supporting
│    documentation for IQ should include descriptions of the physical an
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 67 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.5/5.0
│
│  Context:
│    tions for the sterilizer and the sterilization process; a) the IQ/OQ
│    data; b) the records, physical and microbiological, of all PQ runs;
│    c) an indication that all gauges, recorders, etc. were calibrated and
│    within their specifications; d) provision for future review and
│    requalification; e) the validation protocol(s)/procedure(s); f) the
│    documented procedures used; g) documented operating procedures
│    including process control limits; h) if a failure occurred, a
│    description of the issues, the corrective action taken, and the
│    effect of the failure on the intent of the validation; i) if a
│    deviation
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 68 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.5/5.0
│
│  Context:
│    hey are effective in achieving compliance with the requirements of
│    ISO 11135. The development, validation and routine control of a
│    sterilization process comprises a number of discrete but interrelated
│    activities; e.g. calibration, maintenance, product definition,
│    process definition, installation qualification, operational
│    qualification and performance qualification. While the activities
│    required by ISO 11135 have been grouped together and are presented in
│    a particular order, ISO 11135 does not require that the activities be
│    performed in the order in which they are presented. The activities
│    required a
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 69 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.5/5.0
│
│  Context:
│    ving compliance with the requirements of ISO 11135. The development,
│    validation and routine control of a sterilization process comprises a
│    number of discrete but interrelated activities; e.g. calibration,
│    maintenance, product definition, process definition, installation
│    qualification, operational qualification and performance
│    qualification. While the activities required by ISO 11135 have been
│    grouped together and are presented in a particular order, ISO 11135
│    does not require that the activities be performed in the order in
│    which they are presented. The activities required are not necessarily
│    sequenti
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 70 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.5/5.0
│
│  Context:
│    rements of ISO 11135. The development, validation and routine control
│    of a sterilization process comprises a number of discrete but
│    interrelated activities; e.g. calibration, maintenance, product
│    definition, process definition, installation qualification,
│    operational qualification and performance qualification. While the
│    activities required by ISO 11135 have been grouped together and are
│    presented in a particular order, ISO 11135 does not require that the
│    activities be performed in the order in which they are presented. The
│    activities required are not necessarily sequential, as the programme
│    of develo
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 71 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.5/5.0
│
│  Context:
│    ypes of microorganisms, identified in the definition above, for
│    validation and/or routine control of the sterilization process.
│    [SOURCE: ISO/TS 11139:2006, definition 2.26] ﻿ © ISO 2014 – All
│    rights reserved 5 BS EN ISO 11135:2014+A1:2019 --- PAGE 28 --- ﻿ ISO
│    11135:2014+A1:2018 3.23 operational qualification OQ process of
│    obtaining and documenting evidence that installed equipment operates
│    within predetermined limits when used in accordance with its
│    operational procedures [SOURCE: ISO/TS 11139:2006, definition 2.27]
│    3.24 overkill approach approach using sterilization process that
│    delivers a minimum of
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 72 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.5/5.0
│
│  Context:
│    eclaration that product is sterile, based on records demonstrating
│    that the process parameters were delivered within specified
│    tolerances [SOURCE: ISO/TS 11139:2006, definition 2.29] Note 1 to
│    entry: This method of process release does not include the use of
│    biological indicators. 3.26 performance qualification PQ process of
│    obtaining and documenting evidence that the equipment, as installed
│    and operated in accordance with operational procedures, consistently
│    performs in accordance with predetermined criteria and thereby yields
│    product meeting its specification [SOURCE: ISO/TS 11139:2006,
│    definition 2.3
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 73 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.5/5.0
│
│  Context:
│    e for the defined product shall be established. The defined product
│    includes new or modified product, packaging or loading
│    configurations. 8.3 Process definition activities shall be performed
│    in a sterilization chamber (developmental chamber or production
│    chamber) that has undergone Installation Qualification (IQ) and
│    Operational Qualification (OQ) procedures (see 9.2 and 9.3). 8.4
│    Documentation and records shall support the validity of process
│    parameters and associated process variables as defined in the process
│    characterization (see 6.2) ﻿ © ISO 2014 – All rights reserved 15 BS
│    EN ISO 11135:2014+A
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 74 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.5/5.0
│
│  Context:
│    established. The defined product includes new or modified product,
│    packaging or loading configurations. 8.3 Process definition
│    activities shall be performed in a sterilization chamber
│    (developmental chamber or production chamber) that has undergone
│    Installation Qualification (IQ) and Operational Qualification (OQ)
│    procedures (see 9.2 and 9.3). 8.4 Documentation and records shall
│    support the validity of process parameters and associated process
│    variables as defined in the process characterization (see 6.2) ﻿ ©
│    ISO 2014 – All rights reserved 15 BS EN ISO 11135:2014+A1:2019 ---
│    PAGE 38 --- ﻿ ISO 11135
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 75 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.5/5.0
│
│  Context:
│    .2.2.5 Drawings of the equipment as installed, plumbing and other
│    ancillary equipment shall be finalized during IQ. 9.2.2.6 Changes
│    made to systems during the IQ shall be assessed for their impact on
│    the design and process specification and documented in the design
│    history file. 9.3 Operational qualification, OQ 9.3.1 Prior to OQ,
│    the calibration of all instrumentation (including any test
│    instruments) used for monitoring, controlling, indicating or
│    recording of the sterilization process shall be confirmed (see
│    4.3.3). 9.3.2 OQ shall demonstrate that the installed equipment is
│    capable of meeting its
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 76 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.5/5.0
│
│  Context:
│    nstalled equipment is capable of meeting its operating specification.
│    ﻿ © ISO 2014 – All rights reserved 17 BS EN ISO 11135:2014+A1:2019
│    --- PAGE 40 --- ﻿ ISO 11135:2014+A1:2018 9.4 Performance
│    qualification, PQ 9.4.1 General 9.4.1.1 PQ consists of both
│    microbiological and physical performance qualification and is
│    performed in the equipment used to sterilize the product. 9.4.1.2 PQ
│    shall be performed on the introduction of new or modified products,
│    packaging, load configuration, equipment or process parameters,
│    unless equivalence to a previously validated product, packaging, load
│    configuration, eq
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 77 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.5/5.0
│
│  Context:
│    sed as part of PQ, these shall comply with ISO 11140‑1, and shall be
│    used in conjunction with microbiological and physical monitoring.
│    9.4.1.10 Biological indicators used in PQ shall comply with the
│    applicable clauses of ISO 11138‑1:2006 and ISO 11138‑2:2009, Clause 5
│    and 9.5. 9.4.2 Performance qualification — Microbiological 9.4.2.1
│    The microbiological PQ (MPQ) shall demonstrate that, on application
│    of the sterilization process, the specified requirements for
│    sterility are met. Studies shall be performed in the production
│    chamber using defined process parameters selected to deliver less
│    lethality t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 78 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.5/5.0
│
│  Context:
│    r, all internal PCDs should test negative. 9.4.2.6 If the overkill
│    cycle calculation approach [see B.1.2 b)] or the BI/bioburden
│    approach (see Annex A) is used, there may be some surviving internal
│    PCDs, but the calculated SAL shall meet the specified value (See ISO
│    14161). 9.4.3 Performance qualification — Physical 9.4.3.1 Physical
│    PQ (PPQ) shall demonstrate a) that the specified acceptance criteria
│    are met throughout the load for the duration of the proposed routine
│    process specification, and b) reproducibility of the process. The PPQ
│    shall include a minimum of three planned qualification cycl
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 79 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.5/5.0
│
│  Context:
│    e service to perform this validation; however, the health care
│    facility is still responsible for ensuring that the validation
│    complies with the requirements of this International Standard.
│    D.9.1.2 No guidance offered. D.9.1.3 No guidance offered. D.9.1.4 No
│    guidance offered. D.9.2 Installation qualification D.9.2.1 Equipment
│    D.9.2.1.1 The supporting documentation for IQ should include
│    descriptions of the physical and operational characteristics of the
│    equipment (including ancillary equipment). Examples of relevant
│    documents include design specifications, the original purchase order,
│    user requireme
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 80 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.5/5.0
│
│  Context:
│    nditioning areas where a small load will not have a significant
│    effect on the area dynamics, it is not necessary (and indeed might be
│    impractical) to perform the studies with the preconditioning area in
│    various loading states. The guidance on PPQ of preconditioning also
│    applies to the performance qualification of conditioning (i.e. during
│    sterilization). See Table C.1 and Table C.2 for the recommended
│    minimum number of sensors. a) No guidance offered. b) It is important
│    to establish and report the product temperature and humidity ranges
│    of the sterilization load after exposure to the specified precon
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 81 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    ed product shall be established. The defined product includes new or
│    modified product, packaging or loading configurations. 8.3 Process
│    definition activities shall be performed in a sterilization chamber
│    (developmental chamber or production chamber) that has undergone
│    Installation Qualification (IQ) and Operational Qualification (OQ)
│    procedures (see 9.2 and 9.3). 8.4 Documentation and records shall
│    support the validity of process parameters and associated process
│    variables as defined in the process characterization (see 6.2) ﻿ ©
│    ISO 2014 – All rights reserved 15 BS EN ISO 11135:2014+A1:20
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 82 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    o ensure that its quality and composition remain within
│    specification. 9.2.2.4 Prior to IQ, the calibration status of any
│    test instrumentation used during the IQ shall be confirmed. 9.2.2.5
│    Drawings of the equipment as installed, plumbing and other ancillary
│    equipment shall be finalized during IQ. 9.2.2.6 Changes made to
│    systems during the IQ shall be assessed for their impact on the
│    design and process specification and documented in the design history
│    file. 9.3 Operational qualification, OQ 9.3.1 Prior to OQ, the
│    calibration of all instrumentation (including any test instruments)
│    used f
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 83 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    n within specification. 9.2.2.4 Prior to IQ, the calibration status
│    of any test instrumentation used during the IQ shall be confirmed.
│    9.2.2.5 Drawings of the equipment as installed, plumbing and other
│    ancillary equipment shall be finalized during IQ. 9.2.2.6 Changes
│    made to systems during the IQ shall be assessed for their impact on
│    the design and process specification and documented in the design
│    history file. 9.3 Operational qualification, OQ 9.3.1 Prior to OQ,
│    the calibration of all instrumentation (including any test
│    instruments) used for monitoring, controlling, indicating or recor
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 84 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    equipment or product that could alter the efficacy of the process
│    (see 8.2). ﻿ 24 © ISO 2014 – All rights reserved BS EN ISO
│    11135:2014+A1:2019 --- PAGE 47 --- ﻿ ISO 11135:2014+A1:2018 12.4.5
│    The magnitude of the change shall be considered in determining the
│    extent to which process definition, IQ, OQ or PQ is undertaken.
│    12.4.6 The outcome of the assessment, including the rationale for
│    decisions reached, shall be documented. 12.5 Assessment of
│    equivalence 12.5.1 Process Equivalence Sterilization equipment that
│    delivers the same process parameters, having undergone IQ and OQ,
│    shall be qu
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 85 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    process definition, IQ, OQ or PQ is undertaken. 12.4.6 The outcome of
│    the assessment, including the rationale for decisions reached, shall
│    be documented. 12.5 Assessment of equivalence 12.5.1 Process
│    Equivalence Sterilization equipment that delivers the same process
│    parameters, having undergone IQ and OQ, shall be qualified either a)
│    in the same manner as the original chamber, or b) using a reduced MPQ
│    that demonstrates the delivery of the required level of
│    microbiological lethality and PPQ to demonstrate temperature and
│    humidity uniformity of the load and control by the production cham
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 86 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    till responsible for ensuring that the validation complies with the
│    requirements of this International Standard. D.9.1.2 No guidance
│    offered. D.9.1.3 No guidance offered. D.9.1.4 No guidance offered.
│    D.9.2 Installation qualification D.9.2.1 Equipment D.9.2.1.1 The
│    supporting documentation for IQ should include descriptions of the
│    physical and operational characteristics of the equipment (including
│    ancillary equipment). Examples of relevant documents include design
│    specifications, the original purchase order, user requirements
│    specifications and functional design specifications. The foll
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 87 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    ssment of the equipment performance and engineering changes that were
│    made during the year to ensure that the results from the original OQ
│    are still valid (see Figure D.1). In order to do so, it is common
│    practice to perform periodic requalification of equipment and should
│    include: a) review of IQ status of equipment; b) assessment of trends
│    in equipment performance; c) temperature and relative humidity
│    profiles of the preconditioning areas (if used); d) chamber
│    temperature profile; e) temperature profile of the aeration areas (if
│    used). These requalification exercises should indicate no
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 88 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    rganisms, identified in the definition above, for validation and/or
│    routine control of the sterilization process. [SOURCE: ISO/TS
│    11139:2006, definition 2.26] ﻿ © ISO 2014 – All rights reserved 5 BS
│    EN ISO 11135:2014+A1:2019 --- PAGE 28 --- ﻿ ISO 11135:2014+A1:2018
│    3.23 operational qualification OQ process of obtaining and
│    documenting evidence that installed equipment operates within
│    predetermined limits when used in accordance with its operational
│    procedures [SOURCE: ISO/TS 11139:2006, definition 2.27] 3.24 overkill
│    approach approach using sterilization process that delivers a minimum
│    of 12
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 89 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    defined product includes new or modified product, packaging or
│    loading configurations. 8.3 Process definition activities shall be
│    performed in a sterilization chamber (developmental chamber or
│    production chamber) that has undergone Installation Qualification
│    (IQ) and Operational Qualification (OQ) procedures (see 9.2 and 9.3).
│    8.4 Documentation and records shall support the validity of process
│    parameters and associated process variables as defined in the process
│    characterization (see 6.2) ﻿ © ISO 2014 – All rights reserved 15 BS
│    EN ISO 11135:2014+A1:2019 --- PAGE 38 --- ﻿ ISO 11135:2014
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 90 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    s of the equipment as installed, plumbing and other ancillary
│    equipment shall be finalized during IQ. 9.2.2.6 Changes made to
│    systems during the IQ shall be assessed for their impact on the
│    design and process specification and documented in the design history
│    file. 9.3 Operational qualification, OQ 9.3.1 Prior to OQ, the
│    calibration of all instrumentation (including any test instruments)
│    used for monitoring, controlling, indicating or recording of the
│    sterilization process shall be confirmed (see 4.3.3). 9.3.2 OQ shall
│    demonstrate that the installed equipment is capable of meeting its
│    oper
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 91 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    as installed, plumbing and other ancillary equipment shall be
│    finalized during IQ. 9.2.2.6 Changes made to systems during the IQ
│    shall be assessed for their impact on the design and process
│    specification and documented in the design history file. 9.3
│    Operational qualification, OQ 9.3.1 Prior to OQ, the calibration of
│    all instrumentation (including any test instruments) used for
│    monitoring, controlling, indicating or recording of the sterilization
│    process shall be confirmed (see 4.3.3). 9.3.2 OQ shall demonstrate
│    that the installed equipment is capable of meeting its operating
│    specificatio
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 92 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    pment or product that could alter the efficacy of the process (see
│    8.2). ﻿ 24 © ISO 2014 – All rights reserved BS EN ISO
│    11135:2014+A1:2019 --- PAGE 47 --- ﻿ ISO 11135:2014+A1:2018 12.4.5
│    The magnitude of the change shall be considered in determining the
│    extent to which process definition, IQ, OQ or PQ is undertaken.
│    12.4.6 The outcome of the assessment, including the rationale for
│    decisions reached, shall be documented. 12.5 Assessment of
│    equivalence 12.5.1 Process Equivalence Sterilization equipment that
│    delivers the same process parameters, having undergone IQ and OQ,
│    shall be qualif
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 93 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    definition, IQ, OQ or PQ is undertaken. 12.4.6 The outcome of the
│    assessment, including the rationale for decisions reached, shall be
│    documented. 12.5 Assessment of equivalence 12.5.1 Process Equivalence
│    Sterilization equipment that delivers the same process parameters,
│    having undergone IQ and OQ, shall be qualified either a) in the same
│    manner as the original chamber, or b) using a reduced MPQ that
│    demonstrates the delivery of the required level of microbiological
│    lethality and PPQ to demonstrate temperature and humidity uniformity
│    of the load and control by the production chamber. Th
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 94 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    modifications of, or significant changes to, the sterilizing
│    equipment have been made that could affect the process. D.12.3.2
│    Review of OQ should include an assessment of the equipment
│    performance and engineering changes that were made during the year to
│    ensure that the results from the original OQ are still valid (see
│    Figure D.1). In order to do so, it is common practice to perform
│    periodic requalification of equipment and should include: a) review
│    of IQ status of equipment; b) assessment of trends in equipment
│    performance; c) temperature and relative humidity profiles of the
│    preconditi
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 95 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    t product is sterile, based on records demonstrating that the process
│    parameters were delivered within specified tolerances [SOURCE: ISO/TS
│    11139:2006, definition 2.29] Note 1 to entry: This method of process
│    release does not include the use of biological indicators. 3.26
│    performance qualification PQ process of obtaining and documenting
│    evidence that the equipment, as installed and operated in accordance
│    with operational procedures, consistently performs in accordance with
│    predetermined criteria and thereby yields product meeting its
│    specification [SOURCE: ISO/TS 11139:2006, definition 2.30]
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 96 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    monstrate that the equipment consistently operates in accordance with
│    predetermined acceptance criteria and the process yields product that
│    is sterile and meets the specified requirements. IQ and OQ may be a
│    one-time exercise for the specific equipment being employed for a
│    sterilization process. PQ should be carried out for each new process
│    and/or product to be validated to demonstrate that the process
│    complies with identified acceptance criteria and is capable of
│    delivering the required SAL to the product. ﻿ 16 © ISO 2014 – All
│    rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 39 ---
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 97 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    rights reserved 17 BS EN ISO 11135:2014+A1:2019 --- PAGE 40 --- ﻿
│    ISO 11135:2014+A1:2018 9.4 Performance qualification, PQ 9.4.1
│    General 9.4.1.1 PQ consists of both microbiological and physical
│    performance qualification and is performed in the equipment used to
│    sterilize the product. 9.4.1.2 PQ shall be performed on the
│    introduction of new or modified products, packaging, load
│    configuration, equipment or process parameters, unless equivalence to
│    a previously validated product, packaging, load configuration,
│    equipment or process has been documented. (See 7.1.2, 7.1.6 and
│    12.5.) 9.4.1.3
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 98 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    the load do not affect the biological challenge in the next
│    microbiological PQ study. 9.4.1.9 If chemical indicators are used as
│    part of PQ, these shall comply with ISO 11140‑1, and shall be used in
│    conjunction with microbiological and physical monitoring. 9.4.1.10
│    Biological indicators used in PQ shall comply with the applicable
│    clauses of ISO 11138‑1:2006 and ISO 11138‑2:2009, Clause 5 and 9.5.
│    9.4.2 Performance qualification — Microbiological 9.4.2.1 The
│    microbiological PQ (MPQ) shall demonstrate that, on application of
│    the sterilization process, the specified requirements for sterili
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 99 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    hall be used in conjunction with microbiological and physical
│    monitoring. 9.4.1.10 Biological indicators used in PQ shall comply
│    with the applicable clauses of ISO 11138‑1:2006 and ISO 11138‑2:2009,
│    Clause 5 and 9.5. 9.4.2 Performance qualification — Microbiological
│    9.4.2.1 The microbiological PQ (MPQ) shall demonstrate that, on
│    application of the sterilization process, the specified requirements
│    for sterility are met. Studies shall be performed in the production
│    chamber using defined process parameters selected to deliver less
│    lethality than the specified sterilization process. 9.4.2.2
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 100 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    9.4.2.6 If the overkill cycle calculation approach [see B.1.2 b)] or
│    the BI/bioburden approach (see Annex A) is used, there may be some
│    surviving internal PCDs, but the calculated SAL shall meet the
│    specified value (See ISO 14161). 9.4.3 Performance qualification —
│    Physical 9.4.3.1 Physical PQ (PPQ) shall demonstrate a) that the
│    specified acceptance criteria are met throughout the load for the
│    duration of the proposed routine process specification, and b)
│    reproducibility of the process. The PPQ shall include a minimum of
│    three planned qualification cycles, consecutive in the same stud
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 101 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    or product that could alter the efficacy of the process (see 8.2). ﻿
│    24 © ISO 2014 – All rights reserved BS EN ISO 11135:2014+A1:2019 ---
│    PAGE 47 --- ﻿ ISO 11135:2014+A1:2018 12.4.5 The magnitude of the
│    change shall be considered in determining the extent to which process
│    definition, IQ, OQ or PQ is undertaken. 12.4.6 The outcome of the
│    assessment, including the rationale for decisions reached, shall be
│    documented. 12.5 Assessment of equivalence 12.5.1 Process Equivalence
│    Sterilization equipment that delivers the same process parameters,
│    having undergone IQ and OQ, shall be qualified ei
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 102 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    e the efficacy and reproducibility of the sterilization process. PQ
│    is normally not started until after completion and approval of the IQ
│    and OQ testing. Acceptance criteria should include conformance with
│    the specifications for the sterilization process parameters and
│    microbiological challenge. PQ activities should be clearly defined in
│    a written document (e.g. protocol). Where elements of the PQ are
│    carried out by separate parties, those parties should approve the
│    relevant documentation. See 4.1 and 4.2. D.9.4.1.1 No guidance
│    offered D.9.4.1.2 See AAMI TIR 28:2009[26]. D.9.4.1.3 No gui
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 103 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.5/5.0
│
│  Context:
│    er completion and approval of the IQ and OQ testing. Acceptance
│    criteria should include conformance with the specifications for the
│    sterilization process parameters and microbiological challenge. PQ
│    activities should be clearly defined in a written document (e.g.
│    protocol). Where elements of the PQ are carried out by separate
│    parties, those parties should approve the relevant documentation. See
│    4.1 and 4.2. D.9.4.1.1 No guidance offered D.9.4.1.2 See AAMI TIR
│    28:2009[26]. D.9.4.1.3 No guidance offered. D.9.4.1.4 In specifying
│    the presentation of product, both load configuration (the comp
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 104 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: performance qualification
│  Relevance Score: 3.5/5.0
│
│  Context:
│    th the requirements of ISO 11135. The development, validation and
│    routine control of a sterilization process comprises a number of
│    discrete but interrelated activities; e.g. calibration, maintenance,
│    product definition, process definition, installation qualification,
│    operational qualification and performance qualification. While the
│    activities required by ISO 11135 have been grouped together and are
│    presented in a particular order, ISO 11135 does not require that the
│    activities be performed in the order in which they are presented. The
│    activities required are not necessarily sequential, as the programme
│    of develo
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 105 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: performance qualification
│  Relevance Score: 3.5/5.0
│
│  Context:
│    ic release declaration that product is sterile, based on records
│    demonstrating that the process parameters were delivered within
│    specified tolerances [SOURCE: ISO/TS 11139:2006, definition 2.29]
│    Note 1 to entry: This method of process release does not include the
│    use of biological indicators. 3.26 performance qualification PQ
│    process of obtaining and documenting evidence that the equipment, as
│    installed and operated in accordance with operational procedures,
│    consistently performs in accordance with predetermined criteria and
│    thereby yields product meeting its specification [SOURCE: ISO/TS
│    11139:2006, definition 2.3
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 106 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: performance qualification
│  Relevance Score: 3.5/5.0
│
│  Context:
│    e that the installed equipment is capable of meeting its operating
│    specification. ﻿ © ISO 2014 – All rights reserved 17 BS EN ISO
│    11135:2014+A1:2019 --- PAGE 40 --- ﻿ ISO 11135:2014+A1:2018 9.4
│    Performance qualification, PQ 9.4.1 General 9.4.1.1 PQ consists of
│    both microbiological and physical performance qualification and is
│    performed in the equipment used to sterilize the product. 9.4.1.2 PQ
│    shall be performed on the introduction of new or modified products,
│    packaging, load configuration, equipment or process parameters,
│    unless equivalence to a previously validated product, packaging, load
│    configuration, eq
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 107 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: performance qualification
│  Relevance Score: 3.5/5.0
│
│  Context:
│    cators are used as part of PQ, these shall comply with ISO 11140‑1,
│    and shall be used in conjunction with microbiological and physical
│    monitoring. 9.4.1.10 Biological indicators used in PQ shall comply
│    with the applicable clauses of ISO 11138‑1:2006 and ISO 11138‑2:2009,
│    Clause 5 and 9.5. 9.4.2 Performance qualification — Microbiological
│    9.4.2.1 The microbiological PQ (MPQ) shall demonstrate that, on
│    application of the sterilization process, the specified requirements
│    for sterility are met. Studies shall be performed in the production
│    chamber using defined process parameters selected to deliver less
│    lethality t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 108 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: performance qualification
│  Relevance Score: 3.5/5.0
│
│  Context:
│    sing. However, all internal PCDs should test negative. 9.4.2.6 If the
│    overkill cycle calculation approach [see B.1.2 b)] or the
│    BI/bioburden approach (see Annex A) is used, there may be some
│    surviving internal PCDs, but the calculated SAL shall meet the
│    specified value (See ISO 14161). 9.4.3 Performance qualification —
│    Physical 9.4.3.1 Physical PQ (PPQ) shall demonstrate a) that the
│    specified acceptance criteria are met throughout the load for the
│    duration of the proposed routine process specification, and b)
│    reproducibility of the process. The PPQ shall include a minimum of
│    three planned qualification cycl
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 109 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: performance qualification
│  Relevance Score: 3.5/5.0
│
│  Context:
│    large preconditioning areas where a small load will not have a
│    significant effect on the area dynamics, it is not necessary (and
│    indeed might be impractical) to perform the studies with the
│    preconditioning area in various loading states. The guidance on PPQ
│    of preconditioning also applies to the performance qualification of
│    conditioning (i.e. during sterilization). See Table C.1 and Table C.2
│    for the recommended minimum number of sensors. a) No guidance
│    offered. b) It is important to establish and report the product
│    temperature and humidity ranges of the sterilization load after
│    exposure to the specified precon
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 110 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.0/5.0
│
│  Context:
│    the Deposit of Microorganisms for the Purposes of Patent and
│    Regulation [SOURCE: ISO/TS 11139:2006, definition 2.38] 3.36
│    reference microorganism microbial strain obtained from a recognized
│    culture collection [SOURCE: ISO/TS 11139:2006, definition 2.39] 3.37
│    requalification repetition of part of validation for the purpose of
│    confirming the continued acceptability of a specified process
│    [SOURCE: ISO/TS 11139:2006, definition 2.40] 3.38 reusable medical
│    device medical device designated or intended by the manufacturer as
│    suitable for reprocessing and re-use Note 1 to entry: This is not a
│    medical device
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 111 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.0/5.0
│
│  Context:
│    stently operates in accordance with acceptance criteria and that the
│    process produces product that meets the intended SAL. 9.4.1.4 The
│    manner of presenting product for sterilization, including the load
│    configuration of a product, shall be specified. NOTE If saleable
│    product has been used during validation, 7.2 provides information
│    concerning the product quality for patient use and 11.4 provides
│    information concerning the requirements for the release of sterile
│    product. 9.4.1.5 The load used for PQ shall be representative of that
│    to be sterilized routinely and shall be defined based upon the most
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 112 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.0/5.0
│
│  Context:
│    l be evaluated. It shall be demonstrated that all product exposed to
│    a sterilization process achieves the required SAL. 9.4.1.7 If
│    material other than product is used, it shall present at least as
│    great a challenge to the sterilization process as the product.
│    9.4.1.8 If loads are reused for the validation cycles, they shall be
│    aerated between exposures to meet the regulations for worker safety
│    and to ensure that EO residues in the load do not affect the
│    biological challenge in the next microbiological PQ study. 9.4.1.9 If
│    chemical indicators are used as part of PQ, these shall comply with
│    ISO 111
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 113 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.0/5.0
│
│  Context:
│    reserved 19 BS EN ISO 11135:2014+A1:2019 --- PAGE 42 --- ﻿ ISO
│    11135:2014+A1:2018 j) during aeration (if used), the temperature of
│    the sterilization load has been established. 9.5 Review and approval
│    of validation 9.5.1 The purpose of this activity is to undertake and
│    document a review of the validation data to confirm the acceptability
│    against the approved validation procedures/protocol for the
│    sterilization process and to approve the process specification. 9.5.2
│    Information gathered or produced during product definition, process
│    definition, IQ, OQ and PQ, including results from incubation of
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 114 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.0/5.0
│
│  Context:
│    se product based on acceptable results of a product test for
│    sterility. The non-conformity shall be addressed per documented
│    procedures. 11.4 If saleable product is used in validation studies
│    the requirements for release of this product for distribution shall
│    be generated before the start of the validation activities. It is
│    important to assess the effect of repeated exposures to the
│    validation/sterilization processes on product and packaging
│    functionality, and levels of residual EO and/or reaction products
│    prior to release. If saleable product is used in MPQ studies, then
│    procedures shall be establ
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 115 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.0/5.0
│
│  Context:
│    y shall be addressed per documented procedures. 11.4 If saleable
│    product is used in validation studies the requirements for release of
│    this product for distribution shall be generated before the start of
│    the validation activities. It is important to assess the effect of
│    repeated exposures to the validation/sterilization processes on
│    product and packaging functionality, and levels of residual EO and/or
│    reaction products prior to release. If saleable product is used in
│    MPQ studies, then procedures shall be established to ensure the
│    product is subjected to a full exposure sterilization process and for
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 116 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ly inoculated. NOTE Direct inoculation with a spore suspension can
│    result in variable resistance of the inoculated product because of
│    surface phenomena, other environmental factors and the occlusion of
│    the spores on or in the product. Therefore, it is important to
│    provide scientific rationale or validation for this practice to
│    ensure that the resistance of the inoculated product is reasonably
│    correlated to the routine product. The inoculum recovery should also
│    be validated if resistance is measured by plate count techniques. See
│    Gillis and Schmidt,[30] West[40] and ISO 11737‑1 for additional infor
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 117 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ion were assessed. c) evidence or assessment of the bioburden of the
│    product and its resistance relative to the internal PCD. d) the
│    documented conclusion that the new or modified product is suitable
│    for adoption into the product family/processing category specifically
│    referenced in the current validation study to achieve the specified
│    SAL. This conclusion should include or reference any results from
│    additional tests performed to supplement the existing validation
│    study and any further testing performed for
│    confirmation/qualification for routine release of product from the
│    existing validated cycl
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 118 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.0/5.0
│
│  Context:
│    he new or modified product is suitable for adoption into the product
│    family/processing category specifically referenced in the current
│    validation study to achieve the specified SAL. This conclusion should
│    include or reference any results from additional tests performed to
│    supplement the existing validation study and any further testing
│    performed for confirmation/qualification for routine release of
│    product from the existing validated cycle (i.e. residual testing,
│    functional testing). This documentation should be approved, retained
│    and retrievable. D.8 Process definition D.8.1 No guidance offered.
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 119 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.0/5.0
│
│  Context:
│    e health care facility is not able to validate the product or assess
│    the appropriateness of its own reprocessing method, it should not
│    reprocess the medical device. D.8.3 A developmental chamber is
│    usually a smaller vessel than the production chamber and can be used
│    to perform studies to support validation. Using a developmental
│    chamber does not preclude confirmation of PQ in a production chamber.
│    D.8.4 When establishing process definition it is important to
│    consider the impact of the selected processing parameters and their
│    tolerances on the safety and functionality of the product and its
│    packagi
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 120 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ty, IQ and OQ are typically performed by the sterilizer manufacturer,
│    although they can be performed by any qualified personnel. MPQ data
│    might be available from the sterilizer manufacturer for general
│    loads. For health care facilities, this means describing and
│    documenting the following: a) the validation steps that need to be
│    performed; b) the way in which these validation steps will be
│    performed, along with a listing of responsible individuals,
│    departments and/or outside contractors; c) the criteria for
│    successful validation. For health care facilities, there is an option
│    of contracting with an
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 121 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.0/5.0
│
│  Context:
│    eristics and manufacturer performance claims (e.g. accuracy,
│    repeatability, size and model) should be kept on file; ﻿ © ISO 2014 –
│    All rights reserved 49 BS EN ISO 11135:2014+A1:2019 --- PAGE 72 ---
│    ﻿ ISO 11135:2014+A1:2018 d) process control logic or software
│    documentation necessary to support validation, including control
│    system layout, control logic diagrams and application software
│    (computerized measurement and control systems) such as program
│    listings, flow charts, ladder logic diagrams where applicable and
│    strategy diagrams. D.9.2.2.6 No guidance offered D.9.3 Operational
│    qualification D.9
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 122 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.0/5.0
│
│  Context:
│    od of time required for the sterilization load to attain acceptable
│    residual levels or measured over the period of time required for the
│    sterilization load temperature to stabilize. NOTE This can be
│    established during additional studies after completion of MPQ/PPQ.
│    D.9.4.4 Review and approval of validation D.9.5.1 No guidance
│    offered. D.9.5.2 Any discrepancies observed during the validation
│    process should be documented, and their effect on the results of the
│    validation should be determined and documented. D.9.5.3 Typically the
│    validation report is approved by the designated responsible person(s)
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 123 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.0/5.0
│
│  Context:
│    measured over the period of time required for the sterilization load
│    temperature to stabilize. NOTE This can be established during
│    additional studies after completion of MPQ/PPQ. D.9.4.4 Review and
│    approval of validation D.9.5.1 No guidance offered. D.9.5.2 Any
│    discrepancies observed during the validation process should be
│    documented, and their effect on the results of the validation should
│    be determined and documented. D.9.5.3 Typically the validation report
│    is approved by the designated responsible person(s) as defined in the
│    validation protocol. D.9.5.4 The validation report(s) should also in
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 124 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.0/5.0
│
│  Context:
│    to stabilize. NOTE This can be established during additional studies
│    after completion of MPQ/PPQ. D.9.4.4 Review and approval of
│    validation D.9.5.1 No guidance offered. D.9.5.2 Any discrepancies
│    observed during the validation process should be documented, and
│    their effect on the results of the validation should be determined
│    and documented. D.9.5.3 Typically the validation report is approved
│    by the designated responsible person(s) as defined in the validation
│    protocol. D.9.5.4 The validation report(s) should also include or
│    reference the following: — The specifications for the sterilizer and
│    th
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 125 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ements. c) EO gas concentration measurement. The frequency of
│    analysis required to demonstrate that the minimum EO concentration is
│    maintained throughout EO exposure should be established during the PQ
│    studies. Monitoring throughout the EO exposure dwell period should
│    also be done as part of the validation, in order to determine how the
│    EO concentration changes over time. The results of this analysis are
│    specific to the product and load configuration being analysed. The
│    analysis performed during the PQ study will result in documented
│    specifications for how often direct analysis should be performed
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 126 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ication that allowable product EO residuals as delineated in ISO
│    10993‑7 are being met. It is important to formally assess the need
│    for requalification of the sterilization process at least annually to
│    ensure that inadvertent process changes have not occurred and to
│    demonstrate that the original validation remains valid. The
│    requalification program should define acceptable ranges and levels of
│    variability in performance that are necessary to maintain the
│    validity of the original validation from year to year. ﻿ 62 © ISO
│    2014 – All rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 85
│    --- ﻿ ISO 1
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 127 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.0/5.0
│
│  Context:
│    st annually to ensure that inadvertent process changes have not
│    occurred and to demonstrate that the original validation remains
│    valid. The requalification program should define acceptable ranges
│    and levels of variability in performance that are necessary to
│    maintain the validity of the original validation from year to year. ﻿
│    62 © ISO 2014 – All rights reserved BS EN ISO 11135:2014+A1:2019 ---
│    PAGE 85 --- ﻿ ISO 11135:2014+A1:2018 D.12.3.5 An investigation should
│    be initiated to try to determine the root cause(s) of a
│    non-conformity. The impact of the non-conformity on the validity of
│    the requali
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 128 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ent is performed. Process data should be collected from the candidate
│    equipment. These data should be compared with the parameter limits
│    for that specific sterilization process and the results obtained in
│    the PQ of the original equipment. The parameter limits are those
│    established in the initial validation for the sterilization process
│    (including all process requirements identified in this International
│    Standard) in the existing equipment. The specifications, acceptance
│    criteria, and pallet or load configuration should be the same as
│    those defined for the initial PQ. The actual parameters to be ev
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 129 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.0/5.0
│
│  Context:
│    he lethality of the sterilization process, as appropriate. ﻿ 66 ©
│    ISO 2014 – All rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE
│    89 --- ﻿ ISO 11135:2014+A1:2018 f) The documented conclusion that the
│    candidate equipment is equivalent to the equipment specifically
│    referenced in the current validation study to achieve the specified
│    product SAL. This conclusion should include or reference any
│    additional tests performed to supplement the existing validation
│    study and any further testing performed for confirmation or
│    qualification for routine release of product from the existing
│    validated cycle
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 130 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 3.0/5.0
│
│  Context:
│    14+A1:2018 f) The documented conclusion that the candidate equipment
│    is equivalent to the equipment specifically referenced in the current
│    validation study to achieve the specified product SAL. This
│    conclusion should include or reference any additional tests performed
│    to supplement the existing validation study and any further testing
│    performed for confirmation or qualification for routine release of
│    product from the existing validated cycle (e.g. residual testing,
│    functional testing on first three lots, etc.). g) Approval by the
│    sterilization specialist and other individuals as required by the n
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 131 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.0/5.0
│
│  Context:
│    
│    ............................................................................................................17
│    9.2.2 Installation
│    qualification........................................................................................................................................17
│    9.3 Operational qualification,
│    OQ..................................................................................................................................................17
│    9.4 Performance qualification,
│    PQ.................................................................................................................
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 132 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.0/5.0
│
│  Context:
│    
│    .................................................................................................17
│    9.3 Operational qualification,
│    OQ..................................................................................................................................................17
│    9.4 Performance qualification,
│    PQ................................................................................................................................................18
│    9.4.1
│    General.......................................................................................................................................
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 133 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.0/5.0
│
│  Context:
│    and/or product to be validated to demonstrate that the process
│    complies with identified acceptance criteria and is capable of
│    delivering the required SAL to the product. ﻿ 16 © ISO 2014 – All
│    rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 39 --- ﻿ ISO
│    11135:2014+A1:2018 9.2 Installation qualification, IQ 9.2.1 Equipment
│    9.2.1.1 Equipment to be used in the sterilization process, including
│    any ancillary items, shall comply with its design specifications.
│    9.2.1.2 Sterilization equipment shall comply with the applicable
│    safety standards. 9.2.1.3 The operating procedures for the equipment
│    shall
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 134 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ance qualification — Physical 9.4.3.1 Physical PQ (PPQ) shall
│    demonstrate a) that the specified acceptance criteria are met
│    throughout the load for the duration of the proposed routine process
│    specification, and b) reproducibility of the process. The PPQ shall
│    include a minimum of three planned qualification cycles, consecutive
│    in the same study, in which all the specified acceptance criteria are
│    met. PPQ may be conducted during the MPQ. If PPQ is performed in
│    parallel with at least three MPQ runs, then a minimum of one
│    additional PPQ run shall be performed using the full routine process
│    specificati
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 135 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.0/5.0
│
│  Context:
│    a) in the same manner as the original chamber, or b) using a reduced
│    MPQ that demonstrates the delivery of the required level of
│    microbiological lethality and PPQ to demonstrate temperature and
│    humidity uniformity of the load and control by the production
│    chamber. The rationale for this reduced qualification shall be
│    recorded and documented. The influence of different geographical
│    locations on the product or load properties shall be determined.
│    12.5.2 Product A product may be added to a validated process if
│    deemed equivalent to or a lesser challenge than an existing qualified
│    product or internal PCD
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 136 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.0/5.0
│
│  Context:
│    routine control use half the number of BIs used during MPQ up to a
│    maximum of 30. The result of the calculation should be rounded to the
│    next higher number. Table C.3 provides guidance for determining the
│    number of BI/PCDs. The actual number of BI/PCDs to be used will
│    depend on: a) microbiological qualification method chosen (see Annex
│    A or Annex B); b) product volume; c) type of chamber (developmental
│    vs. production). When using the Stumbo-Murphy-Cochran procedure and
│    the Overkill Cycle Calculation approach the recommended number of
│    BI/PCDs can be based on the product volume to be sterilized. When thi
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 137 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.0/5.0
│
│  Context:
│    family/processing category specifically referenced in the current
│    validation study to achieve the specified SAL. This conclusion should
│    include or reference any results from additional tests performed to
│    supplement the existing validation study and any further testing
│    performed for confirmation/qualification for routine release of
│    product from the existing validated cycle (i.e. residual testing,
│    functional testing). This documentation should be approved, retained
│    and retrievable. D.8 Process definition D.8.1 No guidance offered.
│    D.8.2 The result of the process definition activities is a detailed
│    sp
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 138 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.0/5.0
│
│  Context:
│    monitor, control, indicate or record parameters such as temperature,
│    humidity, pressure and EO concentration. ﻿ 48 © ISO 2014 – All
│    rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 71 --- ﻿ ISO
│    11135:2014+A1:2018 k) the documented procedures for IQ should specify
│    how each element of this qualification is planned, performed and
│    reviewed. D.9.2.1.2 Guidance can be found in IEC 61010‑2‑40.
│    D.9.2.1.3 No guidance offered. D.9.2.2 Installation qualification
│    D.9.2.2.1 The location in which the equipment is to be installed
│    should comply with all pertinent national, regional and local
│    regulations. D
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 139 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.0/5.0
│
│  Context:
│    N ISO 11135:2014+A1:2019 --- PAGE 71 --- ﻿ ISO 11135:2014+A1:2018 k)
│    the documented procedures for IQ should specify how each element of
│    this qualification is planned, performed and reviewed. D.9.2.1.2
│    Guidance can be found in IEC 61010‑2‑40. D.9.2.1.3 No guidance
│    offered. D.9.2.2 Installation qualification D.9.2.2.1 The location in
│    which the equipment is to be installed should comply with all
│    pertinent national, regional and local regulations. D.9.2.2.2
│    National and local requirements for occupational health and safety
│    should be consulted as to how they apply to potential EO exposure. To
│    protect
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 140 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.0/5.0
│
│  Context:
│    upport validation, including control system layout, control logic
│    diagrams and application software (computerized measurement and
│    control systems) such as program listings, flow charts, ladder logic
│    diagrams where applicable and strategy diagrams. D.9.2.2.6 No
│    guidance offered D.9.3 Operational qualification D.9.3.1 The
│    following information should be documented for all instrumentation
│    used for monitoring, controlling, indicating or recording: a)
│    equipment identification; b) calibration schedule; c) actual
│    completion date for each calibration, as well as who performed it; d)
│    the next scheduled ca
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 141 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.0/5.0
│
│  Context:
│    . MPQ should be conducted using product that is at or below the
│    minimum temperature specified for product to enter the
│    preconditioning area. If it is anticipated that initial product
│    temperature could vary, for example because of transport for
│    sterilization at a remote facility, the design of the qualification
│    testing should reflect this possibility. For fractional cycles
│    (sub-lethal or half cycle), it might also be necessary to shorten the
│    post-exposure phases of the cycle or to remove BIs prior to the
│    aeration phase or after an abbreviated aeration phase. This is done
│    to minimize “residual kill” of
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 142 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.0/5.0
│
│  Context:
│    of the preconditioning areas (if used); d) chamber temperature
│    profile; e) temperature profile of the aeration areas (if used).
│    These requalification exercises should indicate no significant
│    changes in the performance of preconditioning (if used), chamber or
│    aeration areas since the previous (re)qualification. If equipment
│    changes are necessary as a result of these exercises, requalification
│    of OQ might need to be repeated. NOTE For large preconditioning or
│    aeration rooms containing multiple sterilization loads, the extent of
│    requalification can be reduced if there have been no significant
│    changes in
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 143 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.0/5.0
│
│  Context:
│    requalification is warranted. Based on this review, the sterilization
│    specialist should determine the extent of physical and
│    microbiological requalification required. The review and decision
│    should be documented. There are three requalification options
│    available as a result of the review: — Full Qualification –
│    consisting of PPQ and MPQ. This can be required in certain
│    situations, e.g. following a significant change to product/packaging
│    design or configuration (creating a new “worst- case” condition),
│    process design or equipment/service. ﻿ © ISO 2014 – All rights
│    reserved 61 BS EN ISO 11135:2014+A1:20
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 144 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.0/5.0
│
│  Context:
│    he results of the evaluation will determine whether the different
│    pieces or sets of equipment perform equivalently. If the different
│    pieces or sets of equipment are equivalent, then the requirement for
│    a reduced MPQ has been satisfied through the testing that was already
│    performed and no further qualification would be necessary. If the
│    conclusion of either the process analysis and evaluation or the
│    microbiological evaluation is that the processes are not equivalent,
│    then the process should be declared “not equivalent” and a full PQ
│    should be performed. D.12.5.9 Maintenance of equivalence Maintenance
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 145 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 3.0/5.0
│
│  Context:
│    s equivalent to the equipment specifically referenced in the current
│    validation study to achieve the specified product SAL. This
│    conclusion should include or reference any additional tests performed
│    to supplement the existing validation study and any further testing
│    performed for confirmation or qualification for routine release of
│    product from the existing validated cycle (e.g. residual testing,
│    functional testing on first three lots, etc.). g) Approval by the
│    sterilization specialist and other individuals as required by the
│    normal change control or process documentation control practices
│    within th
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 146 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    to be validated to demonstrate that the process complies with
│    identified acceptance criteria and is capable of delivering the
│    required SAL to the product. ﻿ 16 © ISO 2014 – All rights reserved
│    BS EN ISO 11135:2014+A1:2019 --- PAGE 39 --- ﻿ ISO 11135:2014+A1:2018
│    9.2 Installation qualification, IQ 9.2.1 Equipment 9.2.1.1 Equipment
│    to be used in the sterilization process, including any ancillary
│    items, shall comply with its design specifications. 9.2.1.2
│    Sterilization equipment shall comply with the applicable safety
│    standards. 9.2.1.3 The operating procedures for the equipment shall
│    be
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 147 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ecorders, gauges and test instruments) that monitor, control,
│    indicate or record parameters such as temperature, humidity, pressure
│    and EO concentration. ﻿ 48 © ISO 2014 – All rights reserved BS EN
│    ISO 11135:2014+A1:2019 --- PAGE 71 --- ﻿ ISO 11135:2014+A1:2018 k)
│    the documented procedures for IQ should specify how each element of
│    this qualification is planned, performed and reviewed. D.9.2.1.2
│    Guidance can be found in IEC 61010‑2‑40. D.9.2.1.3 No guidance
│    offered. D.9.2.2 Installation qualification D.9.2.2.1 The location in
│    which the equipment is to be installed should comply with all
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 148 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    release, it could result in loads being released that have not been
│    adequately sterilized. D.12.2.3 No guidance offered. D.12.2.4 It is
│    necessary to periodically review the maintenance records and to make
│    any adjustments that are indicated by the data. D.12.3
│    Requalification D.12.3.1 Review of IQ should include confirmation of
│    the acceptable calibration status of control and monitoring
│    equipment. The change control and preventive maintenance programs
│    indicate that no ﻿ 60 © ISO 2014 – All rights reserved BS EN ISO
│    11135:2014+A1:2019 --- PAGE 83 --- ﻿ ISO 11135:2014+A1:2018
│    modifications
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 149 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ion for the candidate equipment, which fully describes the equipment,
│    operating specifications, and tolerances, and which refers to or
│    provides a list of applicable operating procedures, calibration
│    procedures, and maintenance schedules. This specification should
│    include or reference the current IQ per this International Standard.
│    b) Evidence or assessment of the ability of the equipment to deliver
│    the intended process. The evidence or assessment should include or
│    reference the current OQ. c) The result of the comparison between the
│    candidate process equipment and the existing validated p
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 150 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    
│    .............................................................................................17
│    9.2.2 Installation
│    qualification........................................................................................................................................17
│    9.3 Operational qualification,
│    OQ..................................................................................................................................................17
│    9.4 Performance qualification,
│    PQ.....................................................................................................................
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 151 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    f the required SAL. ﻿ 28 © ISO 2014 – All rights reserved BS EN ISO
│    11135:2014+A1:2019 --- PAGE 51 --- ﻿ ISO 11135:2014+A1:2018 Annex C
│    (informative) Temperature sensors, RH sensors and biological
│    indicator numbers C.1 Temperature sensors It is recommended to use
│    one sensor per 2,5 m3 during OQ to establish a thermal map of the
│    room or chamber that captures potential hot or cold locations.
│    Therefore, monitoring should include more than one plane and
│    locations near doors. For PQ, one temperature sensor is required per
│    cubic metre of product volume. The minimum number of temperature sens
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 152 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    thin the sterile barrier system or amongst the unit packages. The
│    result of the calculation should be rounded to the next higher
│    number. Table C.1 provides guidance for determining the number of
│    temperature sensors. Table C.1 — Minimum recommended number of
│    temperature sensors Volume m3 Number for OQ (usable chamber/room
│    volume) Number for PQ (product load volume) Preconditioning
│    Conditioning/ sterilization Aeration Preconditioning Conditioning/
│    sterilization Aeration ≤ 1 3 3 10 4 10 15 6 15 20 8 20 25 10 25 30 12
│    30 35 14 35 40 16 40 50 20 50 100 40 100 EXAMPLE During OQ of a
│    preconditioning
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 153 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    Volume m3 Number for OQ (usable chamber/room volume) Number for PQ
│    (product load volume) Preconditioning Conditioning/ sterilization
│    Aeration Preconditioning Conditioning/ sterilization Aeration ≤ 1 3 3
│    10 4 10 15 6 15 20 8 20 25 10 25 30 12 30 35 14 35 40 16 40 50 20 50
│    100 40 100 EXAMPLE During OQ of a preconditioning room with a usable
│    chamber volume of 70 m3: 70/2,5 = 28. EXAMPLE During PQ with a
│    product load volume of 2 m3: 2/1 = 2. The number of sensors to use is
│    at least three (the minimum number of sensors to use). C.2 Humidity
│    sensors The recommendation is to use one sensor per 2,5
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 154 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    g (where possible) within the load. This can be achieved by placing
│    the sensor within the sterile barrier system or amongst the unit
│    packages. Table C.2 provides guidance for determining the number of
│    humidity sensors. Table C.2 — Minimum recommended number of humidity
│    sensors Volume m3 Number for OQ (usable chamber/room volume) Number
│    for PQ (product load volume) Preconditioning Conditioning/
│    sterilization Aeration Preconditioning Conditioning/ sterilization
│    Aeration ≤ 1 2 N/A 2 N/A 10 4 4 15 6 6 20 8 8 25 10 10 30 12 12 35 14
│    14 40 16 16 50 20 20 100 40 40 EXAMPLE 1 During OQ for a usable ch
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 155 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    e m3 Number for OQ (usable chamber/room volume) Number for PQ
│    (product load volume) Preconditioning Conditioning/ sterilization
│    Aeration Preconditioning Conditioning/ sterilization Aeration ≤ 1 2
│    N/A 2 N/A 10 4 4 15 6 6 20 8 8 25 10 10 30 12 12 35 14 14 40 16 16 50
│    20 20 100 40 40 EXAMPLE 1 During OQ for a usable chamber volume of 6
│    m3: 6/2,5 = 2,4. The number of sensors to use is at least three.
│    EXAMPLE 2 During PQ for a product volume of 60 m3: 60/2,5 = 24. The
│    number of sensors to use is at least 24. C.3 Biological Indicators
│    The minimum recommended number of BI/PCDs to use is as follows:
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 156 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    the phase. g) No guidance offered. h) No guidance offered. i) The
│    temperature sensors within the sterilization load should be placed in
│    the locations that are most likely to experience the greatest
│    temperature variation. These locations should take into account hot
│    or cold spots located during OQ. The locations of hot and cold spots
│    within a load can be significantly different than the locations in an
│    empty chamber. During PQ, it is important to take into account the
│    relationship between the load temperature and the chamber temperature
│    in order to ensure adequate load temperature in the r
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 157 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    d preventive maintenance programs indicate that no ﻿ 60 © ISO 2014 –
│    All rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 83 --- ﻿
│    ISO 11135:2014+A1:2018 modifications of, or significant changes to,
│    the sterilizing equipment have been made that could affect the
│    process. D.12.3.2 Review of OQ should include an assessment of the
│    equipment performance and engineering changes that were made during
│    the year to ensure that the results from the original OQ are still
│    valid (see Figure D.1). In order to do so, it is common practice to
│    perform periodic requalification of equipment and should
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 158 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    e aeration areas (if used). These requalification exercises should
│    indicate no significant changes in the performance of preconditioning
│    (if used), chamber or aeration areas since the previous
│    (re)qualification. If equipment changes are necessary as a result of
│    these exercises, requalification of OQ might need to be repeated.
│    NOTE For large preconditioning or aeration rooms containing multiple
│    sterilization loads, the extent of requalification can be reduced if
│    there have been no significant changes in equipment. The rationale
│    for reduced requalification is documented. D.12.3.3 Review of P
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 159 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    tion procedures, and maintenance schedules. This specification should
│    include or reference the current IQ per this International Standard.
│    b) Evidence or assessment of the ability of the equipment to deliver
│    the intended process. The evidence or assessment should include or
│    reference the current OQ. c) The result of the comparison between the
│    candidate process equipment and the existing validated process
│    equipment. This comparison should clearly demonstrate that all major
│    systems and critical parameters were assessed, including statistical
│    analysis (if used). d) Evidence or assessment of
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 160 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    
│    ..................................................................................17
│    9.3 Operational qualification,
│    OQ..................................................................................................................................................17
│    9.4 Performance qualification,
│    PQ................................................................................................................................................18
│    9.4.1
│    General...........................................................................................................................................
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 161 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    figuration of a product, shall be specified. NOTE If saleable product
│    has been used during validation, 7.2 provides information concerning
│    the product quality for patient use and 11.4 provides information
│    concerning the requirements for the release of sterile product.
│    9.4.1.5 The load used for PQ shall be representative of that to be
│    sterilized routinely and shall be defined based upon the most
│    challenging routine load. 9.4.1.6 For establishments that have widely
│    varying load configurations, the extent to which the variation
│    affects the sterilization process shall be evaluated. It shall
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 162 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    nge to the sterilization process as the product. 9.4.1.8 If loads are
│    reused for the validation cycles, they shall be aerated between
│    exposures to meet the regulations for worker safety and to ensure
│    that EO residues in the load do not affect the biological challenge
│    in the next microbiological PQ study. 9.4.1.9 If chemical indicators
│    are used as part of PQ, these shall comply with ISO 11140‑1, and
│    shall be used in conjunction with microbiological and physical
│    monitoring. 9.4.1.10 Biological indicators used in PQ shall comply
│    with the applicable clauses of ISO 11138‑1:2006 and ISO 11138‑
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 163 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    d biological indicator numbers C.1 Temperature sensors It is
│    recommended to use one sensor per 2,5 m3 during OQ to establish a
│    thermal map of the room or chamber that captures potential hot or
│    cold locations. Therefore, monitoring should include more than one
│    plane and locations near doors. For PQ, one temperature sensor is
│    required per cubic metre of product volume. The minimum number of
│    temperature sensors is three. For PQ, humidity sensors should be
│    placed within the packaging (where possible) within the load. This
│    can be achieved by placing the sensor within the sterile barrier
│    system
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 164 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    the unit packages. The result of the calculation should be rounded to
│    the next higher number. Table C.1 provides guidance for determining
│    the number of temperature sensors. Table C.1 — Minimum recommended
│    number of temperature sensors Volume m3 Number for OQ (usable
│    chamber/room volume) Number for PQ (product load volume)
│    Preconditioning Conditioning/ sterilization Aeration Preconditioning
│    Conditioning/ sterilization Aeration ≤ 1 3 3 10 4 10 15 6 15 20 8 20
│    25 10 25 30 12 30 35 14 35 40 16 40 50 20 50 100 40 100 EXAMPLE
│    During OQ of a preconditioning room with a usable chamber volume of
│    70 m3:
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 165 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    itioning Conditioning/ sterilization Aeration Preconditioning
│    Conditioning/ sterilization Aeration ≤ 1 3 3 10 4 10 15 6 15 20 8 20
│    25 10 25 30 12 30 35 14 35 40 16 40 50 20 50 100 40 100 EXAMPLE
│    During OQ of a preconditioning room with a usable chamber volume of
│    70 m3: 70/2,5 = 28. EXAMPLE During PQ with a product load volume of 2
│    m3: 2/1 = 2. The number of sensors to use is at least three (the
│    minimum number of sensors to use). C.2 Humidity sensors The
│    recommendation is to use one sensor per 2,5 m3 to establish a
│    humidity map of the area or product that captures potential
│    variability in th
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 166 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    an be achieved by placing the sensor within the sterile barrier
│    system or amongst the unit packages. Table C.2 provides guidance for
│    determining the number of humidity sensors. Table C.2 — Minimum
│    recommended number of humidity sensors Volume m3 Number for OQ
│    (usable chamber/room volume) Number for PQ (product load volume)
│    Preconditioning Conditioning/ sterilization Aeration Preconditioning
│    Conditioning/ sterilization Aeration ≤ 1 2 N/A 2 N/A 10 4 4 15 6 6 20
│    8 8 25 10 10 30 12 12 35 14 14 40 16 16 50 20 20 100 40 40 EXAMPLE 1
│    During OQ for a usable chamber volume of 6 m3: 6/2,5 = 2,4. The numb
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 167 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ization Aeration Preconditioning Conditioning/ sterilization Aeration
│    ≤ 1 2 N/A 2 N/A 10 4 4 15 6 6 20 8 8 25 10 10 30 12 12 35 14 14 40 16
│    16 50 20 20 100 40 40 EXAMPLE 1 During OQ for a usable chamber volume
│    of 6 m3: 6/2,5 = 2,4. The number of sensors to use is at least three.
│    EXAMPLE 2 During PQ for a product volume of 60 m3: 60/2,5 = 24. The
│    number of sensors to use is at least 24. C.3 Biological Indicators
│    The minimum recommended number of BI/PCDs to use is as follows: a)
│    For MPQ with a product load volume of up to 10 m3, use three BIs per
│    m3 of product volume, with a minimum of five
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 168 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    propriateness of its own reprocessing method, it should not reprocess
│    the medical device. D.8.3 A developmental chamber is usually a
│    smaller vessel than the production chamber and can be used to perform
│    studies to support validation. Using a developmental chamber does not
│    preclude confirmation of PQ in a production chamber. D.8.4 When
│    establishing process definition it is important to consider the
│    impact of the selected processing parameters and their tolerances on
│    the safety and functionality of the product and its packaging. As
│    there are a number of parameters within a sterilization proce
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 169 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ; density). Consideration should be given to include load material
│    with substantially varying characteristics such as: absorbent
│    materials, barriers to diffusion such as rigid materials, sealed
│    liquids, containers, etc. D.9.4.1.7 No guidance offered D.9.4.1.8 If
│    the load is to be re-used during PQ, the loads should be aerated and
│    re-equilibrated to ambient conditions prior to starting the next run.
│    After repeated use, the suitability of the load should be considered.
│    Aeration between exposures will ensure that EO residues in the load
│    do not affect the biological indicator. If equilibratio
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 170 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ed in the locations that are most likely to experience the greatest
│    temperature variation. These locations should take into account hot
│    or cold spots located during OQ. The locations of hot and cold spots
│    within a load can be significantly different than the locations in an
│    empty chamber. During PQ, it is important to take into account the
│    relationship between the load temperature and the chamber temperature
│    in order to ensure adequate load temperature in the routine process.
│    If sensors are used in the sterilization chamber and 100 % EO or
│    potentially flammable sterilant mixtures are used,
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 171 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ed exposures to EO due to irreversible deterioration of materials
│    currently utilized as sensing elements. c) EO gas concentration
│    measurement. The frequency of analysis required to demonstrate that
│    the minimum EO concentration is maintained throughout EO exposure
│    should be established during the PQ studies. Monitoring throughout
│    the EO exposure dwell period should also be done as part of the
│    validation, in order to determine how the EO concentration changes
│    over time. The results of this analysis are specific to the product
│    and load configuration being analysed. The analysis performed duri
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 172 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    s. Monitoring throughout the EO exposure dwell period should also be
│    done as part of the validation, in order to determine how the EO
│    concentration changes over time. The results of this analysis are
│    specific to the product and load configuration being analysed. The
│    analysis performed during the PQ study will result in documented
│    specifications for how often direct analysis should be performed
│    during the cycle. It is recommended that when direct analysis of EO
│    concentration is performed, at a minimum, direct analysis of EO
│    concentration be performed during the first and last portions of E
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 173 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    a associated with a validated process in the candidate equipment and
│    the original equipment is performed. Process data should be collected
│    from the candidate equipment. These data should be compared with the
│    parameter limits for that specific sterilization process and the
│    results obtained in the PQ of the original equipment. The parameter
│    limits are those established in the initial validation for the
│    sterilization process (including all process requirements identified
│    in this International Standard) in the existing equipment. The
│    specifications, acceptance criteria, and pallet or load conf
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 174 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ablished in the initial validation for the sterilization process
│    (including all process requirements identified in this International
│    Standard) in the existing equipment. The specifications, acceptance
│    criteria, and pallet or load configuration should be the same as
│    those defined for the initial PQ. The actual parameters to be
│    evaluated in the equivalence determination are generally a subset of
│    the entire process specification. The parameters selected and the
│    rationale for their selection should be documented. Statistical
│    methods that evaluate both the central tendencies of the test data a
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 175 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    n. Product EO sterilization residuals levels should be verified in
│    the candidate aeration room/chamber/cell. D.12.5.6 Evaluation of
│    sterilization chamber performance An evaluation that compares the
│    delivery of process parameters for the load in the candidate
│    equipment to the data obtained in the PQ or in production runs should
│    be performed. The critical process and load parameters to be compared
│    should be defined for the sterilization process before the evaluation
│    is performed. These parameters are unique for each sterilization
│    process but can include the following: a) Load parameters: 1)
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 176 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ough the testing that was already performed and no further
│    qualification would be necessary. If the conclusion of either the
│    process analysis and evaluation or the microbiological evaluation is
│    that the processes are not equivalent, then the process should be
│    declared “not equivalent” and a full PQ should be performed. D.12.5.9
│    Maintenance of equivalence Maintenance of equivalence should include
│    a review of changes to each piece of equipment, the manufacturing
│    process, the product load, and the sterilization process to ensure
│    that these changes do not compromise the overall determination o
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 177 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    nce qualification —
│    Microbiological.....................................................................................18
│    9.4.3 Performance qualification —
│    Physical.......................................................................................................19
│    9.5 Review and approval of
│    validation......................................................................................................................................20
│    10 Routine monitoring and
│    control.................................................................................................................................
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 178 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    e activities required by ISO 11135 have been grouped together and are
│    presented in a particular order, ISO 11135 does not require that the
│    activities be performed in the order in which they are presented. The
│    activities required are not necessarily sequential, as the programme
│    of development and validation may be iterative. It is possible that
│    performing these different activities will involve a number of
│    separate individuals and/or organizations, each of whom undertakes
│    one or more of these activities. This International Standard does not
│    specify the particular individuals or organizations to car
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 179 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    2 microorganism entity of microscopic size, encompassing bacteria,
│    fungi, protozoa and viruses Note 1 to entry: A specific standard
│    might not require demonstration of the effectiveness of the
│    sterilization process in inactivating all types of microorganisms,
│    identified in the definition above, for validation and/or routine
│    control of the sterilization process. [SOURCE: ISO/TS 11139:2006,
│    definition 2.26] ﻿ © ISO 2014 – All rights reserved 5 BS EN ISO
│    11135:2014+A1:2019 --- PAGE 28 --- ﻿ ISO 11135:2014+A1:2018 3.23
│    operational qualification OQ process of obtaining and documenting
│    evidence that instal
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 180 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ble chamber volume defined space within the sterilizer chamber, which
│    is not restricted by fixed or mobile parts and which is available to
│    accept the sterilization load Note 1 to entry: The volume allowed for
│    gas circulation around the load inside the chamber is not included as
│    usable space. 3.57 validation documented procedure for obtaining,
│    recording and interpreting the results required to establish that a
│    process will consistently yield product complying with predetermined
│    specifications [SOURCE: ISO/TS 11139:2006, definition 2.55] 3.58
│    virgin material material that has not been previously used,
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 181 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ying with predetermined specifications [SOURCE: ISO/TS 11139:2006,
│    definition 2.55] 3.58 virgin material material that has not been
│    previously used, or subjected to processing other than for its
│    original production 4 Quality management systems 4.1 Documentation
│    4.1.1 Procedures for development, validation, routine control and
│    product release from sterilization shall be specified. ﻿ 10 © ISO
│    2014 – All rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 33
│    --- ﻿ ISO 11135:2014+A1:2018 4.1.2 Documents and records required by
│    this International Standard shall be reviewed and approved by
│    designat
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 182 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    the requirements of this international standard are undertaken by
│    organizations with separate quality management systems, the
│    responsibilities and authority of each party shall be specified. When
│    a HCF contracts out the sterilization of reusable medical devices, it
│    is the HCF’s responsibility for validation and release of the
│    sterilized product. 4.3 Product realization 4.3.1 Procedures for
│    purchasing shall be specified. These procedures shall comply with the
│    applicable clauses of ISO 13485. 4.3.2 Procedures for identification
│    and traceability of product shall be specified. These procedures
│    shall
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 183 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    uring the sterilization process, and removal of EO at the end of the
│    process. 7.1.6 It shall be demonstrated that the specified
│    sterilization process is effective in sterilizing the most
│    difficult-to-sterilize location within the product. This can be
│    achieved by performing process definition and validation of a new
│    product; or through the demonstration of equivalence to a previously
│    validated product, or internal process challenge device (internal
│    PCD) used to qualify the product SAL when exposed to the specified
│    sterilization process (See 8.6 and D.8.6). ﻿ 14 © ISO 2014 – All
│    rights reserved BS E
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 184 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    eries. 7.4 Documentation The results of product definition shall be
│    documented by the manufacturer of the device. 8 Process definition
│    8.1 The purpose of this activity is to obtain a process specification
│    which can be applied for the sterilization of the defined product
│    (see Clause 7) during the validation studies. 8.2 The sterilization
│    process applicable for the defined product shall be established. The
│    defined product includes new or modified product, packaging or
│    loading configurations. 8.3 Process definition activities shall be
│    performed in a sterilization chamber (developmental chamber or pr
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 185 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    tablishment of the sterilization process shall a) comply with ISO
│    11138‑2:2006, Clause 5 and 9.5, b) be shown to be at least as
│    resistant to EO as is the bioburden of product to be sterilized, and
│    c) be placed within an appropriate PCD. The appropriateness of the
│    PCD used for process definition, validation or routine monitoring and
│    control shall be determined. The PCD shall present a challenge to the
│    sterilization process that is equivalent or greater than the
│    challenge presented by the natural bioburden at the most difficult to
│    sterilize location within the product. NOTE For information on the s
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 186 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    dicators shall not be used as the sole means of establishing the
│    sterilization process and shall not be used as an indicator that the
│    required SAL has been achieved. 8.9 If tests of sterility are
│    performed during the definition of the sterilization process, they
│    shall comply with ISO 11737‑2. 9 Validation 9.1 General 9.1.1 The
│    purpose of validation is to demonstrate that the sterilization
│    process established in the process definition (see Clause 8) can be
│    delivered effectively and reproducibly to the product within the
│    sterilization load. Validation consists of a number of identified
│    stages: ins
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 187 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    , including results from incubation of biological indicators, shall
│    be recorded and reviewed for acceptability. The results of this
│    review shall be recorded. 9.5.3 A validation report shall be
│    prepared. The report shall be reviewed and approved by the designated
│    responsible person(s). 9.5.4 The validation report shall describe or
│    reference specific qualified product, defined load configurations and
│    the documented specification for the EO sterilization process and
│    shall address: NOTE For practical purposes, rates can be determined
│    as the time taken (with tolerances) to attain a specified pressure
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 188 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    n successive repetitions; h) aeration (if used): 1) time and
│    temperature within the chamber and/or room; 2) pressure changes (if
│    any) within the chamber and/or room; 3) rate of change of air or
│    other gas; 4) temperature of the sterilization load. 9.5.5 If
│    parametric release is to be used, the validation report shall also
│    specify: a) the value and tolerances for chamber humidity by direct
│    measurement during conditioning; b) the value and tolerances for the
│    EO concentration determined from direct analysis of chamber
│    atmosphere using analytical methods to establish the process
│    specification for ro
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 189 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ed conditions throughout EO exposure. c) temperature of the chamber;
│    recorded from two separate monitoring locations. 9.5.6 A process
│    specification including the process parameters and their tolerances
│    shall be established for routine processing based upon the
│    documentation generated during the validation. This process
│    specification shall also include the criteria for designating EO
│    processed product as conforming product and approved for release. ﻿ ©
│    ISO 2014 – All rights reserved 21 BS EN ISO 11135:2014+A1:2019 ---
│    PAGE 44 --- ﻿ ISO 11135:2014+A1:2018 10 Routine monitoring and
│    control 10.1 Th
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 190 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    or more of the conformance criteria of 11.1 are not fulfilled. In the
│    event of a positive BI, it is not acceptable to release product based
│    on acceptable results of a product test for sterility. The
│    non-conformity shall be addressed per documented procedures. 11.4 If
│    saleable product is used in validation studies the requirements for
│    release of this product for distribution shall be generated before
│    the start of the validation activities. It is important to assess the
│    effect of repeated exposures to the validation/sterilization
│    processes on product and packaging functionality, and levels of resid
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 191 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    us, quality policy, planning, responsibility, authority and
│    communication, and management review. Each organization should
│    establish procedures for identifying training needs and ensure that
│    all personnel are trained to adequately perform their assigned
│    responsibilities. D.4.2.2 The development, validation and routine
│    control of a sterilization process can involve a number of separate
│    parties, each of whom is responsible for certain elements. It is
│    important that the respective ﻿ 32 © ISO 2014 – All rights reserved
│    BS EN ISO 11135:2014+A1:2019 --- PAGE 55 --- ﻿ ISO 11135:2014+A1:2018
│    procedures c
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 192 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    e seal integrity. The ability of the sterile barrier system (SBS) to
│    protect product during customary handling and distribution should be
│    demonstrated. Evidence should also be generated to show that the SBS
│    can withstand the sterilization process without losing its ability to
│    protect the product. Validation of the SBS should consider the
│    potential stresses that the SBS can be exposed to during an EO
│    sterilization process. Considerations would include vacuum/pressure
│    levels, rate of pressure change, temperature, etc. It is common
│    practice to demonstrate suitability of the SBS by exposure of the SBS
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 193 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    7.3.1 Guidance on testing for bacterial endotoxins is provided in
│    ANSI/AAMI/ST72 and the applicable pharmacopeia. D.7.3.2 In health
│    care facilities, attention to microbiological quality will comprise
│    having strict procedures for collection and handling of used,
│    reusable medical devices, and for validation and control of the
│    cleaning processes for reusable medical devices in accordance with
│    the medical device manufacturer’s instructions. When using the
│    bioburden approach (see Annex A) bioburden testing should be
│    performed at least quarterly. The period of monitoring can be
│    extended following a do
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 194 [MED ] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    See also ISO 17664. If the medical device or packaging manufacturer
│    supplies instructions for reprocessing that are not specific enough
│    or not appropriate (e.g. an EO process with 100 % EO, where the
│    health care facility uses a mixture of EO and diluent gas), the
│    facility should either perform a validation or assess the
│    appropriateness of its own reprocessing method, based on materials
│    effect data and reprocessing instructions for other devices. If the
│    health care facility is not able to validate the product or assess
│    the appropriateness of its own reprocessing method, it should not
│    reprocess the
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 195 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    rilize configuration. It is theorized that this occurs because the EO
│    is removed more rapidly from the external PCD than the internal PCD,
│    resulting in less gas exposure time to the microbiological challenge.
│    D.8.7 No guidance offered. D.8.8 No guidance offered. D.8.9 No
│    guidance offered. D.9 Validation D.9.1 General D.9.1.1 The object of
│    validation is to document the evidence required to provide a high
│    degree of assurance that a specific process will consistently produce
│    product meeting the required sterility assurance level (SAL). Product
│    sterilized in the validated process should be shown t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 196 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    occurs because the EO is removed more rapidly from the external PCD
│    than the internal PCD, resulting in less gas exposure time to the
│    microbiological challenge. D.8.7 No guidance offered. D.8.8 No
│    guidance offered. D.8.9 No guidance offered. D.9 Validation D.9.1
│    General D.9.1.1 The object of validation is to document the evidence
│    required to provide a high degree of assurance that a specific
│    process will consistently produce product meeting the required
│    sterility assurance level (SAL). Product sterilized in the validated
│    process should be shown to meet predetermined specifications and
│    quality
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 197 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    onsistently produce product meeting the required sterility assurance
│    level (SAL). Product sterilized in the validated process should be
│    shown to meet predetermined specifications and quality
│    characteristics related to product functionality and safety (i.e.
│    through product compatibility studies). Validation of the
│    sterilization process should be performed according to an approved
│    written document (e.g. protocol) that defines the testing procedures
│    and the acceptance criteria, prior to initiation of testing. This
│    document should be reviewed by a sterilization specialist(s). The
│    elements of validation
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 198 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ics, metals, cotton, etc.), it is important to verify the load
│    configuration because these materials might not behave similarly when
│    heated during preconditioning and conditioning. D.9.4.1.6 In addition
│    to considering maximum/minimum load size (see D.9.4.1.4) and product
│    effects (see D.9.4.1.5), validation load composition should consider
│    any widely varying load material/packaging characteristics routinely
│    sterilized, when developing a representative or most challenging load
│    for validation. Products or surrogate product materials utilized in
│    validation loads should represent those that typically p
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 199 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    .6 In addition to considering maximum/minimum load size (see
│    D.9.4.1.4) and product effects (see D.9.4.1.5), validation load
│    composition should consider any widely varying load
│    material/packaging characteristics routinely sterilized, when
│    developing a representative or most challenging load for validation.
│    Products or surrogate product materials utilized in validation loads
│    should represent those that typically present the most challenging
│    condition for lethality (i.e. for penetration of heat, humidity, and
│    EO gas diffusion; density). Consideration should be given to include
│    load material with sub
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 200 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    9.4.1.4) and product effects (see D.9.4.1.5), validation load
│    composition should consider any widely varying load
│    material/packaging characteristics routinely sterilized, when
│    developing a representative or most challenging load for validation.
│    Products or surrogate product materials utilized in validation loads
│    should represent those that typically present the most challenging
│    condition for lethality (i.e. for penetration of heat, humidity, and
│    EO gas diffusion; density). Consideration should be given to include
│    load material with substantially varying characteristics such as:
│    absorbent materials
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 201 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    uired SAL is achieved. D.12.5.2 Criteria for process equivalence
│    Process equivalence can be established regardless of whether the
│    equipment is located in the same facility or in different facilities.
│    The criteria to be met prior to the establishment of a process
│    equivalence program are: a) full validation of the sterilization
│    process in at least one existing system according to the requirements
│    of Clause 9; b) performance of the IQ and OQ studies demonstrating
│    and documenting that all equipment has been installed in accordance
│    with engineering specification requirements and operates in
│    accordance
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 202 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    t of applicable sterilizer operating procedures and specifications
│    issued or changed to authorize use of the candidate equipment for
│    routine processing of product. D.12.5.11 Product D.12.5.11.1 Product
│    family A product family is a collection of products determined to be
│    similar or equivalent for validation purposes. Although product
│    families can be used for other reasons (EO residuals, bioburden, or
│    biocompatibility) for EO sterilization a product family usually
│    refers to products that have been grouped together for the purposes
│    of determining that the required SAL has been delivered to the produ
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 203 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ulation that is equal to or greater than that of the bioburden. This
│    method is appropriate when sufficient bioburden data are available
│    from the bioburden monitoring program to demonstrate that the product
│    bioburden resistance along with the population can be appropriately
│    represented during the validation studies to deliver a 10−6 SAL to
│    the product. NOTE This method can involve the use of a BI or other
│    internal PCD with a population of less than 106. The relative
│    resistance and population of the internal PCD should be compared with
│    the resistance and population of the product bioburden. The log r
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 204 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ifferent parts of both the product and material; c) weights and
│    densities of items; d) load configuration, especially for a mixed
│    product load. Health care considerations: To demonstrate adequate
│    penetration of EO, humidity and heat into product, a PCD should be
│    chosen for routine monitoring and validation of the EO sterilization
│    process. The resistance of the PCD to EO should be shown to be equal
│    to or greater than the resistance of the bioburden of product to be
│    sterilized at the most difficult to sterilize location on the
│    product. D.14.2.3 [B.2.3] No guidance offered D.14.2.4 [B.2.4]
│    Obtaining
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 205 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ization process where there is only sufficient product, at most, for
│    a single sterilization load, for example, during research and
│    development of new product or for clinical trial product. This
│    approach shall only be used to release product to market from
│    multiple batches if it is part of a full validation. Single batch
│    release data can be generated under either a stand-alone protocol for
│    release of that batch, or as one part of a full validation. NOTE The
│    requirements of ISO 11135 apply for any aspects not specifically
│    addressed in this annex. E.2 Procedure E.2.1 Assess the packaged
│    product to d
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 206 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.5/5.0
│
│  Context:
│    of new product or for clinical trial product. This approach shall
│    only be used to release product to market from multiple batches if it
│    is part of a full validation. Single batch release data can be
│    generated under either a stand-alone protocol for release of that
│    batch, or as one part of a full validation. NOTE The requirements of
│    ISO 11135 apply for any aspects not specifically addressed in this
│    annex. E.2 Procedure E.2.1 Assess the packaged product to determine
│    if it can be assigned to an existing product family for sterilization
│    purposes. This assessment considers product composition, design,
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 207 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 2.5/5.0
│
│  Context:
│    
│    ..................................................................................18
│    9.4.1
│    General...................................................................................................................................................................................18
│    9.4.2 Performance qualification —
│    Microbiological.....................................................................................18
│    9.4.3 Performance qualification —
│    Physical.......................................................................................................19
│    9.5 Review and approval of validation.......
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 208 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 2.5/5.0
│
│  Context:
│    procedures shall include, but are not limited to a) step-by-step
│    operating instructions, b) fault conditions, the manner in which they
│    are indicated, and actions to be taken, c) instructions for
│    maintenance and calibration, and d) details of contacts for technical
│    support. 9.2.2 Installation qualification 9.2.2.1 Installation of the
│    equipment and all associated services shall be in accordance with the
│    architectural and engineering drawings. The installation shall comply
│    with all pertinent national, regional and local regulations. 9.2.2.2
│    Instructions for installation shall be specified and shall
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 209 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 2.5/5.0
│
│  Context:
│    s from other tests (e.g. EO residuals, endotoxin, physical testing,
│    etc.) before product can enter the distribution chain. 11.2 If a
│    process does not fulfil all of the conformance criteria above, the
│    cause shall be investigated. If repair or alteration to the equipment
│    is required, the necessary qualification shall be performed before
│    this process can be used again. 11.3 Product shall be considered as
│    non-conforming and handled in accordance with the applicable clauses
│    of ISO 13485 if one or more of the conformance criteria of 11.1 are
│    not fulfilled. In the event of a positive BI, it is not acceptab
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 210 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 2.5/5.0
│
│  Context:
│    e of the bioburden allows one to establish exposure time so that an
│    SAL can be predicted. Attention shall be given to the impact of
│    packaging and the removal of EO from the PCD. Guidance on this
│    approach can be found in ISO 14161. A.1.2 The conditions used for
│    recovery of biological indicators in qualification studies, including
│    duration of incubation, shall be established and documented. The
│    incubation period shall take into account the possibility of delayed
│    outgrowth of spores that have been exposed to EO. Refer to ISO 14161
│    for additional information on biological indicator incubation times.
│    A.1.3
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 211 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 2.5/5.0
│
│  Context:
│    lation approach: The routine processing parameters that deliver
│    minimally a 12 SLR of the biological indicator shall be established
│    using one of the methods described in A.1.3. The number of cycles is
│    dictated by the method used. B.1.3 The conditions used for recovery
│    of biological indicators in qualification studies shall be
│    established and documented. The incubation period shall take into
│    account the possibility of delayed outgrowth of spores that have been
│    exposed to EO. Further guidance on the biological indicator
│    incubation times can be found in ISO 14161. B.1.4 The resistance of
│    the product bi
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 212 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 2.5/5.0
│
│  Context:
│    storage areas for the containers of EO should include provision for
│    temperature control. It might not be possible to calibrate
│    controlling and monitoring instruments under actual processing
│    conditions, e.g. humidity sensors. Calibration results for these
│    instruments should be correlated against qualification studies.
│    Processing conditions can have a detrimental effect on some types of
│    sensors, e.g. humidity sensors. Sensors might require replacement
│    after repeated exposure to processing conditions due to irreversible
│    deterioration of materials currently used as sensing elements. It
│    might be necessary
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 213 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 2.5/5.0
│
│  Context:
│    iffer significantly in density from that of the reference load; or 4)
│    differ significantly in total load volume. D.7.1.3 The presence of
│    either occluded spaces or mated surfaces should be evaluated in
│    consideration to the designation of an internal PCD that would be
│    used for subsequent lethality qualification studies. D.7.1.4 The
│    major function of a sterile barrier system for a sterilized medical
│    device is to ensure that the product remains sterile until used.
│    During sterilization, the sterile barrier system needs to be able to
│    withstand the process conditions and to remain intact to ensure
│    product q
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 214 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ange in the resistance of the product bioburden to the sterilization
│    process, which might adversely affect the ability of the
│    sterilization process to sterilize product to the specified SAL; e)
│    confirmation that individual sterilization processes have operated
│    within specification since the last qualification; f) confirmation
│    that there have been no changes to the sterilization process that
│    could affect product sterility; g) review of sterility failures of
│    BIs or PCDs that have occurred where process specifications were met
│    to determine whether requalification is warranted. Based on this
│    review, the
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 215 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 2.5/5.0
│
│  Context:
│    following a significant change to product/packaging design or
│    configuration (creating a new “worst- case” condition), process
│    design or equipment/service. ﻿ © ISO 2014 – All rights reserved 61
│    BS EN ISO 11135:2014+A1:2019 --- PAGE 84 --- ﻿ ISO 11135:2014+A1:2018
│    — No physical or microbiological qualification required – In
│    circumstances where no changes have been made to product, packaging,
│    equipment/services and process, acceptable chamber performance and
│    engineering review, and the routine sterilization process has
│    operated reliably in the intervening period, then professional
│    judgment can be used
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 216 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 2.5/5.0
│
│  Context:
│    se product, representative member, or internal PCD which is placed
│    within the product sterile barrier system. The review for product
│    equivalence can be conducted within each product family or processing
│    category. Alternatively, a worst-case product or representative
│    member can be selected for the qualification study. In the following
│    paragraphs, several aspects of product evaluation are addressed.
│    D.12.5.11.2 Determination of adverse effects to product Before
│    determining whether a candidate product or packaging system can be
│    adopted into a product family or processing category, one should
│    determine wh
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 217 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 2.5/5.0
│
│  Context:
│    can have on the expiry date of the products involved. The EO process
│    for which the product will be tested should constitute a
│    representative challenge to the product and its packaging system.
│    Documentation should address how the challenge process differs from
│    the nominal process, and the product qualification should demonstrate
│    that these parameters are acceptable for product acceptance. The
│    candidate product and its packaging should be evaluated to determine
│    the effect on product EO residual levels, and any changes to either
│    should be evaluated for the impact on product release. ISO 10993‑7
│    should b
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 218 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ns. 9.2.2.2 Instructions for installation shall be specified and
│    shall include instructions pertinent to the health and safety of
│    personnel. 9.2.2.3 Conditions for the safe storage of EO shall be
│    specified to ensure that its quality and composition remain within
│    specification. 9.2.2.4 Prior to IQ, the calibration status of any
│    test instrumentation used during the IQ shall be confirmed. 9.2.2.5
│    Drawings of the equipment as installed, plumbing and other ancillary
│    equipment shall be finalized during IQ. 9.2.2.6 Changes made to
│    systems during the IQ shall be assessed for their impact on the
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 219 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    include instructions pertinent to the health and safety of personnel.
│    9.2.2.3 Conditions for the safe storage of EO shall be specified to
│    ensure that its quality and composition remain within specification.
│    9.2.2.4 Prior to IQ, the calibration status of any test
│    instrumentation used during the IQ shall be confirmed. 9.2.2.5
│    Drawings of the equipment as installed, plumbing and other ancillary
│    equipment shall be finalized during IQ. 9.2.2.6 Changes made to
│    systems during the IQ shall be assessed for their impact on the
│    design and process specification and documented in the design history
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 220 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ance with design specifications and with the facility’s policies and
│    procedures. In healthcare facilities IQ is generally the
│    responsibility of the sterilizer manufacturer, while in industrial
│    facilities it is often performed by site personnel in conjunction
│    with a factory representative. If the IQ is performed by the
│    manufacturer, or by a third party, the facility is responsible for
│    retention and management of documents and records relating to the
│    purchase, installation of the equipment. D.9.2.2.3 The storage
│    conditions for EO should be in accordance with the EO manufacturer’s
│    recommendat
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 221 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    t is located in the same facility or in different facilities. The
│    criteria to be met prior to the establishment of a process
│    equivalence program are: a) full validation of the sterilization
│    process in at least one existing system according to the requirements
│    of Clause 9; b) performance of the IQ and OQ studies demonstrating
│    and documenting that all equipment has been installed in accordance
│    with engineering specification requirements and operates in
│    accordance with those requirements; c) definition of the process to
│    include the tolerances allowed and documentation of all phases of the
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 222 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    nformation should be documented for all instrumentation used for
│    monitoring, controlling, indicating or recording: a) equipment
│    identification; b) calibration schedule; c) actual completion date
│    for each calibration, as well as who performed it; d) the next
│    scheduled calibration date. D.9.3.2 OQ for EO equipment is carried
│    out either with an empty sterilizer chamber or using appropriate test
│    material to demonstrate the capability of the equipment to deliver
│    the range of operating parameters and operating limits contained in
│    the process specification. This range of parameters and operatin
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 223 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    rate the capability of the equipment to deliver the range of
│    operating parameters and operating limits contained in the process
│    specification. This range of parameters and operating limits should
│    include the initial sterilization process that has been defined in
│    process definition (see Clause 8). OQ should also determine the
│    performance of associated ancillary systems. For example, the
│    capability of the EO vaporizer to achieve a minimum EO input
│    temperature. The system software (e.g. computerized measurement and
│    control systems) should be tested in all fault conditions during OQ.
│    The user is
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 224 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    e Clause 8). OQ should also determine the performance of associated
│    ancillary systems. For example, the capability of the EO vaporizer to
│    achieve a minimum EO input temperature. The system software (e.g.
│    computerized measurement and control systems) should be tested in all
│    fault conditions during OQ. The user is responsible for assuring the
│    software is validated. OQ can include the following when using a
│    predefined cycle: a) Preconditioning Phase 1) The pattern of air
│    circulation throughout the area to be occupied by the sterilization
│    load(s) should be determined. This can be performed by s
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 225 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ancillary systems. For example, the capability of the EO vaporizer to
│    achieve a minimum EO input temperature. The system software (e.g.
│    computerized measurement and control systems) should be tested in all
│    fault conditions during OQ. The user is responsible for assuring the
│    software is validated. OQ can include the following when using a
│    predefined cycle: a) Preconditioning Phase 1) The pattern of air
│    circulation throughout the area to be occupied by the sterilization
│    load(s) should be determined. This can be performed by smoke tests in
│    combination with calculation of air change rates and
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 226 [MED ] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ports. The remaining temperature sensors should be distributed evenly
│    throughout the usable chamber volume. NOTE See Table C.1 for the
│    recommended number of sensors. ﻿ 50 © ISO 2014 – All rights reserved
│    BS EN ISO 11135:2014+A1:2019 --- PAGE 73 --- ﻿ ISO 11135:2014+A1:2018
│    3) In empty chamber OQ exercises, the recorded temperature range,
│    within the usable chamber volume during EO or inert gas exposure, of
│    ± 3 °C of the average recorded chamber temperature at each time point
│    should be obtained after an equilibration period. When the OQ
│    exercise is carried out using a loaded chamber, then
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 227 [MED ] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    73 --- ﻿ ISO 11135:2014+A1:2018 3) In empty chamber OQ exercises, the
│    recorded temperature range, within the usable chamber volume during
│    EO or inert gas exposure, of ± 3 °C of the average recorded chamber
│    temperature at each time point should be obtained after an
│    equilibration period. When the OQ exercise is carried out using a
│    loaded chamber, then the ± 3 °C tolerance might not be achievable. 4)
│    chamber leak rate (performed either under vacuum for subatmospheric
│    cycles or under vacuum and at pressure for superatmospheric cycles);
│    5) pressure rise on injection of steam during the condit
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 228 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    cated in the same facility or in different facilities. The criteria
│    to be met prior to the establishment of a process equivalence program
│    are: a) full validation of the sterilization process in at least one
│    existing system according to the requirements of Clause 9; b)
│    performance of the IQ and OQ studies demonstrating and documenting
│    that all equipment has been installed in accordance with engineering
│    specification requirements and operates in accordance with those
│    requirements; c) definition of the process to include the tolerances
│    allowed and documentation of all phases of the process
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 229 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    shall be performed on the introduction of new or modified products,
│    packaging, load configuration, equipment or process parameters,
│    unless equivalence to a previously validated product, packaging, load
│    configuration, equipment or process has been documented. (See 7.1.2,
│    7.1.6 and 12.5.) 9.4.1.3 PQ shall use product, or material
│    representative of that to be sterilized routinely, to demonstrate
│    that the equipment consistently operates in accordance with
│    acceptance criteria and that the process produces product that meets
│    the intended SAL. 9.4.1.4 The manner of presenting product for
│    sterili
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 230 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ermal map of the room or chamber that captures potential hot or cold
│    locations. Therefore, monitoring should include more than one plane
│    and locations near doors. For PQ, one temperature sensor is required
│    per cubic metre of product volume. The minimum number of temperature
│    sensors is three. For PQ, humidity sensors should be placed within
│    the packaging (where possible) within the load. This can be achieved
│    by placing the sensor within the sterile barrier system or amongst
│    the unit packages. The result of the calculation should be rounded to
│    the next higher number. Table C.1 provides guidan
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 231 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    or product that captures potential variability in the humidity
│    levels. The minimum number of sensors is two. The result of the
│    calculation should be rounded to the next higher number. ﻿ © ISO 2014
│    – All rights reserved 29 BS EN ISO 11135:2014+A1:2019 --- PAGE 52
│    --- ﻿ ISO 11135:2014+A1:2018 For PQ, humidity sensors should be
│    placed within the packaging (where possible) within the load. This
│    can be achieved by placing the sensor within the sterile barrier
│    system or amongst the unit packages. Table C.2 provides guidance for
│    determining the number of humidity sensors. Table C.2 — Minimum recom
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 232 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    perature should be maintained above the process environmental
│    dewpoint temperature during the preconditioning and conditioning
│    phases of the sterilization process. The actual temperature and
│    humidity ranges within the sterilization load at the end of
│    preconditioning should be demonstrated during PQ. Where applicable, a
│    maximum time between removal of the load from preconditioning and the
│    start of the sterilization cycle needs to be established. A transfer
│    time of 60 min or less is common practice. a) When product enters the
│    sterilization chamber without preconditioning, consideration should
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 233 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    large industrial sterilizer, this would refer to the positioning of
│    cases in a pallet or tote. For smaller sterilizers, as used by health
│    care facilities, this refers to the positioning of baskets, packs and
│    rigid containers on a sterilization carriage or carrier. The product
│    and load used during PQ should be at least as difficult to sterilize
│    as the most challenging load expected during normal production. The
│    load can consist of product or materials that have characteristics
│    similar to those of a load to be sterilized routinely. Changes in the
│    load configuration can affect the lethality of
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 234 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    stics similar to those of a load to be sterilized routinely. Changes
│    in the load configuration can affect the lethality of a sterilization
│    process. It is important that the acceptable load configurations be
│    specified. If multiple load configurations are allowed, the load
│    configuration used in the PQ studies should represent the most
│    difficult-to-sterilize configuration, or should have a known
│    relationship to the most difficult-to-sterilize configuration. Some
│    variations in the load size might be justified as having no
│    significant impact. During PQ, two types of load can be chosen: a)
│    salea
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 235 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    allowed, the load configuration used in the PQ studies should
│    represent the most difficult-to-sterilize configuration, or should
│    have a known relationship to the most difficult-to-sterilize
│    configuration. Some variations in the load size might be justified as
│    having no significant impact. During PQ, two types of load can be
│    chosen: a) saleable product; b) non saleable product or appropriate
│    test material. D.9.4.1.5 When the load is composed of products, such
│    as surgical kits, lumens of varying size and length, various
│    packaging, and varying physical mass that contain a number of
│    different
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 236 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ation load after exposure to the specified preconditioning time (if
│    used). c) During the product transfer from preconditioning (if used)
│    to the sterilization chamber, conditions of product temperature and
│    humidity might be impacted. It is important to ensure that this
│    effect is considered during PQ and is commonly addressed during PQ by
│    ensuring that the time of transfer specified in the PQ reflects the
│    maximum time specification to be used for product transfer during
│    routine sterilization. d) Temperature and humidity sensors should be
│    located within the sterile barrier system or amongst
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 237 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    cified preconditioning time (if used). c) During the product transfer
│    from preconditioning (if used) to the sterilization chamber,
│    conditions of product temperature and humidity might be impacted. It
│    is important to ensure that this effect is considered during PQ and
│    is commonly addressed during PQ by ensuring that the time of transfer
│    specified in the PQ reflects the maximum time specification to be
│    used for product transfer during routine sterilization. d)
│    Temperature and humidity sensors should be located within the sterile
│    barrier system or amongst the unit packages in the sterilizati
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 238 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ct transfer from preconditioning (if used) to the sterilization
│    chamber, conditions of product temperature and humidity might be
│    impacted. It is important to ensure that this effect is considered
│    during PQ and is commonly addressed during PQ by ensuring that the
│    time of transfer specified in the PQ reflects the maximum time
│    specification to be used for product transfer during routine
│    sterilization. d) Temperature and humidity sensors should be located
│    within the sterile barrier system or amongst the unit packages in the
│    sterilization load. When preconditioning is used, the product should
│    b
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 239 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    eeded for the sterilization load to attain the minimum predetermined
│    temperature and humidity. For product, consideration should be given
│    to locating humidity sensors in areas of the load that are most
│    likely to experience variation in humidity, e.g. pallet centers,
│    pallet edges and surfaces. For PQ, humidity sensors should be placed
│    within the packaging (where possible) within the load. This can be
│    achieved by placing the sensor within the sterile barrier system or
│    amongst the unit packages. e) No guidance offered. f) If parametric
│    release is used, the EO concentration profile for the ent
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 240 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    port, it might be necessary to store the product prior to
│    preconditioning, or extend preconditioning time to allow the internal
│    temperature and humidity to be within acceptable ranges. NOTE The
│    minimum temperature of products entering preconditioning or the
│    storage conditions are defined during PQ. b) The reference position
│    for routine monitoring of temperature and relative humidity during
│    preconditioning should be correlated to the location at which it is
│    most difficult to achieve the desired conditions. Monitoring data for
│    the operation of the preconditioning area should be reviewed in
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 241 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    +A1:2019 --- PAGE 79 --- ﻿ ISO 11135:2014+A1:2018 o) No guidance
│    offered. D.10.3 Observations of growth from biological indicators not
│    attributable to failure to meet physical process specifications
│    should be analysed; this can lead to a need for process or equipment
│    modifications, and for the PQ to be repeated. D.10.4 The following
│    guidance is provided for health care facility applications: External
│    chemical indicators in health care facilities: Sterilizer indicator
│    tape, an indicating label or an indicating printed legend should be
│    affixed to or printed on each package assembled by the
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 242 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    nt to understand that this measurement provides an EO concentration
│    at that position in the chamber throughout the entire exposure phase
│    without any restrictions of reactivity effects or load impact. The
│    reproducibility and accuracy of the results from direct analysis
│    should be determined during PQ. Routine cycle analysis should fall
│    within the determined range for the cycle to be acceptable. It can be
│    necessary to introduce an equilibration time at the start of the EO
│    dwell phase of the cycle to allow the chamber concentration to
│    stabilize as the EO gas is distributed throughout the chamb
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 243 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    hed by comparing the data obtained when running the same validated
│    process in each piece of equipment. This comparison should include an
│    evaluation of the equipment’s capability to reproducibly deliver the
│    desired process parameters when running a normal production load.
│    Data obtained during the PQ on the process can also be used. The
│    delivered parameters and tolerances should be those that were
│    previously validated in the PQ of the sterilization process in the
│    original equipment. The evaluation of equivalence involves performing
│    a process analysis and evaluation as well as a microbiologic
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 244 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ude an evaluation of the equipment’s capability to reproducibly
│    deliver the desired process parameters when running a normal
│    production load. Data obtained during the PQ on the process can also
│    be used. The delivered parameters and tolerances should be those that
│    were previously validated in the PQ of the sterilization process in
│    the original equipment. The evaluation of equivalence involves
│    performing a process analysis and evaluation as well as a
│    microbiological evaluation. D.12.5.4 Process analysis and evaluation
│    An analysis of process data associated with a validated process in
│    the can
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 245 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    product (often called the “master product”); the entire family is
│    considered an equivalent challenge to the sterilization process, or
│    it is represented by a product PCD (internal PCD). In addition to
│    product families, processing categories can also be used in EO
│    sterilization routinely once the PQ has been completed. A processing
│    category is a collection of EO product families that can be
│    dissimilar in the details used to establish the product family, such
│    as material of construction or packaging, or manufacturers, but each
│    of the EO product families within a processing category should be
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 246 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: PQ
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ), temperature sensors, and humidity sensors throughout the
│    sterilization load, including locations where sterilizing conditions
│    are most difficult to achieve. It is recommended to use the number of
│    internal PCDs, temperature sensors, and humidity sensors as detailed
│    in Table C.1, Table C.2, for PQ and Table C.3 for MPQ. E.2.12 Process
│    the same load by exposing it to the defined sterilization process
│    where the specified exposure time is at least double that of the half
│    cycle in E.2.7 (i.e. a full sterilization cycle) in the same
│    sterilization chamber. E.2.13 Remove internal PCDs and test
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 247 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: performance qualification
│  Relevance Score: 2.5/5.0
│
│  Context:
│    
│    ..............................................................................................18
│    9.4.1
│    General...................................................................................................................................................................................18
│    9.4.2 Performance qualification —
│    Microbiological.....................................................................................18
│    9.4.3 Performance qualification —
│    Physical.......................................................................................................19
│    9.5 Review and approval of validation.......
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 248 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.0/5.0
│
│  Context:
│    E: ISO/TS 11139:2006, definition 2.51] 3.54 test for sterility
│    technical operation defined in a Pharmacopoeia performed on product
│    following exposure to a sterilization process [SOURCE: ISO/TS
│    11139:2006, definition 2.53] 3.55 test of sterility technical
│    operation performed as part of development, validation, or
│    requalification to determine the presence or absence of viable
│    microorganisms on product or portions thereof [SOURCE: ISO/TS
│    11139:2006, definition 2.54] 3.56 usable chamber volume defined space
│    within the sterilizer chamber, which is not restricted by fixed or
│    mobile parts and which is avail
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 249 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.0/5.0
│
│  Context:
│    lthough they can be performed by any qualified personnel. MPQ data
│    might be available from the sterilizer manufacturer for general
│    loads. For health care facilities, this means describing and
│    documenting the following: a) the validation steps that need to be
│    performed; b) the way in which these validation steps will be
│    performed, along with a listing of responsible individuals,
│    departments and/or outside contractors; c) the criteria for
│    successful validation. For health care facilities, there is an option
│    of contracting with an outside service to perform this validation;
│    however, the health care
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 250 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: validation
│  Relevance Score: 2.0/5.0
│
│  Context:
│    b) the way in which these validation steps will be performed, along
│    with a listing of responsible individuals, departments and/or outside
│    contractors; c) the criteria for successful validation. For health
│    care facilities, there is an option of contracting with an outside
│    service to perform this validation; however, the health care facility
│    is still responsible for ensuring that the validation complies with
│    the requirements of this International Standard. D.9.1.2 No guidance
│    offered. D.9.1.3 No guidance offered. D.9.1.4 No guidance offered.
│    D.9.2 Installation qualification D.9.2.1 Equipment D.9.
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 251 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ................................................................16
│    9.1
│    General........................................................................................................................................................................................................16
│    9.2 Installation qualification,
│    IQ.....................................................................................................................................................17
│    9.2.1
│    Equipment................................................................................................................................
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 252 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 2.0/5.0
│
│  Context:
│    
│    ........................................................................................17
│    9.2.1
│    Equipment..........................................................................................................................................................................17
│    9.2.2 Installation
│    qualification........................................................................................................................................17
│    9.3 Operational qualification,
│    OQ...............................................................................................................................
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 253 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: qualification
│  Relevance Score: 2.0/5.0
│
│  Context:
│    re facility, free-standing surgical centre, clinic, medical office,
│    or dental office. 3.19 health care product medical device(s),
│    including in vitro diagnostic medical device(s), or medicinal
│    product(s), including biopharmaceutical(s) [SOURCE: ISO/TS
│    11139:2006, definition 2.20] 3.20 installation qualification IQ
│    process of obtaining and documenting evidence that equipment has been
│    provided and installed in accordance with its specification [SOURCE:
│    ISO/TS 11139:2006, definition 2.22] 3.21 medical device any
│    instrument, apparatus, implement, machine, appliance, implant, in
│    vitro reagent or calibrator,
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 254 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 2.0/5.0
│
│  Context:
│    .................................................16 9.1
│    General........................................................................................................................................................................................................16
│    9.2 Installation qualification,
│    IQ.....................................................................................................................................................17
│    9.2.1
│    Equipment....................................................................................................................................
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 255 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ree-standing surgical centre, clinic, medical office, or dental
│    office. 3.19 health care product medical device(s), including in
│    vitro diagnostic medical device(s), or medicinal product(s),
│    including biopharmaceutical(s) [SOURCE: ISO/TS 11139:2006, definition
│    2.20] 3.20 installation qualification IQ process of obtaining and
│    documenting evidence that equipment has been provided and installed
│    in accordance with its specification [SOURCE: ISO/TS 11139:2006,
│    definition 2.22] 3.21 medical device any instrument, apparatus,
│    implement, machine, appliance, implant, in vitro reagent or
│    calibrator, sof
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 256 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: IQ
│  Relevance Score: 2.0/5.0
│
│  Context:
│    temperature and humidity (if humidity additions are controlled by
│    sensor readings); — means of controlling time, chamber pressure,
│    temperature and humidity, if humidity additions are controlled by
│    sensor readings (when sensors are fixed on the equipment, ensure that
│    a correlation is made during IQ or OQ to the pressure rise); — if
│    humidity is not controlled by sensor readings, means to monitor and
│    control steam additions; — if parametric release is used, analytical
│    instrumentation for the direct analysis of humidity during
│    conditioning and EO concentration during EO exposure time (also se
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 257 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: OQ
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ature and humidity (if humidity additions are controlled by sensor
│    readings); — means of controlling time, chamber pressure, temperature
│    and humidity, if humidity additions are controlled by sensor readings
│    (when sensors are fixed on the equipment, ensure that a correlation
│    is made during IQ or OQ to the pressure rise); — if humidity is not
│    controlled by sensor readings, means to monitor and control steam
│    additions; — if parametric release is used, analytical
│    instrumentation for the direct analysis of humidity during
│    conditioning and EO concentration during EO exposure time (also see
│    9.5.
│
└───────────────────────────────────────────────────────────────────────────────


CATEGORY: BIOLOGICAL

┌─ PARAMETER 01 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: SLR
│  Relevance Score: 4.0/5.0
│
│  Context:
│    and documenting evidence that installed equipment operates within
│    predetermined limits when used in accordance with its operational
│    procedures [SOURCE: ISO/TS 11139:2006, definition 2.27] 3.24 overkill
│    approach approach using sterilization process that delivers a minimum
│    of 12 Spore Log Reduction (SLR) to a biological indicator having a
│    resistance equal to or greater than the product bioburden 3.25
│    parametric release declaration that product is sterile, based on
│    records demonstrating that the process parameters were delivered
│    within specified tolerances [SOURCE: ISO/TS 11139:2006, definition 2
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 02 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: spore log reduction
│  Relevance Score: 4.0/5.0
│
│  Context:
│    process of obtaining and documenting evidence that installed
│    equipment operates within predetermined limits when used in
│    accordance with its operational procedures [SOURCE: ISO/TS
│    11139:2006, definition 2.27] 3.24 overkill approach approach using
│    sterilization process that delivers a minimum of 12 Spore Log
│    Reduction (SLR) to a biological indicator having a resistance equal
│    to or greater than the product bioburden 3.25 parametric release
│    declaration that product is sterile, based on records demonstrating
│    that the process parameters were delivered within specified
│    tolerances [SOURCE: ISO/TS 11139:2006, definit
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 03 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: biological indicator
│  Relevance Score: 4.0/5.0
│
│  Context:
│    ting evidence that installed equipment operates within predetermined
│    limits when used in accordance with its operational procedures
│    [SOURCE: ISO/TS 11139:2006, definition 2.27] 3.24 overkill approach
│    approach using sterilization process that delivers a minimum of 12
│    Spore Log Reduction (SLR) to a biological indicator having a
│    resistance equal to or greater than the product bioburden 3.25
│    parametric release declaration that product is sterile, based on
│    records demonstrating that the process parameters were delivered
│    within specified tolerances [SOURCE: ISO/TS 11139:2006, definition
│    2.29] Note 1 to entry: This m
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 04 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: D-value
│  Relevance Score: 3.5/5.0
│
│  Context:
│    of the biological indicator (see D.8.6). The resistance of the
│    internal PCD is demonstrated by running the sterilization cycle at
│    graded exposure times, or by exposing graded BI populations to a
│    single sterilization exposure time, and then determining the lethal
│    rate (rate of inactivation through D-value calculations) when exposed
│    to the sterilization cycle. Knowledge of the BI lethality rate and
│    the population and relative resistance of the bioburden allows one to
│    establish exposure time so that an SAL can be predicted. Attention
│    shall be given to the impact of packaging and the removal of EO fr
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 05 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: D-value
│  Relevance Score: 3.5/5.0
│
│  Context:
│    cordance with ISO 11737‑1 and 11737-2. Enumeration: enumeration
│    consists of exposing internal PCDs to the fractional cycle, removing
│    the challenge and performing survivor counts on the samples or
│    biological indicators. The survivor count can be used in developing a
│    survivor curve and D value. The D-value is then calculated using a
│    linear regression model. See ISO 14161:2009. Fraction-negative:
│    fraction-negative analysis involves running sterilization cycles in
│    which some, but not all, of the biological indicators are
│    inactivated. This includes: a) Holcomb-Spearman-Karber (HSK)
│    procedure; b) Lim
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 06 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: SLR
│  Relevance Score: 3.5/5.0
│
│  Context:
│    r, drainage. [SOURCE: ISO/TS 11139:2006, definition 2.41] 3.40 single
│    use medical device medical device designated or intended by the
│    manufacturer for one-time use only 3.41 specify stipulate in detail
│    within an approved document [SOURCE: ISO/TS 11139:2006, definition
│    2.42] 3.42 Spore-log-reduction SLR log of initial spore population,
│    N0, minus the log of the final population, Nu [SOURCE: ISO
│    14161:2009, definition 3.19] Note 1 to entry: Describing the
│    reduction in the number of spores on a biological indicator or
│    inoculated item produced by exposure to specified conditions. For
│    Direct Enumera
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 07 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: SLR
│  Relevance Score: 3.5/5.0
│
│  Context:
│    initial spore population, N0, minus the log of the final population,
│    Nu [SOURCE: ISO 14161:2009, definition 3.19] Note 1 to entry:
│    Describing the reduction in the number of spores on a biological
│    indicator or inoculated item produced by exposure to specified
│    conditions. For Direct Enumeration: SLR = log N0 − log Nu where N0 is
│    the initial population; Nu is the final population. For Fraction
│    Negative: SLR = log N0 – log [ln (q/n)] where N0 is the initial
│    population; q is the number of replicate samples tested; n is the
│    number of samples negative for growth. If there are no surviv
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 08 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: SLR
│  Relevance Score: 3.5/5.0
│
│  Context:
│    Note 1 to entry: Describing the reduction in the number of spores on
│    a biological indicator or inoculated item produced by exposure to
│    specified conditions. For Direct Enumeration: SLR = log N0 − log Nu
│    where N0 is the initial population; Nu is the final population. For
│    Fraction Negative: SLR = log N0 – log [ln (q/n)] where N0 is the
│    initial population; q is the number of replicate samples tested; n is
│    the number of samples negative for growth. If there are no survivors,
│    the true SLR cannot be calculated. The SLR can be reported as
│    “greater than” log N0 if one surviving organism
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 09 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: SLR
│  Relevance Score: 3.5/5.0
│
│  Context:
│    strate the adequacy of the recovery technique for BIs exposed to EO
│    gas. NOTE This short cycle can also be used to demonstrate the
│    relative resistance of Biological Indicator, PCD and product
│    bioburden. b) Cycle calculation approach: The routine processing
│    parameters that deliver minimally a 12 SLR of the biological
│    indicator shall be established using one of the methods described in
│    A.1.3. The number of cycles is dictated by the method used. B.1.3 The
│    conditions used for recovery of biological indicators in
│    qualification studies shall be established and documented. The
│    incubation period
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 10 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: SLR
│  Relevance Score: 3.5/5.0
│
│  Context:
│    d with the resistance and population of the product bioburden. The
│    log reduction of the internal PCD can be used to calculate the
│    sterility assurance level achieved for the product bioburden with the
│    most resistance to the sterilization process. If this is the case,
│    then the Spore Log Reduction (SLR) data developed in a lethality
│    study for the BI can be used to demonstrate the effectiveness of the
│    process for the product. If the data are generated using an
│    enumeration method, then the SLR can also be predicted from the
│    survivor curve data that are generated. The user should be aware that
│    th
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 11 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: SLR
│  Relevance Score: 3.5/5.0
│
│  Context:
│    th the most resistance to the sterilization process. If this is the
│    case, then the Spore Log Reduction (SLR) data developed in a
│    lethality study for the BI can be used to demonstrate the
│    effectiveness of the process for the product. If the data are
│    generated using an enumeration method, then the SLR can also be
│    predicted from the survivor curve data that are generated. The user
│    should be aware that the minimum cycle time derived from this
│    approach is not, by itself, adequate to validate the sterilization
│    process. Demonstration of the ability to maintain process parameters
│    within defined lim
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 12 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: SLR
│  Relevance Score: 3.5/5.0
│
│  Context:
│    e facilities commonly use this method which is to demonstrate total
│    inactivation of the 106 challenge BIs at a half-cycle exposure time.
│    When this exposure time is doubled, a minimum 12 SLR is delivered
│    during EO exposure. This approach will lead to a process delivering
│    considerably more than 12 SLR. Cycle Calculation: This method
│    consists of exposing internal PCDs to the experimental cycle,
│    removing the challenge and testing for survivors. This testing can be
│    conducted by using a fraction-negative technique or by performing
│    viable microbial counts on the samples or challenge indicators. Thi
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 13 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: spore log reduction
│  Relevance Score: 3.5/5.0
│
│  Context:
│    PCD should be compared with the resistance and population of the
│    product bioburden. The log reduction of the internal PCD can be used
│    to calculate the sterility assurance level achieved for the product
│    bioburden with the most resistance to the sterilization process. If
│    this is the case, then the Spore Log Reduction (SLR) data developed
│    in a lethality study for the BI can be used to demonstrate the
│    effectiveness of the process for the product. If the data are
│    generated using an enumeration method, then the SLR can also be
│    predicted from the survivor curve data that are generated. The user
│    should be aware th
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 14 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: biological indicator
│  Relevance Score: 3.5/5.0
│
│  Context:
│    tail within an approved document [SOURCE: ISO/TS 11139:2006,
│    definition 2.42] 3.42 Spore-log-reduction SLR log of initial spore
│    population, N0, minus the log of the final population, Nu [SOURCE:
│    ISO 14161:2009, definition 3.19] Note 1 to entry: Describing the
│    reduction in the number of spores on a biological indicator or
│    inoculated item produced by exposure to specified conditions. For
│    Direct Enumeration: SLR = log N0 − log Nu where N0 is the initial
│    population; Nu is the final population. For Fraction Negative: SLR =
│    log N0 – log [ln (q/n)] where N0 is the initial population; q is the
│    number of re
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 15 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: biological indicator
│  Relevance Score: 3.5/5.0
│
│  Context:
│    the sterilization process parameters (sterilization cycle exposure
│    time). Use of the method requires that product bioburden levels shall
│    be demonstrated to be relatively consistent over time and the
│    resistance of the bioburden be shown to be equal to, or less
│    resistant than the resistance of the biological indicator (see
│    D.8.6). The resistance of the internal PCD is demonstrated by running
│    the sterilization cycle at graded exposure times, or by exposing
│    graded BI populations to a single sterilization exposure time, and
│    then determining the lethal rate (rate of inactivation through
│    D-value calculations) when
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 16 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: biological indicator
│  Relevance Score: 3.5/5.0
│
│  Context:
│    be at least double this minimum time. A fractional cycle of short
│    duration from which BI survivors can be recovered shall also be run
│    to demonstrate the adequacy of the recovery technique for BIs exposed
│    to EO gas. NOTE This short cycle can also be used to demonstrate the
│    relative resistance of Biological Indicator, PCD and product
│    bioburden. b) Cycle calculation approach: The routine processing
│    parameters that deliver minimally a 12 SLR of the biological
│    indicator shall be established using one of the methods described in
│    A.1.3. The number of cycles is dictated by the method used. B.1.3 The
│    conditions u
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 17 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: biological indicator
│  Relevance Score: 3.5/5.0
│
│  Context:
│    adequacy of the recovery technique for BIs exposed to EO gas. NOTE
│    This short cycle can also be used to demonstrate the relative
│    resistance of Biological Indicator, PCD and product bioburden. b)
│    Cycle calculation approach: The routine processing parameters that
│    deliver minimally a 12 SLR of the biological indicator shall be
│    established using one of the methods described in A.1.3. The number
│    of cycles is dictated by the method used. B.1.3 The conditions used
│    for recovery of biological indicators in qualification studies shall
│    be established and documented. The incubation period shall take into
│    account the p
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 18 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 3.5/5.0
│
│  Context:
│    uct bioburden. The log reduction of the internal PCD can be used to
│    calculate the sterility assurance level achieved for the product
│    bioburden with the most resistance to the sterilization process. If
│    this is the case, then the Spore Log Reduction (SLR) data developed
│    in a lethality study for the BI can be used to demonstrate the
│    effectiveness of the process for the product. If the data are
│    generated using an enumeration method, then the SLR can also be
│    predicted from the survivor curve data that are generated. The user
│    should be aware that the minimum cycle time derived from this
│    approach
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 19 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: D-value
│  Relevance Score: 3.0/5.0
│
│  Context:
│    se microorganisms generally die at a rate that is approximately
│    logarithmic for a given process, a time unit of exposure to EO gas
│    can be found to result in the destruction of 90 % of the
│    microorganism’s population regardless of the population size. Each of
│    these time units is referred to as the D-value for the product
│    microbiological contaminant, when exposed to the specified
│    sterilization process. The D-value of a specified microorganism and
│    the microbiological lethality delivered to the product when exposed
│    to a specified sterilization process can be calculated using the
│    results from one of t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 20 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: D-value
│  Relevance Score: 3.0/5.0
│
│  Context:
│    f exposure to EO gas can be found to result in the destruction of 90
│    % of the microorganism’s population regardless of the population
│    size. Each of these time units is referred to as the D-value for the
│    product microbiological contaminant, when exposed to the specified
│    sterilization process. The D-value of a specified microorganism and
│    the microbiological lethality delivered to the product when exposed
│    to a specified sterilization process can be calculated using the
│    results from one of two commonly used methods. The first method
│    (enumeration) consists of an enumeration or physical count of the
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 21 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: D-value
│  Relevance Score: 3.0/5.0
│
│  Context:
│    al destruction data. In: Selected Papers on the Microbiology and
│    Engineering of Sterilization Processes, (Pflug I.J. ed.).
│    Environmental Sterilization Laboratory, Minneapolis, Fifth Edition,
│    1988, pp. 83–100. [33] Mosley G.A. Estimating the effects of EtO
│    BIER-Vessel Operating Precision on D-value Calculations, Medical
│    Device & Diagnostic Industry, April 2002 [34] Mosley G.A., & Gillis
│    J.R. Factors Affecting Tailing in Ethylene Oxide Sterilization. Part
│    1: When Tailing is an Artifact and Scientific Deficiencies in ISO
│    11135 and EN 550. PDA J. Pharm. Sci. Technol. 2004, 58 (2) pp. 81
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 22 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: SLR
│  Relevance Score: 3.0/5.0
│
│  Context:
│    Due to its relative ease of use and the conservative SAL obtained,
│    medical device manufacturers and health care facilities commonly use
│    this method which is to demonstrate total inactivation of the 106
│    challenge BIs at a half-cycle exposure time. When this exposure time
│    is doubled, a minimum 12 SLR is delivered during EO exposure. This
│    approach will lead to a process delivering considerably more than 12
│    SLR. Cycle Calculation: This method consists of exposing internal
│    PCDs to the experimental cycle, removing the challenge and testing
│    for survivors. This testing can be conducted by using a f
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 23 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: spore log reduction
│  Relevance Score: 3.0/5.0
│
│  Context:
│    OTE For EO gas mixtures with carbon dioxide, nitrogen or other inert
│    gas blends, EO molecular diffusion rates into polymer materials can
│    be affected by the volume percent of EO gas molecules within the
│    sterilant, which can result in longer EO exposure times to achieve
│    the desired microbiological spore log reduction. The storage
│    conditions and shelf life for EO should be in accordance with the EO
│    manufacturer’s recommendations and all applicable regulations. This
│    is particularly important with premixed gas mixtures where
│    stratification might be an issue. D.5.3 Microbicidal effectiveness No
│    guidance offered.
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 24 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: biological indicator
│  Relevance Score: 3.0/5.0
│
│  Context:
│    y: This can be performed within the sterilizer and/or in a separate
│    chamber or room. 3.2 aeration area either a chamber or a room in
│    which aeration occurs 3.3 bioburden population of viable
│    microorganisms on or in product and/or sterile barrier system
│    [SOURCE: ISO/TS 11139:2006, definition 2.2] 3.4 biological indicator
│    test system containing viable microorganisms providing a defined
│    resistance to a specified sterilization process [SOURCE: ISO/TS
│    11139:2006, definition 2.3] 3.5 calibration set of operations that
│    establish, under specified conditions, the relationship between
│    values of a quantity indicated by a m
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 25 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: biological indicator
│  Relevance Score: 3.0/5.0
│
│  Context:
│    rmance of the sterilization process used for a particular
│    sterilization load shall be documented. The criteria shall include:
│    a) confirmation that the data recorded during routine processing meet
│    the sterilization process specification; b) confirmation of no growth
│    of the test organism from any biological indicator (if used). NOTE
│    Formal release of the load from sterilization could require results
│    from other tests (e.g. EO residuals, endotoxin, physical testing,
│    etc.) before product can enter the distribution chain. 11.2 If a
│    process does not fulfil all of the conformance criteria above, the
│    cause shall be
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 26 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: biological indicator
│  Relevance Score: 3.0/5.0
│
│  Context:
│    cisions reached, shall be documented. The requirements of 7.2 still
│    need to be addressed for the product. ﻿ © ISO 2014 – All rights
│    reserved 25 BS EN ISO 11135:2014+A1:2019 --- PAGE 48 --- ﻿ ISO
│    11135:2014+A1:2018 Annex A (normative) Determination of lethal rate
│    of the sterilization process — Biological indicator/bioburden
│    approach A.1 General A.1.1 This approach combines knowledge of the
│    resistance of a biological indicator to a given sterilization process
│    with knowledge of the bioburden population and resistance to
│    establish the sterilization process parameters (sterilization cycle
│    exposure time). Use
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 27 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: biological indicator
│  Relevance Score: 3.0/5.0
│
│  Context:
│    014 – All rights reserved 25 BS EN ISO 11135:2014+A1:2019 --- PAGE
│    48 --- ﻿ ISO 11135:2014+A1:2018 Annex A (normative) Determination of
│    lethal rate of the sterilization process — Biological
│    indicator/bioburden approach A.1 General A.1.1 This approach combines
│    knowledge of the resistance of a biological indicator to a given
│    sterilization process with knowledge of the bioburden population and
│    resistance to establish the sterilization process parameters
│    (sterilization cycle exposure time). Use of the method requires that
│    product bioburden levels shall be demonstrated to be relatively
│    consistent over time a
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 28 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: biological indicator
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ry of biological indicators in qualification studies, including
│    duration of incubation, shall be established and documented. The
│    incubation period shall take into account the possibility of delayed
│    outgrowth of spores that have been exposed to EO. Refer to ISO 14161
│    for additional information on biological indicator incubation times.
│    A.1.3 After time-graded exposures to EO or population-graded BIs
│    exposed to EO, with all other parameters remaining the same, the
│    lethality of the process can be determined by using one of the
│    following methods: a) direct enumeration; b) the fraction-negative
│    method; or c) a
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 29 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: biological indicator
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ted by the method used. B.1.3 The conditions used for recovery of
│    biological indicators in qualification studies shall be established
│    and documented. The incubation period shall take into account the
│    possibility of delayed outgrowth of spores that have been exposed to
│    EO. Further guidance on the biological indicator incubation times can
│    be found in ISO 14161. B.1.4 The resistance of the product bioburden
│    shall be shown to be such that, total inactivation time of the
│    product bioburden is less than the total inactivation time of the
│    product BI (internal PCD). B.2 Procedure B.2.1 Create a challenge to
│    the st
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 30 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: biological indicator
│  Relevance Score: 3.0/5.0
│
│  Context:
│    f the load is to be re-used during PQ, the loads should be aerated
│    and re-equilibrated to ambient conditions prior to starting the next
│    run. After repeated use, the suitability of the load should be
│    considered. Aeration between exposures will ensure that EO residues
│    in the load do not affect the biological indicator. If equilibration
│    time is insufficient, the load could be warmer than the normal
│    ambient conditions, or the load humidity could be much lower than the
│    normal ambient load conditions. Either of these situations produce
│    data that are not representative of normal production. Too high a
│    starting tem
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 31 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: biological indicator
│  Relevance Score: 3.0/5.0
│
│  Context:
│    configuration, especially for a mixed product load. See ISO 11138‑1
│    and ISO 14161 to ensure that the requirement for the minimum number
│    of samples is met. ISO 14161:2009, Annex A, provides additional
│    guidance on the application of the relationship between the BI and
│    the product bioburden in the biological indicator/bioburden approach.
│    It is important that the internal PCD provides an equal or greater
│    challenge than that of the bioburden located in the most inaccessible
│    portion of the product. See D.7.1.6 for information on the
│    development of PCDs and D.8.6 for information on determining the
│    appropriateness
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 32 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: biological indicator
│  Relevance Score: 3.0/5.0
│
│  Context:
│    Cochran procedure (SMCP), and the survival-curve method (EN). Biomed.
│    Instrum. Technol. 1995, 29 (2) pp. 113–124 [42] Stumbo C.R., Murphy
│    J.R., Cochran J. Nature of Thermal Death Time Curves for P.A. 3679
│    and Clostridium Botulinum. Food Technol. 1950, 4 pp. 321–326 [43] USP
│    Monograph on Biological Indicator for Ethylene Oxide Sterilization,
│    Paper Carrier, USP36– NF31 (2013), page 2659 ﻿ © ISO 2014 – All
│    rights reserved 79 BS EN ISO 11135:2014+A1:2019 --- PAGE 102 ---
│    This page deliberately left blank BSI is the national body
│    responsible for preparing British Standards and other
│    standards-related pu
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 33 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 3.0/5.0
│
│  Context:
│    monstrated by running the sterilization cycle at graded exposure
│    times, or by exposing graded BI populations to a single sterilization
│    exposure time, and then determining the lethal rate (rate of
│    inactivation through D-value calculations) when exposed to the
│    sterilization cycle. Knowledge of the BI lethality rate and the
│    population and relative resistance of the bioburden allows one to
│    establish exposure time so that an SAL can be predicted. Attention
│    shall be given to the impact of packaging and the removal of EO from
│    the PCD. Guidance on this approach can be found in ISO 14161. A.1.2
│    The
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 34 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 3.0/5.0
│
│  Context:
│    h a population of not less than 106 and, where appropriate, placed
│    within a PCD) shall be performed in order to confirm the minimum
│    exposure time. The specified exposure time for the sterilization
│    process shall be at least double this minimum time. A fractional
│    cycle of short duration from which BI survivors can be recovered
│    shall also be run to demonstrate the adequacy of the recovery
│    technique for BIs exposed to EO gas. NOTE This short cycle can also
│    be used to demonstrate the relative resistance of Biological
│    Indicator, PCD and product bioburden. b) Cycle calculation approach:
│    The rout
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 35 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 3.0/5.0
│
│  Context:
│    have been exposed to EO. Further guidance on the biological indicator
│    incubation times can be found in ISO 14161. B.1.4 The resistance of
│    the product bioburden shall be shown to be such that, total
│    inactivation time of the product bioburden is less than the total
│    inactivation time of the product BI (internal PCD). B.2 Procedure
│    B.2.1 Create a challenge to the sterilization process, PCD,
│    comprising a known number of microorganisms with known resistance to
│    EO, by placing biological indicators in the product or inoculating
│    product at locations where sterilizing conditions are most difficult
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 36 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 3.0/5.0
│
│  Context:
│    00 40 40 EXAMPLE 1 During OQ for a usable chamber volume of 6 m3:
│    6/2,5 = 2,4. The number of sensors to use is at least three. EXAMPLE
│    2 During PQ for a product volume of 60 m3: 60/2,5 = 24. The number of
│    sensors to use is at least 24. C.3 Biological Indicators The minimum
│    recommended number of BI/PCDs to use is as follows: a) For MPQ with a
│    product load volume of up to 10 m3, use three BIs per m3 of product
│    volume, with a minimum of five BIs. b) For MPQ with a product load
│    volume above 10 m3, use one additional BI per additional m3 beyond
│    10m3. If BIs are used for routine control use h
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 37 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 3.0/5.0
│
│  Context:
│    at least 24. C.3 Biological Indicators The minimum recommended number
│    of BI/PCDs to use is as follows: a) For MPQ with a product load
│    volume of up to 10 m3, use three BIs per m3 of product volume, with a
│    minimum of five BIs. b) For MPQ with a product load volume above 10
│    m3, use one additional BI per additional m3 beyond 10m3. If BIs are
│    used for routine control use half the number of BIs used during MPQ
│    up to a maximum of 30. The result of the calculation should be
│    rounded to the next higher number. Table C.3 provides guidance for
│    determining the number of BI/PCDs. The actual number of BI
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 38 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ric release is based upon a documented review of processing records
│    rather than the testing of biological indicators or PCDs. The values
│    and tolerances for both RH and EO concentration might need to be
│    generated after review of a predefined number of routine cycles.
│    During this evaluation period, BI’s might be used as part of the
│    routine monitoring and control of loads processed. The rationale for
│    the number of runs selected should be justified and recorded. This
│    can be influenced by uniformity of the load, existing data, seasonal
│    variations or frequency of sterilization. EO sterilizers use
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 39 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ts and densities of items; d) load configuration, especially for a
│    mixed product load. See ISO 11138‑1 and ISO 14161 to ensure that the
│    requirement for the minimum number of samples is met. ISO 14161:2009,
│    Annex A, provides additional guidance on the application of the
│    relationship between the BI and the product bioburden in the
│    biological indicator/bioburden approach. It is important that the
│    internal PCD provides an equal or greater challenge than that of the
│    bioburden located in the most inaccessible portion of the product.
│    See D.7.1.6 for information on the development of PCDs and D.8
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 40 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ] and C.3. The sample set exposed at zero time should be exposed to
│    all stages of the experimental cycle prior to sterilant injection.
│    D.14.1.3 [B.1.3] Information on the incubation period for biological
│    indicators is provided in ISO 14161:2009, 12.3. D.14.1.4 [B.1.4] The
│    appropriateness of the BI relative to the bioburden inactivation time
│    can be demonstrated by a test of sterility, either before or during
│    process definition using a fractional-cycle of the appropriate
│    exposure time. D.14.2 [B.2] Procedure D.14.2.1 [B.2.1] Internal PCDs
│    placed within the product sterile barrier system can
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 41 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: microbial
│  Relevance Score: 3.0/5.0
│
│  Context:
│    hamber volume occupied by product 3.35 recognized culture collection
│    depository authority under the Budapest Treaty on The International
│    Recognition of the Deposit of Microorganisms for the Purposes of
│    Patent and Regulation [SOURCE: ISO/TS 11139:2006, definition 2.38]
│    3.36 reference microorganism microbial strain obtained from a
│    recognized culture collection [SOURCE: ISO/TS 11139:2006, definition
│    2.39] 3.37 requalification repetition of part of validation for the
│    purpose of confirming the continued acceptability of a specified
│    process [SOURCE: ISO/TS 11139:2006, definition 2.40] 3.38 reusable
│    medica
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 42 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: microbial
│  Relevance Score: 3.0/5.0
│
│  Context:
│    y, an SAL of 10-6 has a lower value but provides a greater assurance
│    of sterility than an SAL of 10-3. [SOURCE: ISO/TS 11139:2006,
│    definition 2.46] 3.47 sterilization validated process used to render
│    product free from viable microorganisms Note 1 to entry: In a
│    sterilization process, the nature of microbial inactivation is
│    exponential and thus the survival of a microorganism on an individual
│    item can be expressed in terms of probability. While this probability
│    can be reduced to a very low number, it can never be reduced to zero.
│    Note 2 to entry: See 3.46, sterility assurance level. [SOURCE: ISO/TS
│    1
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 43 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: microbial
│  Relevance Score: 3.0/5.0
│
│  Context:
│    use the EO outside of the range of compositions that are widely
│    recognized or if a novel diluent is to be used. NOTE The inactivation
│    of microorganisms by EO has been comprehensively documented in
│    literature. This literature provides knowledge of the manner in which
│    the process variables affect microbial inactivation. Reference to
│    these general studies on microbial inactivation is not required by
│    this International Standard. 5.4 Material effects The effects of EO
│    on a wide variety of materials used to manufacture medical devices
│    have been comprehensively documented and such documentation is of v
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 44 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: microbial
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ly recognized or if a novel diluent is to be used. NOTE The
│    inactivation of microorganisms by EO has been comprehensively
│    documented in literature. This literature provides knowledge of the
│    manner in which the process variables affect microbial inactivation.
│    Reference to these general studies on microbial inactivation is not
│    required by this International Standard. 5.4 Material effects The
│    effects of EO on a wide variety of materials used to manufacture
│    medical devices have been comprehensively documented and such
│    documentation is of value to those designing and developing medical
│    devices that ar
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 45 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: microbial
│  Relevance Score: 3.0/5.0
│
│  Context:
│    terization. Preconditioning can be performed in a separate
│    preconditioning area (chamber, cell or room). Humidification by steam
│    is necessary because humidifiers that operate by dispersion of
│    unheated water as an aerosol (e.g. spinning disc humidifiers and
│    nebulizers) can be a potential source of microbial contamination. The
│    preconditioning area (if used) should have the following performance
│    and monitoring capabilities: — adequate air circulation to ensure the
│    uniformity of temperature and humidity in the usable space, and to
│    ensure that uniformity is maintained in a loaded room or chamber; —
│    ai
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 46 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: microbial
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ers, see Table C.3. D.9.4.2.3 No guidance offered D.9.4.2.4 If a
│    developmental chamber was used for process definition, consideration
│    should be given to establishing the relationship between data from
│    the developmental chamber studies and data from the production
│    chamber. The development of the microbial inactivation curves is not
│    always possible in production chambers because of the size of the
│    chamber and the time required to inject and remove EO in the chamber.
│    These long injection and vacuum times limit the ability to obtain the
│    required fractional recovery of indicator organisms. These inac
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 47 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: microbial
│  Relevance Score: 3.0/5.0
│
│  Context:
│    For example, a collection of products (intravenous sets) might
│    constitute a product family and might be placed in a processing
│    category that includes a separate collection of products (e.g. a
│    family of syringes). The commonality within the processing category
│    might be the PCD that represents the microbial challenge for those
│    products in that group. All products within this processing category
│    should present an equivalent or lesser challenge to the sterilization
│    process when compared with the worst-case product, representative
│    member, or internal PCD which is placed within the product sterile
│    barr
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 48 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: microbial
│  Relevance Score: 3.0/5.0
│
│  Context:
│    of the EO sterilization process. The resistance of the PCD to EO
│    should be shown to be equal to or greater than the resistance of the
│    bioburden of product to be sterilized at the most difficult to
│    sterilize location on the product. D.14.2.3 [B.2.3] No guidance
│    offered D.14.2.4 [B.2.4] Obtaining microbial enumeration data or
│    fractional kill data requires exposing the microbial challenge to
│    less lethality than is present in the normal production cycle. This
│    is usually accomplished by reducing the exposure time while holding
│    all other parameters either constant at ﻿ 72 © ISO 2014 – All rights
│    rese
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 49 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: microbial
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ostic Industry. 1983, 5 (6) pp. 46–49 [31] Global Harmonization
│    Taskforce (GHTF) Study Group 1 (SG1), Document No. N29R16:2005
│    Information Document Concerning the Definition of the Term “Medical
│    Device” [32] Holcomb R.G., & Pflug I.J. The Spearman-Karber method of
│    analyzing quantal assay microbial destruction data. In: Selected
│    Papers on the Microbiology and Engineering of Sterilization
│    Processes, (Pflug I.J. ed.). Environmental Sterilization Laboratory,
│    Minneapolis, Fifth Edition, 1988, pp. 83–100. [33] Mosley G.A.
│    Estimating the effects of EtO BIER-Vessel Operating Precision on D-
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 50 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 2.5/5.0
│
│  Context:
│    nal PCDs during the half cycle are acceptable if they have
│    demonstrated greater resistance than the internal PCDs providing a
│    “worst-case challenge” for routine processing. However, all internal
│    PCDs should test negative. 9.4.2.6 If the overkill cycle calculation
│    approach [see B.1.2 b)] or the BI/bioburden approach (see Annex A) is
│    used, there may be some surviving internal PCDs, but the calculated
│    SAL shall meet the specified value (See ISO 14161). 9.4.3 Performance
│    qualification — Physical 9.4.3.1 Physical PQ (PPQ) shall demonstrate
│    a) that the specified acceptance criteria are met t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 51 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ecessary qualification shall be performed before this process can be
│    used again. 11.3 Product shall be considered as non-conforming and
│    handled in accordance with the applicable clauses of ISO 13485 if one
│    or more of the conformance criteria of 11.1 are not fulfilled. In the
│    event of a positive BI, it is not acceptable to release product based
│    on acceptable results of a product test for sterility. The
│    non-conformity shall be addressed per documented procedures. 11.4 If
│    saleable product is used in validation studies the requirements for
│    release of this product for distribution shall be gen
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 52 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 2.5/5.0
│
│  Context:
│    y consistent over time and the resistance of the bioburden be shown
│    to be equal to, or less resistant than the resistance of the
│    biological indicator (see D.8.6). The resistance of the internal PCD
│    is demonstrated by running the sterilization cycle at graded exposure
│    times, or by exposing graded BI populations to a single sterilization
│    exposure time, and then determining the lethal rate (rate of
│    inactivation through D-value calculations) when exposed to the
│    sterilization cycle. Knowledge of the BI lethality rate and the
│    population and relative resistance of the bioburden allows one to
│    esta
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 53 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ve 10 m3, use one additional BI per additional m3 beyond 10m3. If BIs
│    are used for routine control use half the number of BIs used during
│    MPQ up to a maximum of 30. The result of the calculation should be
│    rounded to the next higher number. Table C.3 provides guidance for
│    determining the number of BI/PCDs. The actual number of BI/PCDs to be
│    used will depend on: a) microbiological qualification method chosen
│    (see Annex A or Annex B); b) product volume; c) type of chamber
│    (developmental vs. production). When using the Stumbo-Murphy-Cochran
│    procedure and the Overkill Cycle Calculation approach
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 54 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 2.5/5.0
│
│  Context:
│    BI per additional m3 beyond 10m3. If BIs are used for routine control
│    use half the number of BIs used during MPQ up to a maximum of 30. The
│    result of the calculation should be rounded to the next higher
│    number. Table C.3 provides guidance for determining the number of
│    BI/PCDs. The actual number of BI/PCDs to be used will depend on: a)
│    microbiological qualification method chosen (see Annex A or Annex B);
│    b) product volume; c) type of chamber (developmental vs. production).
│    When using the Stumbo-Murphy-Cochran procedure and the Overkill Cycle
│    Calculation approach the recommended number of BI/
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 55 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 2.5/5.0
│
│  Context:
│    BI/PCDs to be used will depend on: a) microbiological qualification
│    method chosen (see Annex A or Annex B); b) product volume; c) type of
│    chamber (developmental vs. production). When using the
│    Stumbo-Murphy-Cochran procedure and the Overkill Cycle Calculation
│    approach the recommended number of BI/PCDs can be based on the
│    product volume to be sterilized. When this approach is being used a
│    minimum quantity of 10 BI/PCD’s are indicated, see Reference [38]. ﻿
│    30 © ISO 2014 – All rights reserved BS EN ISO 11135:2014+A1:2019 ---
│    PAGE 53 --- ﻿ ISO 11135:2014+A1:2018 Table C.3 — Examples of mini
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 56 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 2.5/5.0
│
│  Context:
│    t volume; c) type of chamber (developmental vs. production). When
│    using the Stumbo-Murphy-Cochran procedure and the Overkill Cycle
│    Calculation approach the recommended number of BI/PCDs can be based
│    on the product volume to be sterilized. When this approach is being
│    used a minimum quantity of 10 BI/PCD’s are indicated, see Reference
│    [38]. ﻿ 30 © ISO 2014 – All rights reserved BS EN ISO
│    11135:2014+A1:2019 --- PAGE 53 --- ﻿ ISO 11135:2014+A1:2018 Table C.3
│    — Examples of minimum recommended number of BI/PCDs Product load
│    volume m3 MPQ Routine control (if used) ≤ 1 5 3 10 30 15 15 35 18 20
│    40 2
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 57 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 2.5/5.0
│
│  Context:
│    product volume to be sterilized. When this approach is being used a
│    minimum quantity of 10 BI/PCD’s are indicated, see Reference [38]. ﻿
│    30 © ISO 2014 – All rights reserved BS EN ISO 11135:2014+A1:2019 ---
│    PAGE 53 --- ﻿ ISO 11135:2014+A1:2018 Table C.3 — Examples of minimum
│    recommended number of BI/PCDs Product load volume m3 MPQ Routine
│    control (if used) ≤ 1 5 3 10 30 15 15 35 18 20 40 20 25 45 23 30 50
│    25 35 55 28 40 60 30 50 70 30 100 120 30 EXAMPLE 1 For product load
│    volume of 3 m3: 3 × 3 = 9. The number of BIs to use is at least nine
│    for MPQ. For routine control: 9/2 = 4,5. The number
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 58 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 2.5/5.0
│
│  Context:
│    is to use a test of sterility of the product and PCD, following a
│    fractional cycle. The results of this study should provide a means of
│    lethality comparison using survival data from the tests of sterility
│    for the product and PCD. Typically in this approach, product tests of
│    sterility samples and BI/PCD are exposed to fractional cycle(s) with
│    the intent of achieving negative growth for all product tests of
│    sterility and survivors of the test microorganism from the BI/PCD.
│    Approach 3 This approach can be applied in cases where a) the product
│    bioburden challenge is equal to or greater than
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 59 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 2.5/5.0
│
│  Context:
│    data from the tests of sterility for the product and PCD. Typically
│    in this approach, product tests of sterility samples and BI/PCD are
│    exposed to fractional cycle(s) with the intent of achieving negative
│    growth for all product tests of sterility and survivors of the test
│    microorganism from the BI/PCD. Approach 3 This approach can be
│    applied in cases where a) the product bioburden challenge is equal to
│    or greater than the challenge of the BI within the PCD, b) the
│    product bioburden contains highly resistant microorganisms, or c)
│    where a BI with a lower population than required by ISO 11
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 60 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ractional cycle(s) with the intent of achieving negative growth for
│    all product tests of sterility and survivors of the test
│    microorganism from the BI/PCD. Approach 3 This approach can be
│    applied in cases where a) the product bioburden challenge is equal to
│    or greater than the challenge of the BI within the PCD, b) the
│    product bioburden contains highly resistant microorganisms, or c)
│    where a BI with a lower population than required by ISO 11138‑2:2006,
│    9.3 is used in the PCD. In this third approach, the lethality
│    challenge of the bioburden and the PCD can be based on direct
│    enumeration m
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 61 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 2.5/5.0
│
│  Context:
│    d survivors of the test microorganism from the BI/PCD. Approach 3
│    This approach can be applied in cases where a) the product bioburden
│    challenge is equal to or greater than the challenge of the BI within
│    the PCD, b) the product bioburden contains highly resistant
│    microorganisms, or c) where a BI with a lower population than
│    required by ISO 11138‑2:2006, 9.3 is used in the PCD. In this third
│    approach, the lethality challenge of the bioburden and the PCD can be
│    based on direct enumeration methods and/or fraction-negative methods.
│    (See ISO 14161). If there is an indication that the challenge
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 62 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ficient bioburden data are available from the bioburden monitoring
│    program to demonstrate that the product bioburden resistance along
│    with the population can be appropriately represented during the
│    validation studies to deliver a 10−6 SAL to the product. NOTE This
│    method can involve the use of a BI or other internal PCD with a
│    population of less than 106. The relative resistance and population
│    of the internal PCD should be compared with the resistance and
│    population of the product bioburden. The log reduction of the
│    internal PCD can be used to calculate the sterility assurance level
│    achieve
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 63 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 2.5/5.0
│
│  Context:
│    obial counts on the samples or challenge indicators. This information
│    can be used to calculate the cycle necessary to deliver the defined
│    SAL for the product. See ISO 14161:2009. When using the
│    Stumbo-Murphy-Cochran procedure and the Overkill Cycle Calculation
│    approach, the recommended number of BI/PCDs can be based on the
│    product volume to be sterilized with a minimum of 10, see Reference
│    [38] and C.3. The sample set exposed at zero time should be exposed
│    to all stages of the experimental cycle prior to sterilant injection.
│    D.14.1.3 [B.1.3] Information on the incubation period for biologi
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 64 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: microbial
│  Relevance Score: 2.5/5.0
│
│  Context:
│    lead to a process delivering considerably more than 12 SLR. Cycle
│    Calculation: This method consists of exposing internal PCDs to the
│    experimental cycle, removing the challenge and testing for survivors.
│    This testing can be conducted by using a fraction-negative technique
│    or by performing viable microbial counts on the samples or challenge
│    indicators. This information can be used to calculate the cycle
│    necessary to deliver the defined SAL for the product. See ISO
│    14161:2009. When using the Stumbo-Murphy-Cochran procedure and the
│    Overkill Cycle Calculation approach, the recommended number of BI/PC
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 65 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: biological indicator
│  Relevance Score: 2.0/5.0
│
│  Context:
│    determination of lethal rate of the sterilization process — Overkill
│    approach................................................................................................................................................................27
│    Annex C (informative) Temperature sensors, RH sensors and biological
│    indicator numbers..............29 Annex D (informative) Guidance on
│    the application of the normative
│    requirements....................................32 Annex E
│    (normative) Single batch
│    release....................................................................................................................
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 66 [MED ] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: biological indicator
│  Relevance Score: 2.0/5.0
│
│  Context:
│    l PCDs. If the lethality challenge of the external PCD is less than
│    the lethality challenge of the internal PCD (not more than 20 %,
│    United States Pharmocopeia Biological indicators for Ethylene Oxide
│    Sterilization), the PCDs may be considered equivalent since this is
│    the confidence level of the biological indicator used within the PCD.
│    NOTE It is not uncommon to find an external PCD in a less
│    difficult-to-sterilize configuration presenting a greater lethality
│    challenge than an internal PCD in a more difficult-to-sterilize
│    configuration. It is theorized that this occurs because the EO is
│    removed more rapidl
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 67 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: biological indicator
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ernal PCD for the sterilization process; c) establish that the
│    candidate product is equivalent to the currently validated master
│    product; or d) establish a new sterilization process for the
│    candidate product. D.13 Guidance on Annex A — Determination of lethal
│    rate of the sterilization process — Biological indicator/bioburden
│    approach D.13.1 [A.1] General D.13.1.1 [A.1.1] This clause provides
│    further guidance to information in Annex A and D.8 through D.9. Since
│    the biological indicator/bioburden approach and the overkill approach
│    use many of the same procedures, some of the text in this clause
│    duplicates te
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 68 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: biological indicator
│  Relevance Score: 2.0/5.0
│
│  Context:
│    process for the candidate product. D.13 Guidance on Annex A —
│    Determination of lethal rate of the sterilization process —
│    Biological indicator/bioburden approach D.13.1 [A.1] General D.13.1.1
│    [A.1.1] This clause provides further guidance to information in Annex
│    A and D.8 through D.9. Since the biological indicator/bioburden
│    approach and the overkill approach use many of the same procedures,
│    some of the text in this clause duplicates text in D.14. The combined
│    biological indicator/bioburden approach is based on the use of a
│    resistant BI or other internal PCD with a population that is equal to
│    or greater tha
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 69 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: biological indicator
│  Relevance Score: 2.0/5.0
│
│  Context:
│    1 [A.1] General D.13.1.1 [A.1.1] This clause provides further
│    guidance to information in Annex A and D.8 through D.9. Since the
│    biological indicator/bioburden approach and the overkill approach use
│    many of the same procedures, some of the text in this clause
│    duplicates text in D.14. The combined biological indicator/bioburden
│    approach is based on the use of a resistant BI or other internal PCD
│    with a population that is equal to or greater than that of the
│    bioburden. This method is appropriate when sufficient bioburden data
│    are available from the bioburden monitoring program to demonstrate
│    that the product b
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 70 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: biological indicator
│  Relevance Score: 2.0/5.0
│
│  Context:
│    C. D.14 Guidance on Annex B — Conservative determination of lethal
│    rate of the sterilization process — Overkill approach D.14.1 [B.1]
│    General D.14.1.1 [B.1.1] This clause provides further guidance to
│    information in Annex B, and supplementary guidance to information in
│    Clauses 8 and 9. Since the biological indicator (BI)/bioburden
│    approach and the overkill approach use many of the same procedures,
│    some of the text in this annex duplicates text in D.13. However, when
│    using the cycle calculation approach, see also D.13.1.1. For further
│    information regarding the use of the overkill approach see ISO
│    14161:2009,
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 71 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 2.0/5.0
│
│  Context:
│    information in Annex A and D.8 through D.9. Since the biological
│    indicator/bioburden approach and the overkill approach use many of
│    the same procedures, some of the text in this clause duplicates text
│    in D.14. The combined biological indicator/bioburden approach is
│    based on the use of a resistant BI or other internal PCD with a
│    population that is equal to or greater than that of the bioburden.
│    This method is appropriate when sufficient bioburden data are
│    available from the bioburden monitoring program to demonstrate that
│    the product bioburden resistance along with the population can be
│    appr
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 72 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: BI
│  Relevance Score: 2.0/5.0
│
│  Context:
│    nnex B — Conservative determination of lethal rate of the
│    sterilization process — Overkill approach D.14.1 [B.1] General
│    D.14.1.1 [B.1.1] This clause provides further guidance to information
│    in Annex B, and supplementary guidance to information in Clauses 8
│    and 9. Since the biological indicator (BI)/bioburden approach and the
│    overkill approach use many of the same procedures, some of the text
│    in this annex duplicates text in D.13. However, when using the cycle
│    calculation approach, see also D.13.1.1. For further information
│    regarding the use of the overkill approach see ISO 14161:2009, 7.2
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 73 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: microbial
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ontrol of a sterilization process for medical devices using ethylene
│    oxide, including requirements that the medical device is safe and
│    performs as intended after treatment. It could also be applied to the
│    development, validation and routine control of a process for
│    attainment of a specific microbial state other than sterility. This
│    BS EN ISO 11135:2014+A1:2019 --- PAGE 13 --- EN ISO
│    11135:2014+A1:2019 (E) General Safety and Performance Requirement is
│    addressed only with regard to devices for which treatment by ethylene
│    oxide is appropriate. This relevant General Safety and Performance
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 74 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: microbial
│  Relevance Score: 2.0/5.0
│
│  Context:
│    Safety and Performance Requirement is addressed only with regard to
│    devices for which treatment by ethylene oxide is appropriate. This
│    relevant General Safety and Performance Requirement is only partly
│    addressed in this European Standard. Design and packaging for
│    maintenance of a specific microbial state during transportation and
│    storage are not covered. Aspects of manufacture other than those
│    related to attainment of a specific microbial state by ethylene oxide
│    are not covered. 11.4 first sentence only 4,5,6,7,8,9,10,11,12 This
│    standard provides requirements for the development, v
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 75 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: microbial
│  Relevance Score: 2.0/5.0
│
│  Context:
│    t General Safety and Performance Requirement is only partly addressed
│    in this European Standard. Design and packaging for maintenance of a
│    specific microbial state during transportation and storage are not
│    covered. Aspects of manufacture other than those related to
│    attainment of a specific microbial state by ethylene oxide are not
│    covered. 11.4 first sentence only 4,5,6,7,8,9,10,11,12 This standard
│    provides requirements for the development, validation and routine
│    control of a sterilization process using for medical devices using
│    ethylene oxide, including requirements that the steril
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 76 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: microbial
│  Relevance Score: 2.0/5.0
│
│  Context:
│    e Requirement is addressed only with regard to devices for which
│    treatment by ethylene oxide is appropriate. This relevant General
│    Safety and Performance Requirement is only partly addressed in this
│    European Standard. Design and packaging for maintenance of a
│    sterility or another specific microbial state during transportation
│    and storage are not covered. Aspects of manufacture other than those
│    related to attainment of sterility or another specific microbial
│    state by ethylene oxide are not covered. 11.3 4,5,6,7,8,9,10,11,12
│    This standard provides requirements for the development, va
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 77 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: microbial
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ment is only partly addressed in this European Standard. Design and
│    packaging for maintenance of a sterility or another specific
│    microbial state during transportation and storage are not covered.
│    Aspects of manufacture other than those related to attainment of
│    sterility or another specific microbial state by ethylene oxide are
│    not covered. 11.3 4,5,6,7,8,9,10,11,12 This standard provides
│    requirements for the development, validation and routine control of a
│    sterilization process for medical devices using ethylene oxide,
│    including requirements that the sterilized medical device is saf
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 78 [MED ] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: microbial
│  Relevance Score: 2.0/5.0
│
│  Context:
│    nd to achieve effective sterilization of medical devices. D.6.1
│    General No guidance offered. D.6.2 Process characterization D.6.2.1
│    No guidance offered. D.6.2.2 The resistance of microorganisms to
│    deactivation by EO is affected by their moisture content. At low
│    levels of humidity, below 30 %, microbial resistance may increase
│    with decreased humidity for some products. For this reason it is
│    common practice to control and monitor the humidity of the atmosphere
│    to which the product is exposed in order to attempt to equilibrate
│    the moisture content of the microorganisms with the local conditions.
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 79 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: microbial
│  Relevance Score: 2.0/5.0
│
│  Context:
│    moisture introduced into the chamber with the load from
│    preconditioning. f) No guidance offered. g) Forced gas circulation is
│    particularly important when gas mixtures are used in order to ensure
│    uniform conditions are maintained and to avoid stratification of
│    gases that might have an impact on microbial lethality. (See
│    D.6.3.2). h) No guidance offered. i) Pressure rise of EO injection
│    (∆P) provides an indirect measure of the mean EO gas concentration in
│    the available space within the sterilizer chamber. As EO
│    concentration is a key variable affecting the efficacy of the
│    sterilization process,
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 80 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: microbial
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ization location or manufacturing location that might have an impact
│    on the bioburden level of the product as presented for sterilization.
│    Increased distances between the manufacturing facility and
│    sterilization site might result in higher bioburden levels,
│    especially if the product will support microbial growth. Differences
│    in manufacturing environments might lead to the manufacture of
│    product with higher or more resistant bioburden levels than
│    previously qualified, even if the product does not support
│    microbiological growth. Another issue to be evaluated when shipping
│    product between sites is t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 81 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: microbial
│  Relevance Score: 2.0/5.0
│
│  Context:
│    e shown to be equal to or greater than the resistance of the
│    bioburden of product to be sterilized at the most difficult to
│    sterilize location on the product. D.14.2.3 [B.2.3] No guidance
│    offered D.14.2.4 [B.2.4] Obtaining microbial enumeration data or
│    fractional kill data requires exposing the microbial challenge to
│    less lethality than is present in the normal production cycle. This
│    is usually accomplished by reducing the exposure time while holding
│    all other parameters either constant at ﻿ 72 © ISO 2014 – All rights
│    reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 95 --- ﻿ ISO
│    11135:2014+A1:201
│
└───────────────────────────────────────────────────────────────────────────────


CATEGORY: MONITORING

┌─ PARAMETER 01 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 4.0/5.0
│
│  Context:
│    2014 – All rights reserved 49 BS EN ISO 11135:2014+A1:2019 --- PAGE
│    72 --- ﻿ ISO 11135:2014+A1:2018 d) process control logic or software
│    documentation necessary to support validation, including control
│    system layout, control logic diagrams and application software
│    (computerized measurement and control systems) such as program
│    listings, flow charts, ladder logic diagrams where applicable and
│    strategy diagrams. D.9.2.2.6 No guidance offered D.9.3 Operational
│    qualification D.9.3.1 The following information should be documented
│    for all instrumentation used for monitoring, controlling, indicating
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 02 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: measurement
│  Relevance Score: 4.0/5.0
│
│  Context:
│    on file; ﻿ © ISO 2014 – All rights reserved 49 BS EN ISO
│    11135:2014+A1:2019 --- PAGE 72 --- ﻿ ISO 11135:2014+A1:2018 d)
│    process control logic or software documentation necessary to support
│    validation, including control system layout, control logic diagrams
│    and application software (computerized measurement and control
│    systems) such as program listings, flow charts, ladder logic diagrams
│    where applicable and strategy diagrams. D.9.2.2.6 No guidance offered
│    D.9.3 Operational qualification D.9.3.1 The following information
│    should be documented for all instrumentation used for monitoring,
│    controllin
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 03 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.5/5.0
│
│  Context:
│    the person who assembled the pack allows for further investigation if
│    a problem should arise. Lot identification information enables
│    personnel to retrieve items sterilized in a specific cycle in the
│    event of a recall and to trace problems to their source. D.4.3.3
│    Requirements for calibration of monitoring and measuring
│    instrumentation are specified in ISO 13485:2003, 7.6. D.4.4
│    Measurement, analysis and improvement — Control of non-conforming
│    product Procedures for control of non-conforming product and
│    corrective action are specified in ISO 13485:2003, 8.3 and 8.5.2,
│    respectively. D.5 Sterilizin
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 04 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.5/5.0
│
│  Context:
│    omputerized measurement and control systems) such as program
│    listings, flow charts, ladder logic diagrams where applicable and
│    strategy diagrams. D.9.2.2.6 No guidance offered D.9.3 Operational
│    qualification D.9.3.1 The following information should be documented
│    for all instrumentation used for monitoring, controlling, indicating
│    or recording: a) equipment identification; b) calibration schedule;
│    c) actual completion date for each calibration, as well as who
│    performed it; d) the next scheduled calibration date. D.9.3.2 OQ for
│    EO equipment is carried out either with an empty sterilizer chamber
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 05 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.5/5.0
│
│  Context:
│    quency of sterilization. EO sterilizers used in health care
│    facilities might not be adequately equipped to permit parametric
│    release of product. D.9.5.6 No guidance offered. ﻿ © ISO 2014 – All
│    rights reserved 55 BS EN ISO 11135:2014+A1:2019 --- PAGE 78 --- ﻿
│    ISO 11135:2014+A1:2018 D.10 Routine monitoring and control D.10.1 No
│    guidance offered. D.10.2 Guidance on the bulleted items of 10.2
│    follows: a) The temperature of products entering the preconditioning
│    area should be at or above the minimum temperature specified or the
│    defined conditions of storage should be met. If the product has been
│    ex
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 06 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.5/5.0
│
│  Context:
│    ected fault in a temperature sensor does not lead to the inadvertent
│    release of an improperly processed load. If there is a difference in
│    the two temperature data points, the acceptable temperature
│    difference should be defined within the processing specification. If
│    either the controlling or the monitoring sensor do not meet
│    specification and an investigation cannot determine the accuracy of
│    the chamber readings, the load is rejected b) Humidity measurement.
│    Direct analysis of the head space for relative humidity can be
│    performed using electronic sensors, Gas Chromotography (GC), Infrared
│    (IR) or
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 07 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.5/5.0
│
│  Context:
│    enables personnel to retrieve items sterilized in a specific cycle in
│    the event of a recall and to trace problems to their source. D.4.3.3
│    Requirements for calibration of monitoring and measuring
│    instrumentation are specified in ISO 13485:2003, 7.6. D.4.4
│    Measurement, analysis and improvement — Control of non-conforming
│    product Procedures for control of non-conforming product and
│    corrective action are specified in ISO 13485:2003, 8.3 and 8.5.2,
│    respectively. D.5 Sterilizing agent characterization D.5.1 General No
│    guidance offered. ﻿ © ISO 2014 – All rights reserved 33 BS EN ISO
│    11135:2014+A1:
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 08 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.5/5.0
│
│  Context:
│    a specific cycle in the event of a recall and to trace problems to
│    their source. D.4.3.3 Requirements for calibration of monitoring and
│    measuring instrumentation are specified in ISO 13485:2003, 7.6. D.4.4
│    Measurement, analysis and improvement — Control of non-conforming
│    product Procedures for control of non-conforming product and
│    corrective action are specified in ISO 13485:2003, 8.3 and 8.5.2,
│    respectively. D.5 Sterilizing agent characterization D.5.1 General No
│    guidance offered. ﻿ © ISO 2014 – All rights reserved 33 BS EN ISO
│    11135:2014+A1:2019 --- PAGE 56 --- ﻿ ISO 11135:2014+A1:2018 D.
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 09 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.5/5.0
│
│  Context:
│    hose influencing process control, for which physical characteristics
│    and manufacturer performance claims (e.g. accuracy, repeatability,
│    size and model) should be kept on file; ﻿ © ISO 2014 – All rights
│    reserved 49 BS EN ISO 11135:2014+A1:2019 --- PAGE 72 --- ﻿ ISO
│    11135:2014+A1:2018 d) process control logic or software documentation
│    necessary to support validation, including control system layout,
│    control logic diagrams and application software (computerized
│    measurement and control systems) such as program listings, flow
│    charts, ladder logic diagrams where applicable and strategy diagrams.
│    D.
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 10 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.5/5.0
│
│  Context:
│    rer performance claims (e.g. accuracy, repeatability, size and model)
│    should be kept on file; ﻿ © ISO 2014 – All rights reserved 49 BS EN
│    ISO 11135:2014+A1:2019 --- PAGE 72 --- ﻿ ISO 11135:2014+A1:2018 d)
│    process control logic or software documentation necessary to support
│    validation, including control system layout, control logic diagrams
│    and application software (computerized measurement and control
│    systems) such as program listings, flow charts, ladder logic diagrams
│    where applicable and strategy diagrams. D.9.2.2.6 No guidance offered
│    D.9.3 Operational qualification D.9.3.1 The following
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 11 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.5/5.0
│
│  Context:
│    e.g. accuracy, repeatability, size and model) should be kept on file;
│    ﻿ © ISO 2014 – All rights reserved 49 BS EN ISO 11135:2014+A1:2019
│    --- PAGE 72 --- ﻿ ISO 11135:2014+A1:2018 d) process control logic or
│    software documentation necessary to support validation, including
│    control system layout, control logic diagrams and application
│    software (computerized measurement and control systems) such as
│    program listings, flow charts, ladder logic diagrams where applicable
│    and strategy diagrams. D.9.2.2.6 No guidance offered D.9.3
│    Operational qualification D.9.3.1 The following information should be
│    d
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 12 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.5/5.0
│
│  Context:
│    lization. EO sterilizers used in health care facilities might not be
│    adequately equipped to permit parametric release of product. D.9.5.6
│    No guidance offered. ﻿ © ISO 2014 – All rights reserved 55 BS EN ISO
│    11135:2014+A1:2019 --- PAGE 78 --- ﻿ ISO 11135:2014+A1:2018 D.10
│    Routine monitoring and control D.10.1 No guidance offered. D.10.2
│    Guidance on the bulleted items of 10.2 follows: a) The temperature of
│    products entering the preconditioning area should be at or above the
│    minimum temperature specified or the defined conditions of storage
│    should be met. If the product has been exposed to ext
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 13 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: parametric release
│  Relevance Score: 3.5/5.0
│
│  Context:
│    14+A1:2019 --- PAGE 45 --- ﻿ ISO 11135:2014+A1:2018 10.4 If chemical
│    indicators are used in routine monitoring, they shall comply with
│    8.8. Chemical indicators shall not replace biological indicators for
│    product release or be used to support a rationale to release a load
│    parametrically. 10.5 If parametric release is performed, the
│    following additional data shall be recorded and retained: a)
│    temperature in the chamber from a minimum of two locations throughout
│    the sterilization cycle; b) chamber humidity during conditioning as
│    determined by direct measurement; c) the EO concentration, determined
│    from dire
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 14 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: process control
│  Relevance Score: 3.5/5.0
│
│  Context:
│    ularly those influencing process control, for which physical
│    characteristics and manufacturer performance claims (e.g. accuracy,
│    repeatability, size and model) should be kept on file; ﻿ © ISO 2014 –
│    All rights reserved 49 BS EN ISO 11135:2014+A1:2019 --- PAGE 72 ---
│    ﻿ ISO 11135:2014+A1:2018 d) process control logic or software
│    documentation necessary to support validation, including control
│    system layout, control logic diagrams and application software
│    (computerized measurement and control systems) such as program
│    listings, flow charts, ladder logic diagrams where applicable and
│    strategy diagrams. D.
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 15 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: measurement
│  Relevance Score: 3.5/5.0
│
│  Context:
│    d arise. Lot identification information enables personnel to retrieve
│    items sterilized in a specific cycle in the event of a recall and to
│    trace problems to their source. D.4.3.3 Requirements for calibration
│    of monitoring and measuring instrumentation are specified in ISO
│    13485:2003, 7.6. D.4.4 Measurement, analysis and improvement —
│    Control of non-conforming product Procedures for control of
│    non-conforming product and corrective action are specified in ISO
│    13485:2003, 8.3 and 8.5.2, respectively. D.5 Sterilizing agent
│    characterization D.5.1 General No guidance offered. ﻿ © ISO 2014 –
│    All rights r
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 16 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: measurement
│  Relevance Score: 3.5/5.0
│
│  Context:
│    ure data points, the acceptable temperature difference should be
│    defined within the processing specification. If either the
│    controlling or the monitoring sensor do not meet specification and an
│    investigation cannot determine the accuracy of the chamber readings,
│    the load is rejected b) Humidity measurement. Direct analysis of the
│    head space for relative humidity can be performed using electronic
│    sensors, Gas Chromotography (GC), Infrared (IR) or other
│    spectroscopic methods currently available to ﻿ © ISO 2014 – All
│    rights reserved 57 BS EN ISO 11135:2014+A1:2019 --- PAGE 80 --- ﻿
│    ISO 11135:2014+A1
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 17 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    sed to control and/or monitor the process shall be prepared and
│    validated in accordance with the elements of a quality system that
│    provides documented evidence that the software meets its design
│    specification. NOTE For further information, attention is drawn to
│    ISO/IEC 90003. 6.3.4 The means of monitoring and controlling the
│    process variables shall be determined and specified. 6.3.5 Means
│    shall be provided to ensure that failure in a control function does
│    not lead to failure in recording of process variables such that an
│    ineffective process appears effective. NOTE This may be achieved
│    either by t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 18 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    e determined and specified. 6.3.5 Means shall be provided to ensure
│    that failure in a control function does not lead to failure in
│    recording of process variables such that an ineffective process
│    appears effective. NOTE This may be achieved either by the use of
│    independent systems for control and monitoring or by a cross-check
│    between control and monitoring which identifies any discrepancies or
│    indicates a fault. 7 Product definition 7.1 General 7.1.1 The purpose
│    of this activity is to define the product to be sterilized, including
│    the microbiological quality of the product prior to sterilization
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 19 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    rilization process shall a) comply with ISO 11138‑2:2006, Clause 5
│    and 9.5, b) be shown to be at least as resistant to EO as is the
│    bioburden of product to be sterilized, and c) be placed within an
│    appropriate PCD. The appropriateness of the PCD used for process
│    definition, validation or routine monitoring and control shall be
│    determined. The PCD shall present a challenge to the sterilization
│    process that is equivalent or greater than the challenge presented by
│    the natural bioburden at the most difficult to sterilize location
│    within the product. NOTE For information on the selection, use and
│    inte
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 20 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    2.2.6 Changes made to systems during the IQ shall be assessed for
│    their impact on the design and process specification and documented
│    in the design history file. 9.3 Operational qualification, OQ 9.3.1
│    Prior to OQ, the calibration of all instrumentation (including any
│    test instruments) used for monitoring, controlling, indicating or
│    recording of the sterilization process shall be confirmed (see
│    4.3.3). 9.3.2 OQ shall demonstrate that the installed equipment is
│    capable of meeting its operating specification. ﻿ © ISO 2014 – All
│    rights reserved 17 BS EN ISO 11135:2014+A1:2019 --- PAGE 40 --- ﻿
│    ISO
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 21 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    generated during the validation. This process specification shall
│    also include the criteria for designating EO processed product as
│    conforming product and approved for release. ﻿ © ISO 2014 – All
│    rights reserved 21 BS EN ISO 11135:2014+A1:2019 --- PAGE 44 --- ﻿
│    ISO 11135:2014+A1:2018 10 Routine monitoring and control 10.1 The
│    purpose of routine monitoring and control is to demonstrate that the
│    validated and specified sterilization process has been delivered to
│    the product. 10.2 Data shall be recorded and retained for each
│    sterilization cycle to demonstrate that the sterilization process
│    specific
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 22 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    fication shall also include the criteria for designating EO processed
│    product as conforming product and approved for release. ﻿ © ISO 2014
│    – All rights reserved 21 BS EN ISO 11135:2014+A1:2019 --- PAGE 44
│    --- ﻿ ISO 11135:2014+A1:2018 10 Routine monitoring and control 10.1
│    The purpose of routine monitoring and control is to demonstrate that
│    the validated and specified sterilization process has been delivered
│    to the product. 10.2 Data shall be recorded and retained for each
│    sterilization cycle to demonstrate that the sterilization process
│    specification has been met. These data shall include at leas
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 23 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    or routine release is different from that used in the MPQ, it should
│    be at least as resistant to the process as is the PCD used in the
│    MPQ. ﻿ 22 © ISO 2014 – All rights reserved BS EN ISO
│    11135:2014+A1:2019 --- PAGE 45 --- ﻿ ISO 11135:2014+A1:2018 10.4 If
│    chemical indicators are used in routine monitoring, they shall comply
│    with 8.8. Chemical indicators shall not replace biological indicators
│    for product release or be used to support a rationale to release a
│    load parametrically. 10.5 If parametric release is performed, the
│    following additional data shall be recorded and retained: a)
│    temperature i
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 24 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    guidance is available in ISO 14937:2009, E.4.2.2. D.4.3 Product
│    realization NOTE In ISO 13485, the requirements for product
│    realization relate to the product lifecycle from the determination of
│    customer requirements, design and development, purchasing, control of
│    production, and calibration of monitoring and measuring devices.
│    D.4.3.1 Requirements for purchasing are specified in ISO 13485:2003,
│    7.4. In particular, it should be noted that the requirements in ISO
│    13485:2003, 7.4 for verification of purchased product apply to
│    product and services, that impact on process quality, received from
│    outs
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 25 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    niformity is maintained in a loaded room or chamber; — airflow
│    detection equipment, alarm systems or indicators monitoring the
│    circulation system to ensure conformance to predetermined tolerances;
│    — means of recording time of load entry into and removal from the
│    preconditioning area; — means of monitoring cell/room temperature and
│    humidity; — means of controlling cell/room temperature and humidity.
│    b) Sterilizer characterization. The sterilization chamber should have
│    the following performance and monitoring capabilities: — means of
│    monitoring time, chamber pressure, temperature and humidity (if h
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 26 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    of recording time of load entry into and removal from the
│    preconditioning area; — means of monitoring cell/room temperature and
│    humidity; — means of controlling cell/room temperature and humidity.
│    b) Sterilizer characterization. The sterilization chamber should have
│    the following performance and monitoring capabilities: — means of
│    monitoring time, chamber pressure, temperature and humidity (if
│    humidity additions are controlled by sensor readings); — means of
│    controlling time, chamber pressure, temperature and humidity, if
│    humidity additions are controlled by sensor readings (when sensors
│    are fixe
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 27 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    and removal from the preconditioning area; — means of monitoring
│    cell/room temperature and humidity; — means of controlling cell/room
│    temperature and humidity. b) Sterilizer characterization. The
│    sterilization chamber should have the following performance and
│    monitoring capabilities: — means of monitoring time, chamber
│    pressure, temperature and humidity (if humidity additions are
│    controlled by sensor readings); — means of controlling time, chamber
│    pressure, temperature and humidity, if humidity additions are
│    controlled by sensor readings (when sensors are fixed on the
│    equipment, ensure that a cor
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 28 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ging. Temperature uniformity, fresh air make-up and air
│    re-circulation throughout the area are important to ensure consistent
│    and reproducible results. The aeration area should have the following
│    performance and monitoring capabilities: — airflow detection
│    equipment, alarm systems or indicators monitoring the air handling
│    system to ensure that it operates within predetermined tolerances and
│    maintains adequate airflow in a loaded room or chamber; — equipment
│    to re-circulate air; — means of monitoring room temperature; — means
│    of controlling room temperature. D.6.3.2 The equipment specification
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 29 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ormance and monitoring capabilities: — airflow detection equipment,
│    alarm systems or indicators monitoring the air handling system to
│    ensure that it operates within predetermined tolerances and maintains
│    adequate airflow in a loaded room or chamber; — equipment to
│    re-circulate air; — means of monitoring room temperature; — means of
│    controlling room temperature. D.6.3.2 The equipment specification
│    should be reviewed to ensure that regulatory and safety requirements
│    are met, technical specifications are appropriate, and services and
│    infrastructure necessary to operate the equipment are available
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 30 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    d to be a sterilant. The consistency of steam supply can be
│    determined by the periodic analysis of the boiler feed water or
│    condensate. e) A minimum of two probes to measure chamber temperature
│    should be used. Large volume chambers can be fitted with more than
│    two probes so as to ensure that the monitoring/control system
│    captures data that reflects the temperature throughout the chamber
│    during use. NOTE The purpose of two separate probes is to prevent the
│    failure of one sensor from causing an out-of- specification process
│    from being erroneously accepted. Comparing two separate temperature
│    sensors w
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 31 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    s should be secured and ventilated. h) Where ambient conditions are
│    subject to temperature variation greater than the range recommended
│    by the supplier, storage areas for the containers of EO should
│    include provision for temperature control. It might not be possible
│    to calibrate controlling and monitoring instruments under actual
│    processing conditions, e.g. humidity sensors. Calibration results for
│    these instruments should be correlated against qualification studies.
│    Processing conditions can have a detrimental effect on some types of
│    sensors, e.g. humidity sensors. Sensors might require replacem
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 32 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    +A1:2019 --- PAGE 61 --- ﻿ ISO 11135:2014+A1:2018 to implement a
│    program of more frequent maintenance for these sensors than that
│    recommended by the sensor manufacturer/supplier. D.6.3.3 No guidance
│    offered. D.6.3.4 No guidance offered. D.6.3.5 If there is an
│    undetected failure of a control or monitoring function, a
│    sterilization load could be released without having met its required
│    processing parameters. To prevent this from happening, it is general
│    practice to have redundant sensors for many critical process
│    parameters. The common options for utilizing these redundant sensors
│    include: a) use
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 33 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ed without having met its required processing parameters. To prevent
│    this from happening, it is general practice to have redundant sensors
│    for many critical process parameters. The common options for
│    utilizing these redundant sensors include: a) use one sensor for
│    control, and another sensor for monitoring and reporting; b) use two
│    sensors, or their average value, for both monitoring and control;
│    this system needs to generate an automatic fault condition if the
│    difference between the two sensors exceeds a defined value; c) use
│    dual element sensors for both monitoring and control; this system
│    need
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 34 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    sable medical devices, and for validation and control of the cleaning
│    processes for reusable medical devices in accordance with the medical
│    device manufacturer’s instructions. When using the bioburden approach
│    (see Annex A) bioburden testing should be performed at least
│    quarterly. The period of monitoring can be extended following a
│    documented risk analysis that considers the following: the use of
│    product families, historical data, statistical analysis,
│    manufacturing frequency and product design. D.7.4 Documentation Upon
│    completion of the product definition the following should be
│    documented: a)
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 35 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    iew of processing records rather than the testing of biological
│    indicators or PCDs. The values and tolerances for both RH and EO
│    concentration might need to be generated after review of a predefined
│    number of routine cycles. During this evaluation period, BI’s might
│    be used as part of the routine monitoring and control of loads
│    processed. The rationale for the number of runs selected should be
│    justified and recorded. This can be influenced by uniformity of the
│    load, existing data, seasonal variations or frequency of
│    sterilization. EO sterilizers used in health care facilities might
│    not be adequately
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 36 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    to EO due to irreversible deterioration of materials currently
│    utilized as sensing elements. c) EO gas concentration measurement.
│    The frequency of analysis required to demonstrate that the minimum EO
│    concentration is maintained throughout EO exposure should be
│    established during the PQ studies. Monitoring throughout the EO
│    exposure dwell period should also be done as part of the validation,
│    in order to determine how the EO concentration changes over time. The
│    results of this analysis are specific to the product and load
│    configuration being analysed. The analysis performed during the PQ
│    study wil
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 37 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    of indicator organism from BIs (if used) should lead to the
│    sterilization load being quarantined and the cause of the failure
│    being investigated. This investigation should be documented and the
│    subsequent handling of product should be in accordance with
│    documented procedures. If a controlling or monitoring sensor has
│    failed, the run should be rejected, unless a) there is an assignable
│    cause for the failure, and b) data from the remaining sensors are
│    within specification. If the decision is to reprocess the load, the
│    suitability of the product and its packaging system for re-
│    sterilization should be
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 38 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ilized. D.12.2.3 No guidance offered. D.12.2.4 It is necessary to
│    periodically review the maintenance records and to make any
│    adjustments that are indicated by the data. D.12.3 Requalification
│    D.12.3.1 Review of IQ should include confirmation of the acceptable
│    calibration status of control and monitoring equipment. The change
│    control and preventive maintenance programs indicate that no ﻿ 60 ©
│    ISO 2014 – All rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE
│    83 --- ﻿ ISO 11135:2014+A1:2018 modifications of, or significant
│    changes to, the sterilizing equipment have been made that could
│    affect
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 39 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    85. 4.3.3 A system complying with the applicable clause(s) of ISO
│    13485 or ISO 10012 shall be specified for the calibration of all
│    equipment, including instrumentation for test purposes, used in
│    meeting the requirements of this International Standard. 4.4
│    Measurement, analysis and improvement — Control of nonconforming
│    product Procedures for control of product designated as nonconforming
│    and for correction, corrective action and preventive action shall be
│    specified. These procedures shall comply with the applicable clauses
│    of ISO 13485. 5 Sterilizing agent characterization 5.1 General The
│    pur
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 40 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    e clause(s) of ISO 13485 or ISO 10012 shall be specified for the
│    calibration of all equipment, including instrumentation for test
│    purposes, used in meeting the requirements of this International
│    Standard. 4.4 Measurement, analysis and improvement — Control of
│    nonconforming product Procedures for control of product designated as
│    nonconforming and for correction, corrective action and preventive
│    action shall be specified. These procedures shall comply with the
│    applicable clauses of ISO 13485. 5 Sterilizing agent characterization
│    5.1 General The purpose of this activity is to define the sterilizi
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 41 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    eir locations; e) fault(s) recognized by the sterilizing equipment;
│    f) safety features, including those for personnel and environmental
│    protection; g) installation requirements, including specifications
│    for required services and requirements for the control of emissions.
│    6.3.3 Software used to control and/or monitor the process shall be
│    prepared and validated in accordance with the elements of a quality
│    system that provides documented evidence that the software meets its
│    design specification. NOTE For further information, attention is
│    drawn to ISO/IEC 90003. 6.3.4 The means of monitoring and
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 42 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    cumented evidence that the software meets its design specification.
│    NOTE For further information, attention is drawn to ISO/IEC 90003.
│    6.3.4 The means of monitoring and controlling the process variables
│    shall be determined and specified. 6.3.5 Means shall be provided to
│    ensure that failure in a control function does not lead to failure in
│    recording of process variables such that an ineffective process
│    appears effective. NOTE This may be achieved either by the use of
│    independent systems for control and monitoring or by a cross-check
│    between control and monitoring which identifies any discrepanc
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 43 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    bles shall be determined and specified. 6.3.5 Means shall be provided
│    to ensure that failure in a control function does not lead to failure
│    in recording of process variables such that an ineffective process
│    appears effective. NOTE This may be achieved either by the use of
│    independent systems for control and monitoring or by a cross-check
│    between control and monitoring which identifies any discrepancies or
│    indicates a fault. 7 Product definition 7.1 General 7.1.1 The purpose
│    of this activity is to define the product to be sterilized, including
│    the microbiological quality of the product prior to
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 44 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    shall be provided to ensure that failure in a control function does
│    not lead to failure in recording of process variables such that an
│    ineffective process appears effective. NOTE This may be achieved
│    either by the use of independent systems for control and monitoring
│    or by a cross-check between control and monitoring which identifies
│    any discrepancies or indicates a fault. 7 Product definition 7.1
│    General 7.1.1 The purpose of this activity is to define the product
│    to be sterilized, including the microbiological quality of the
│    product prior to sterilization and the manner in which product is pa
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 45 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ess shall a) comply with ISO 11138‑2:2006, Clause 5 and 9.5, b) be
│    shown to be at least as resistant to EO as is the bioburden of
│    product to be sterilized, and c) be placed within an appropriate PCD.
│    The appropriateness of the PCD used for process definition,
│    validation or routine monitoring and control shall be determined. The
│    PCD shall present a challenge to the sterilization process that is
│    equivalent or greater than the challenge presented by the natural
│    bioburden at the most difficult to sterilize location within the
│    product. NOTE For information on the selection, use and
│    interpretation o
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 46 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    g the validation. This process specification shall also include the
│    criteria for designating EO processed product as conforming product
│    and approved for release. ﻿ © ISO 2014 – All rights reserved 21 BS
│    EN ISO 11135:2014+A1:2019 --- PAGE 44 --- ﻿ ISO 11135:2014+A1:2018 10
│    Routine monitoring and control 10.1 The purpose of routine monitoring
│    and control is to demonstrate that the validated and specified
│    sterilization process has been delivered to the product. 10.2 Data
│    shall be recorded and retained for each sterilization cycle to
│    demonstrate that the sterilization process specification has be
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 47 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    also include the criteria for designating EO processed product as
│    conforming product and approved for release. ﻿ © ISO 2014 – All
│    rights reserved 21 BS EN ISO 11135:2014+A1:2019 --- PAGE 44 --- ﻿
│    ISO 11135:2014+A1:2018 10 Routine monitoring and control 10.1 The
│    purpose of routine monitoring and control is to demonstrate that the
│    validated and specified sterilization process has been delivered to
│    the product. 10.2 Data shall be recorded and retained for each
│    sterilization cycle to demonstrate that the sterilization process
│    specification has been met. These data shall include at least the
│    follow
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 48 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    release of the sterilized product Further guidance is available in
│    ISO 14937:2009, E.4.2.2. D.4.3 Product realization NOTE In ISO 13485,
│    the requirements for product realization relate to the product
│    lifecycle from the determination of customer requirements, design and
│    development, purchasing, control of production, and calibration of
│    monitoring and measuring devices. D.4.3.1 Requirements for purchasing
│    are specified in ISO 13485:2003, 7.4. In particular, it should be
│    noted that the requirements in ISO 13485:2003, 7.4 for verification
│    of purchased product apply to product and services, that
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 49 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    terilant. The consistency of steam supply can be determined by the
│    periodic analysis of the boiler feed water or condensate. e) A
│    minimum of two probes to measure chamber temperature should be used.
│    Large volume chambers can be fitted with more than two probes so as
│    to ensure that the monitoring/control system captures data that
│    reflects the temperature throughout the chamber during use. NOTE The
│    purpose of two separate probes is to prevent the failure of one
│    sensor from causing an out-of- specification process from being
│    erroneously accepted. Comparing two separate temperature sensors will
│    det
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 50 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    orage of cylinders, tanks or cartridges of EO or EO gas mixtures
│    should be secured and ventilated. h) Where ambient conditions are
│    subject to temperature variation greater than the range recommended
│    by the supplier, storage areas for the containers of EO should
│    include provision for temperature control. It might not be possible
│    to calibrate controlling and monitoring instruments under actual
│    processing conditions, e.g. humidity sensors. Calibration results for
│    these instruments should be correlated against qualification studies.
│    Processing conditions can have a detrimental effect on some types
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 51 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    11135:2014+A1:2019 --- PAGE 61 --- ﻿ ISO 11135:2014+A1:2018 to
│    implement a program of more frequent maintenance for these sensors
│    than that recommended by the sensor manufacturer/supplier. D.6.3.3 No
│    guidance offered. D.6.3.4 No guidance offered. D.6.3.5 If there is an
│    undetected failure of a control or monitoring function, a
│    sterilization load could be released without having met its required
│    processing parameters. To prevent this from happening, it is general
│    practice to have redundant sensors for many critical process
│    parameters. The common options for utilizing these redundant sensors
│    in
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 52 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    rilization load could be released without having met its required
│    processing parameters. To prevent this from happening, it is general
│    practice to have redundant sensors for many critical process
│    parameters. The common options for utilizing these redundant sensors
│    include: a) use one sensor for control, and another sensor for
│    monitoring and reporting; b) use two sensors, or their average value,
│    for both monitoring and control; this system needs to generate an
│    automatic fault condition if the difference between the two sensors
│    exceeds a defined value; c) use dual element sensors for both monit
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 53 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    on testing for bacterial endotoxins is provided in ANSI/AAMI/ST72 and
│    the applicable pharmacopeia. D.7.3.2 In health care facilities,
│    attention to microbiological quality will comprise having strict
│    procedures for collection and handling of used, reusable medical
│    devices, and for validation and control of the cleaning processes for
│    reusable medical devices in accordance with the medical device
│    manufacturer’s instructions. When using the bioburden approach (see
│    Annex A) bioburden testing should be performed at least quarterly.
│    The period of monitoring can be extended following a documented risk
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 54 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    the equipment should include: a) pipe work and instrumentation
│    schematic drawings (i.e. process and instrumentation diagrams); b) a
│    list of other pertinent mechanical and electrical drawings and their
│    location; c) a list of critical instruments and devices, particularly
│    those influencing process control, for which physical characteristics
│    and manufacturer performance claims (e.g. accuracy, repeatability,
│    size and model) should be kept on file; ﻿ © ISO 2014 – All rights
│    reserved 49 BS EN ISO 11135:2014+A1:2019 --- PAGE 72 --- ﻿ ISO
│    11135:2014+A1:2018 d) process control logic or software docume
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 55 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    rilization process that has been defined in process definition (see
│    Clause 8). OQ should also determine the performance of associated
│    ancillary systems. For example, the capability of the EO vaporizer to
│    achieve a minimum EO input temperature. The system software (e.g.
│    computerized measurement and control systems) should be tested in all
│    fault conditions during OQ. The user is responsible for assuring the
│    software is validated. OQ can include the following when using a
│    predefined cycle: a) Preconditioning Phase 1) The pattern of air
│    circulation throughout the area to be occupied by the sterilizat
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 56 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ng records rather than the testing of biological indicators or PCDs.
│    The values and tolerances for both RH and EO concentration might need
│    to be generated after review of a predefined number of routine
│    cycles. During this evaluation period, BI’s might be used as part of
│    the routine monitoring and control of loads processed. The rationale
│    for the number of runs selected should be justified and recorded.
│    This can be influenced by uniformity of the load, existing data,
│    seasonal variations or frequency of sterilization. EO sterilizers
│    used in health care facilities might not be adequately equipped to
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 57 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    equately sterilized. D.12.2.3 No guidance offered. D.12.2.4 It is
│    necessary to periodically review the maintenance records and to make
│    any adjustments that are indicated by the data. D.12.3
│    Requalification D.12.3.1 Review of IQ should include confirmation of
│    the acceptable calibration status of control and monitoring
│    equipment. The change control and preventive maintenance programs
│    indicate that no ﻿ 60 © ISO 2014 – All rights reserved BS EN ISO
│    11135:2014+A1:2019 --- PAGE 83 --- ﻿ ISO 11135:2014+A1:2018
│    modifications of, or significant changes to, the sterilizing
│    equipment have been made tha
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 58 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ered. D.12.2.4 It is necessary to periodically review the maintenance
│    records and to make any adjustments that are indicated by the data.
│    D.12.3 Requalification D.12.3.1 Review of IQ should include
│    confirmation of the acceptable calibration status of control and
│    monitoring equipment. The change control and preventive maintenance
│    programs indicate that no ﻿ 60 © ISO 2014 – All rights reserved BS
│    EN ISO 11135:2014+A1:2019 --- PAGE 83 --- ﻿ ISO 11135:2014+A1:2018
│    modifications of, or significant changes to, the sterilizing
│    equipment have been made that could affect the process. D.12.3.2
│    Review
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 59 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ftware [18] ISO/TS 11139:2006, Sterilization of health care products
│    — Vocabulary [19] ISO/TS 16775, Packaging for terminally sterilized
│    medical devices — Guidance on the application of ISO 11607-1 and ISO
│    11607-22) [20] IEC 61010‑1, Safety requirements for electrical
│    equipment for measurement, control, and laboratory use — Part 1:
│    General requirements [21] IEC 61010‑2‑040, Safety requirements for
│    electrical equipment for measurement, control and laboratory use —
│    Part 2-040: Particular requirements for sterilizers and
│    washer-disinfectors used to treat medical materials 2) To be
│    published. ﻿
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 60 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    devices — Guidance on the application of ISO 11607-1 and ISO
│    11607-22) [20] IEC 61010‑1, Safety requirements for electrical
│    equipment for measurement, control, and laboratory use — Part 1:
│    General requirements [21] IEC 61010‑2‑040, Safety requirements for
│    electrical equipment for measurement, control and laboratory use —
│    Part 2-040: Particular requirements for sterilizers and
│    washer-disinfectors used to treat medical materials 2) To be
│    published. ﻿ © ISO 2014 – All rights reserved 77 BS EN ISO
│    11135:2014+A1:2019 --- PAGE 100 --- ﻿ ISO 11135:2014+A1:2018 [22]
│    ANSI/AAMI ST41:1999, Ethylene o
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 61 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: parametric release
│  Relevance Score: 3.0/5.0
│
│  Context:
│    mes of repetition and any variations in successive repetitions; h)
│    aeration (if used): 1) time and temperature within the chamber and/or
│    room; 2) pressure changes (if any) within the chamber and/or room; 3)
│    rate of change of air or other gas; 4) temperature of the
│    sterilization load. 9.5.5 If parametric release is to be used, the
│    validation report shall also specify: a) the value and tolerances for
│    chamber humidity by direct measurement during conditioning; b) the
│    value and tolerances for the EO concentration determined from direct
│    analysis of chamber atmosphere using analytical methods to establish
│    th
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 62 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: process control
│  Relevance Score: 3.0/5.0
│
│  Context:
│    sts for the equipment should include: a) pipe work and
│    instrumentation schematic drawings (i.e. process and instrumentation
│    diagrams); b) a list of other pertinent mechanical and electrical
│    drawings and their location; c) a list of critical instruments and
│    devices, particularly those influencing process control, for which
│    physical characteristics and manufacturer performance claims (e.g.
│    accuracy, repeatability, size and model) should be kept on file; ﻿ ©
│    ISO 2014 – All rights reserved 49 BS EN ISO 11135:2014+A1:2019 ---
│    PAGE 72 --- ﻿ ISO 11135:2014+A1:2018 d) process control logic or
│    software docume
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 63 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: measurement
│  Relevance Score: 3.0/5.0
│
│  Context:
│    y with the applicable clauses of ISO 13485. 4.3.3 A system complying
│    with the applicable clause(s) of ISO 13485 or ISO 10012 shall be
│    specified for the calibration of all equipment, including
│    instrumentation for test purposes, used in meeting the requirements
│    of this International Standard. 4.4 Measurement, analysis and
│    improvement — Control of nonconforming product Procedures for control
│    of product designated as nonconforming and for correction, corrective
│    action and preventive action shall be specified. These procedures
│    shall comply with the applicable clauses of ISO 13485. 5 Sterilizing
│    agent c
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 64 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: measurement
│  Relevance Score: 3.0/5.0
│
│  Context:
│    or room; 2) pressure changes (if any) within the chamber and/or room;
│    3) rate of change of air or other gas; 4) temperature of the
│    sterilization load. 9.5.5 If parametric release is to be used, the
│    validation report shall also specify: a) the value and tolerances for
│    chamber humidity by direct measurement during conditioning; b) the
│    value and tolerances for the EO concentration determined from direct
│    analysis of chamber atmosphere using analytical methods to establish
│    the process specification for routine processing. The sampling shall
│    be conducted at defined intervals sufficient to verify the re
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 65 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: measurement
│  Relevance Score: 3.0/5.0
│
│  Context:
│    release a load parametrically. 10.5 If parametric release is
│    performed, the following additional data shall be recorded and
│    retained: a) temperature in the chamber from a minimum of two
│    locations throughout the sterilization cycle; b) chamber humidity
│    during conditioning as determined by direct measurement; c) the EO
│    concentration, determined from direct analysis of chamber atmosphere
│    using analytical methods at defined intervals sufficient to verify
│    the required conditions throughout the exposure time. 11 Product
│    release from sterilization 11.1 The criteria for designating
│    conformance of the ste
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 66 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: measurement
│  Relevance Score: 3.0/5.0
│
│  Context:
│    the initial sterilization process that has been defined in process
│    definition (see Clause 8). OQ should also determine the performance
│    of associated ancillary systems. For example, the capability of the
│    EO vaporizer to achieve a minimum EO input temperature. The system
│    software (e.g. computerized measurement and control systems) should
│    be tested in all fault conditions during OQ. The user is responsible
│    for assuring the software is validated. OQ can include the following
│    when using a predefined cycle: a) Preconditioning Phase 1) The
│    pattern of air circulation throughout the area to be occupied by th
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 67 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: measurement
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ughout the conditioning phase. Electronic sensors require periodic
│    calibration to offset the effect of exposure to the EO gas and can
│    require replacement after repeated exposures to EO due to
│    irreversible deterioration of materials currently utilized as sensing
│    elements. c) EO gas concentration measurement. The frequency of
│    analysis required to demonstrate that the minimum EO concentration is
│    maintained throughout EO exposure should be established during the PQ
│    studies. Monitoring throughout the EO exposure dwell period should
│    also be done as part of the validation, in order to determine how the
│    E
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 68 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: measurement
│  Relevance Score: 3.0/5.0
│
│  Context:
│    computer software [18] ISO/TS 11139:2006, Sterilization of health
│    care products — Vocabulary [19] ISO/TS 16775, Packaging for
│    terminally sterilized medical devices — Guidance on the application
│    of ISO 11607-1 and ISO 11607-22) [20] IEC 61010‑1, Safety
│    requirements for electrical equipment for measurement, control, and
│    laboratory use — Part 1: General requirements [21] IEC 61010‑2‑040,
│    Safety requirements for electrical equipment for measurement, control
│    and laboratory use — Part 2-040: Particular requirements for
│    sterilizers and washer-disinfectors used to treat medical materials
│    2) To be publ
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 69 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: measurement
│  Relevance Score: 3.0/5.0
│
│  Context:
│    lized medical devices — Guidance on the application of ISO 11607-1
│    and ISO 11607-22) [20] IEC 61010‑1, Safety requirements for
│    electrical equipment for measurement, control, and laboratory use —
│    Part 1: General requirements [21] IEC 61010‑2‑040, Safety
│    requirements for electrical equipment for measurement, control and
│    laboratory use — Part 2-040: Particular requirements for sterilizers
│    and washer-disinfectors used to treat medical materials 2) To be
│    published. ﻿ © ISO 2014 – All rights reserved 77 BS EN ISO
│    11135:2014+A1:2019 --- PAGE 100 --- ﻿ ISO 11135:2014+A1:2018 [22]
│    ANSI/AAMI ST41:1999, E
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 70 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.5/5.0
│
│  Context:
│    equired product SAL is achieved. A PCD located within the confines of
│    the product or product shipper case is an internal PCD, whereas a PCD
│    located between shipper cases or on the exterior surfaces of the load
│    is an external PCD. An external PCD is an item designed to be used
│    for microbiological monitoring of routine production cycles. 3.29
│    process parameter specified value for a process variable Note 1 to
│    entry: The specification for a sterilization process includes the
│    process parameters and their tolerances. [SOURCE: ISO/TS 11139:2006,
│    definition 2.34] ﻿ 6 © ISO 2014 – All rights reserved BS EN I
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 71 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.5/5.0
│
│  Context:
│    for worker safety and to ensure that EO residues in the load do not
│    affect the biological challenge in the next microbiological PQ study.
│    9.4.1.9 If chemical indicators are used as part of PQ, these shall
│    comply with ISO 11140‑1, and shall be used in conjunction with
│    microbiological and physical monitoring. 9.4.1.10 Biological
│    indicators used in PQ shall comply with the applicable clauses of ISO
│    11138‑1:2006 and ISO 11138‑2:2009, Clause 5 and 9.5. 9.4.2
│    Performance qualification — Microbiological 9.4.2.1 The
│    microbiological PQ (MPQ) shall demonstrate that, on application of
│    the sterilization proc
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 72 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.5/5.0
│
│  Context:
│    of the process being validated, this may be documented as unrelated
│    to the performance of the process without requiring three further
│    consecutive successful runs. Examples of this type of failure may
│    include, but are not limited to, power failures, other loss of
│    services, or failure of external monitoring equipment. 9.4.3.2 PPQ
│    shall confirm the process such that: a) the minimum temperature of
│    product to enter the sterilization process and/or the defined
│    conditions required to achieve it shall be established; b) at the end
│    of the defined preconditioning time (if used), the sterilization load
│    tem
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 73 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.5/5.0
│
│  Context:
│    lysis of chamber atmosphere using analytical methods to establish the
│    process specification for routine processing. The sampling shall be
│    conducted at defined intervals sufficient to verify the required
│    conditions throughout EO exposure. c) temperature of the chamber;
│    recorded from two separate monitoring locations. 9.5.6 A process
│    specification including the process parameters and their tolerances
│    shall be established for routine processing based upon the
│    documentation generated during the validation. This process
│    specification shall also include the criteria for designating EO
│    processed product
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 74 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.5/5.0
│
│  Context:
│    used; j) EO-injection time k) inert gas injection, if used; l)
│    exposure time; m) time taken to evacuate the chamber; n) time and
│    pressure changes during post exposure flushing; o) time, temperature,
│    pressure changes (if any) during aeration. 10.3 If biological
│    indicators are used in routine monitoring, they shall comply with 8.6
│    and 8.7. If the PCD that is used for routine release is different
│    from that used in the MPQ, it should be at least as resistant to the
│    process as is the PCD used in the MPQ. ﻿ 22 © ISO 2014 – All rights
│    reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 45 --- ﻿ ISO 11135
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 75 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.5/5.0
│
│  Context:
│    11135:2014+A1:2018 Annex C (informative) Temperature sensors, RH
│    sensors and biological indicator numbers C.1 Temperature sensors It
│    is recommended to use one sensor per 2,5 m3 during OQ to establish a
│    thermal map of the room or chamber that captures potential hot or
│    cold locations. Therefore, monitoring should include more than one
│    plane and locations near doors. For PQ, one temperature sensor is
│    required per cubic metre of product volume. The minimum number of
│    temperature sensors is three. For PQ, humidity sensors should be
│    placed within the packaging (where possible) within the load. This
│    can
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 76 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.5/5.0
│
│  Context:
│    . Humidification by steam is necessary because humidifiers that
│    operate by dispersion of unheated water as an aerosol (e.g. spinning
│    disc humidifiers and nebulizers) can be a potential source of
│    microbial contamination. The preconditioning area (if used) should
│    have the following performance and monitoring capabilities: —
│    adequate air circulation to ensure the uniformity of temperature and
│    humidity in the usable space, and to ensure that uniformity is
│    maintained in a loaded room or chamber; — airflow detection
│    equipment, alarm systems or indicators monitoring the circulation
│    system to ensure conf
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 77 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.5/5.0
│
│  Context:
│    on area (chamber, cell or room) can be used to remove EO residuals
│    from product/packaging. Temperature uniformity, fresh air make-up and
│    air re-circulation throughout the area are important to ensure
│    consistent and reproducible results. The aeration area should have
│    the following performance and monitoring capabilities: — airflow
│    detection equipment, alarm systems or indicators monitoring the air
│    handling system to ensure that it operates within predetermined
│    tolerances and maintains adequate airflow in a loaded room or
│    chamber; — equipment to re-circulate air; — means of monitoring room
│    tempera
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 78 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.5/5.0
│
│  Context:
│    f the sensors has failed. A dual element temperature probe can be
│    used to meet this need. f) It is important to maintain uniform
│    conditions within the sterilizer chamber during processing. This can
│    be achieved by forced gas circulation. If used, a gas circulation
│    system should be equipped with a monitoring device to indicate when
│    circulation is ineffective as devices that solely monitor “power on”
│    to the fan or pump are not sufficient. g) Areas used for storage of
│    cylinders, tanks or cartridges of EO or EO gas mixtures should be
│    secured and ventilated. h) Where ambient conditions are subject to t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 79 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.5/5.0
│
│  Context:
│    l versus external PCDs can be assessed using concurrent exposure(s)
│    in a fractional cycle(s). The resulting data can be used for: a)
│    making decisions about which internal PCD is appropriate to validate
│    the sterilization process; b) evaluating candidate designs for
│    external PCDs (i.e. for routine monitoring of the process); c)
│    assessing the equivalence of new or modified products for adoption
│    into a validated sterilization process; or d) deciding if a new or
│    modified product or internal PCD should become the master product for
│    a product family or processing group. There can be instances when it
│    is
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 80 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.5/5.0
│
│  Context:
│    area should be determined in the same manner as recommended for
│    preconditioning areas. The air flow rates and air flow patterns
│    through the area should also be determined. D.9.4 Performance
│    qualification D.9.4.1 General PQ consists of rigorous microbiological
│    and physical testing, beyond routine monitoring, to demonstrate the
│    efficacy and reproducibility of the sterilization process. PQ is
│    normally not started until after completion and approval of the IQ
│    and OQ testing. Acceptance criteria should include conformance with
│    the specifications for the sterilization process parameters and
│    microbiologi
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 81 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.5/5.0
│
│  Context:
│    t EO product families. PCDs should be placed within the product case
│    and evenly distributed in the sterilization load, but distribution
│    should include those locations where sterilization conditions are the
│    most difficult to achieve. The locations used should include those
│    selected for temperature monitoring. For loads that are palletized,
│    these locations should also include the top and bottom of the pallets
│    to ensure that all potential stratification within the chamber is
│    assessed. For guidance on sample numbers, see Table C.3. D.9.4.2.3 No
│    guidance offered D.9.4.2.4 If a developmental chamber was
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 82 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.5/5.0
│
│  Context:
│    roduct prior to preconditioning, or extend preconditioning time to
│    allow the internal temperature and humidity to be within acceptable
│    ranges. NOTE The minimum temperature of products entering
│    preconditioning or the storage conditions are defined during PQ. b)
│    The reference position for routine monitoring of temperature and
│    relative humidity during preconditioning should be correlated to the
│    location at which it is most difficult to achieve the desired
│    conditions. Monitoring data for the operation of the preconditioning
│    area should be reviewed in conjunction with other data for the
│    release of pro
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 83 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.5/5.0
│
│  Context:
│    f products entering preconditioning or the storage conditions are
│    defined during PQ. b) The reference position for routine monitoring
│    of temperature and relative humidity during preconditioning should be
│    correlated to the location at which it is most difficult to achieve
│    the desired conditions. Monitoring data for the operation of the
│    preconditioning area should be reviewed in conjunction with other
│    data for the release of product. c) No guidance offered. d) No
│    guidance offered. e) The humidity is typically calculated by
│    measuring pressure changes. (See also AAMI TIR15.[24]) The humidity
│    in the
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 84 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.5/5.0
│
│  Context:
│    tation of the indicator suggests inadequate EO processing, the
│    contents of the package should not be used. The complete unused
│    package, including load identification and the chemical indicator,
│    should be returned to the processing department for appropriate
│    follow up. The results of the physical monitoring, chemical
│    indicators elsewhere in the load, and the biological monitoring,
│    should be reviewed, in order to reach a conclusion as to whether the
│    entire load should be recalled or not. Records of this review should
│    be retained. A single non-responsive or inconclusive indicator should
│    not be consid
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 85 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.5/5.0
│
│  Context:
│    the package should not be used. The complete unused package,
│    including load identification and the chemical indicator, should be
│    returned to the processing department for appropriate follow up. The
│    results of the physical monitoring, chemical indicators elsewhere in
│    the load, and the biological monitoring, should be reviewed, in order
│    to reach a conclusion as to whether the entire load should be
│    recalled or not. Records of this review should be retained. A single
│    non-responsive or inconclusive indicator should not be considered as
│    evidence that the entire load is non-sterile. Chemical indicators
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 86 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ormance of the equipment. The procedures should be documented, and
│    maintenance personnel should be trained. Equipment to be maintained
│    and/or calibrated on a routine basis can include, but is not limited
│    to, the following preconditioning, chamber and aeration equipment: a)
│    gaskets and seals; b) monitoring gauges; c) EO monitoring equipment
│    (i.e. environmental and/or chamber); d) door safety interlocks; e)
│    safety pressure relief valves or rupture discs; f) filters (for
│    periodic replacement); g) volatizers/vaporizers; h) chamber jacket
│    re-circulation system; i) chamber jacket system; j) audibl
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 87 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.5/5.0
│
│  Context:
│    The procedures should be documented, and maintenance personnel should
│    be trained. Equipment to be maintained and/or calibrated on a routine
│    basis can include, but is not limited to, the following
│    preconditioning, chamber and aeration equipment: a) gaskets and
│    seals; b) monitoring gauges; c) EO monitoring equipment (i.e.
│    environmental and/or chamber); d) door safety interlocks; e) safety
│    pressure relief valves or rupture discs; f) filters (for periodic
│    replacement); g) volatizers/vaporizers; h) chamber jacket
│    re-circulation system; i) chamber jacket system; j) audible and
│    visual alarms; k) t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 88 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.5/5.0
│
│  Context:
│    or half cycle is performed to demonstrate that the sterilization
│    process is capable of delivering the defined minimum specified
│    product SAL in all the evaluated pieces or sets of equipment. NOTE If
│    the run used during process analysis was a fractional or half cycle
│    and included microbiological monitoring, then the data can also be
│    used for this evaluation. In addition to the delivery of the
│    specified product SAL, additional factors that should be evaluated
│    include any changes to the sterilization location or manufacturing
│    location that might have an impact on the bioburden level of the
│    product as
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 89 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.5/5.0
│
│  Context:
│    rbency of the different parts of both the product and material; c)
│    weights and densities of items; d) load configuration, especially for
│    a mixed product load. Health care considerations: To demonstrate
│    adequate penetration of EO, humidity and heat into product, a PCD
│    should be chosen for routine monitoring and validation of the EO
│    sterilization process. The resistance of the PCD to EO should be
│    shown to be equal to or greater than the resistance of the bioburden
│    of product to be sterilized at the most difficult to sterilize
│    location on the product. D.14.2.3 [B.2.3] No guidance offered
│    D.14.2.4 [B
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 90 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    The guidance, in Annex D, is intended for people who have a basic
│    knowledge of the principles of EO sterilization. Methods other than
│    those given in the guidance can be used if they are effective in
│    achieving compliance with the requirements of ISO 11135. The
│    development, validation and routine control of a sterilization
│    process comprises a number of discrete but interrelated activities;
│    e.g. calibration, maintenance, product definition, process
│    definition, installation qualification, operational qualification and
│    performance qualification. While the activities required by ISO 11135
│    have been
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 91 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ned specifications [SOURCE: ISO/TS 11139:2006, definition 2.55] 3.58
│    virgin material material that has not been previously used, or
│    subjected to processing other than for its original production 4
│    Quality management systems 4.1 Documentation 4.1.1 Procedures for
│    development, validation, routine control and product release from
│    sterilization shall be specified. ﻿ 10 © ISO 2014 – All rights
│    reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 33 --- ﻿ ISO
│    11135:2014+A1:2018 4.1.2 Documents and records required by this
│    International Standard shall be reviewed and approved by designated
│    personnel (see
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 92 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    protect the health and safety of personnel shall be identified. 5.5.2
│    The potential effect on the environment of the operation of the
│    sterilization process shall be assessed and measures to protect the
│    environment shall be identified. This assessment, including potential
│    impact and measures for control, shall be documented. 5.5.3 Users of
│    EO shall comply with applicable local, national and international
│    requirements regarding the emission and disposal of EO and its
│    diluents as well as any by-products. 6 Process and equipment
│    characterization 6.1 General 6.1.1 The purpose of this activity is
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 93 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    cess, including sensor characteristics and their locations; e)
│    fault(s) recognized by the sterilizing equipment; f) safety features,
│    including those for personnel and environmental protection; g)
│    installation requirements, including specifications for required
│    services and requirements for the control of emissions. 6.3.3
│    Software used to control and/or monitor the process shall be prepared
│    and validated in accordance with the elements of a quality system
│    that provides documented evidence that the software meets its design
│    specification. NOTE For further information, attention is drawn to
│    ISO
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 94 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    irmed that the product and its packaging meet specified requirements
│    for safety, quality and performance following the application of the
│    defined sterilization process using the process parameter tolerances
│    that have been determined to have the greatest impact on the
│    product/package. NOTE Design control is one aspect addressed in ISO
│    14971. 7.2.2 If multiple sterilization cycles are permitted, the
│    effects of such processing on the product and its packaging shall be
│    evaluated. 7.2.3 The biological safety of product following exposure
│    to the sterilization process shall be established in accordan
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 95 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    /or direct monitoring; f) conditioning time; g) indication of the
│    satisfactory operation of the chamber gas circulation system (if
│    used) during EO injection and during exposure; h) temperature and
│    pressure in the chamber throughout the sterilization cycle; i) If
│    pressure is used as the primary control measure, the requirement for
│    the secondary measure is only to confirm admission of EO to the
│    chamber by at least one of the following: 1) the mass of EO used (see
│    D.10.2 i); 2) the direct measurement of the concentration of EO in
│    the sterilizer chamber; 3) volume of EO used; j) EO-injection ti
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 96 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    s of the system for ensuring the condition of the product presented
│    for sterilization (see 7.3.1) shall be demonstrated. ﻿ © ISO 2014 –
│    All rights reserved 23 BS EN ISO 11135:2014+A1:2019 --- PAGE 46 ---
│    ﻿ ISO 11135:2014+A1:2018 12.1.2 The accuracy and reliability of the
│    instrumentation used to control and monitor the sterilization process
│    shall be verified periodically in accordance with 4.3.3. 12.2
│    Maintenance of equipment 12.2.1 Preventative maintenance shall be
│    planned and performed in accordance with documented procedures. All
│    procedures shall follow manufacturers’ recommendations as well
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 97 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    parameters, having undergone IQ and OQ, shall be qualified either a)
│    in the same manner as the original chamber, or b) using a reduced MPQ
│    that demonstrates the delivery of the required level of
│    microbiological lethality and PPQ to demonstrate temperature and
│    humidity uniformity of the load and control by the production
│    chamber. The rationale for this reduced qualification shall be
│    recorded and documented. The influence of different geographical
│    locations on the product or load properties shall be determined.
│    12.5.2 Product A product may be added to a validated process if
│    deemed equivalent to
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 98 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    number of BI/PCDs to use is as follows: a) For MPQ with a product
│    load volume of up to 10 m3, use three BIs per m3 of product volume,
│    with a minimum of five BIs. b) For MPQ with a product load volume
│    above 10 m3, use one additional BI per additional m3 beyond 10m3. If
│    BIs are used for routine control use half the number of BIs used
│    during MPQ up to a maximum of 30. The result of the calculation
│    should be rounded to the next higher number. Table C.3 provides
│    guidance for determining the number of BI/PCDs. The actual number of
│    BI/PCDs to be used will depend on: a) microbiological qualification m
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 99 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    approach is being used a minimum quantity of 10 BI/PCD’s are
│    indicated, see Reference [38]. ﻿ 30 © ISO 2014 – All rights reserved
│    BS EN ISO 11135:2014+A1:2019 --- PAGE 53 --- ﻿ ISO 11135:2014+A1:2018
│    Table C.3 — Examples of minimum recommended number of BI/PCDs Product
│    load volume m3 MPQ Routine control (if used) ≤ 1 5 3 10 30 15 15 35
│    18 20 40 20 25 45 23 30 50 25 35 55 28 40 60 30 50 70 30 100 120 30
│    EXAMPLE 1 For product load volume of 3 m3: 3 × 3 = 9. The number of
│    BIs to use is at least nine for MPQ. For routine control: 9/2 = 4,5.
│    The number of BIs is at least five. EXAMPLE 2 For a produc
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 100 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    nning, responsibility, authority and communication, and management
│    review. Each organization should establish procedures for identifying
│    training needs and ensure that all personnel are trained to
│    adequately perform their assigned responsibilities. D.4.2.2 The
│    development, validation and routine control of a sterilization
│    process can involve a number of separate parties, each of whom is
│    responsible for certain elements. It is important that the respective
│    ﻿ 32 © ISO 2014 – All rights reserved BS EN ISO 11135:2014+A1:2019
│    --- PAGE 55 --- ﻿ ISO 11135:2014+A1:2018 procedures clearly outline
│    the r
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 101 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ity are specified in ISO 13485:2003, 7.5.3. For those facilities that
│    do not fully comply with ISO 13485, such as health care facilities,
│    procedures for identification of product and maintenance of
│    traceability should include the labelling of each item or package
│    prior to sterilization with a lot control identifier that includes
│    the following information: a) the sterilizer ID or code; b) the date
│    of sterilization; c) the cycle number (i.e. the cycle run of the day
│    or sterilizer); d) the identity of the person who assembled the pack.
│    Including the identity of the person who assembled the pack al
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 102 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    – All rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 57 --- ﻿
│    ISO 11135:2014+A1:2018 D.5.5.3 Effluent gas should be discharged
│    through an EO gas treatment system, such as a catalytic oxidizer, wet
│    acid scrubber or thermal oxidizer in compliance with local permit
│    requirements or emission control legislation. When choosing a
│    diluent, the ozone depleting potential of the diluent as well as the
│    disposal of any by- products should be taken into consideration. D.6
│    Process and equipment characterization In health care facilities,
│    process and equipment characterization are generally the responsi
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 103 [MED ] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    zation D.6.2.1 No guidance offered. D.6.2.2 The resistance of
│    microorganisms to deactivation by EO is affected by their moisture
│    content. At low levels of humidity, below 30 %, microbial resistance
│    may increase with decreased humidity for some products. For this
│    reason it is common practice to control and monitor the humidity of
│    the atmosphere to which the product is exposed in order to attempt to
│    equilibrate the moisture content of the microorganisms with the local
│    conditions. Consideration should be given to the packaged product to
│    ensure that excessive relative humidity will not impact the
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 104 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    laims for the number of allowable cycles should be considered to be
│    the maximum. A system should be in place which will provide
│    notification if the maximum number of cycles is reached. NOTE See ISO
│    17664 for more information. D.7.2.3 No guidance offered. D.7.2.4
│    Proper aeration is essential to control EO residues in medical
│    devices after EO processing. Consideration should be given to the
│    placement of the residual product test samples within the load,
│    taking into account the most challenging positions for EO removal.
│    Local environment, health and safety regulations can require extra
│    worker exp
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 105 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    he electrical supply, which should adequately and consistently supply
│    the power needed for proper equipment and instrumentation operation;
│    e) gas circulation systems, where used; f) gas injection systems; g)
│    vacuum systems, including pumps, pump cooling systems and piping; h)
│    exhaust, emission control and abatement systems; i) other critical
│    systems that could affect process conditions, such as process
│    automation, safety systems, etc.; j) the calibration of instruments
│    (e.g. sensors, recorders, gauges and test instruments) that monitor,
│    control, indicate or record parameters such as temperat
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 106 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    oling systems and piping; h) exhaust, emission control and abatement
│    systems; i) other critical systems that could affect process
│    conditions, such as process automation, safety systems, etc.; j) the
│    calibration of instruments (e.g. sensors, recorders, gauges and test
│    instruments) that monitor, control, indicate or record parameters
│    such as temperature, humidity, pressure and EO concentration. ﻿ 48 ©
│    ISO 2014 – All rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE
│    71 --- ﻿ ISO 11135:2014+A1:2018 k) the documented procedures for IQ
│    should specify how each element of this qualification is p
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 107 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    admission of air (or other gases); 10) number of times these last two
│    stages are repeated and any variations in successive repetitions; 11)
│    the reliability of the supply of filtered air, inert gasses, water
│    and steam; 12) replicate cycles should be carried out to demonstrate
│    the repeatability of control; 13) a chamber wall temperature study
│    should be completed to verify adequate temperature uniformity
│    provided by the jacket heating system. The study should characterize
│    the temperature profile for comparison on a periodic basis to ensure
│    the system continues to operate effectively. c) Aeration
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 108 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    intaining process effectiveness D.12.1 General D.12.1.1 To ensure
│    that the sterilization process continues to deliver the required
│    product SAL, it is necessary to evaluate any changes to the product
│    and packaging, the processes and equipment. The use of a
│    comprehensive product and process change control system is
│    recommended. One parameter commonly monitored to ensure the continued
│    ability to sterilize the load is the product bioburden. The bioburden
│    should be monitored per ISO 11737‑1. If significant changes are
│    observed in the number and/or types of microorganisms, their possible
│    effect on the
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 109 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    facilities to obtain from the manufacturers detailed reprocessing
│    instructions specific to the medical device, e.g. disassembly.
│    Policies and procedures should be in place to ensure that medical
│    devices are decontaminated. D.12.1.2 A documented program for
│    calibration of instrumentation used to control and monitor a
│    sterilization process is necessary to ensure that the process
│    continues to deliver product with the required SAL and performance
│    characteristics. ﻿ © ISO 2014 – All rights reserved 59 BS EN ISO
│    11135:2014+A1:2019 --- PAGE 82 --- ﻿ ISO 11135:2014+A1:2018 D.12.2
│    Maintenance of equip
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 110 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    n or might differ in size or in the extent of ancillary equipment.
│    Process equivalence can be established through analysis of process
│    data in combination with a microbiological evaluation. The process
│    data should demonstrate that the candidate equipment is performing
│    within an acceptable range of control (i.e. validated process
│    parameters can be reliably delivered to the product). The data
│    analysis should confirm that the process operates within the defined
│    tolerances for the validated parameters. The microbiological
│    evaluation will demonstrate that the required SAL is achieved.
│    D.12.5.2 Criter
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 111 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    does not apply to aeration. An evaluation that compares the load
│    temperature and humidity profiles within each environment should be
│    performed. At a minimum, temperature and humidity uniformity within
│    the load and the relationship of this uniformity with the
│    corresponding set points and recorded control variables for the areas
│    should be evaluated. If the pieces of equipment use different set
│    points or have different control limits, it might not be possible to
│    declare that they are equivalent. Process equivalence for the
│    preconditioning or aeration processes can be established if analysis
│    of per
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 112 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    should be performed. At a minimum, temperature and humidity
│    uniformity within the load and the relationship of this uniformity
│    with the corresponding set points and recorded control variables for
│    the areas should be evaluated. If the pieces of equipment use
│    different set points or have different control limits, it might not
│    be possible to declare that they are equivalent. Process equivalence
│    for the preconditioning or aeration processes can be established if
│    analysis of performance data concludes that conditions within the
│    load meet the parameter limits (e.g. temperature distribution,
│    residual
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 113 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    view of changes to each piece of equipment, the manufacturing
│    process, the product load, and the sterilization process to ensure
│    that these changes do not compromise the overall determination of
│    equivalence. This review should be conducted before changes are made
│    and should be part of the change control process. If any process
│    fails the periodic equivalence review, then it should be removed from
│    the equivalence list and requalified on its own. D.12.5.10
│    Documentation All decisions related to the outcome of the analysis
│    determining whether candidate equipment can be declared equivalent to
│    the ex
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 114 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    further testing performed for confirmation or qualification for
│    routine release of product from the existing validated cycle (e.g.
│    residual testing, functional testing on first three lots, etc.). g)
│    Approval by the sterilization specialist and other individuals as
│    required by the normal change control or process documentation
│    control practices within the organization. h) A list of applicable
│    sterilizer operating procedures and specifications issued or changed
│    to authorize use of the candidate equipment for routine processing of
│    product. D.12.5.11 Product D.12.5.11.1 Product family A product
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 115 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    nfirmation or qualification for routine release of product from the
│    existing validated cycle (e.g. residual testing, functional testing
│    on first three lots, etc.). g) Approval by the sterilization
│    specialist and other individuals as required by the normal change
│    control or process documentation control practices within the
│    organization. h) A list of applicable sterilizer operating procedures
│    and specifications issued or changed to authorize use of the
│    candidate equipment for routine processing of product. D.12.5.11
│    Product D.12.5.11.1 Product family A product family is a collection
│    of product
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 116 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.5/5.0
│
│  Context:
│    whether a candidate product or packaging system can be adopted into a
│    product family or processing category, one should determine whether
│    the candidate product or packaging system will remain functional and
│    effective. A system to evaluate these aspects should be addressed by
│    the design or change control process. Consideration should be given
│    to functionality, integrity, stability, biocompatibility, and
│    residuals, with special consideration given to determining the effect
│    that the sterilization process might have on drugs that could be
│    included in devices or components. For products that contain
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 117 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: parametric release
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ordance with its operational procedures [SOURCE: ISO/TS 11139:2006,
│    definition 2.27] 3.24 overkill approach approach using sterilization
│    process that delivers a minimum of 12 Spore Log Reduction (SLR) to a
│    biological indicator having a resistance equal to or greater than the
│    product bioburden 3.25 parametric release declaration that product is
│    sterile, based on records demonstrating that the process parameters
│    were delivered within specified tolerances [SOURCE: ISO/TS
│    11139:2006, definition 2.29] Note 1 to entry: This method of process
│    release does not include the use of biological indicators. 3.26
│    performanc
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 118 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: parametric release
│  Relevance Score: 2.5/5.0
│
│  Context:
│    in humidity, e.g. pallet centers, pallet edges and surfaces. For PQ,
│    humidity sensors should be placed within the packaging (where
│    possible) within the load. This can be achieved by placing the sensor
│    within the sterile barrier system or amongst the unit packages. e) No
│    guidance offered. f) If parametric release is used, the EO
│    concentration profile for the entire gas dwell phase should be
│    assessed to determine how the gas concentration changes over the
│    phase. g) No guidance offered. h) No guidance offered. i) The
│    temperature sensors within the sterilization load should be placed in
│    the locations that
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 119 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: parametric release
│  Relevance Score: 2.5/5.0
│
│  Context:
│    e sterilizer, incomplete delivery of the sterilization parameters, or
│    inadequate preconditioning. The “pass” result of a chemical indicator
│    does not prove that the item where the indicator is placed is
│    sterile. d) Indicators should be of Class 3, 4, 5 or 6 in accordance
│    with ISO 11140‑1. D.10.5 Parametric release is a method of releasing
│    product from sterilization as sterile without the use of BIs, relying
│    instead on a demonstration of conformity of the physical processing
│    parameters to all specifications. Therefore, data are gathered for
│    additional processing parameters such as direct analysis of chambe
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 120 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: parametric release
│  Relevance Score: 2.5/5.0
│
│  Context:
│    th EO and diluent gas molecules, selective absorption and adsorption
│    of EO in the load and the volume taken up by the load, the values
│    obtained by calculating the mean EO gas concentration can differ
│    considerably from the direct measured value. NOTE 2 Health care
│    facilities do not routinely use parametric release. D.11 Product
│    release from sterilization D.11.1 This confirmation should include a
│    formal review of the process documentation by a designated individual
│    (or by a validated automated process) to verify and document that the
│    physical cycle variables are within the tolerances defined in the
│    steril
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 121 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: parametric release
│  Relevance Score: 2.5/5.0
│
│  Context:
│    lization D.11.1 This confirmation should include a formal review of
│    the process documentation by a designated individual (or by a
│    validated automated process) to verify and document that the physical
│    cycle variables are within the tolerances defined in the
│    sterilization process specification. If parametric release has been
│    approved and used, product can be released based on compliance with
│    specified process parameters. Routine release of a product following
│    sterilization can be based on a review of electronic records in lieu
│    of paper records. Likewise, required signatures can be made
│    electronically. Users
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 122 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: measurement
│  Relevance Score: 2.5/5.0
│
│  Context:
│    rmity of the physical processing parameters to all specifications.
│    Therefore, data are gathered for additional processing parameters
│    such as direct analysis of chamber relative humidity and EO
│    concentration, in order to ensure that the sterilization process has
│    met specification. a) Temperature measurement. The requirement to
│    measure temperature within the sterilizer from a minimum of two
│    locations is established in order to ensure that an undetected fault
│    in a temperature sensor does not lead to the inadvertent release of
│    an improperly processed load. If there is a difference in the two
│    temperatur
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 123 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: measurement
│  Relevance Score: 2.5/5.0
│
│  Context:
│    often direct analysis should be performed during the cycle. It is
│    recommended that when direct analysis of EO concentration is
│    performed, at a minimum, direct analysis of EO concentration be
│    performed during the first and last portions of EO exposure.
│    Particular attention should be given to the measurement and
│    documentation of humidity during conditioning and that of EO
│    concentration during exposure. The EO sampling device providing
│    direct EO concentration measurement using IR, GC, microwave, and
│    other similar technologies should be positioned in a location to
│    represent the EO gas concentration wi
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 124 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: measurement
│  Relevance Score: 2.5/5.0
│
│  Context:
│    sis of EO concentration be performed during the first and last
│    portions of EO exposure. Particular attention should be given to the
│    measurement and documentation of humidity during conditioning and
│    that of EO concentration during exposure. The EO sampling device
│    providing direct EO concentration measurement using IR, GC,
│    microwave, and other similar technologies should be positioned in a
│    location to represent the EO gas concentration within the sterilizer
│    chamber. However, it is important to understand that this measurement
│    provides an EO concentration at that position in the chamber
│    throughout the
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 125 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: measurement
│  Relevance Score: 2.5/5.0
│
│  Context:
│    n during exposure. The EO sampling device providing direct EO
│    concentration measurement using IR, GC, microwave, and other similar
│    technologies should be positioned in a location to represent the EO
│    gas concentration within the sterilizer chamber. However, it is
│    important to understand that this measurement provides an EO
│    concentration at that position in the chamber throughout the entire
│    exposure phase without any restrictions of reactivity effects or load
│    impact. The reproducibility and accuracy of the results from direct
│    analysis should be determined during PQ. Routine cycle analysis
│    should fall
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 126 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.0/5.0
│
│  Context:
│    
│    hysical.......................................................................................................19
│    9.5 Review and approval of
│    validation......................................................................................................................................20
│    10 Routine monitoring and
│    control........................................................................................................................................................22
│    11 Product release from
│    sterilization...............................................................................................
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 127 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ice any instrument, apparatus, implement, machine, appliance,
│    implant, in vitro reagent or calibrator, software, material or
│    related article, intended by the manufacturer to be used, alone or in
│    combination, for human beings for one or more of the specific
│    purpose(s) of — diagnosis, prevention, monitoring, treatment or
│    alleviation of disease, — diagnosis, monitoring, treatment,
│    alleviation of, or compensation for an injury, — investigation,
│    replacement or modification or support of the anatomy or of a
│    physiological process, — control of conception, — disinfection of
│    medical devices, — providing
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 128 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.0/5.0
│
│  Context:
│    mplant, in vitro reagent or calibrator, software, material or related
│    article, intended by the manufacturer to be used, alone or in
│    combination, for human beings for one or more of the specific
│    purpose(s) of — diagnosis, prevention, monitoring, treatment or
│    alleviation of disease, — diagnosis, monitoring, treatment,
│    alleviation of, or compensation for an injury, — investigation,
│    replacement or modification or support of the anatomy or of a
│    physiological process, — control of conception, — disinfection of
│    medical devices, — providing information for medical purposes by
│    means of in vitro examinat
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 129 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.0/5.0
│
│  Context:
│    sterilizing agent is delivered to the chamber; c) description of the
│    means by which any other gas(es), including steam, are delivered to
│    the chamber; ﻿ © ISO 2014 – All rights reserved 13 BS EN ISO
│    11135:2014+A1:2019 --- PAGE 36 --- ﻿ ISO 11135:2014+A1:2018 d)
│    description of instrumentation for monitoring, controlling and
│    recording the sterilization process, including sensor characteristics
│    and their locations; e) fault(s) recognized by the sterilizing
│    equipment; f) safety features, including those for personnel and
│    environmental protection; g) installation requirements, including
│    specifications
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 130 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ovided to ensure that failure in a control function does not lead to
│    failure in recording of process variables such that an ineffective
│    process appears effective. NOTE This may be achieved either by the
│    use of independent systems for control and monitoring or by a
│    cross-check between control and monitoring which identifies any
│    discrepancies or indicates a fault. 7 Product definition 7.1 General
│    7.1.1 The purpose of this activity is to define the product to be
│    sterilized, including the microbiological quality of the product
│    prior to sterilization and the manner in which product is packaged
│    and pres
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 131 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ing (if used) of each sterilization load; d) elapsed time between
│    removal of the sterilization load from preconditioning (if used) and
│    the commencement of the sterilization cycle; e) chamber humidity
│    during conditioning and/or humidity dwell phases by pressure,
│    pressure rise (∆P) and/or direct monitoring; f) conditioning time; g)
│    indication of the satisfactory operation of the chamber gas
│    circulation system (if used) during EO injection and during exposure;
│    h) temperature and pressure in the chamber throughout the
│    sterilization cycle; i) If pressure is used as the primary control
│    measure, the
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 132 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.0/5.0
│
│  Context:
│    uld have the following performance and monitoring capabilities: —
│    adequate air circulation to ensure the uniformity of temperature and
│    humidity in the usable space, and to ensure that uniformity is
│    maintained in a loaded room or chamber; — airflow detection
│    equipment, alarm systems or indicators monitoring the circulation
│    system to ensure conformance to predetermined tolerances; — means of
│    recording time of load entry into and removal from the
│    preconditioning area; — means of monitoring cell/room temperature and
│    humidity; — means of controlling cell/room temperature and humidity.
│    b) Sterilizer c
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 133 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.0/5.0
│
│  Context:
│    appening, it is general practice to have redundant sensors for many
│    critical process parameters. The common options for utilizing these
│    redundant sensors include: a) use one sensor for control, and another
│    sensor for monitoring and reporting; b) use two sensors, or their
│    average value, for both monitoring and control; this system needs to
│    generate an automatic fault condition if the difference between the
│    two sensors exceeds a defined value; c) use dual element sensors for
│    both monitoring and control; this system needs to generate an
│    automatic fault condition if the difference between the two el
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 134 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: monitoring
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ntrol, and another sensor for monitoring and reporting; b) use two
│    sensors, or their average value, for both monitoring and control;
│    this system needs to generate an automatic fault condition if the
│    difference between the two sensors exceeds a defined value; c) use
│    dual element sensors for both monitoring and control; this system
│    needs to generate an automatic fault condition if the difference
│    between the two elements exceeds a defined value. D.7 Product
│    definition D.7.1 General D.7.1.1 Product definition involves
│    documentation of essential information about the medical device to be
│    sterilized
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 135 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ......................................................11 4.3 Product
│    realization...........................................................................................................................................................................11
│    4.4 Measurement, analysis and improvement — Control of nonconforming
│    product....................11 5 Sterilizing agent
│    characterization...................................................................................................................................................11
│    5.1 General.....................................................
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 136 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.0/5.0
│
│  Context:
│    
│    ...............................................................................................19
│    9.5 Review and approval of
│    validation......................................................................................................................................20
│    10 Routine monitoring and
│    control........................................................................................................................................................22
│    11 Product release from
│    sterilization...........................................................................................................
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 137 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ore of the specific purpose(s) of — diagnosis, prevention,
│    monitoring, treatment or alleviation of disease, — diagnosis,
│    monitoring, treatment, alleviation of, or compensation for an injury,
│    — investigation, replacement or modification or support of the
│    anatomy or of a physiological process, — control of conception, —
│    disinfection of medical devices, — providing information for medical
│    purposes by means of in vitro examination of specimens derived from
│    the human body, and which does not achieve its principal intended
│    action in or on the human body by pharmacological, immunological or
│    metabol
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 138 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ng time, chamber pressure, temperature and humidity, if humidity
│    additions are controlled by sensor readings (when sensors are fixed
│    on the equipment, ensure that a correlation is made during IQ or OQ
│    to the pressure rise); — if humidity is not controlled by sensor
│    readings, means to monitor and control steam additions; — if
│    parametric release is used, analytical instrumentation for the direct
│    analysis of humidity during conditioning and EO concentration during
│    EO exposure time (also see 9.5.5 and D.9.5.5); — a system controlling
│    the admission of gaseous EO to the chamber; — means to demonstra
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 139 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.0/5.0
│
│  Context:
│    general practice to have redundant sensors for many critical process
│    parameters. The common options for utilizing these redundant sensors
│    include: a) use one sensor for control, and another sensor for
│    monitoring and reporting; b) use two sensors, or their average value,
│    for both monitoring and control; this system needs to generate an
│    automatic fault condition if the difference between the two sensors
│    exceeds a defined value; c) use dual element sensors for both
│    monitoring and control; this system needs to generate an automatic
│    fault condition if the difference between the two elements excee
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 140 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.0/5.0
│
│  Context:
│    her sensor for monitoring and reporting; b) use two sensors, or their
│    average value, for both monitoring and control; this system needs to
│    generate an automatic fault condition if the difference between the
│    two sensors exceeds a defined value; c) use dual element sensors for
│    both monitoring and control; this system needs to generate an
│    automatic fault condition if the difference between the two elements
│    exceeds a defined value. D.7 Product definition D.7.1 General D.7.1.1
│    Product definition involves documentation of essential information
│    about the medical device to be sterilized (i.e. the ne
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 141 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: control
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ll PQ runs; c) an indication that all gauges, recorders, etc. were
│    calibrated and within their specifications; d) provision for future
│    review and requalification; e) the validation
│    protocol(s)/procedure(s); f) the documented procedures used; g)
│    documented operating procedures including process control limits; h)
│    if a failure occurred, a description of the issues, the corrective
│    action taken, and the effect of the failure on the intent of the
│    validation; i) if a deviation to the protocol occurred, details of
│    this deviation and an assessment of its impact upon the validation
│    and its results. D
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 142 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: parametric release
│  Relevance Score: 2.0/5.0
│
│  Context:
│    erature and humidity, if humidity additions are controlled by sensor
│    readings (when sensors are fixed on the equipment, ensure that a
│    correlation is made during IQ or OQ to the pressure rise); — if
│    humidity is not controlled by sensor readings, means to monitor and
│    control steam additions; — if parametric release is used, analytical
│    instrumentation for the direct analysis of humidity during
│    conditioning and EO concentration during EO exposure time (also see
│    9.5.5 and D.9.5.5); — a system controlling the admission of gaseous
│    EO to the chamber; — means to demonstrate that gaseous EO is injected
│    into the ch
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 143 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: process control
│  Relevance Score: 2.0/5.0
│
│  Context:
│    al, of all PQ runs; c) an indication that all gauges, recorders, etc.
│    were calibrated and within their specifications; d) provision for
│    future review and requalification; e) the validation
│    protocol(s)/procedure(s); f) the documented procedures used; g)
│    documented operating procedures including process control limits; h)
│    if a failure occurred, a description of the issues, the corrective
│    action taken, and the effect of the failure on the intent of the
│    validation; i) if a deviation to the protocol occurred, details of
│    this deviation and an assessment of its impact upon the validation
│    and its results. D
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 144 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: measurement
│  Relevance Score: 2.0/5.0
│
│  Context:
│    
│    ..............................................................................................11
│    4.3 Product
│    realization...........................................................................................................................................................................11
│    4.4 Measurement, analysis and improvement — Control of nonconforming
│    product....................11 5 Sterilizing agent
│    characterization...................................................................................................................................................11
│    5.1 General.................
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 145 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: measurement
│  Relevance Score: 2.0/5.0
│
│  Context:
│    d pressure in the chamber throughout the sterilization cycle; i) If
│    pressure is used as the primary control measure, the requirement for
│    the secondary measure is only to confirm admission of EO to the
│    chamber by at least one of the following: 1) the mass of EO used (see
│    D.10.2 i); 2) the direct measurement of the concentration of EO in
│    the sterilizer chamber; 3) volume of EO used; j) EO-injection time k)
│    inert gas injection, if used; l) exposure time; m) time taken to
│    evacuate the chamber; n) time and pressure changes during post
│    exposure flushing; o) time, temperature, pressure changes (if an
│
└───────────────────────────────────────────────────────────────────────────────


CATEGORY: CONCENTRATION

┌─ PARAMETER 01 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 3.5/5.0
│
│  Context:
│    s, pallet edges and surfaces. For PQ, humidity sensors should be
│    placed within the packaging (where possible) within the load. This
│    can be achieved by placing the sensor within the sterile barrier
│    system or amongst the unit packages. e) No guidance offered. f) If
│    parametric release is used, the EO concentration profile for the
│    entire gas dwell phase should be assessed to determine how the gas
│    concentration changes over the phase. g) No guidance offered. h) No
│    guidance offered. i) The temperature sensors within the sterilization
│    load should be placed in the locations that are most likely to
│    experience
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 02 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 3.5/5.0
│
│  Context:
│    to offset the effect of exposure to the EO gas and can require
│    replacement after repeated exposures to EO due to irreversible
│    deterioration of materials currently utilized as sensing elements. c)
│    EO gas concentration measurement. The frequency of analysis required
│    to demonstrate that the minimum EO concentration is maintained
│    throughout EO exposure should be established during the PQ studies.
│    Monitoring throughout the EO exposure dwell period should also be
│    done as part of the validation, in order to determine how the EO
│    concentration changes over time. The results of this analysis are
│    specific to the
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 03 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 3.5/5.0
│
│  Context:
│    nded that when direct analysis of EO concentration is performed, at a
│    minimum, direct analysis of EO concentration be performed during the
│    first and last portions of EO exposure. Particular attention should
│    be given to the measurement and documentation of humidity during
│    conditioning and that of EO concentration during exposure. The EO
│    sampling device providing direct EO concentration measurement using
│    IR, GC, microwave, and other similar technologies should be
│    positioned in a location to represent the EO gas concentration within
│    the sterilizer chamber. However, it is important to understand that
│    this m
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 04 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 3.5/5.0
│
│  Context:
│    mum, direct analysis of EO concentration be performed during the
│    first and last portions of EO exposure. Particular attention should
│    be given to the measurement and documentation of humidity during
│    conditioning and that of EO concentration during exposure. The EO
│    sampling device providing direct EO concentration measurement using
│    IR, GC, microwave, and other similar technologies should be
│    positioned in a location to represent the EO gas concentration within
│    the sterilizer chamber. However, it is important to understand that
│    this measurement provides an EO concentration at that position in the
│    chamber th
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 05 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 3.5/5.0
│
│  Context:
│    O sampling device providing direct EO concentration measurement using
│    IR, GC, microwave, and other similar technologies should be
│    positioned in a location to represent the EO gas concentration within
│    the sterilizer chamber. However, it is important to understand that
│    this measurement provides an EO concentration at that position in the
│    chamber throughout the entire exposure phase without any restrictions
│    of reactivity effects or load impact. The reproducibility and
│    accuracy of the results from direct analysis should be determined
│    during PQ. Routine cycle analysis should fall within the determined
│    range
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 06 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.5/5.0
│
│  Context:
│    pallet edges and surfaces. For PQ, humidity sensors should be placed
│    within the packaging (where possible) within the load. This can be
│    achieved by placing the sensor within the sterile barrier system or
│    amongst the unit packages. e) No guidance offered. f) If parametric
│    release is used, the EO concentration profile for the entire gas
│    dwell phase should be assessed to determine how the gas concentration
│    changes over the phase. g) No guidance offered. h) No guidance
│    offered. i) The temperature sensors within the sterilization load
│    should be placed in the locations that are most likely to experience
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 07 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.5/5.0
│
│  Context:
│    possible) within the load. This can be achieved by placing the sensor
│    within the sterile barrier system or amongst the unit packages. e) No
│    guidance offered. f) If parametric release is used, the EO
│    concentration profile for the entire gas dwell phase should be
│    assessed to determine how the gas concentration changes over the
│    phase. g) No guidance offered. h) No guidance offered. i) The
│    temperature sensors within the sterilization load should be placed in
│    the locations that are most likely to experience the greatest
│    temperature variation. These locations should take into account hot
│    or cold spots l
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 08 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.5/5.0
│
│  Context:
│    ndication throughout the conditioning phase. Electronic sensors
│    require periodic calibration to offset the effect of exposure to the
│    EO gas and can require replacement after repeated exposures to EO due
│    to irreversible deterioration of materials currently utilized as
│    sensing elements. c) EO gas concentration measurement. The frequency
│    of analysis required to demonstrate that the minimum EO concentration
│    is maintained throughout EO exposure should be established during the
│    PQ studies. Monitoring throughout the EO exposure dwell period should
│    also be done as part of the validation, in order to determi
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 09 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.5/5.0
│
│  Context:
│    offset the effect of exposure to the EO gas and can require
│    replacement after repeated exposures to EO due to irreversible
│    deterioration of materials currently utilized as sensing elements. c)
│    EO gas concentration measurement. The frequency of analysis required
│    to demonstrate that the minimum EO concentration is maintained
│    throughout EO exposure should be established during the PQ studies.
│    Monitoring throughout the EO exposure dwell period should also be
│    done as part of the validation, in order to determine how the EO
│    concentration changes over time. The results of this analysis are
│    specific to the
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 10 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.5/5.0
│
│  Context:
│    d that when direct analysis of EO concentration is performed, at a
│    minimum, direct analysis of EO concentration be performed during the
│    first and last portions of EO exposure. Particular attention should
│    be given to the measurement and documentation of humidity during
│    conditioning and that of EO concentration during exposure. The EO
│    sampling device providing direct EO concentration measurement using
│    IR, GC, microwave, and other similar technologies should be
│    positioned in a location to represent the EO gas concentration within
│    the sterilizer chamber. However, it is important to understand that
│    this m
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 11 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.5/5.0
│
│  Context:
│    , direct analysis of EO concentration be performed during the first
│    and last portions of EO exposure. Particular attention should be
│    given to the measurement and documentation of humidity during
│    conditioning and that of EO concentration during exposure. The EO
│    sampling device providing direct EO concentration measurement using
│    IR, GC, microwave, and other similar technologies should be
│    positioned in a location to represent the EO gas concentration within
│    the sterilizer chamber. However, it is important to understand that
│    this measurement provides an EO concentration at that position in the
│    chamber th
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 12 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.5/5.0
│
│  Context:
│    the measurement and documentation of humidity during conditioning and
│    that of EO concentration during exposure. The EO sampling device
│    providing direct EO concentration measurement using IR, GC,
│    microwave, and other similar technologies should be positioned in a
│    location to represent the EO gas concentration within the sterilizer
│    chamber. However, it is important to understand that this measurement
│    provides an EO concentration at that position in the chamber
│    throughout the entire exposure phase without any restrictions of
│    reactivity effects or load impact. The reproducibility and accuracy
│    of the res
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 13 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.5/5.0
│
│  Context:
│    ampling device providing direct EO concentration measurement using
│    IR, GC, microwave, and other similar technologies should be
│    positioned in a location to represent the EO gas concentration within
│    the sterilizer chamber. However, it is important to understand that
│    this measurement provides an EO concentration at that position in the
│    chamber throughout the entire exposure phase without any restrictions
│    of reactivity effects or load impact. The reproducibility and
│    accuracy of the results from direct analysis should be determined
│    during PQ. Routine cycle analysis should fall within the determined
│    range
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 14 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: gas concentration
│  Relevance Score: 3.5/5.0
│
│  Context:
│    ere possible) within the load. This can be achieved by placing the
│    sensor within the sterile barrier system or amongst the unit
│    packages. e) No guidance offered. f) If parametric release is used,
│    the EO concentration profile for the entire gas dwell phase should be
│    assessed to determine how the gas concentration changes over the
│    phase. g) No guidance offered. h) No guidance offered. i) The
│    temperature sensors within the sterilization load should be placed in
│    the locations that are most likely to experience the greatest
│    temperature variation. These locations should take into account hot
│    or cold spots l
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 15 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: gas concentration
│  Relevance Score: 3.5/5.0
│
│  Context:
│    me indication throughout the conditioning phase. Electronic sensors
│    require periodic calibration to offset the effect of exposure to the
│    EO gas and can require replacement after repeated exposures to EO due
│    to irreversible deterioration of materials currently utilized as
│    sensing elements. c) EO gas concentration measurement. The frequency
│    of analysis required to demonstrate that the minimum EO concentration
│    is maintained throughout EO exposure should be established during the
│    PQ studies. Monitoring throughout the EO exposure dwell period should
│    also be done as part of the validation, in order to determi
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 16 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: gas concentration
│  Relevance Score: 3.5/5.0
│
│  Context:
│    n to the measurement and documentation of humidity during
│    conditioning and that of EO concentration during exposure. The EO
│    sampling device providing direct EO concentration measurement using
│    IR, GC, microwave, and other similar technologies should be
│    positioned in a location to represent the EO gas concentration within
│    the sterilizer chamber. However, it is important to understand that
│    this measurement provides an EO concentration at that position in the
│    chamber throughout the entire exposure phase without any restrictions
│    of reactivity effects or load impact. The reproducibility and
│    accuracy of the res
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 17 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ization cycle; c) aeration (if used). 6.2.3 The process variables for
│    preconditioning (if used) include at a minimum: a) time; b)
│    temperature; c) humidity; d) transfer time. 6.2.4 The process
│    variables for the sterilization cycle include: a) exposure time; b)
│    temperature; c) humidity; d) EO concentration; e) pressure. 6.2.5 The
│    process variables for aeration (if used) include at a minimum: a)
│    time; b) temperature. NOTE In aeration these parameters are
│    considered process variables only if aeration is considered to
│    contribute to ensuring the microbicidal effectiveness of the
│    sterilization proce
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 18 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    3) rate of change of air or other gas; 4) temperature of the
│    sterilization load. 9.5.5 If parametric release is to be used, the
│    validation report shall also specify: a) the value and tolerances for
│    chamber humidity by direct measurement during conditioning; b) the
│    value and tolerances for the EO concentration determined from direct
│    analysis of chamber atmosphere using analytical methods to establish
│    the process specification for routine processing. The sampling shall
│    be conducted at defined intervals sufficient to verify the required
│    conditions throughout EO exposure. c) temperature of the chamber;
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 19 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    etrically. 10.5 If parametric release is performed, the following
│    additional data shall be recorded and retained: a) temperature in the
│    chamber from a minimum of two locations throughout the sterilization
│    cycle; b) chamber humidity during conditioning as determined by
│    direct measurement; c) the EO concentration, determined from direct
│    analysis of chamber atmosphere using analytical methods at defined
│    intervals sufficient to verify the required conditions throughout the
│    exposure time. 11 Product release from sterilization 11.1 The
│    criteria for designating conformance of the sterilization process
│    used fo
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 20 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    idity and rate (∆P/time) of attainment of pressure on injection of
│    steam; 2) number of steam pulse/vacuum stages, if applicable; e) EO
│    injection: 1) pressure, pressure rise (∆P) and rate (∆P/time) of
│    attainment of specified pressure on admission of EO and correlation
│    of methods used to monitor EO concentration; 2) pressure, pressure
│    rise (∆P) and rate (∆P/time) of attainment of specified pressure on
│    admission of any inert gasses (if used); f) maintenance of specified
│    conditions for the exposure time: 1) pressure differential used to
│    apply sterilant or inert gas make-ups (if used); 2) chamber tempera
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 21 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ocess definition it is important to consider the impact of the
│    selected processing parameters and their tolerances on the safety and
│    functionality of the product and its packaging. As there are a number
│    of parameters within a sterilization process, (temperature, humidity,
│    pressure changes/rates, EO concentration and time), it is impractical
│    to assess the tolerances of all combinations of all variables. A
│    determination should be made as to which variables will have the
│    greatest impact, and those should be assessed. Data supporting this
│    activity can be collected from alternative studies, e.g. product and
│    i
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 22 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    onditioning phase; 6) the temperature of the injected EO-gas should
│    be within the volatizer specification or above the boiling point of
│    EO (10,7°C at atmospheric pressure); 7) pressure rise and rate of
│    attainment on admission of EO and correlation of factors with which
│    it is intended to monitor EO concentration; 8) depth and rate of
│    attainment of vacuum used to remove EO; 9) pressure rise and rate of
│    attainment of pressure on admission of air (or other gases); 10)
│    number of times these last two stages are repeated and any variations
│    in successive repetitions; 11) the reliability of the supply of filte
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 23 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    time required to inject and remove EO in the chamber. These long
│    injection and vacuum times limit the ability to obtain the required
│    fractional recovery of indicator organisms. These inactivation curves
│    can be developed in a developmental chamber that can deliver
│    equivalent parameters especially EO concentration used in the
│    production chamber. Methods for demonstrating a relationship between
│    the data developed in the developmental chamber and a production
│    chamber involve a physical profile comparison and load density
│    comparison. The sterilization conditions delivered in the
│    developmental chamber should
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 24 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    re in conformance with the specifications established during the
│    validation for the specific product(s) in a defined load. Parametric
│    release is based upon a documented review of processing records
│    rather than the testing of biological indicators or PCDs. The values
│    and tolerances for both RH and EO concentration might need to be
│    generated after review of a predefined number of routine cycles.
│    During this evaluation period, BI’s might be used as part of the
│    routine monitoring and control of loads processed. The rationale for
│    the number of runs selected should be justified and recorded. This
│    can be influe
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 25 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    g product from sterilization as sterile without the use of BIs,
│    relying instead on a demonstration of conformity of the physical
│    processing parameters to all specifications. Therefore, data are
│    gathered for additional processing parameters such as direct analysis
│    of chamber relative humidity and EO concentration, in order to ensure
│    that the sterilization process has met specification. a) Temperature
│    measurement. The requirement to measure temperature within the
│    sterilizer from a minimum of two locations is established in order to
│    ensure that an undetected fault in a temperature sensor does not lead
│    to t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 26 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    t. The frequency of analysis required to demonstrate that the minimum
│    EO concentration is maintained throughout EO exposure should be
│    established during the PQ studies. Monitoring throughout the EO
│    exposure dwell period should also be done as part of the validation,
│    in order to determine how the EO concentration changes over time. The
│    results of this analysis are specific to the product and load
│    configuration being analysed. The analysis performed during the PQ
│    study will result in documented specifications for how often direct
│    analysis should be performed during the cycle. It is recommended that
│    when d
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 27 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    . The results of this analysis are specific to the product and load
│    configuration being analysed. The analysis performed during the PQ
│    study will result in documented specifications for how often direct
│    analysis should be performed during the cycle. It is recommended that
│    when direct analysis of EO concentration is performed, at a minimum,
│    direct analysis of EO concentration be performed during the first and
│    last portions of EO exposure. Particular attention should be given to
│    the measurement and documentation of humidity during conditioning and
│    that of EO concentration during exposure. The EO sampling
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 28 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    oad configuration being analysed. The analysis performed during the
│    PQ study will result in documented specifications for how often
│    direct analysis should be performed during the cycle. It is
│    recommended that when direct analysis of EO concentration is
│    performed, at a minimum, direct analysis of EO concentration be
│    performed during the first and last portions of EO exposure.
│    Particular attention should be given to the measurement and
│    documentation of humidity during conditioning and that of EO
│    concentration during exposure. The EO sampling device providing
│    direct EO concentration measurement using IR, G
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 29 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    inaccessible portion of the product. See D.7.1.6 for information on
│    the development of PCDs and D.8.6 for information on determining the
│    appropriateness of the internal PCD, placed within the sterile
│    barrier system of the product. The parameters that primarily affect
│    lethality are exposure time, EO concentration, humidity and
│    temperature. If an adjustment of parameters other than exposure time
│    is made, the overall effect to the cycle should be evaluated since
│    the adjustment might not achieve the desired result because the
│    parameters are interrelated. For example, the result of decreasing
│    temperature wou
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 30 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    e. If an adjustment of parameters other than exposure time is made,
│    the overall effect to the cycle should be evaluated since the
│    adjustment might not achieve the desired result because the
│    parameters are interrelated. For example, the result of decreasing
│    temperature would actually increase the EO concentration and the
│    relative humidity if no change is made to the pressure parameters.
│    The data obtained from process lethality studies are used to
│    establish the minimum EO gas exposure time required for the
│    sterilization process. If these studies are performed in a
│    developmental chamber, caution should be t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 31 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    or at selected minimum acceptable processing conditions. Utilizing
│    the allowed minimum process temperature for the enumeration study
│    ensures the required lethality is obtained when operating within the
│    specified temperature range. The parameters that primarily affect
│    lethality are exposure time, EO concentration, humidity, and
│    temperature. If an adjustment of parameters other than exposure time
│    is made, the overall effect to the cycle should be evaluated since
│    the adjustment might not achieve the desired result because the
│    parameters are interrelated. For example, the result of decreasing
│    temperature wo
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 32 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ature. If an adjustment of parameters other than exposure time is
│    made, the overall effect to the cycle should be evaluated since the
│    adjustment might not achieve the desired result because the
│    parameters are interrelated. For example, the result of decreasing
│    temperature would actually increase EO concentration and relative
│    humidity if no change is made to the steam injection pressure and the
│    EO injection pressure rise. D.14.2.5 [B.2.5] SLRs can be calculated
│    using the results of fractional cycles. If there are no surviving
│    internal PCDs, a worst-case estimate of the SLR can be obtained by
│    running the
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 33 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    tion cycle; c) aeration (if used). 6.2.3 The process variables for
│    preconditioning (if used) include at a minimum: a) time; b)
│    temperature; c) humidity; d) transfer time. 6.2.4 The process
│    variables for the sterilization cycle include: a) exposure time; b)
│    temperature; c) humidity; d) EO concentration; e) pressure. 6.2.5 The
│    process variables for aeration (if used) include at a minimum: a)
│    time; b) temperature. NOTE In aeration these parameters are
│    considered process variables only if aeration is considered to
│    contribute to ensuring the microbicidal effectiveness of the
│    sterilization proce
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 34 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    rate of change of air or other gas; 4) temperature of the
│    sterilization load. 9.5.5 If parametric release is to be used, the
│    validation report shall also specify: a) the value and tolerances for
│    chamber humidity by direct measurement during conditioning; b) the
│    value and tolerances for the EO concentration determined from direct
│    analysis of chamber atmosphere using analytical methods to establish
│    the process specification for routine processing. The sampling shall
│    be conducted at defined intervals sufficient to verify the required
│    conditions throughout EO exposure. c) temperature of the chamber;
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 35 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ically. 10.5 If parametric release is performed, the following
│    additional data shall be recorded and retained: a) temperature in the
│    chamber from a minimum of two locations throughout the sterilization
│    cycle; b) chamber humidity during conditioning as determined by
│    direct measurement; c) the EO concentration, determined from direct
│    analysis of chamber atmosphere using analytical methods at defined
│    intervals sufficient to verify the required conditions throughout the
│    exposure time. 11 Product release from sterilization 11.1 The
│    criteria for designating conformance of the sterilization process
│    used fo
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 36 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ty and rate (∆P/time) of attainment of pressure on injection of
│    steam; 2) number of steam pulse/vacuum stages, if applicable; e) EO
│    injection: 1) pressure, pressure rise (∆P) and rate (∆P/time) of
│    attainment of specified pressure on admission of EO and correlation
│    of methods used to monitor EO concentration; 2) pressure, pressure
│    rise (∆P) and rate (∆P/time) of attainment of specified pressure on
│    admission of any inert gasses (if used); f) maintenance of specified
│    conditions for the exposure time: 1) pressure differential used to
│    apply sterilant or inert gas make-ups (if used); 2) chamber tempera
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 37 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ss definition it is important to consider the impact of the selected
│    processing parameters and their tolerances on the safety and
│    functionality of the product and its packaging. As there are a number
│    of parameters within a sterilization process, (temperature, humidity,
│    pressure changes/rates, EO concentration and time), it is impractical
│    to assess the tolerances of all combinations of all variables. A
│    determination should be made as to which variables will have the
│    greatest impact, and those should be assessed. Data supporting this
│    activity can be collected from alternative studies, e.g. product and
│    i
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 38 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    r critical systems that could affect process conditions, such as
│    process automation, safety systems, etc.; j) the calibration of
│    instruments (e.g. sensors, recorders, gauges and test instruments)
│    that monitor, control, indicate or record parameters such as
│    temperature, humidity, pressure and EO concentration. ﻿ 48 © ISO
│    2014 – All rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 71
│    --- ﻿ ISO 11135:2014+A1:2018 k) the documented procedures for IQ
│    should specify how each element of this qualification is planned,
│    performed and reviewed. D.9.2.1.2 Guidance can be found in IEC
│    61010‑2‑40. D.9.2.1.
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 39 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    itioning phase; 6) the temperature of the injected EO-gas should be
│    within the volatizer specification or above the boiling point of EO
│    (10,7°C at atmospheric pressure); 7) pressure rise and rate of
│    attainment on admission of EO and correlation of factors with which
│    it is intended to monitor EO concentration; 8) depth and rate of
│    attainment of vacuum used to remove EO; 9) pressure rise and rate of
│    attainment of pressure on admission of air (or other gases); 10)
│    number of times these last two stages are repeated and any variations
│    in successive repetitions; 11) the reliability of the supply of filte
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 40 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    e required to inject and remove EO in the chamber. These long
│    injection and vacuum times limit the ability to obtain the required
│    fractional recovery of indicator organisms. These inactivation curves
│    can be developed in a developmental chamber that can deliver
│    equivalent parameters especially EO concentration used in the
│    production chamber. Methods for demonstrating a relationship between
│    the data developed in the developmental chamber and a production
│    chamber involve a physical profile comparison and load density
│    comparison. The sterilization conditions delivered in the
│    developmental chamber should
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 41 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    in conformance with the specifications established during the
│    validation for the specific product(s) in a defined load. Parametric
│    release is based upon a documented review of processing records
│    rather than the testing of biological indicators or PCDs. The values
│    and tolerances for both RH and EO concentration might need to be
│    generated after review of a predefined number of routine cycles.
│    During this evaluation period, BI’s might be used as part of the
│    routine monitoring and control of loads processed. The rationale for
│    the number of runs selected should be justified and recorded. This
│    can be influe
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 42 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    roduct from sterilization as sterile without the use of BIs, relying
│    instead on a demonstration of conformity of the physical processing
│    parameters to all specifications. Therefore, data are gathered for
│    additional processing parameters such as direct analysis of chamber
│    relative humidity and EO concentration, in order to ensure that the
│    sterilization process has met specification. a) Temperature
│    measurement. The requirement to measure temperature within the
│    sterilizer from a minimum of two locations is established in order to
│    ensure that an undetected fault in a temperature sensor does not lead
│    to t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 43 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    The frequency of analysis required to demonstrate that the minimum EO
│    concentration is maintained throughout EO exposure should be
│    established during the PQ studies. Monitoring throughout the EO
│    exposure dwell period should also be done as part of the validation,
│    in order to determine how the EO concentration changes over time. The
│    results of this analysis are specific to the product and load
│    configuration being analysed. The analysis performed during the PQ
│    study will result in documented specifications for how often direct
│    analysis should be performed during the cycle. It is recommended that
│    when d
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 44 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    he results of this analysis are specific to the product and load
│    configuration being analysed. The analysis performed during the PQ
│    study will result in documented specifications for how often direct
│    analysis should be performed during the cycle. It is recommended that
│    when direct analysis of EO concentration is performed, at a minimum,
│    direct analysis of EO concentration be performed during the first and
│    last portions of EO exposure. Particular attention should be given to
│    the measurement and documentation of humidity during conditioning and
│    that of EO concentration during exposure. The EO sampling
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 45 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    configuration being analysed. The analysis performed during the PQ
│    study will result in documented specifications for how often direct
│    analysis should be performed during the cycle. It is recommended that
│    when direct analysis of EO concentration is performed, at a minimum,
│    direct analysis of EO concentration be performed during the first and
│    last portions of EO exposure. Particular attention should be given to
│    the measurement and documentation of humidity during conditioning and
│    that of EO concentration during exposure. The EO sampling device
│    providing direct EO concentration measurement using IR, G
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 46 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    accuracy of the results from direct analysis should be determined
│    during PQ. Routine cycle analysis should fall within the determined
│    range for the cycle to be acceptable. It can be necessary to
│    introduce an equilibration time at the start of the EO dwell phase of
│    the cycle to allow the chamber concentration to stabilize as the EO
│    gas is distributed throughout the chamber and penetrates into the
│    void spaces in the load. NOTE 1 An electronic sensor measures EO gas
│    concentration at only one sample site, whereas the calculated EO gas
│    concentration represents the mean EO gas concentration within the spa
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 47 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    cupied by the EO gas molecules, potential stratification within the
│    chamber especially when the sterilant is made up of both EO and
│    diluent gas molecules, selective absorption and adsorption of EO in
│    the load and the volume taken up by the load, the values obtained by
│    calculating the mean EO gas concentration can differ considerably
│    from the direct measured value. NOTE 2 Health care facilities do not
│    routinely use parametric release. D.11 Product release from
│    sterilization D.11.1 This confirmation should include a formal review
│    of the process documentation by a designated individual (or by a
│    valida
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 48 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    accessible portion of the product. See D.7.1.6 for information on the
│    development of PCDs and D.8.6 for information on determining the
│    appropriateness of the internal PCD, placed within the sterile
│    barrier system of the product. The parameters that primarily affect
│    lethality are exposure time, EO concentration, humidity and
│    temperature. If an adjustment of parameters other than exposure time
│    is made, the overall effect to the cycle should be evaluated since
│    the adjustment might not achieve the desired result because the
│    parameters are interrelated. For example, the result of decreasing
│    temperature wou
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 49 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    If an adjustment of parameters other than exposure time is made, the
│    overall effect to the cycle should be evaluated since the adjustment
│    might not achieve the desired result because the parameters are
│    interrelated. For example, the result of decreasing temperature would
│    actually increase the EO concentration and the relative humidity if
│    no change is made to the pressure parameters. The data obtained from
│    process lethality studies are used to establish the minimum EO gas
│    exposure time required for the sterilization process. If these
│    studies are performed in a developmental chamber, caution should be t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 50 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    at selected minimum acceptable processing conditions. Utilizing the
│    allowed minimum process temperature for the enumeration study ensures
│    the required lethality is obtained when operating within the
│    specified temperature range. The parameters that primarily affect
│    lethality are exposure time, EO concentration, humidity, and
│    temperature. If an adjustment of parameters other than exposure time
│    is made, the overall effect to the cycle should be evaluated since
│    the adjustment might not achieve the desired result because the
│    parameters are interrelated. For example, the result of decreasing
│    temperature wo
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 51 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    re. If an adjustment of parameters other than exposure time is made,
│    the overall effect to the cycle should be evaluated since the
│    adjustment might not achieve the desired result because the
│    parameters are interrelated. For example, the result of decreasing
│    temperature would actually increase EO concentration and relative
│    humidity if no change is made to the steam injection pressure and the
│    EO injection pressure rise. D.14.2.5 [B.2.5] SLRs can be calculated
│    using the results of fractional cycles. If there are no surviving
│    internal PCDs, a worst-case estimate of the SLR can be obtained by
│    running the
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 52 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: gas concentration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    e occupied by the EO gas molecules, potential stratification within
│    the chamber especially when the sterilant is made up of both EO and
│    diluent gas molecules, selective absorption and adsorption of EO in
│    the load and the volume taken up by the load, the values obtained by
│    calculating the mean EO gas concentration can differ considerably
│    from the direct measured value. NOTE 2 Health care facilities do not
│    routinely use parametric release. D.11 Product release from
│    sterilization D.11.1 This confirmation should include a formal review
│    of the process documentation by a designated individual (or by a
│    valida
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 53 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 2.5/5.0
│
│  Context:
│    e maintained and to avoid stratification of gases that might have an
│    impact on microbial lethality. (See D.6.3.2). h) No guidance offered.
│    i) Pressure rise of EO injection (∆P) provides an indirect measure of
│    the mean EO gas concentration in the available space within the
│    sterilizer chamber. As EO concentration is a key variable affecting
│    the efficacy of the sterilization process, it is considered essential
│    that a separate second system be provided for documenting that the
│    pressure rise is due to EO admission (see AAMI TIR15[25] for more
│    information). During EO injection and EO exposure phases of the s
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 54 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: ethylene oxide
│  Relevance Score: 2.5/5.0
│
│  Context:
│    10,11,12 This relevant Essential Requirement is only partly addressed
│    in this European Standard. This Essential Requirement is addressed
│    only with regard to devices for which sterilization by ethylene oxide
│    is appropriate. Aspects of manufacture other than those related to
│    sterilization by ethylene oxide are not covered. WARNING 1 —
│    Presumption of conformity stays valid only as long as a reference to
│    this European Standard is maintained in the list published in the
│    Official Journal of the European Union. Users of this standard should
│    consult frequently the latest list published in the Official
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 55 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: ethylene oxide
│  Relevance Score: 2.5/5.0
│
│  Context:
│    of manufacture other than those related to sterilization by ethylene
│    oxide are not covered. B.2.4 4,5,6,7,8,9,10,11,12 This relevant
│    Essential requirement is addressed only with regard to:
│    sterilization, not covering other special microbiological state
│    devices for which sterilization by ethylene oxide is appropriate
│    WARNING 1 — Presumption of conformity stays valid only as long as a
│    reference to this European Standard is maintained in the list
│    published in the Official Journal of the European Union. Users of
│    this standard should consult frequently the latest list published in
│    the Official Jo
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 56 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: ethylene oxide
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ual to the partial pressure of the water vapour in the atmosphere
│    Note 1 to entry: Any cooling of the atmosphere below the dew point
│    would produce water condensation. 3.11 establish determine by
│    theoretical evaluation and confirm by experimentation [SOURCE: ISO/TS
│    11139:2006, definition 2.17] 3.12 ethylene oxide (EO) injection time
│    duration of the stage beginning with the first introduction of the EO
│    (mixture) into the chamber to the completion of that injection 3.13
│    exposure time period for which the process parameters are maintained
│    within their specified tolerances [SOURCE: ISO/TS 11139:2006,
│    definitio
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 57 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: ethylene oxide
│  Relevance Score: 2.5/5.0
│
│  Context:
│    f cycle lethality, it is the period of sterilization between the end
│    of EO injection and the beginning of EO removal. 3.14 fault one or
│    more of the process parameters lying outside of its/their specified
│    tolerance(s) [SOURCE: ISO/TS 11139:2006, definition 2.19] 3.15
│    flushing procedure by which the ethylene oxide is removed from the
│    load and chamber by either multiple alternate admissions of filtered
│    air, inert gas or steam and evacuations of the chamber or continuous
│    passage of filtered air, inert gas or steam through the load and
│    chamber 3.16 fractional cycle a cycle in which the exposure time to
│    EO gas
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 58 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: ethylene oxide
│  Relevance Score: 2.5/5.0
│
│  Context:
│    9:2006, definition 2.48] 3.50 sterilization process series of actions
│    or operations needed to achieve the specified requirements for
│    sterility [SOURCE: ISO/TS 11139:2006, definition 2.49] Note 1 to
│    entry: This series of actions or operations includes preconditioning
│    (if necessary), exposure to the ethylene oxide under defined
│    conditions and any necessary post-treatment required for the removal
│    of ethylene oxide and its by-products. It does not include any
│    cleaning, disinfection or packaging operations that precede the
│    sterilization process. ﻿ © ISO 2014 – All rights reserved 9 BS EN
│    ISO 11135:2014+A1:20
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 59 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: ethylene oxide
│  Relevance Score: 2.5/5.0
│
│  Context:
│    h a mixture can be assessed by measuring the relative proportions of
│    EO, air, diluent gas (e.g. CO2, etc.), inert gas (e.g. nitrogen) and
│    water vapour in the sterilizer. Caution should be exercised to ensure
│    no separation of the EO blend can occur as this might lead to safety
│    and quality issues. Ethylene oxide sterilizers should be installed in
│    a dedicated room. The operating controls for the sterilization
│    equipment should be mounted outside the room so that operators can
│    set or change program parameters without entering the sterilization
│    room. All airflow from the sterilizer access area should be exh
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 60 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: ethylene oxide
│  Relevance Score: 2.5/5.0
│
│  Context:
│    t, control and laboratory use — Part 2-040: Particular requirements
│    for sterilizers and washer-disinfectors used to treat medical
│    materials 2) To be published. ﻿ © ISO 2014 – All rights reserved 77
│    BS EN ISO 11135:2014+A1:2019 --- PAGE 100 --- ﻿ ISO
│    11135:2014+A1:2018 [22] ANSI/AAMI ST41:1999, Ethylene oxide
│    sterilization in health care facilities: Safety and effectiveness
│    [23] ANSI/AAMI ST67. Sterilization medical devices — Requirements for
│    products labeled ‘STERILE. AAMI, Arlington, VA, 2006 [24] AAMI TIR15.
│    Physical aspects of ethylene oxide. AAMI, Arlington, VA, 2009 [25]
│    AAMI TIR16. 2009
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 61 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: ethylene oxide
│  Relevance Score: 2.5/5.0
│
│  Context:
│    tal Sterilization Laboratory, Minneapolis, Fifth Edition, 1988, pp.
│    83–100. [33] Mosley G.A. Estimating the effects of EtO BIER-Vessel
│    Operating Precision on D-value Calculations, Medical Device &
│    Diagnostic Industry, April 2002 [34] Mosley G.A., & Gillis J.R.
│    Factors Affecting Tailing in Ethylene Oxide Sterilization. Part 1:
│    When Tailing is an Artifact and Scientific Deficiencies in ISO 11135
│    and EN 550. PDA J. Pharm. Sci. Technol. 2004, 58 (2) pp. 81–95 [35]
│    Mosley G.A., Gillis J.R., Krushefski G. Evaluating the formulae for
│    integrated lethality in ethylene oxide sterilization using si
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 62 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: ethylene oxide
│  Relevance Score: 2.5/5.0
│
│  Context:
│    s Affecting Tailing in Ethylene Oxide Sterilization. Part 1: When
│    Tailing is an Artifact and Scientific Deficiencies in ISO 11135 and
│    EN 550. PDA J. Pharm. Sci. Technol. 2004, 58 (2) pp. 81–95 [35]
│    Mosley G.A., Gillis J.R., Krushefski G. Evaluating the formulae for
│    integrated lethality in ethylene oxide sterilization using six
│    different endospore forming strains of bacteria, and comparisons of
│    integrated lethality for ethylene oxide and steam systems. PDA J.
│    Pharm. Sci. Technol. 2005, 59 (1) pp. 64–86 [36] Mosley G.A., Gillis
│    J.R., Whitbourne J.E. Formulae for Calculations of Integrated L
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 63 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: ethylene oxide
│  Relevance Score: 2.5/5.0
│
│  Context:
│    d EN 550. PDA J. Pharm. Sci. Technol. 2004, 58 (2) pp. 81–95 [35]
│    Mosley G.A., Gillis J.R., Krushefski G. Evaluating the formulae for
│    integrated lethality in ethylene oxide sterilization using six
│    different endospore forming strains of bacteria, and comparisons of
│    integrated lethality for ethylene oxide and steam systems. PDA J.
│    Pharm. Sci. Technol. 2005, 59 (1) pp. 64–86 [36] Mosley G.A., Gillis
│    J.R., Whitbourne J.E. Formulae for Calculations of Integrated
│    Lethality for EtO Sterilization Processes, Refining the Concepts and
│    Exploring the Applications. Pharm. Tech. 2002, 26 (10) pp. 11
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 64 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: ethylene oxide
│  Relevance Score: 2.5/5.0
│
│  Context:
│    S. ed.). Lippincott, Williams & Wilkins, Philadelphia, 2001, pp.
│    79–129. [39] Rodriguez A.C., Young B., Caulk K., Zelewski J.,
│    Dwasnica S., Aguirre S. Calculating Accumulated Lethality and
│    Survivorship in EtO Sterilization Processes. MD. 2001 September, p. 1
│    [40] West K . L . Ethylene oxide sterilization: A study of resistance
│    relationships. In: Sterilization of Medical Products, (Gaughran E., &
│    Kereluk K. eds.). Johnson & Johnson, New Brunswick, NJ, 1977 3)
│    Revision of 2003 version under preparation. ﻿ 78 © ISO 2014 – All
│    rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 65 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: ethylene oxide
│  Relevance Score: 2.5/5.0
│
│  Context:
│    and the survival-curve method (EN). Biomed. Instrum. Technol. 1995,
│    29 (2) pp. 113–124 [42] Stumbo C.R., Murphy J.R., Cochran J. Nature
│    of Thermal Death Time Curves for P.A. 3679 and Clostridium Botulinum.
│    Food Technol. 1950, 4 pp. 321–326 [43] USP Monograph on Biological
│    Indicator for Ethylene Oxide Sterilization, Paper Carrier, USP36–
│    NF31 (2013), page 2659 ﻿ © ISO 2014 – All rights reserved 79 BS EN
│    ISO 11135:2014+A1:2019 --- PAGE 102 --- This page deliberately left
│    blank BSI is the national body responsible for preparing British
│    Standards and other standards-related publications, informa
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 66 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ant when gas mixtures are used in order to ensure uniform conditions
│    are maintained and to avoid stratification of gases that might have
│    an impact on microbial lethality. (See D.6.3.2). h) No guidance
│    offered. i) Pressure rise of EO injection (∆P) provides an indirect
│    measure of the mean EO gas concentration in the available space
│    within the sterilizer chamber. As EO concentration is a key variable
│    affecting the efficacy of the sterilization process, it is considered
│    essential that a separate second system be provided for documenting
│    that the pressure rise is due to EO admission (see AAMI TIR15[25]
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 67 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 2.5/5.0
│
│  Context:
│    aintained and to avoid stratification of gases that might have an
│    impact on microbial lethality. (See D.6.3.2). h) No guidance offered.
│    i) Pressure rise of EO injection (∆P) provides an indirect measure of
│    the mean EO gas concentration in the available space within the
│    sterilizer chamber. As EO concentration is a key variable affecting
│    the efficacy of the sterilization process, it is considered essential
│    that a separate second system be provided for documenting that the
│    pressure rise is due to EO admission (see AAMI TIR15[25] for more
│    information). During EO injection and EO exposure phases of the s
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 68 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 2.5/5.0
│
│  Context:
│    weight. c) Other process parameters that might be considered include:
│    1) vacuum depth and rate of evacuation (∆P/time) at selected times
│    during the cycle; 2) humidification time and steam injection rate
│    (∆P/time); 3) EO injection temperature and rate (∆P/time) and the
│    amount of EO used (weight, concentration, or pressure); and 4) air or
│    nitrogen injection rate (∆P/time). An analysis of the process data
│    are used to indicate that the processes are or are not equivalent in
│    their ability to meet the existing process parameter limits and any
│    additional acceptance criteria. The data generated should be a
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 69 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: gas concentration
│  Relevance Score: 2.5/5.0
│
│  Context:
│    portant when gas mixtures are used in order to ensure uniform
│    conditions are maintained and to avoid stratification of gases that
│    might have an impact on microbial lethality. (See D.6.3.2). h) No
│    guidance offered. i) Pressure rise of EO injection (∆P) provides an
│    indirect measure of the mean EO gas concentration in the available
│    space within the sterilizer chamber. As EO concentration is a key
│    variable affecting the efficacy of the sterilization process, it is
│    considered essential that a separate second system be provided for
│    documenting that the pressure rise is due to EO admission (see AAMI
│    TIR15[25]
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 70 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ent, ensure that a correlation is made during IQ or OQ to the
│    pressure rise); — if humidity is not controlled by sensor readings,
│    means to monitor and control steam additions; — if parametric release
│    is used, analytical instrumentation for the direct analysis of
│    humidity during conditioning and EO concentration during EO exposure
│    time (also see 9.5.5 and D.9.5.5); — a system controlling the
│    admission of gaseous EO to the chamber; — means to demonstrate that
│    gaseous EO is injected into the chamber. This can be done by
│    measuring the temperature of the EO gas flowing from the vaporizer to
│    the sterilizer c
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 71 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 2.0/5.0
│
│  Context:
│    e 9.5.5 and D.9.5.5); — a system controlling the admission of gaseous
│    EO to the chamber; — means to demonstrate that gaseous EO is injected
│    into the chamber. This can be done by measuring the temperature of
│    the EO gas flowing from the vaporizer to the sterilizer chamber. This
│    system can control EO concentration during EO exposure time. — means
│    to detect and alert deviations to cycle parameters so that remedial
│    action can be taken in a timely fashion. ﻿ © ISO 2014 – All rights
│    reserved 37 BS EN ISO 11135:2014+A1:2019 --- PAGE 60 --- ﻿ ISO
│    11135:2014+A1:2018 c) Aeration area characterization. An aeratio
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 72 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 2.0/5.0
│
│  Context:
│    rational during sterilant dwell; f) temperature set point and range
│    within the sterilization chamber; g) humidity control set point
│    (pressure or %RH) and range within the sterilization chamber
│    environment; h) EO and diluent gas (if used) injection pressure set
│    point and range; this will include EO concentration if EO analysis
│    equipment is installed on the sterilization chamber; ﻿ 44 © ISO 2014
│    – All rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 67 --- ﻿
│    ISO 11135:2014+A1:2018 i) EO dwell time; j) setting for the
│    in-chamber gas flushing prior to the removal of the load from the
│    sterilization
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 73 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: EO concentration
│  Relevance Score: 2.0/5.0
│
│  Context:
│    information). During EO injection and EO exposure phases of the
│    sterilization process, EO is absorbed by product and packaging
│    materials, which influences the correlation between the control
│    measure (pressure differential) and the secondary measure (i.e. mass
│    of EO dispensed or direct measure of EO concentration). j) Since EO
│    injection times can vary from cycle to cycle, it is common practice
│    to specify a time range for an acceptable EO injection time. k) No
│    guidance offered. l) No guidance offered. m) The time taken for
│    evacuation immediately after EO exposure can vary from cycle to
│    cycle; it is com
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 74 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 2.0/5.0
│
│  Context:
│    , ensure that a correlation is made during IQ or OQ to the pressure
│    rise); — if humidity is not controlled by sensor readings, means to
│    monitor and control steam additions; — if parametric release is used,
│    analytical instrumentation for the direct analysis of humidity during
│    conditioning and EO concentration during EO exposure time (also see
│    9.5.5 and D.9.5.5); — a system controlling the admission of gaseous
│    EO to the chamber; — means to demonstrate that gaseous EO is injected
│    into the chamber. This can be done by measuring the temperature of
│    the EO gas flowing from the vaporizer to the sterilizer c
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 75 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 2.0/5.0
│
│  Context:
│    .5.5 and D.9.5.5); — a system controlling the admission of gaseous EO
│    to the chamber; — means to demonstrate that gaseous EO is injected
│    into the chamber. This can be done by measuring the temperature of
│    the EO gas flowing from the vaporizer to the sterilizer chamber. This
│    system can control EO concentration during EO exposure time. — means
│    to detect and alert deviations to cycle parameters so that remedial
│    action can be taken in a timely fashion. ﻿ © ISO 2014 – All rights
│    reserved 37 BS EN ISO 11135:2014+A1:2019 --- PAGE 60 --- ﻿ ISO
│    11135:2014+A1:2018 c) Aeration area characterization. An aeratio
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 76 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ional during sterilant dwell; f) temperature set point and range
│    within the sterilization chamber; g) humidity control set point
│    (pressure or %RH) and range within the sterilization chamber
│    environment; h) EO and diluent gas (if used) injection pressure set
│    point and range; this will include EO concentration if EO analysis
│    equipment is installed on the sterilization chamber; ﻿ 44 © ISO 2014
│    – All rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 67 --- ﻿
│    ISO 11135:2014+A1:2018 i) EO dwell time; j) setting for the
│    in-chamber gas flushing prior to the removal of the load from the
│    sterilization
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 77 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ormation). During EO injection and EO exposure phases of the
│    sterilization process, EO is absorbed by product and packaging
│    materials, which influences the correlation between the control
│    measure (pressure differential) and the secondary measure (i.e. mass
│    of EO dispensed or direct measure of EO concentration). j) Since EO
│    injection times can vary from cycle to cycle, it is common practice
│    to specify a time range for an acceptable EO injection time. k) No
│    guidance offered. l) No guidance offered. m) The time taken for
│    evacuation immediately after EO exposure can vary from cycle to
│    cycle; it is com
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 78 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 2.0/5.0
│
│  Context:
│    It can be necessary to introduce an equilibration time at the start
│    of the EO dwell phase of the cycle to allow the chamber concentration
│    to stabilize as the EO gas is distributed throughout the chamber and
│    penetrates into the void spaces in the load. NOTE 1 An electronic
│    sensor measures EO gas concentration at only one sample site, whereas
│    the calculated EO gas concentration represents the mean EO gas
│    concentration within the space (volume) available for EO gas
│    molecules to reside. Due to several factors, such as EO sensor
│    dynamic performance characteristics, placement of the EO sensor
│    within the v
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 79 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 2.0/5.0
│
│  Context:
│    f the EO dwell phase of the cycle to allow the chamber concentration
│    to stabilize as the EO gas is distributed throughout the chamber and
│    penetrates into the void spaces in the load. NOTE 1 An electronic
│    sensor measures EO gas concentration at only one sample site, whereas
│    the calculated EO gas concentration represents the mean EO gas
│    concentration within the space (volume) available for EO gas
│    molecules to reside. Due to several factors, such as EO sensor
│    dynamic performance characteristics, placement of the EO sensor
│    within the volume occupied by the EO gas molecules, potential
│    stratification with
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 80 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ow the chamber concentration to stabilize as the EO gas is
│    distributed throughout the chamber and penetrates into the void
│    spaces in the load. NOTE 1 An electronic sensor measures EO gas
│    concentration at only one sample site, whereas the calculated EO gas
│    concentration represents the mean EO gas concentration within the
│    space (volume) available for EO gas molecules to reside. Due to
│    several factors, such as EO sensor dynamic performance
│    characteristics, placement of the EO sensor within the volume
│    occupied by the EO gas molecules, potential stratification within the
│    chamber especially when the steril
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 81 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: concentration
│  Relevance Score: 2.0/5.0
│
│  Context:
│    the cycle (e.g. beginning and/or end of conditioning). This parameter
│    can be measured directly or can be based on pressure rise due to
│    steam injection; 2) chamber process temperature at selected times
│    during the cycle (e.g. end of conditioning or during the EO dwell
│    period); 3) chamber EO gas concentration at selected times during EO
│    dwell period during the cycle (if measured), or EO pressure rise or
│    gas weight. c) Other process parameters that might be considered
│    include: 1) vacuum depth and rate of evacuation (∆P/time) at selected
│    times during the cycle; 2) humidification time and steam injecti
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 82 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: gas concentration
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ble. It can be necessary to introduce an equilibration time at the
│    start of the EO dwell phase of the cycle to allow the chamber
│    concentration to stabilize as the EO gas is distributed throughout
│    the chamber and penetrates into the void spaces in the load. NOTE 1
│    An electronic sensor measures EO gas concentration at only one sample
│    site, whereas the calculated EO gas concentration represents the mean
│    EO gas concentration within the space (volume) available for EO gas
│    molecules to reside. Due to several factors, such as EO sensor
│    dynamic performance characteristics, placement of the EO sensor
│    within the v
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 83 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: gas concentration
│  Relevance Score: 2.0/5.0
│
│  Context:
│    rt of the EO dwell phase of the cycle to allow the chamber
│    concentration to stabilize as the EO gas is distributed throughout
│    the chamber and penetrates into the void spaces in the load. NOTE 1
│    An electronic sensor measures EO gas concentration at only one sample
│    site, whereas the calculated EO gas concentration represents the mean
│    EO gas concentration within the space (volume) available for EO gas
│    molecules to reside. Due to several factors, such as EO sensor
│    dynamic performance characteristics, placement of the EO sensor
│    within the volume occupied by the EO gas molecules, potential
│    stratification with
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 84 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: gas concentration
│  Relevance Score: 2.0/5.0
│
│  Context:
│    allow the chamber concentration to stabilize as the EO gas is
│    distributed throughout the chamber and penetrates into the void
│    spaces in the load. NOTE 1 An electronic sensor measures EO gas
│    concentration at only one sample site, whereas the calculated EO gas
│    concentration represents the mean EO gas concentration within the
│    space (volume) available for EO gas molecules to reside. Due to
│    several factors, such as EO sensor dynamic performance
│    characteristics, placement of the EO sensor within the volume
│    occupied by the EO gas molecules, potential stratification within the
│    chamber especially when the steril
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 85 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: gas concentration
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ring the cycle (e.g. beginning and/or end of conditioning). This
│    parameter can be measured directly or can be based on pressure rise
│    due to steam injection; 2) chamber process temperature at selected
│    times during the cycle (e.g. end of conditioning or during the EO
│    dwell period); 3) chamber EO gas concentration at selected times
│    during EO dwell period during the cycle (if measured), or EO pressure
│    rise or gas weight. c) Other process parameters that might be
│    considered include: 1) vacuum depth and rate of evacuation (∆P/time)
│    at selected times during the cycle; 2) humidification time and steam
│    injecti
│
└───────────────────────────────────────────────────────────────────────────────


CATEGORY: PRESSURE

┌─ PARAMETER 01 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.5/5.0
│
│  Context:
│    /TS 11139:2006, definition 2.6] 3.7 conditioning treatment of product
│    within the sterilization cycle, but prior to ethylene oxide
│    admission, to attain a predetermined temperature and relative
│    humidity Note 1 to entry: This part of the sterilization cycle can be
│    carried out either at atmospheric pressure or under vacuum. Note 2 to
│    entry: See 3.27, preconditioning. ﻿ © ISO 2014 – All rights reserved
│    3 BS EN ISO 11135:2014+A1:2019 --- PAGE 26 --- ﻿ ISO
│    11135:2014+A1:2018 3.8 D value D10 value time or dose required to
│    achieve inactivation of 90 % of a population of the test
│    microorganism under sta
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 02 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.5/5.0
│
│  Context:
│    terminal pressure) and rate (ΔP/time) of attainment of vacuum to
│    remove EO; ﻿ 36 © ISO 2014 – All rights reserved BS EN ISO
│    11135:2014+A1:2019 --- PAGE 59 --- ﻿ ISO 11135:2014+A1:2018 3) number
│    of times of repetition and any variations in successive repetitions;
│    i) air/inert gas admission: 1) pressure (ΔP or terminal pressure) and
│    rate (ΔP/time) of attainment of pressure on admission of the inert
│    gas or air; 2) number of times of repetition and any variations in
│    successive repetitions; 3) equilibration to atmospheric pressure
│    using air admission. D.6.2.5 Recirculation velocity should be spec
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 03 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.5/5.0
│
│  Context:
│    ate (ΔP/time) of attainment of vacuum to remove EO; ﻿ 36 © ISO 2014
│    – All rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 59 --- ﻿
│    ISO 11135:2014+A1:2018 3) number of times of repetition and any
│    variations in successive repetitions; i) air/inert gas admission: 1)
│    pressure (ΔP or terminal pressure) and rate (ΔP/time) of attainment
│    of pressure on admission of the inert gas or air; 2) number of times
│    of repetition and any variations in successive repetitions; 3)
│    equilibration to atmospheric pressure using air admission. D.6.2.5
│    Recirculation velocity should be specified when assessing prod
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 04 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.5/5.0
│
│  Context:
│    er temperature at each time point should be obtained after an
│    equilibration period. When the OQ exercise is carried out using a
│    loaded chamber, then the ± 3 °C tolerance might not be achievable. 4)
│    chamber leak rate (performed either under vacuum for subatmospheric
│    cycles or under vacuum and at pressure for superatmospheric cycles);
│    5) pressure rise on injection of steam during the conditioning phase;
│    6) the temperature of the injected EO-gas should be within the
│    volatizer specification or above the boiling point of EO (10,7°C at
│    atmospheric pressure); 7) pressure rise and rate of attainment o
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 05 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.5/5.0
│
│  Context:
│    e obtained after an equilibration period. When the OQ exercise is
│    carried out using a loaded chamber, then the ± 3 °C tolerance might
│    not be achievable. 4) chamber leak rate (performed either under
│    vacuum for subatmospheric cycles or under vacuum and at pressure for
│    superatmospheric cycles); 5) pressure rise on injection of steam
│    during the conditioning phase; 6) the temperature of the injected
│    EO-gas should be within the volatizer specification or above the
│    boiling point of EO (10,7°C at atmospheric pressure); 7) pressure
│    rise and rate of attainment on admission of EO and correlation of
│    factor
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 06 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.5/5.0
│
│  Context:
│    ubatmospheric cycles or under vacuum and at pressure for
│    superatmospheric cycles); 5) pressure rise on injection of steam
│    during the conditioning phase; 6) the temperature of the injected
│    EO-gas should be within the volatizer specification or above the
│    boiling point of EO (10,7°C at atmospheric pressure); 7) pressure
│    rise and rate of attainment on admission of EO and correlation of
│    factors with which it is intended to monitor EO concentration; 8)
│    depth and rate of attainment of vacuum used to remove EO; 9) pressure
│    rise and rate of attainment of pressure on admission of air (or other
│    gases); 1
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 07 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.5/5.0
│
│  Context:
│    ycles or under vacuum and at pressure for superatmospheric cycles);
│    5) pressure rise on injection of steam during the conditioning phase;
│    6) the temperature of the injected EO-gas should be within the
│    volatizer specification or above the boiling point of EO (10,7°C at
│    atmospheric pressure); 7) pressure rise and rate of attainment on
│    admission of EO and correlation of factors with which it is intended
│    to monitor EO concentration; 8) depth and rate of attainment of
│    vacuum used to remove EO; 9) pressure rise and rate of attainment of
│    pressure on admission of air (or other gases); 10) number of t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 08 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.5/5.0
│
│  Context:
│    olatizer specification or above the boiling point of EO (10,7°C at
│    atmospheric pressure); 7) pressure rise and rate of attainment on
│    admission of EO and correlation of factors with which it is intended
│    to monitor EO concentration; 8) depth and rate of attainment of
│    vacuum used to remove EO; 9) pressure rise and rate of attainment of
│    pressure on admission of air (or other gases); 10) number of times
│    these last two stages are repeated and any variations in successive
│    repetitions; 11) the reliability of the supply of filtered air, inert
│    gasses, water and steam; 12) replicate cycles should be carri
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 09 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.5/5.0
│
│  Context:
│    ling point of EO (10,7°C at atmospheric pressure); 7) pressure rise
│    and rate of attainment on admission of EO and correlation of factors
│    with which it is intended to monitor EO concentration; 8) depth and
│    rate of attainment of vacuum used to remove EO; 9) pressure rise and
│    rate of attainment of pressure on admission of air (or other gases);
│    10) number of times these last two stages are repeated and any
│    variations in successive repetitions; 11) the reliability of the
│    supply of filtered air, inert gasses, water and steam; 12) replicate
│    cycles should be carried out to demonstrate the repeatability
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 10 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 3.5/5.0
│
│  Context:
│    inition 2.6] 3.7 conditioning treatment of product within the
│    sterilization cycle, but prior to ethylene oxide admission, to attain
│    a predetermined temperature and relative humidity Note 1 to entry:
│    This part of the sterilization cycle can be carried out either at
│    atmospheric pressure or under vacuum. Note 2 to entry: See 3.27,
│    preconditioning. ﻿ © ISO 2014 – All rights reserved 3 BS EN ISO
│    11135:2014+A1:2019 --- PAGE 26 --- ﻿ ISO 11135:2014+A1:2018 3.8 D
│    value D10 value time or dose required to achieve inactivation of 90 %
│    of a population of the test microorganism under stated conditions [S
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 11 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 3.5/5.0
│
│  Context:
│    recorded chamber temperature at each time point should be obtained
│    after an equilibration period. When the OQ exercise is carried out
│    using a loaded chamber, then the ± 3 °C tolerance might not be
│    achievable. 4) chamber leak rate (performed either under vacuum for
│    subatmospheric cycles or under vacuum and at pressure for
│    superatmospheric cycles); 5) pressure rise on injection of steam
│    during the conditioning phase; 6) the temperature of the injected
│    EO-gas should be within the volatizer specification or above the
│    boiling point of EO (10,7°C at atmospheric pressure); 7) pressure
│    rise and rate
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 12 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 3.5/5.0
│
│  Context:
│    EO-gas should be within the volatizer specification or above the
│    boiling point of EO (10,7°C at atmospheric pressure); 7) pressure
│    rise and rate of attainment on admission of EO and correlation of
│    factors with which it is intended to monitor EO concentration; 8)
│    depth and rate of attainment of vacuum used to remove EO; 9) pressure
│    rise and rate of attainment of pressure on admission of air (or other
│    gases); 10) number of times these last two stages are repeated and
│    any variations in successive repetitions; 11) the reliability of the
│    supply of filtered air, inert gasses, water and steam; 12)
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 13 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: atmospheric pressure
│  Relevance Score: 3.5/5.0
│
│  Context:
│    [SOURCE: ISO/TS 11139:2006, definition 2.6] 3.7 conditioning
│    treatment of product within the sterilization cycle, but prior to
│    ethylene oxide admission, to attain a predetermined temperature and
│    relative humidity Note 1 to entry: This part of the sterilization
│    cycle can be carried out either at atmospheric pressure or under
│    vacuum. Note 2 to entry: See 3.27, preconditioning. ﻿ © ISO 2014 –
│    All rights reserved 3 BS EN ISO 11135:2014+A1:2019 --- PAGE 26 --- ﻿
│    ISO 11135:2014+A1:2018 3.8 D value D10 value time or dose required to
│    achieve inactivation of 90 % of a population of the test
│    microorganism under sta
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 14 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: atmospheric pressure
│  Relevance Score: 3.5/5.0
│
│  Context:
│    vacuum for subatmospheric cycles or under vacuum and at pressure for
│    superatmospheric cycles); 5) pressure rise on injection of steam
│    during the conditioning phase; 6) the temperature of the injected
│    EO-gas should be within the volatizer specification or above the
│    boiling point of EO (10,7°C at atmospheric pressure); 7) pressure
│    rise and rate of attainment on admission of EO and correlation of
│    factors with which it is intended to monitor EO concentration; 8)
│    depth and rate of attainment of vacuum used to remove EO; 9) pressure
│    rise and rate of attainment of pressure on admission of air (or other
│    gases); 1
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 15 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    holding time under vacuum (if used); NOTE The rate of evacuation is
│    commonly specified as either a minimum allowed evacuation time, a
│    maximum allowed evacuation time or as an acceptable range of
│    evacuation times, rather than the specific time for each run. d)
│    inert gas flushing (if used): 1) pressure (ΔP or terminal pressure)
│    and rate (∆P/time) of attainment of pressure associated with inert
│    gas/steam; 2) depth (∆P or terminal pressure) and rate (∆P/time) of
│    attainment of vacuum; 3) number of times of repetition and any
│    variations in successive repetitions; e) conditioning and/or humidity
│    d
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 16 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    um (if used); NOTE The rate of evacuation is commonly specified as
│    either a minimum allowed evacuation time, a maximum allowed
│    evacuation time or as an acceptable range of evacuation times, rather
│    than the specific time for each run. d) inert gas flushing (if used):
│    1) pressure (ΔP or terminal pressure) and rate (∆P/time) of
│    attainment of pressure associated with inert gas/steam; 2) depth (∆P
│    or terminal pressure) and rate (∆P/time) of attainment of vacuum; 3)
│    number of times of repetition and any variations in successive
│    repetitions; e) conditioning and/or humidity dwell phases (if used):
│    1)
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 17 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    commonly specified as either a minimum allowed evacuation time, a
│    maximum allowed evacuation time or as an acceptable range of
│    evacuation times, rather than the specific time for each run. d)
│    inert gas flushing (if used): 1) pressure (ΔP or terminal pressure)
│    and rate (∆P/time) of attainment of pressure associated with inert
│    gas/steam; 2) depth (∆P or terminal pressure) and rate (∆P/time) of
│    attainment of vacuum; 3) number of times of repetition and any
│    variations in successive repetitions; e) conditioning and/or humidity
│    dwell phases (if used): 1) pressure levels and/or rate of attainment
│    of
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 18 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    t of vacuum; 2) pressure (∆P or terminal pressure) and rate (∆P/time)
│    of attainment of pressure associated with inert gas/air/steam; 3)
│    number of times of repetition and any variations in successive
│    repetitions; h) aeration (if used): 1) time and temperature within
│    the chamber and/or room; 2) pressure changes (if any) within the
│    chamber and/or room; 3) rate of change of air or other gas; 4)
│    temperature of the sterilization load. 9.5.5 If parametric release is
│    to be used, the validation report shall also specify: a) the value
│    and tolerances for chamber humidity by direct measurement during co
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 19 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ycles), if applicable: 1) stabilization period and/or hold time; 2)
│    pressure change; c) inert gas addition (if used); 1) pressure (∆P or
│    terminal pressure) and rate (∆P/time) of attainment of pressure on
│    admission of the inert gas. d) conditioning (if used); 1) during the
│    conditioning phase, pressure rise (∆P or terminal pressure) or %
│    relative humidity and rate (∆P/time) of attainment of pressure on
│    injection of steam; 2) number of steam pulse/vacuum stages, if
│    applicable; e) EO injection: 1) pressure, pressure rise (∆P) and rate
│    (∆P/time) of attainment of specified pressure on admission
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 20 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    bilization period and/or hold time; 2) pressure change; c) inert gas
│    addition (if used); 1) pressure (∆P or terminal pressure) and rate
│    (∆P/time) of attainment of pressure on admission of the inert gas. d)
│    conditioning (if used); 1) during the conditioning phase, pressure
│    rise (∆P or terminal pressure) or % relative humidity and rate
│    (∆P/time) of attainment of pressure on injection of steam; 2) number
│    of steam pulse/vacuum stages, if applicable; e) EO injection: 1)
│    pressure, pressure rise (∆P) and rate (∆P/time) of attainment of
│    specified pressure on admission of EO and correlation of metho
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 21 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    addition (if used); 1) pressure (∆P or terminal pressure) and rate
│    (∆P/time) of attainment of pressure on admission of the inert gas. d)
│    conditioning (if used); 1) during the conditioning phase, pressure
│    rise (∆P or terminal pressure) or % relative humidity and rate
│    (∆P/time) of attainment of pressure on injection of steam; 2) number
│    of steam pulse/vacuum stages, if applicable; e) EO injection: 1)
│    pressure, pressure rise (∆P) and rate (∆P/time) of attainment of
│    specified pressure on admission of EO and correlation of methods used
│    to monitor EO concentration; 2) pressure, pressure rise (∆P)
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 22 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    mission of the inert gas. d) conditioning (if used); 1) during the
│    conditioning phase, pressure rise (∆P or terminal pressure) or %
│    relative humidity and rate (∆P/time) of attainment of pressure on
│    injection of steam; 2) number of steam pulse/vacuum stages, if
│    applicable; e) EO injection: 1) pressure, pressure rise (∆P) and rate
│    (∆P/time) of attainment of specified pressure on admission of EO and
│    correlation of methods used to monitor EO concentration; 2) pressure,
│    pressure rise (∆P) and rate (∆P/time) of attainment of specified
│    pressure on admission of any inert gasses (if used); f) mainte
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 23 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    f the inert gas. d) conditioning (if used); 1) during the
│    conditioning phase, pressure rise (∆P or terminal pressure) or %
│    relative humidity and rate (∆P/time) of attainment of pressure on
│    injection of steam; 2) number of steam pulse/vacuum stages, if
│    applicable; e) EO injection: 1) pressure, pressure rise (∆P) and rate
│    (∆P/time) of attainment of specified pressure on admission of EO and
│    correlation of methods used to monitor EO concentration; 2) pressure,
│    pressure rise (∆P) and rate (∆P/time) of attainment of specified
│    pressure on admission of any inert gasses (if used); f) maintenance
│    of s
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 24 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    tioning phase, pressure rise (∆P or terminal pressure) or % relative
│    humidity and rate (∆P/time) of attainment of pressure on injection of
│    steam; 2) number of steam pulse/vacuum stages, if applicable; e) EO
│    injection: 1) pressure, pressure rise (∆P) and rate (∆P/time) of
│    attainment of specified pressure on admission of EO and correlation
│    of methods used to monitor EO concentration; 2) pressure, pressure
│    rise (∆P) and rate (∆P/time) of attainment of specified pressure on
│    admission of any inert gasses (if used); f) maintenance of specified
│    conditions for the exposure time: 1) pressure different
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 25 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    me) of attainment of pressure on injection of steam; 2) number of
│    steam pulse/vacuum stages, if applicable; e) EO injection: 1)
│    pressure, pressure rise (∆P) and rate (∆P/time) of attainment of
│    specified pressure on admission of EO and correlation of methods used
│    to monitor EO concentration; 2) pressure, pressure rise (∆P) and rate
│    (∆P/time) of attainment of specified pressure on admission of any
│    inert gasses (if used); f) maintenance of specified conditions for
│    the exposure time: 1) pressure differential used to apply sterilant
│    or inert gas make-ups (if used); 2) chamber temperature; g) EO r
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 26 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ainment of pressure on injection of steam; 2) number of steam
│    pulse/vacuum stages, if applicable; e) EO injection: 1) pressure,
│    pressure rise (∆P) and rate (∆P/time) of attainment of specified
│    pressure on admission of EO and correlation of methods used to
│    monitor EO concentration; 2) pressure, pressure rise (∆P) and rate
│    (∆P/time) of attainment of specified pressure on admission of any
│    inert gasses (if used); f) maintenance of specified conditions for
│    the exposure time: 1) pressure differential used to apply sterilant
│    or inert gas make-ups (if used); 2) chamber temperature; g) EO
│    removal: 1)
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 27 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    lse/vacuum stages, if applicable; e) EO injection: 1) pressure,
│    pressure rise (∆P) and rate (∆P/time) of attainment of specified
│    pressure on admission of EO and correlation of methods used to
│    monitor EO concentration; 2) pressure, pressure rise (∆P) and rate
│    (∆P/time) of attainment of specified pressure on admission of any
│    inert gasses (if used); f) maintenance of specified conditions for
│    the exposure time: 1) pressure differential used to apply sterilant
│    or inert gas make-ups (if used); 2) chamber temperature; g) EO
│    removal: 1) depth (ΔP or terminal pressure) and rate (ΔP/time) of
│    attainmen
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 28 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    specified pressure on admission of EO and correlation of methods used
│    to monitor EO concentration; 2) pressure, pressure rise (∆P) and rate
│    (∆P/time) of attainment of specified pressure on admission of any
│    inert gasses (if used); f) maintenance of specified conditions for
│    the exposure time: 1) pressure differential used to apply sterilant
│    or inert gas make-ups (if used); 2) chamber temperature; g) EO
│    removal: 1) depth (ΔP or terminal pressure) and rate (ΔP/time) of
│    attainment of vacuum to remove EO; h) flushing (if used): 1) pressure
│    rise and rate of attainment of pressure; 2) depth (ΔP or
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 29 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    time) of attainment of specified pressure on admission of any inert
│    gasses (if used); f) maintenance of specified conditions for the
│    exposure time: 1) pressure differential used to apply sterilant or
│    inert gas make-ups (if used); 2) chamber temperature; g) EO removal:
│    1) depth (ΔP or terminal pressure) and rate (ΔP/time) of attainment
│    of vacuum to remove EO; h) flushing (if used): 1) pressure rise and
│    rate of attainment of pressure; 2) depth (ΔP or terminal pressure)
│    and rate (ΔP/time) of attainment of vacuum to remove EO; ﻿ 36 © ISO
│    2014 – All rights reserved BS EN ISO 11135:2014+A1:2019 -
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 30 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    tenance of specified conditions for the exposure time: 1) pressure
│    differential used to apply sterilant or inert gas make-ups (if used);
│    2) chamber temperature; g) EO removal: 1) depth (ΔP or terminal
│    pressure) and rate (ΔP/time) of attainment of vacuum to remove EO; h)
│    flushing (if used): 1) pressure rise and rate of attainment of
│    pressure; 2) depth (ΔP or terminal pressure) and rate (ΔP/time) of
│    attainment of vacuum to remove EO; ﻿ 36 © ISO 2014 – All rights
│    reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 59 --- ﻿ ISO
│    11135:2014+A1:2018 3) number of times of repetition and any
│    variations in
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 31 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    e EO; ﻿ 36 © ISO 2014 – All rights reserved BS EN ISO
│    11135:2014+A1:2019 --- PAGE 59 --- ﻿ ISO 11135:2014+A1:2018 3) number
│    of times of repetition and any variations in successive repetitions;
│    i) air/inert gas admission: 1) pressure (ΔP or terminal pressure) and
│    rate (ΔP/time) of attainment of pressure on admission of the inert
│    gas or air; 2) number of times of repetition and any variations in
│    successive repetitions; 3) equilibration to atmospheric pressure
│    using air admission. D.6.2.5 Recirculation velocity should be
│    specified when assessing product residual levels. D.6.3 Equipment
│    characte
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 32 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    iations in successive repetitions; i) air/inert gas admission: 1)
│    pressure (ΔP or terminal pressure) and rate (ΔP/time) of attainment
│    of pressure on admission of the inert gas or air; 2) number of times
│    of repetition and any variations in successive repetitions; 3)
│    equilibration to atmospheric pressure using air admission. D.6.2.5
│    Recirculation velocity should be specified when assessing product
│    residual levels. D.6.3 Equipment characterization D.6.3.1 The
│    following factors should be considered when characterizing the
│    equipment: a) Preconditioning area characterization. Preconditioning
│    can be
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 33 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ld also be generated to show that the SBS can withstand the
│    sterilization process without losing its ability to protect the
│    product. Validation of the SBS should consider the potential stresses
│    that the SBS can be exposed to during an EO sterilization process.
│    Considerations would include vacuum/pressure levels, rate of pressure
│    change, temperature, etc. It is common practice to demonstrate
│    suitability of the SBS by exposure of the SBS to multiple
│    sterilization processes (see D.7.2.1 and D.7.2.2). Packaging
│    considerations are addressed in more detail in the ISO 11607‑1 and
│    ISO 11607‑2. D.7.1.5 T
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 34 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    how that the SBS can withstand the sterilization process without
│    losing its ability to protect the product. Validation of the SBS
│    should consider the potential stresses that the SBS can be exposed to
│    during an EO sterilization process. Considerations would include
│    vacuum/pressure levels, rate of pressure change, temperature, etc. It
│    is common practice to demonstrate suitability of the SBS by exposure
│    of the SBS to multiple sterilization processes (see D.7.2.1 and
│    D.7.2.2). Packaging considerations are addressed in more detail in
│    the ISO 11607‑1 and ISO 11607‑2. D.7.1.5 The load configuration in
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 35 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    are examples of equipment components that should be qualified to
│    ensure that the equipment was installed according to the applicable
│    specifications and requirements: a) chamber and door construction; b)
│    seals and connections on chamber and piping construction (i.e.
│    ability to maintain specified pressure and vacuum extremes); c)
│    supply systems for gases and liquids (e.g. air, nitrogen, steam, EO
│    and water), including filters (if used); d) the electrical supply,
│    which should adequately and consistently supply the power needed for
│    proper equipment and instrumentation operation; e) gas circulatio
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 36 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    rocess parameters that might be considered include: 1) vacuum depth
│    and rate of evacuation (∆P/time) at selected times during the cycle;
│    2) humidification time and steam injection rate (∆P/time); 3) EO
│    injection temperature and rate (∆P/time) and the amount of EO used
│    (weight, concentration, or pressure); and 4) air or nitrogen
│    injection rate (∆P/time). An analysis of the process data are used to
│    indicate that the processes are or are not equivalent in their
│    ability to meet the existing process parameter limits and any
│    additional acceptance criteria. The data generated should be analysed
│    and co
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 37 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 3.0/5.0
│
│  Context:
│    /area, temperature and humidity of chamber/area; 2) temperature and
│    humidity of the sterilization load; 3) maximum elapsed time between
│    removal of the load from preconditioning and commencement of the
│    sterilization cycle; c) vacuum levels and rate of evacuation (if
│    used): 1) holding time under vacuum (if used); NOTE The rate of
│    evacuation is commonly specified as either a minimum allowed
│    evacuation time, a maximum allowed evacuation time or as an
│    acceptable range of evacuation times, rather than the specific time
│    for each run. d) inert gas flushing (if used): 1) pressure (ΔP or
│    terminal pr
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 38 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ) and rate (∆P/time) of attainment of pressure on admission of the
│    inert gas. d) conditioning (if used); 1) during the conditioning
│    phase, pressure rise (∆P or terminal pressure) or % relative humidity
│    and rate (∆P/time) of attainment of pressure on injection of steam;
│    2) number of steam pulse/vacuum stages, if applicable; e) EO
│    injection: 1) pressure, pressure rise (∆P) and rate (∆P/time) of
│    attainment of specified pressure on admission of EO and correlation
│    of methods used to monitor EO concentration; 2) pressure, pressure
│    rise (∆P) and rate (∆P/time) of attainment of specified pressure o
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 39 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 3.0/5.0
│
│  Context:
│    admission of any inert gasses (if used); f) maintenance of specified
│    conditions for the exposure time: 1) pressure differential used to
│    apply sterilant or inert gas make-ups (if used); 2) chamber
│    temperature; g) EO removal: 1) depth (ΔP or terminal pressure) and
│    rate (ΔP/time) of attainment of vacuum to remove EO; h) flushing (if
│    used): 1) pressure rise and rate of attainment of pressure; 2) depth
│    (ΔP or terminal pressure) and rate (ΔP/time) of attainment of vacuum
│    to remove EO; ﻿ 36 © ISO 2014 – All rights reserved BS EN ISO
│    11135:2014+A1:2019 --- PAGE 59 --- ﻿ ISO 11135:2014+A1:2018 3)
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 40 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ce should also be generated to show that the SBS can withstand the
│    sterilization process without losing its ability to protect the
│    product. Validation of the SBS should consider the potential stresses
│    that the SBS can be exposed to during an EO sterilization process.
│    Considerations would include vacuum/pressure levels, rate of pressure
│    change, temperature, etc. It is common practice to demonstrate
│    suitability of the SBS by exposure of the SBS to multiple
│    sterilization processes (see D.7.2.1 and D.7.2.2). Packaging
│    considerations are addressed in more detail in the ISO 11607‑1 and
│    ISO 11607‑2. D
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 41 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 3.0/5.0
│
│  Context:
│    of equipment components that should be qualified to ensure that the
│    equipment was installed according to the applicable specifications
│    and requirements: a) chamber and door construction; b) seals and
│    connections on chamber and piping construction (i.e. ability to
│    maintain specified pressure and vacuum extremes); c) supply systems
│    for gases and liquids (e.g. air, nitrogen, steam, EO and water),
│    including filters (if used); d) the electrical supply, which should
│    adequately and consistently supply the power needed for proper
│    equipment and instrumentation operation; e) gas circulation systems,
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 42 [HIGH] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ert gas exposure, of ± 3 °C of the average recorded chamber
│    temperature at each time point should be obtained after an
│    equilibration period. When the OQ exercise is carried out using a
│    loaded chamber, then the ± 3 °C tolerance might not be achievable. 4)
│    chamber leak rate (performed either under vacuum for subatmospheric
│    cycles or under vacuum and at pressure for superatmospheric cycles);
│    5) pressure rise on injection of steam during the conditioning phase;
│    6) the temperature of the injected EO-gas should be within the
│    volatizer specification or above the boiling point of EO (10,7°C at
│    atmosp
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 43 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: atmospheric pressure
│  Relevance Score: 3.0/5.0
│
│  Context:
│    and any variations in successive repetitions; i) air/inert gas
│    admission: 1) pressure (ΔP or terminal pressure) and rate (ΔP/time)
│    of attainment of pressure on admission of the inert gas or air; 2)
│    number of times of repetition and any variations in successive
│    repetitions; 3) equilibration to atmospheric pressure using air
│    admission. D.6.2.5 Recirculation velocity should be specified when
│    assessing product residual levels. D.6.3 Equipment characterization
│    D.6.3.1 The following factors should be considered when
│    characterizing the equipment: a) Preconditioning area
│    characterization. Preconditioning can be
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 44 [MED ] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.5/5.0
│
│  Context:
│    International Standard, the D value is the exposure time required to
│    achieve 90 % inactivation of the population of the test organism. 3.9
│    development act of elaborating a specification [SOURCE: ISO/TS
│    11139:2006, definition 2.13] 3.10 dew point The temperature at which
│    the saturation water vapour pressure is equal to the partial pressure
│    of the water vapour in the atmosphere Note 1 to entry: Any cooling of
│    the atmosphere below the dew point would produce water condensation.
│    3.11 establish determine by theoretical evaluation and confirm by
│    experimentation [SOURCE: ISO/TS 11139:2006, definition 2.17]
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 45 [MED ] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ue is the exposure time required to achieve 90 % inactivation of the
│    population of the test organism. 3.9 development act of elaborating a
│    specification [SOURCE: ISO/TS 11139:2006, definition 2.13] 3.10 dew
│    point The temperature at which the saturation water vapour pressure
│    is equal to the partial pressure of the water vapour in the
│    atmosphere Note 1 to entry: Any cooling of the atmosphere below the
│    dew point would produce water condensation. 3.11 establish determine
│    by theoretical evaluation and confirm by experimentation [SOURCE:
│    ISO/TS 11139:2006, definition 2.17] 3.12 ethylene oxide (EO) injecti
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 46 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ation (if used). 6.2.3 The process variables for preconditioning (if
│    used) include at a minimum: a) time; b) temperature; c) humidity; d)
│    transfer time. 6.2.4 The process variables for the sterilization
│    cycle include: a) exposure time; b) temperature; c) humidity; d) EO
│    concentration; e) pressure. 6.2.5 The process variables for aeration
│    (if used) include at a minimum: a) time; b) temperature. NOTE In
│    aeration these parameters are considered process variables only if
│    aeration is considered to contribute to ensuring the microbicidal
│    effectiveness of the sterilization process (See AAMI
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 47 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.5/5.0
│
│  Context:
│    alidation report shall describe or reference specific qualified
│    product, defined load configurations and the documented specification
│    for the EO sterilization process and shall address: NOTE For
│    practical purposes, rates can be determined as the time taken (with
│    tolerances) to attain a specified pressure change. a) the minimum
│    temperature of product to enter the sterilization process and/or the
│    defined conditions required to achieve the minimum required
│    temperature; b) preconditioning (if used): 1) time in chamber/area,
│    temperature and humidity of chamber/area; 2) temperature and humidity
│    of t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 48 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ta shall be recorded and retained for each sterilization cycle to
│    demonstrate that the sterilization process specification has been
│    met. These data shall include at least the following: NOTE For
│    practical purposes, rates can be determined as the time taken (with
│    tolerances) to attain a specified pressure change. a) the minimum
│    temperature of product entering the sterilization process and/or the
│    defined conditions used to acclimate the load; b) temperature and
│    humidity within the preconditioning area (if used), monitored and
│    recorded from a specified position; c) time of commencement of
│    precond
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 49 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.5/5.0
│
│  Context:
│    least one of the following: 1) the mass of EO used (see D.10.2 i); 2)
│    the direct measurement of the concentration of EO in the sterilizer
│    chamber; 3) volume of EO used; j) EO-injection time k) inert gas
│    injection, if used; l) exposure time; m) time taken to evacuate the
│    chamber; n) time and pressure changes during post exposure flushing;
│    o) time, temperature, pressure changes (if any) during aeration. 10.3
│    If biological indicators are used in routine monitoring, they shall
│    comply with 8.6 and 8.7. If the PCD that is used for routine release
│    is different from that used in the MPQ, it should b
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 50 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.5/5.0
│
│  Context:
│    the direct measurement of the concentration of EO in the sterilizer
│    chamber; 3) volume of EO used; j) EO-injection time k) inert gas
│    injection, if used; l) exposure time; m) time taken to evacuate the
│    chamber; n) time and pressure changes during post exposure flushing;
│    o) time, temperature, pressure changes (if any) during aeration. 10.3
│    If biological indicators are used in routine monitoring, they shall
│    comply with 8.6 and 8.7. If the PCD that is used for routine release
│    is different from that used in the MPQ, it should be at least as
│    resistant to the process as is the PCD used in the MPQ.
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 51 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.5/5.0
│
│  Context:
│    onditioning area; — means of monitoring cell/room temperature and
│    humidity; — means of controlling cell/room temperature and humidity.
│    b) Sterilizer characterization. The sterilization chamber should have
│    the following performance and monitoring capabilities: — means of
│    monitoring time, chamber pressure, temperature and humidity (if
│    humidity additions are controlled by sensor readings); — means of
│    controlling time, chamber pressure, temperature and humidity, if
│    humidity additions are controlled by sensor readings (when sensors
│    are fixed on the equipment, ensure that a correlation is made durin
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 52 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ty. b) Sterilizer characterization. The sterilization chamber should
│    have the following performance and monitoring capabilities: — means
│    of monitoring time, chamber pressure, temperature and humidity (if
│    humidity additions are controlled by sensor readings); — means of
│    controlling time, chamber pressure, temperature and humidity, if
│    humidity additions are controlled by sensor readings (when sensors
│    are fixed on the equipment, ensure that a correlation is made during
│    IQ or OQ to the pressure rise); — if humidity is not controlled by
│    sensor readings, means to monitor and control steam additions;
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 53 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.5/5.0
│
│  Context:
│    r sterilization process. To ensure EO penetration, the permeability
│    of the packaging to the particular sterilizing environment is of
│    utmost importance. As air removal is part of the EO sterilization
│    process the packaging system should also allow gases to vent into,
│    and out of, the package during pressure changes during gas injections
│    and evacuations without damage to, or rupture of, the seal integrity.
│    The ability of the sterile barrier system (SBS) to protect product
│    during customary handling and distribution should be demonstrated.
│    Evidence should also be generated to show that the SBS can wit
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 54 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.5/5.0
│
│  Context:
│    g system. These tests can be performed after exposure in the
│    sterilizer or other environmental chambers that simulate the
│    specified process and can range from a simple visual inspection to a
│    battery of specialized tests. Elements that could affect safety,
│    quality or performance include: a) cycle pressure changes that could
│    affect the sterile barrier system seal integrity; b) effects of EO
│    exposure time, temperature, humidity and, if applicable, any diluent
│    gases present in the intended sterilization mixture; c) inclusion of
│    new materials known to retain higher EO residuals; d) packaging
│    charact
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 55 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.5/5.0
│
│  Context:
│    .4 When establishing process definition it is important to consider
│    the impact of the selected processing parameters and their tolerances
│    on the safety and functionality of the product and its packaging. As
│    there are a number of parameters within a sterilization process,
│    (temperature, humidity, pressure changes/rates, EO concentration and
│    time), it is impractical to assess the tolerances of all combinations
│    of all variables. A determination should be made as to which
│    variables will have the greatest impact, and those should be
│    assessed. Data supporting this activity can be collected from alterna
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 56 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.5/5.0
│
│  Context:
│    systems; i) other critical systems that could affect process
│    conditions, such as process automation, safety systems, etc.; j) the
│    calibration of instruments (e.g. sensors, recorders, gauges and test
│    instruments) that monitor, control, indicate or record parameters
│    such as temperature, humidity, pressure and EO concentration. ﻿ 48 ©
│    ISO 2014 – All rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE
│    71 --- ﻿ ISO 11135:2014+A1:2018 k) the documented procedures for IQ
│    should specify how each element of this qualification is planned,
│    performed and reviewed. D.9.2.1.2 Guidance can be found in IE
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 57 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.5/5.0
│
│  Context:
│    is most difficult to achieve the desired conditions. Monitoring data
│    for the operation of the preconditioning area should be reviewed in
│    conjunction with other data for the release of product. c) No
│    guidance offered. d) No guidance offered. e) The humidity is
│    typically calculated by measuring pressure changes. (See also AAMI
│    TIR15.[24]) The humidity in the chamber is typically calculated by
│    measuring the partial pressure of water vapour injected into the
│    chamber. The relative humidity value is then determined using the
│    steam tables by a ratio of the partial pressure to the saturated
│    vapour pr
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 58 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ly calculated by measuring pressure changes. (See also AAMI
│    TIR15.[24]) The humidity in the chamber is typically calculated by
│    measuring the partial pressure of water vapour injected into the
│    chamber. The relative humidity value is then determined using the
│    steam tables by a ratio of the partial pressure to the saturated
│    vapour pressure for the actual cycle process temperature. This will
│    indicate the relative humidity value in the head space of the chamber
│    and will be accurate until load or other reactions impact the actual
│    water vapour content in the head space. Consideration should be given
│    to
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 59 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.5/5.0
│
│  Context:
│    re changes. (See also AAMI TIR15.[24]) The humidity in the chamber is
│    typically calculated by measuring the partial pressure of water
│    vapour injected into the chamber. The relative humidity value is then
│    determined using the steam tables by a ratio of the partial pressure
│    to the saturated vapour pressure for the actual cycle process
│    temperature. This will indicate the relative humidity value in the
│    head space of the chamber and will be accurate until load or other
│    reactions impact the actual water vapour content in the head space.
│    Consideration should be given to the amount of moisture introduce
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 60 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.5/5.0
│
│  Context:
│    overall effect to the cycle should be evaluated since the adjustment
│    might not achieve the desired result because the parameters are
│    interrelated. For example, the result of decreasing temperature would
│    actually increase the EO concentration and the relative humidity if
│    no change is made to the pressure parameters. The data obtained from
│    process lethality studies are used to establish the minimum EO gas
│    exposure time required for the sterilization process. If these
│    studies are performed in a developmental chamber, caution should be
│    taken in directly applying this time to the sterilization proces
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 61 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.5/5.0
│
│  Context:
│    effect to the cycle should be evaluated since the adjustment might
│    not achieve the desired result because the parameters are
│    interrelated. For example, the result of decreasing temperature would
│    actually increase EO concentration and relative humidity if no change
│    is made to the steam injection pressure and the EO injection pressure
│    rise. D.14.2.5 [B.2.5] SLRs can be calculated using the results of
│    fractional cycles. If there are no surviving internal PCDs, a
│    worst-case estimate of the SLR can be obtained by running the
│    calculation with one assumed survivor. Regardless of the method used,
│    it i
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 62 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 2.5/5.0
│
│  Context:
│    equired temperature; b) preconditioning (if used): 1) time in
│    chamber/area, temperature and humidity of chamber/area; 2)
│    temperature and humidity of the sterilization load; 3) maximum
│    elapsed time between removal of the load from preconditioning and
│    commencement of the sterilization cycle; c) vacuum levels and rate of
│    evacuation (if used): 1) holding time under vacuum (if used); NOTE
│    The rate of evacuation is commonly specified as either a minimum
│    allowed evacuation time, a maximum allowed evacuation time or as an
│    acceptable range of evacuation times, rather than the specific time
│    for each
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 63 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 2.5/5.0
│
│  Context:
│    d liquids (e.g. air, nitrogen, steam, EO and water), including
│    filters (if used); d) the electrical supply, which should adequately
│    and consistently supply the power needed for proper equipment and
│    instrumentation operation; e) gas circulation systems, where used; f)
│    gas injection systems; g) vacuum systems, including pumps, pump
│    cooling systems and piping; h) exhaust, emission control and
│    abatement systems; i) other critical systems that could affect
│    process conditions, such as process automation, safety systems, etc.;
│    j) the calibration of instruments (e.g. sensors, recorders, gauges
│    and
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 64 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 2.5/5.0
│
│  Context:
│    rom the developmental chamber studies and data from the production
│    chamber. The development of the microbial inactivation curves is not
│    always possible in production chambers because of the size of the
│    chamber and the time required to inject and remove EO in the chamber.
│    These long injection and vacuum times limit the ability to obtain the
│    required fractional recovery of indicator organisms. These
│    inactivation curves can be developed in a developmental chamber that
│    can deliver equivalent parameters especially EO concentration used in
│    the production chamber. Methods for demonstrating a relation
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 65 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ximum allowed evacuation time or as an acceptable range of evacuation
│    times, rather than the specific time for each run. d) inert gas
│    flushing (if used): 1) pressure (ΔP or terminal pressure) and rate
│    (∆P/time) of attainment of pressure associated with inert gas/steam;
│    2) depth (∆P or terminal pressure) and rate (∆P/time) of attainment
│    of vacuum; 3) number of times of repetition and any variations in
│    successive repetitions; e) conditioning and/or humidity dwell phases
│    (if used): 1) pressure levels and/or rate of attainment of vacuum or
│    relative humidity levels (whichever is being controlled a
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 66 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.0/5.0
│
│  Context:
│    and rate (∆P/time) of attainment of pressure associated with inert
│    gas/steam; 2) depth (∆P or terminal pressure) and rate (∆P/time) of
│    attainment of vacuum; 3) number of times of repetition and any
│    variations in successive repetitions; e) conditioning and/or humidity
│    dwell phases (if used): 1) pressure levels and/or rate of attainment
│    of vacuum or relative humidity levels (whichever is being controlled
│    and monitored); 2) number of steam pulses/vacuum (if used); 3) time;
│    4) chamber temperature; ﻿ 20 © ISO 2014 – All rights reserved BS EN
│    ISO 11135:2014+A1:2019 --- PAGE 43 --- ﻿ ISO 11135:201
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 67 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ulses/vacuum (if used); 3) time; 4) chamber temperature; ﻿ 20 © ISO
│    2014 – All rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 43
│    --- ﻿ ISO 11135:2014+A1:2018 5) temperature and humidity of the
│    sterilization load at the end of conditioning; f) EO injection and
│    exposure: 1) EO injection pressure rise (∆P), EO injection time and
│    terminal pressure of EO injection phase; 2) evidence that the gaseous
│    EO has been admitted to the sterilization chamber by the pressure
│    rise and by one of the following; i) Mass of EO used (see D.10.2 i);
│    ii) Direct measurement of the concentration of EO; iii)
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 68 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ii) Volume of EO used. 3) sterilizer chamber temperature; 4) exposure
│    time; 5) temperature of the sterilization load; 6) an indication of
│    the satisfactory operation of the chamber gas circulation system (if
│    used) during exposure; g) post exposure flushing (if used): 1) depth
│    (∆P or terminal pressure) and rate (∆P/time) of attainment of vacuum;
│    2) pressure (∆P or terminal pressure) and rate (∆P/time) of
│    attainment of pressure associated with inert gas/air/steam; 3) number
│    of times of repetition and any variations in successive repetitions;
│    h) aeration (if used): 1) time and temperature wit
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 69 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ; 4) exposure time; 5) temperature of the sterilization load; 6) an
│    indication of the satisfactory operation of the chamber gas
│    circulation system (if used) during exposure; g) post exposure
│    flushing (if used): 1) depth (∆P or terminal pressure) and rate
│    (∆P/time) of attainment of vacuum; 2) pressure (∆P or terminal
│    pressure) and rate (∆P/time) of attainment of pressure associated
│    with inert gas/air/steam; 3) number of times of repetition and any
│    variations in successive repetitions; h) aeration (if used): 1) time
│    and temperature within the chamber and/or room; 2) pressure changes
│    (if any)
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 70 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.0/5.0
│
│  Context:
│    temperature of the sterilization load; 6) an indication of the
│    satisfactory operation of the chamber gas circulation system (if
│    used) during exposure; g) post exposure flushing (if used): 1) depth
│    (∆P or terminal pressure) and rate (∆P/time) of attainment of vacuum;
│    2) pressure (∆P or terminal pressure) and rate (∆P/time) of
│    attainment of pressure associated with inert gas/air/steam; 3) number
│    of times of repetition and any variations in successive repetitions;
│    h) aeration (if used): 1) time and temperature within the chamber
│    and/or room; 2) pressure changes (if any) within the chamber and/o
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 71 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.0/5.0
│
│  Context:
│    indication of the satisfactory operation of the chamber gas
│    circulation system (if used) during exposure; g) post exposure
│    flushing (if used): 1) depth (∆P or terminal pressure) and rate
│    (∆P/time) of attainment of vacuum; 2) pressure (∆P or terminal
│    pressure) and rate (∆P/time) of attainment of pressure associated
│    with inert gas/air/steam; 3) number of times of repetition and any
│    variations in successive repetitions; h) aeration (if used): 1) time
│    and temperature within the chamber and/or room; 2) pressure changes
│    (if any) within the chamber and/or room; 3) rate of change of air or
│    other gas
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 72 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.0/5.0
│
│  Context:
│    preconditioning and final transfer of product into the sterilizer to
│    the start of cycle. D.6.2.4 The following is a list of phases that
│    can be included in a sterilization cycle along with the performance
│    factors that might be considered for each phase: a) air removal: 1)
│    depth (∆P or terminal pressure) and rate (∆P/time) of attainment of
│    vacuum; b) chamber leak test (performed either under vacuum for
│    subatmospheric cycles or under vacuum and at pressure for
│    superatmospheric cycles), if applicable: 1) stabilization period
│    and/or hold time; 2) pressure change; c) inert gas addition (if
│    used);
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 73 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.0/5.0
│
│  Context:
│    a sterilization cycle along with the performance factors that might
│    be considered for each phase: a) air removal: 1) depth (∆P or
│    terminal pressure) and rate (∆P/time) of attainment of vacuum; b)
│    chamber leak test (performed either under vacuum for subatmospheric
│    cycles or under vacuum and at pressure for superatmospheric cycles),
│    if applicable: 1) stabilization period and/or hold time; 2) pressure
│    change; c) inert gas addition (if used); 1) pressure (∆P or terminal
│    pressure) and rate (∆P/time) of attainment of pressure on admission
│    of the inert gas. d) conditioning (if used); 1) during t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 74 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ) air removal: 1) depth (∆P or terminal pressure) and rate (∆P/time)
│    of attainment of vacuum; b) chamber leak test (performed either under
│    vacuum for subatmospheric cycles or under vacuum and at pressure for
│    superatmospheric cycles), if applicable: 1) stabilization period
│    and/or hold time; 2) pressure change; c) inert gas addition (if
│    used); 1) pressure (∆P or terminal pressure) and rate (∆P/time) of
│    attainment of pressure on admission of the inert gas. d) conditioning
│    (if used); 1) during the conditioning phase, pressure rise (∆P or
│    terminal pressure) or % relative humidity and rate (∆P/t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 75 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.0/5.0
│
│  Context:
│    rate (∆P/time) of attainment of vacuum; b) chamber leak test
│    (performed either under vacuum for subatmospheric cycles or under
│    vacuum and at pressure for superatmospheric cycles), if applicable:
│    1) stabilization period and/or hold time; 2) pressure change; c)
│    inert gas addition (if used); 1) pressure (∆P or terminal pressure)
│    and rate (∆P/time) of attainment of pressure on admission of the
│    inert gas. d) conditioning (if used); 1) during the conditioning
│    phase, pressure rise (∆P or terminal pressure) or % relative humidity
│    and rate (∆P/time) of attainment of pressure on injection of steam; 2
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 76 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ment of vacuum; b) chamber leak test (performed either under vacuum
│    for subatmospheric cycles or under vacuum and at pressure for
│    superatmospheric cycles), if applicable: 1) stabilization period
│    and/or hold time; 2) pressure change; c) inert gas addition (if
│    used); 1) pressure (∆P or terminal pressure) and rate (∆P/time) of
│    attainment of pressure on admission of the inert gas. d) conditioning
│    (if used); 1) during the conditioning phase, pressure rise (∆P or
│    terminal pressure) or % relative humidity and rate (∆P/time) of
│    attainment of pressure on injection of steam; 2) number of steam
│    pulse/
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 77 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ed either under vacuum for subatmospheric cycles or under vacuum and
│    at pressure for superatmospheric cycles), if applicable: 1)
│    stabilization period and/or hold time; 2) pressure change; c) inert
│    gas addition (if used); 1) pressure (∆P or terminal pressure) and
│    rate (∆P/time) of attainment of pressure on admission of the inert
│    gas. d) conditioning (if used); 1) during the conditioning phase,
│    pressure rise (∆P or terminal pressure) or % relative humidity and
│    rate (∆P/time) of attainment of pressure on injection of steam; 2)
│    number of steam pulse/vacuum stages, if applicable; e) EO injection
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 78 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.0/5.0
│
│  Context:
│    exposure time: 1) pressure differential used to apply sterilant or
│    inert gas make-ups (if used); 2) chamber temperature; g) EO removal:
│    1) depth (ΔP or terminal pressure) and rate (ΔP/time) of attainment
│    of vacuum to remove EO; h) flushing (if used): 1) pressure rise and
│    rate of attainment of pressure; 2) depth (ΔP or terminal pressure)
│    and rate (ΔP/time) of attainment of vacuum to remove EO; ﻿ 36 © ISO
│    2014 – All rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 59
│    --- ﻿ ISO 11135:2014+A1:2018 3) number of times of repetition and any
│    variations in successive repetitions; i) air/inert g
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 79 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.0/5.0
│
│  Context:
│    tial used to apply sterilant or inert gas make-ups (if used); 2)
│    chamber temperature; g) EO removal: 1) depth (ΔP or terminal
│    pressure) and rate (ΔP/time) of attainment of vacuum to remove EO; h)
│    flushing (if used): 1) pressure rise and rate of attainment of
│    pressure; 2) depth (ΔP or terminal pressure) and rate (ΔP/time) of
│    attainment of vacuum to remove EO; ﻿ 36 © ISO 2014 – All rights
│    reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 59 --- ﻿ ISO
│    11135:2014+A1:2018 3) number of times of repetition and any
│    variations in successive repetitions; i) air/inert gas admission: 1)
│    pressure (ΔP or te
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 80 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ical device. The sterilization process parameters to be established
│    include: a) temperature range within the preconditioning room (if
│    used); b) relative humidity range within the preconditioning room (if
│    used); c) time set point and range within the preconditioning room
│    (if used); d) vacuum and pressure levels and rates of pressure
│    changes in the sterilization chamber; e) if used, confirmation that
│    chamber recirculation operational during sterilant dwell; f)
│    temperature set point and range within the sterilization chamber; g)
│    humidity control set point (pressure or %RH) and range within the ste
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 81 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.0/5.0
│
│  Context:
│    n process parameters to be established include: a) temperature range
│    within the preconditioning room (if used); b) relative humidity range
│    within the preconditioning room (if used); c) time set point and
│    range within the preconditioning room (if used); d) vacuum and
│    pressure levels and rates of pressure changes in the sterilization
│    chamber; e) if used, confirmation that chamber recirculation
│    operational during sterilant dwell; f) temperature set point and
│    range within the sterilization chamber; g) humidity control set point
│    (pressure or %RH) and range within the sterilization chamber
│    environme
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 82 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.0/5.0
│
│  Context:
│    g room (if used); d) vacuum and pressure levels and rates of pressure
│    changes in the sterilization chamber; e) if used, confirmation that
│    chamber recirculation operational during sterilant dwell; f)
│    temperature set point and range within the sterilization chamber; g)
│    humidity control set point (pressure or %RH) and range within the
│    sterilization chamber environment; h) EO and diluent gas (if used)
│    injection pressure set point and range; this will include EO
│    concentration if EO analysis equipment is installed on the
│    sterilization chamber; ﻿ 44 © ISO 2014 – All rights reserved BS EN
│    ISO 11135:20
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 83 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ); g) volatizers/vaporizers; h) chamber jacket re-circulation system;
│    i) chamber jacket system; j) audible and visual alarms; k)
│    temperature and humidity sensor equipment; l) boiler system for steam
│    and heat supply; m) evacuation equipment (vacuum pumps); n) weighing
│    scales; o) valves; p) pressure transducers; q) timers; r) recorders;
│    s) air/gas circulation systems. D.12.2.2 Sterilization equipment that
│    is not calibrated or is not properly maintained can generate an
│    inaccurate record of the process parameters during the sterilization
│    cycle. If these data are used for product release, i
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 84 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: pressure
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ly or can be based on pressure rise due to steam injection; 2)
│    chamber process temperature at selected times during the cycle (e.g.
│    end of conditioning or during the EO dwell period); 3) chamber EO gas
│    concentration at selected times during EO dwell period during the
│    cycle (if measured), or EO pressure rise or gas weight. c) Other
│    process parameters that might be considered include: 1) vacuum depth
│    and rate of evacuation (∆P/time) at selected times during the cycle;
│    2) humidification time and steam injection rate (∆P/time); 3) EO
│    injection temperature and rate (∆P/time) and the amount of EO u
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 85 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 2.0/5.0
│
│  Context:
│    ble range of evacuation times, rather than the specific time for each
│    run. d) inert gas flushing (if used): 1) pressure (ΔP or terminal
│    pressure) and rate (∆P/time) of attainment of pressure associated
│    with inert gas/steam; 2) depth (∆P or terminal pressure) and rate
│    (∆P/time) of attainment of vacuum; 3) number of times of repetition
│    and any variations in successive repetitions; e) conditioning and/or
│    humidity dwell phases (if used): 1) pressure levels and/or rate of
│    attainment of vacuum or relative humidity levels (whichever is being
│    controlled and monitored); 2) number of steam pulses/va
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 86 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 2.0/5.0
│
│  Context:
│    associated with inert gas/steam; 2) depth (∆P or terminal pressure)
│    and rate (∆P/time) of attainment of vacuum; 3) number of times of
│    repetition and any variations in successive repetitions; e)
│    conditioning and/or humidity dwell phases (if used): 1) pressure
│    levels and/or rate of attainment of vacuum or relative humidity
│    levels (whichever is being controlled and monitored); 2) number of
│    steam pulses/vacuum (if used); 3) time; 4) chamber temperature; ﻿ 20
│    © ISO 2014 – All rights reserved BS EN ISO 11135:2014+A1:2019 ---
│    PAGE 43 --- ﻿ ISO 11135:2014+A1:2018 5) temperature and humidity of t
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 87 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 2.0/5.0
│
│  Context:
│    um; 3) number of times of repetition and any variations in successive
│    repetitions; e) conditioning and/or humidity dwell phases (if used):
│    1) pressure levels and/or rate of attainment of vacuum or relative
│    humidity levels (whichever is being controlled and monitored); 2)
│    number of steam pulses/vacuum (if used); 3) time; 4) chamber
│    temperature; ﻿ 20 © ISO 2014 – All rights reserved BS EN ISO
│    11135:2014+A1:2019 --- PAGE 43 --- ﻿ ISO 11135:2014+A1:2018 5)
│    temperature and humidity of the sterilization load at the end of
│    conditioning; f) EO injection and exposure: 1) EO injection pressure
│    ris
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 88 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 2.0/5.0
│
│  Context:
│    temperature; 4) exposure time; 5) temperature of the sterilization
│    load; 6) an indication of the satisfactory operation of the chamber
│    gas circulation system (if used) during exposure; g) post exposure
│    flushing (if used): 1) depth (∆P or terminal pressure) and rate
│    (∆P/time) of attainment of vacuum; 2) pressure (∆P or terminal
│    pressure) and rate (∆P/time) of attainment of pressure associated
│    with inert gas/air/steam; 3) number of times of repetition and any
│    variations in successive repetitions; h) aeration (if used): 1) time
│    and temperature within the chamber and/or room; 2) pressure ch
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 89 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 2.0/5.0
│
│  Context:
│    into the sterilizer to the start of cycle. D.6.2.4 The following is a
│    list of phases that can be included in a sterilization cycle along
│    with the performance factors that might be considered for each phase:
│    a) air removal: 1) depth (∆P or terminal pressure) and rate (∆P/time)
│    of attainment of vacuum; b) chamber leak test (performed either under
│    vacuum for subatmospheric cycles or under vacuum and at pressure for
│    superatmospheric cycles), if applicable: 1) stabilization period
│    and/or hold time; 2) pressure change; c) inert gas addition (if
│    used); 1) pressure (∆P or terminal pressure) and
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 90 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 2.0/5.0
│
│  Context:
│    The following is a list of phases that can be included in a
│    sterilization cycle along with the performance factors that might be
│    considered for each phase: a) air removal: 1) depth (∆P or terminal
│    pressure) and rate (∆P/time) of attainment of vacuum; b) chamber leak
│    test (performed either under vacuum for subatmospheric cycles or
│    under vacuum and at pressure for superatmospheric cycles), if
│    applicable: 1) stabilization period and/or hold time; 2) pressure
│    change; c) inert gas addition (if used); 1) pressure (∆P or terminal
│    pressure) and rate (∆P/time) of attainment of pressure on admission
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 91 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 2.0/5.0
│
│  Context:
│    be included in a sterilization cycle along with the performance
│    factors that might be considered for each phase: a) air removal: 1)
│    depth (∆P or terminal pressure) and rate (∆P/time) of attainment of
│    vacuum; b) chamber leak test (performed either under vacuum for
│    subatmospheric cycles or under vacuum and at pressure for
│    superatmospheric cycles), if applicable: 1) stabilization period
│    and/or hold time; 2) pressure change; c) inert gas addition (if
│    used); 1) pressure (∆P or terminal pressure) and rate (∆P/time) of
│    attainment of pressure on admission of the inert gas. d) conditioning
│    (if us
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 92 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 2.0/5.0
│
│  Context:
│    -ups (if used); 2) chamber temperature; g) EO removal: 1) depth (ΔP
│    or terminal pressure) and rate (ΔP/time) of attainment of vacuum to
│    remove EO; h) flushing (if used): 1) pressure rise and rate of
│    attainment of pressure; 2) depth (ΔP or terminal pressure) and rate
│    (ΔP/time) of attainment of vacuum to remove EO; ﻿ 36 © ISO 2014 –
│    All rights reserved BS EN ISO 11135:2014+A1:2019 --- PAGE 59 --- ﻿
│    ISO 11135:2014+A1:2018 3) number of times of repetition and any
│    variations in successive repetitions; i) air/inert gas admission: 1)
│    pressure (ΔP or terminal pressure) and rate (ΔP/time) of attai
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 93 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 2.0/5.0
│
│  Context:
│    s for a medical device. The sterilization process parameters to be
│    established include: a) temperature range within the preconditioning
│    room (if used); b) relative humidity range within the preconditioning
│    room (if used); c) time set point and range within the
│    preconditioning room (if used); d) vacuum and pressure levels and
│    rates of pressure changes in the sterilization chamber; e) if used,
│    confirmation that chamber recirculation operational during sterilant
│    dwell; f) temperature set point and range within the sterilization
│    chamber; g) humidity control set point (pressure or %RH) and range w
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 94 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 2.0/5.0
│
│  Context:
│    rupture discs; f) filters (for periodic replacement); g)
│    volatizers/vaporizers; h) chamber jacket re-circulation system; i)
│    chamber jacket system; j) audible and visual alarms; k) temperature
│    and humidity sensor equipment; l) boiler system for steam and heat
│    supply; m) evacuation equipment (vacuum pumps); n) weighing scales;
│    o) valves; p) pressure transducers; q) timers; r) recorders; s)
│    air/gas circulation systems. D.12.2.2 Sterilization equipment that is
│    not calibrated or is not properly maintained can generate an
│    inaccurate record of the process parameters during the sterilization
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 95 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: vacuum
│  Relevance Score: 2.0/5.0
│
│  Context:
│    selected times during the cycle (e.g. end of conditioning or during
│    the EO dwell period); 3) chamber EO gas concentration at selected
│    times during EO dwell period during the cycle (if measured), or EO
│    pressure rise or gas weight. c) Other process parameters that might
│    be considered include: 1) vacuum depth and rate of evacuation
│    (∆P/time) at selected times during the cycle; 2) humidification time
│    and steam injection rate (∆P/time); 3) EO injection temperature and
│    rate (∆P/time) and the amount of EO used (weight, concentration, or
│    pressure); and 4) air or nitrogen injection rate (∆P/time). A
│
└───────────────────────────────────────────────────────────────────────────────


CATEGORY: TIME

┌─ PARAMETER 01 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 3.0/5.0
│
│  Context:
│    stablish determine by theoretical evaluation and confirm by
│    experimentation [SOURCE: ISO/TS 11139:2006, definition 2.17] 3.12
│    ethylene oxide (EO) injection time duration of the stage beginning
│    with the first introduction of the EO (mixture) into the chamber to
│    the completion of that injection 3.13 exposure time period for which
│    the process parameters are maintained within their specified
│    tolerances [SOURCE: ISO/TS 11139:2006, definition 2.18] Note 1 to
│    entry: For the purpose of calculation of cycle lethality, it is the
│    period of sterilization between the end of EO injection and the
│    beginning of EO remova
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 02 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ations to a single sterilization exposure time, and then determining
│    the lethal rate (rate of inactivation through D-value calculations)
│    when exposed to the sterilization cycle. Knowledge of the BI
│    lethality rate and the population and relative resistance of the
│    bioburden allows one to establish exposure time so that an SAL can be
│    predicted. Attention shall be given to the impact of packaging and
│    the removal of EO from the PCD. Guidance on this approach can be
│    found in ISO 14161. A.1.2 The conditions used for recovery of
│    biological indicators in qualification studies, including duration of
│    incubation,
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 03 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 3.0/5.0
│
│  Context:
│    proaches given in a) and b) below. a) Half-cycle approach: a total of
│    three consecutive experiments resulting in total inactivation of the
│    biological indicators (with a population of not less than 106 and,
│    where appropriate, placed within a PCD) shall be performed in order
│    to confirm the minimum exposure time. The specified exposure time for
│    the sterilization process shall be at least double this minimum time.
│    A fractional cycle of short duration from which BI survivors can be
│    recovered shall also be run to demonstrate the adequacy of the
│    recovery technique for BIs exposed to EO gas. NOTE This short
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 04 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: duration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    water vapour in the atmosphere Note 1 to entry: Any cooling of the
│    atmosphere below the dew point would produce water condensation. 3.11
│    establish determine by theoretical evaluation and confirm by
│    experimentation [SOURCE: ISO/TS 11139:2006, definition 2.17] 3.12
│    ethylene oxide (EO) injection time duration of the stage beginning
│    with the first introduction of the EO (mixture) into the chamber to
│    the completion of that injection 3.13 exposure time period for which
│    the process parameters are maintained within their specified
│    tolerances [SOURCE: ISO/TS 11139:2006, definition 2.18] Note 1 to
│    entry: For
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 05 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: duration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    establish exposure time so that an SAL can be predicted. Attention
│    shall be given to the impact of packaging and the removal of EO from
│    the PCD. Guidance on this approach can be found in ISO 14161. A.1.2
│    The conditions used for recovery of biological indicators in
│    qualification studies, including duration of incubation, shall be
│    established and documented. The incubation period shall take into
│    account the possibility of delayed outgrowth of spores that have been
│    exposed to EO. Refer to ISO 14161 for additional information on
│    biological indicator incubation times. A.1.3 After time-graded
│    exposures
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 06 [HIGH]  ─────────────────────────────────────────────────
│
│  Keyword: duration
│  Relevance Score: 3.0/5.0
│
│  Context:
│    ical indicators (with a population of not less than 106 and, where
│    appropriate, placed within a PCD) shall be performed in order to
│    confirm the minimum exposure time. The specified exposure time for
│    the sterilization process shall be at least double this minimum time.
│    A fractional cycle of short duration from which BI survivors can be
│    recovered shall also be run to demonstrate the adequacy of the
│    recovery technique for BIs exposed to EO gas. NOTE This short cycle
│    can also be used to demonstrate the relative resistance of Biological
│    Indicator, PCD and product bioburden. b) Cycle calculation appr
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 07 [MED ] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    - ﻿ ISO 11135:2014+A1:2018 3.8 D value D10 value time or dose
│    required to achieve inactivation of 90 % of a population of the test
│    microorganism under stated conditions [SOURCE: ISO/TS 11139:2006,
│    definition 2.11] Note 1 to entry: For the purposes of this
│    International Standard, the D value is the exposure time required to
│    achieve 90 % inactivation of the population of the test organism. 3.9
│    development act of elaborating a specification [SOURCE: ISO/TS
│    11139:2006, definition 2.13] 3.10 dew point The temperature at which
│    the saturation water vapour pressure is equal to the partial pressure
│    of the water
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 08 [MED ] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    hich the ethylene oxide is removed from the load and chamber by
│    either multiple alternate admissions of filtered air, inert gas or
│    steam and evacuations of the chamber or continuous passage of
│    filtered air, inert gas or steam through the load and chamber 3.16
│    fractional cycle a cycle in which the exposure time to EO gas is
│    reduced compared to that specified in the sterilization process ﻿ 4
│    © ISO 2014 – All rights reserved BS EN ISO 11135:2014+A1:2019 ---
│    PAGE 27 --- ﻿ ISO 11135:2014+A1:2018 3.17 half cycle a cycle in which
│    the exposure time to EO gas is reduced by 50 % compared to that
│    specified in th
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 09 [MED ] [NUMERICAL] ──────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    e load and chamber 3.16 fractional cycle a cycle in which the
│    exposure time to EO gas is reduced compared to that specified in the
│    sterilization process ﻿ 4 © ISO 2014 – All rights reserved BS EN ISO
│    11135:2014+A1:2019 --- PAGE 27 --- ﻿ ISO 11135:2014+A1:2018 3.17 half
│    cycle a cycle in which the exposure time to EO gas is reduced by 50 %
│    compared to that specified in the sterilization process 3.18 health
│    care facility HCF governmental and private organizations and
│    institutions devoted to the promotion and maintenance of health, and
│    the prevention and treatment of diseases and injuries EXAMPLE A healt
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 10 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    2018 a) preconditioning (if used); b) the sterilization cycle; c)
│    aeration (if used). 6.2.3 The process variables for preconditioning
│    (if used) include at a minimum: a) time; b) temperature; c) humidity;
│    d) transfer time. 6.2.4 The process variables for the sterilization
│    cycle include: a) exposure time; b) temperature; c) humidity; d) EO
│    concentration; e) pressure. 6.2.5 The process variables for aeration
│    (if used) include at a minimum: a) time; b) temperature. NOTE In
│    aeration these parameters are considered process variables only if
│    aeration is considered to contribute to ensuring the
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 11 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ry measure is only to confirm admission of EO to the chamber by at
│    least one of the following: 1) the mass of EO used (see D.10.2 i); 2)
│    the direct measurement of the concentration of EO in the sterilizer
│    chamber; 3) volume of EO used; j) EO-injection time k) inert gas
│    injection, if used; l) exposure time; m) time taken to evacuate the
│    chamber; n) time and pressure changes during post exposure flushing;
│    o) time, temperature, pressure changes (if any) during aeration. 10.3
│    If biological indicators are used in routine monitoring, they shall
│    comply with 8.6 and 8.7. If the PCD that is used for rout
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 12 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    roughout the sterilization cycle; b) chamber humidity during
│    conditioning as determined by direct measurement; c) the EO
│    concentration, determined from direct analysis of chamber atmosphere
│    using analytical methods at defined intervals sufficient to verify
│    the required conditions throughout the exposure time. 11 Product
│    release from sterilization 11.1 The criteria for designating
│    conformance of the sterilization process used for a particular
│    sterilization load shall be documented. The criteria shall include:
│    a) confirmation that the data recorded during routine processing meet
│    the sterilization proc
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 13 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    iological indicator/bioburden approach A.1 General A.1.1 This
│    approach combines knowledge of the resistance of a biological
│    indicator to a given sterilization process with knowledge of the
│    bioburden population and resistance to establish the sterilization
│    process parameters (sterilization cycle exposure time). Use of the
│    method requires that product bioburden levels shall be demonstrated
│    to be relatively consistent over time and the resistance of the
│    bioburden be shown to be equal to, or less resistant than the
│    resistance of the biological indicator (see D.8.6). The resistance of
│    the internal PCD is
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 14 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ) of attainment of specified pressure on admission of EO and
│    correlation of methods used to monitor EO concentration; 2) pressure,
│    pressure rise (∆P) and rate (∆P/time) of attainment of specified
│    pressure on admission of any inert gasses (if used); f) maintenance
│    of specified conditions for the exposure time: 1) pressure
│    differential used to apply sterilant or inert gas make-ups (if used);
│    2) chamber temperature; g) EO removal: 1) depth (ΔP or terminal
│    pressure) and rate (ΔP/time) of attainment of vacuum to remove EO; h)
│    flushing (if used): 1) pressure rise and rate of attainment of
│    pressure; 2)
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 15 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    chambers that simulate the specified process and can range from a
│    simple visual inspection to a battery of specialized tests. Elements
│    that could affect safety, quality or performance include: a) cycle
│    pressure changes that could affect the sterile barrier system seal
│    integrity; b) effects of EO exposure time, temperature, humidity and,
│    if applicable, any diluent gases present in the intended
│    sterilization mixture; c) inclusion of new materials known to retain
│    higher EO residuals; d) packaging characteristics; e) the presence of
│    lubricants, especially within mated surface areas; f) whether the
│    medi
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 16 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    in a less difficult-to-sterilize configuration presenting a greater
│    lethality challenge than an internal PCD in a more
│    difficult-to-sterilize configuration. It is theorized that this
│    occurs because the EO is removed more rapidly from the external PCD
│    than the internal PCD, resulting in less gas exposure time to the
│    microbiological challenge. D.8.7 No guidance offered. D.8.8 No
│    guidance offered. D.8.9 No guidance offered. D.9 Validation D.9.1
│    General D.9.1.1 The object of validation is to document the evidence
│    required to provide a high degree of assurance that a specific
│    process will consistentl
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 17 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    red ﻿ 52 © ISO 2014 – All rights reserved BS EN ISO
│    11135:2014+A1:2019 --- PAGE 75 --- ﻿ ISO 11135:2014+A1:2018 D.9.4.2
│    Performance qualification — Microbiological D.9.4.2.1 Results
│    obtained during process definition and, where applicable, IQ and OQ
│    should be used to set the parameters for MPQ. Exposure time is the
│    key parameter that is varied during microbiological qualification.
│    Other parameters can be adjusted as necessary to provide assurance
│    that the MPQ delivers less lethality than the normal production
│    process. For example, temperature, humidity, and/or EO concentrations
│    could be run at set p
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 18 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ted in the most inaccessible portion of the product. See D.7.1.6 for
│    information on the development of PCDs and D.8.6 for information on
│    determining the appropriateness of the internal PCD, placed within
│    the sterile barrier system of the product. The parameters that
│    primarily affect lethality are exposure time, EO concentration,
│    humidity and temperature. If an adjustment of parameters other than
│    exposure time is made, the overall effect to the cycle should be
│    evaluated since the adjustment might not achieve the desired result
│    because the parameters are interrelated. For example, the result of
│    decreasi
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 19 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    f PCDs and D.8.6 for information on determining the appropriateness
│    of the internal PCD, placed within the sterile barrier system of the
│    product. The parameters that primarily affect lethality are exposure
│    time, EO concentration, humidity and temperature. If an adjustment of
│    parameters other than exposure time is made, the overall effect to
│    the cycle should be evaluated since the adjustment might not achieve
│    the desired result because the parameters are interrelated. For
│    example, the result of decreasing temperature would actually increase
│    the EO concentration and the relative humidity if no change is
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 20 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    methods are commonly used in this approach. Half cycle approach: Due
│    to its relative ease of use and the conservative SAL obtained,
│    medical device manufacturers and health care facilities commonly use
│    this method which is to demonstrate total inactivation of the 106
│    challenge BIs at a half-cycle exposure time. When this exposure time
│    is doubled, a minimum 12 SLR is delivered during EO exposure. This
│    approach will lead to a process delivering considerably more than 12
│    SLR. Cycle Calculation: This method consists of exposing internal
│    PCDs to the experimental cycle, removing the challenge and testing fo
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 21 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    d in this approach. Half cycle approach: Due to its relative ease of
│    use and the conservative SAL obtained, medical device manufacturers
│    and health care facilities commonly use this method which is to
│    demonstrate total inactivation of the 106 challenge BIs at a
│    half-cycle exposure time. When this exposure time is doubled, a
│    minimum 12 SLR is delivered during EO exposure. This approach will
│    lead to a process delivering considerably more than 12 SLR. Cycle
│    Calculation: This method consists of exposing internal PCDs to the
│    experimental cycle, removing the challenge and testing for survivors.
│    This testing
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 22 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ion period for biological indicators is provided in ISO 14161:2009,
│    12.3. D.14.1.4 [B.1.4] The appropriateness of the BI relative to the
│    bioburden inactivation time can be demonstrated by a test of
│    sterility, either before or during process definition using a
│    fractional-cycle of the appropriate exposure time. D.14.2 [B.2]
│    Procedure D.14.2.1 [B.2.1] Internal PCDs placed within the product
│    sterile barrier system can be used for this method. If used, they
│    should provide at least as great a challenge to sterilization process
│    as the product they represent. The challenge of the internal PCD to
│    the sterili
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 23 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ze location on the product. D.14.2.3 [B.2.3] No guidance offered
│    D.14.2.4 [B.2.4] Obtaining microbial enumeration data or fractional
│    kill data requires exposing the microbial challenge to less lethality
│    than is present in the normal production cycle. This is usually
│    accomplished by reducing the exposure time while holding all other
│    parameters either constant at ﻿ 72 © ISO 2014 – All rights reserved
│    BS EN ISO 11135:2014+A1:2019 --- PAGE 95 --- ﻿ ISO 11135:2014+A1:2018
│    nominal conditions, or at selected minimum acceptable processing
│    conditions. Utilizing the allowed minimum process temperature for th
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 24 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    nal conditions, or at selected minimum acceptable processing
│    conditions. Utilizing the allowed minimum process temperature for the
│    enumeration study ensures the required lethality is obtained when
│    operating within the specified temperature range. The parameters that
│    primarily affect lethality are exposure time, EO concentration,
│    humidity, and temperature. If an adjustment of parameters other than
│    exposure time is made, the overall effect to the cycle should be
│    evaluated since the adjustment might not achieve the desired result
│    because the parameters are interrelated. For example, the result of
│    decreas
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 25 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    process temperature for the enumeration study ensures the required
│    lethality is obtained when operating within the specified temperature
│    range. The parameters that primarily affect lethality are exposure
│    time, EO concentration, humidity, and temperature. If an adjustment
│    of parameters other than exposure time is made, the overall effect to
│    the cycle should be evaluated since the adjustment might not achieve
│    the desired result because the parameters are interrelated. For
│    example, the result of decreasing temperature would actually increase
│    EO concentration and relative humidity if no change is made to
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 26 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: exposure time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    s are most difficult to achieve. It is recommended to use the number
│    of internal PCDs, temperature sensors, and humidity sensors as
│    detailed in Table C.1, Table C.2, for PQ and Table C.3 for MPQ.
│    E.2.12 Process the same load by exposing it to the defined
│    sterilization process where the specified exposure time is at least
│    double that of the half cycle in E.2.7 (i.e. a full sterilization
│    cycle) in the same sterilization chamber. E.2.13 Remove internal PCDs
│    and test biological indicators in accordance with manufacturer’s
│    instructions according to ISO 11138‑7. E.2.14 Other test samples
│    should also be re
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 27 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: dwell time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ould be given to the possibility of excessive condensation in product
│    and packaging. b) Residues of EO and its reaction products can be
│    hazardous. It is essential for the manufacturer of the product to be
│    sterilized to be aware of the possible occurrence of residues in the
│    product. Temperature, dwell time, forced heated air circulation, load
│    characteristics, product and packaging ﻿ © ISO 2014 – All rights
│    reserved 35 BS EN ISO 11135:2014+A1:2019 --- PAGE 58 --- ﻿ ISO
│    11135:2014+A1:2018 materials all affect the efficiency of aeration,
│    and the set points and tolerances should be taken into account
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 28 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: cycle time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    eloped in a lethality study for the BI can be used to demonstrate the
│    effectiveness of the process for the product. If the data are
│    generated using an enumeration method, then the SLR can also be
│    predicted from the survivor curve data that are generated. The user
│    should be aware that the minimum cycle time derived from this
│    approach is not, by itself, adequate to validate the sterilization
│    process. Demonstration of the ability to maintain process parameters
│    within defined limits during the proposed full cycle is necessary. If
│    the product bioburden is tested at frequent intervals and is
│    consistent,
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 29 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: cycle time
│  Relevance Score: 2.5/5.0
│
│  Context:
│    ach use many of the same procedures, some of the text in this annex
│    duplicates text in D.13. However, when using the cycle calculation
│    approach, see also D.13.1.1. For further information regarding the
│    use of the overkill approach see ISO 14161:2009, 7.2. The user should
│    be aware that the minimum cycle time derived from this approach is
│    not, by itself, adequate to validate the sterilization process.
│    Demonstration of the ability to maintain process parameters within
│    defined limits during the proposed full cycle is necessary. ﻿ © ISO
│    2014 – All rights reserved 71 BS EN ISO 11135:2014+A1:2019 --- PAG
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 30 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: duration
│  Relevance Score: 2.5/5.0
│
│  Context:
│    studies undertaken in the test or prototype equipment. For the
│    purposes of this International Standard, the sterilizing agent is EO.
│    5.2 Sterilizing agent The sterilizing agent specification shall
│    include, if appropriate, conditions of storage to maintain the EO
│    within its specification for the duration of the stated shelf life. ﻿
│    © ISO 2014 – All rights reserved 11 BS EN ISO 11135:2014+A1:2019 ---
│    PAGE 34 --- ﻿ ISO 11135:2014+A1:2018 5.3 Microbicidal effectiveness
│    Microbicidal effectiveness data shall be developed if it is proposed
│    to use the EO outside of the range of compositions that are w
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 31 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: duration
│  Relevance Score: 2.5/5.0
│
│  Context:
│    nnex A) is used, there may be some surviving internal PCDs, but the
│    calculated SAL shall meet the specified value (See ISO 14161). 9.4.3
│    Performance qualification — Physical 9.4.3.1 Physical PQ (PPQ) shall
│    demonstrate a) that the specified acceptance criteria are met
│    throughout the load for the duration of the proposed routine process
│    specification, and b) reproducibility of the process. The PPQ shall
│    include a minimum of three planned qualification cycles, consecutive
│    in the same study, in which all the specified acceptance criteria are
│    met. PPQ may be conducted during the MPQ. If PPQ is perf
│
└───────────────────────────────────────────────────────────────────────────────

┌─ PARAMETER 32 [MED ]  ─────────────────────────────────────────────────
│
│  Keyword: duration
│  Relevance Score: 2.5/5.0
│
│  Context:
│    l endotoxin test, as appropriate. The number of samples selected for
│    the product test of sterility shall be not less than that used for
│    bioburden determination. If comparative resistance of the internal
│    PCD versus product bioburden has previously been assessed using a
│    fractional cycle of shorter duration than that of the half cycle in
│    E.2.7, there have been no positive test results from the product test
│    of sterility samples and the bioburden testing demonstrates
│    comparable results (numbers and types), then it is not necessary to
│    perform the product test of sterility for product test samples expo
│
└───────────────────────────────────────────────────────────────────────────────

